<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id>
<journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id>
<journal-id journal-id-type="publisher-id">ijms</journal-id>
<journal-title-group>
<journal-title>International Journal of Molecular Sciences</journal-title>
</journal-title-group>
<issn pub-type="epub">1422-0067</issn>
<publisher>
<publisher-name>MDPI</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27983596</article-id>
<article-id pub-id-type="pmc">5187886</article-id>
<article-id pub-id-type="doi">10.3390/ijms17122086</article-id>
<article-id pub-id-type="publisher-id">ijms-17-02086</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Estrogenic Endocrine Disrupting Chemicals Influencing NRF1 Regulated Gene Networks in the Development of Complex Human Brain Diseases</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Preciados</surname>
<given-names>Mark</given-names>
</name>
<xref ref-type="aff" rid="af1-ijms-17-02086">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yoo</surname>
<given-names>Changwon</given-names>
</name>
<xref ref-type="aff" rid="af2-ijms-17-02086">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Roy</surname>
<given-names>Deodutta</given-names>
</name>
<xref ref-type="aff" rid="af1-ijms-17-02086">1</xref>
<xref ref-type="corresp" rid="c1-ijms-17-02086">*</xref>
</contrib>
</contrib-group>
<contrib-group>
<contrib contrib-type="editor">
<name>
<surname>Tchounwou</surname>
<given-names>Paul B.</given-names>
</name>
<role>Academic Editor</role>
</contrib>
</contrib-group>
<aff id="af1-ijms-17-02086"><label>1</label>Department of Environmental &amp; Occupational Health, Florida International University, Miami, FL 33199, USA; <email>mprec001@fiu.edu</email></aff>
<aff id="af2-ijms-17-02086"><label>2</label>Department of Biostatistics, Florida International University, Miami, FL 33199, USA; <email>cyoo@fiu.edu</email></aff>
<author-notes>
<corresp id="c1-ijms-17-02086"><label>*</label>Correspondence: <email>droy@fiu.edu</email>; Tel.: +1-305-348-1694; Fax: +1-305-348-4901</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>13</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<month>12</month>
<year>2016</year>
</pub-date>
<volume>17</volume>
<issue>12</issue>
<elocation-id>2086</elocation-id>
<history>
<date date-type="received">
<day>25</day>
<month>10</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>11</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>© 2016 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement>
<copyright-year>2016</copyright-year>
<license>
<license-p><!--CREATIVE COMMONS-->This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<p>During the development of an individual from a single cell to prenatal stages to adolescence to adulthood and through the complete life span, humans are exposed to countless environmental and stochastic factors, including estrogenic endocrine disrupting chemicals. Brain cells and neural circuits are likely to be influenced by estrogenic endocrine disruptors (EEDs) because they strongly dependent on estrogens. In this review, we discuss both environmental, epidemiological, and experimental evidence on brain health with exposure to oral contraceptives, hormonal therapy, and EEDs such as bisphenol-A (BPA), polychlorinated biphenyls (PCBs), phthalates, and metalloestrogens, such as, arsenic, cadmium, and manganese. Also we discuss the brain health effects associated from exposure to EEDs including the promotion of neurodegeneration, protection against neurodegeneration, and involvement in various neurological deficits; changes in rearing behavior, locomotion, anxiety, learning difficulties, memory issues, and neuronal abnormalities. The effects of EEDs on the brain are varied during the entire life span and far-reaching with many different mechanisms. To understand endocrine disrupting chemicals mechanisms, we use bioinformatics, molecular, and epidemiologic approaches. Through those approaches, we learn how the effects of EEDs on the brain go beyond known mechanism to disrupt the circulatory and neural estrogen function and estrogen-mediated signaling. Effects on EEDs-modified estrogen and nuclear respiratory factor 1 (NRF1) signaling genes with exposure to natural estrogen, pharmacological estrogen-ethinyl estradiol, PCBs, phthalates, BPA, and metalloestrogens are presented here. Bioinformatics analysis of gene-EEDs interactions and brain disease associations identified hundreds of genes that were altered by exposure to estrogen, phthalate, PCBs, BPA or metalloestrogens. Many genes modified by EEDs are common targets of both 17 β-estradiol (E2) and NRF1. Some of these genes are involved with brain diseases, such as Alzheimer’s Disease (AD), Parkinson’s Disease, Huntington’s Disease, Amyotrophic Lateral Sclerosis, Autism Spectrum Disorder, and Brain Neoplasms. For example, the search of enriched pathways showed that top ten E2 interacting genes in AD—<italic>APOE</italic>, <italic>APP</italic>, <italic>ATP5A1</italic>, <italic>CALM1</italic>, <italic>CASP3</italic>, <italic>GSK3B</italic>, <italic>IL1B</italic>, <italic>MAPT</italic>, <italic>PSEN2</italic> and <italic>TNF—</italic>underlie the enrichment of the Kyoto Encyclopedia of Genes and Genomes (KEGG) AD pathway. With AD, the six E2-responsive genes are NRF1 target genes: <italic>APBB2</italic>, <italic>DPYSL2</italic>, <italic>EIF2S1</italic>, <italic>ENO1</italic>, <italic>MAPT</italic>, and <italic>PAXIP1</italic>. These genes are also responsive to the following EEDs: ethinyl estradiol (<italic>APBB2</italic>, <italic>DPYSL2</italic>, <italic>EIF2S1</italic>, <italic>ENO1</italic>, <italic>MAPT</italic>, and <italic>PAXIP1</italic>), BPA (<italic>APBB2</italic>, <italic>EIF2S1</italic>, <italic>ENO1</italic>, <italic>MAPT</italic>, and <italic>PAXIP1</italic>), dibutyl phthalate (DPYSL2, EIF2S1, and ENO1), diethylhexyl phthalate (<italic>DPYSL2</italic> and <italic>MAPT</italic>). To validate findings from Comparative Toxicogenomics Database (CTD) curated data, we used Bayesian network (BN) analysis on microarray data of AD patients. We observed that both gender and NRF1 were associated with AD. The female NRF1 gene network is completely different from male human AD patients. AD-associated NRF1 target genes—<italic>APLP1</italic>, <italic>APP</italic>, <italic>GRIN1</italic>, <italic>GRIN2B</italic>, <italic>MAPT</italic>, <italic>PSEN2</italic>, <italic>PEN2</italic>, and <italic>IDE</italic>—are also regulated by E2. NRF1 regulates targets genes with diverse functions, including cell growth, apoptosis/autophagy, mitochondrial biogenesis, genomic instability, neurogenesis, neuroplasticity, synaptogenesis, and senescence. By activating or repressing the genes involved in cell proliferation, growth suppression, DNA damage/repair, apoptosis/autophagy, angiogenesis, estrogen signaling, neurogenesis, synaptogenesis, and senescence, and inducing a wide range of DNA damage, genomic instability and DNA methylation and transcriptional repression, NRF1 may act as a major regulator of EEDs-induced brain health deficits. In summary, estrogenic endocrine disrupting chemicals-modified genes in brain health deficits are part of both estrogen and NRF1 signaling pathways. Our findings suggest that in addition to estrogen signaling, EEDs influencing NRF1 regulated communities of genes across genomic and epigenomic multiple networks may contribute in the development of complex chronic human brain health disorders.</p>
</abstract>
<kwd-group>
<kwd>estrogen</kwd>
<kwd>endocrine disrupting chemicals</kwd>
<kwd>nuclear respiratory factor 1 (NRF1)</kwd>
<kwd>brain health</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-ijms-17-02086">
<title>1. Introduction</title>
<p>Endocrine disruptors (EDs) are defined as exogenous substances or mixtures that alter functions of the endocrine system and consequently cause adverse health effects in an organism, its progeny, or populations [<xref ref-type="bibr" rid="B1-ijms-17-02086">1</xref>]. EDs encompass a plethora of chemicals: industrial chemicals, plastics, plasticizers, pesticides, fungicides, pharmaceutical agents, and natural chemicals found in human and animal foods [<xref ref-type="bibr" rid="B1-ijms-17-02086">1</xref>,<xref ref-type="bibr" rid="B2-ijms-17-02086">2</xref>,<xref ref-type="bibr" rid="B3-ijms-17-02086">3</xref>,<xref ref-type="bibr" rid="B4-ijms-17-02086">4</xref>]. EDs can be taken in the body through various routes of exposure: ingestion, inhalation, and dermal contact [<xref ref-type="bibr" rid="B1-ijms-17-02086">1</xref>,<xref ref-type="bibr" rid="B2-ijms-17-02086">2</xref>]. The main occurrence of EDs is in the environment through manufacturing and the production of e-waste. In addition to affecting the individual organism, EDs have been shown to affect children and subsequent generations [<xref ref-type="bibr" rid="B1-ijms-17-02086">1</xref>]. EDs affect all sensitive periods in a human lifetime: gestation, childhood, puberty, reproductive life, and old age [<xref ref-type="bibr" rid="B1-ijms-17-02086">1</xref>]. A subset of EDs, estrogenic endocrine disruptors (EEDs), specifically affect processes in the body that are influenced and modulated by the estrogen hormones and encompass the same chemical classes and routes of exposure as EEDs [<xref ref-type="bibr" rid="B1-ijms-17-02086">1</xref>,<xref ref-type="bibr" rid="B2-ijms-17-02086">2</xref>,<xref ref-type="bibr" rid="B3-ijms-17-02086">3</xref>,<xref ref-type="bibr" rid="B4-ijms-17-02086">4</xref>].</p>
<p>The human brain, a jelly-like mass of tissue weighing around 1.4 kg (3 pounds), is the most complex biological structure in the universe. Each individual brain originates from a single neural stem cell, which becomes approximately 100 billion neurons at birth. During some stage of the embryo’s development, 250,000 to 500,000 neurons per minute are produced. We also now know new brain cells are being generated throughout our lives—a process called neurogenesis. The brain has bursts of growth and then periods of consolidation, when excess connections are pruned. The most bursts are observed in the first two or three years of life, during puberty, and also a final burst in young adulthood. All these processes are strongly dependent on estrogens [<xref ref-type="bibr" rid="B5-ijms-17-02086">5</xref>]. How the brain ages or become susceptible to stressors depends on genes and the environment. Adult human brain contains around 86 billion neurons, and close to 85 billion glial cells, which are as important as neurons, that amplify neural signals. Each cell contains approximately 25–30,000 genes that code for proteins which perform most life functions. Both formation and function of a protein is controlled by inter-, intra-, and extra- cellular environment within a brain tissue of a human. With estrogen having an important role in brain development, there has been a strong interest in investigating effects of EEDs on brain because their effects on circulatory and neural estrogen functions have adverse effects on brain health. There is a general agreement that human populations are constantly exposed to a wide variety of EEDs. Brain cells and neural circuits are likely to be influenced by environmental stressors that includes EEDs, because they are strongly dependent on estrogens [<xref ref-type="bibr" rid="B6-ijms-17-02086">6</xref>]. For those reasons, the brain is very susceptible to the effects of EEDs during critical development periods. Findings from experimental models, clinical observations, and epidemiological studies converge to implicate exposure to EEDs as a significant brain health concern to children as well as adults, because certain EEDs are able to alter neurogenesis, neural transmission, and the formation of neural networks, thus implicating EEDs with an increase in neurological disorders, including autism, attention deficit and hyperactivity disorder as well as learning disabilities and aggressiveness [<xref ref-type="bibr" rid="B1-ijms-17-02086">1</xref>,<xref ref-type="bibr" rid="B6-ijms-17-02086">6</xref>]. EEDs have been implicated as one of the causes of neurodegenerative conditions and diseases [<xref ref-type="bibr" rid="B1-ijms-17-02086">1</xref>,<xref ref-type="bibr" rid="B6-ijms-17-02086">6</xref>,<xref ref-type="bibr" rid="B7-ijms-17-02086">7</xref>]. Research suggests maternal exposure to EEDs produce various neurological deficits: changes in rearing behavior, locomotion, anxiety, learning difficulties, memory issues, and neuronal abnormalities [<xref ref-type="bibr" rid="B1-ijms-17-02086">1</xref>,<xref ref-type="bibr" rid="B6-ijms-17-02086">6</xref>,<xref ref-type="bibr" rid="B7-ijms-17-02086">7</xref>].</p>
<p>There is emerging consensus that susceptibility to many of the complex and chronic brain diseases that individuals develop occur as a result of multiple interactions between biologically unique and inherited individual DNA sequence variation, epigenetic individuality, and genetic and epigenetic variation. Exposure to environmental and stochastic factors occur in both germ and somatic cells during intrauterine, postnatal, childhood, and adult life. Low DNA sequence variation across unrelated individuals and our closest related species are not sufficient enough to account for all major differences in physiological and chronic brain disease phenotypic outcomes. Nuclear respiratory factor 1 (NRF1) is one of the sequence-specific DNA-binding redox sensitive transcription factors that constitutes the most important and diverse gene-regulatory mechanism. Context specific NRF1 proteins binding to DNA response elements depends on the variation in DNA binding sequences and the local cell-dependent chromatin alterations, including histone modification, DNA methylation status, and accessibility of regulatory elements [<xref ref-type="bibr" rid="B8-ijms-17-02086">8</xref>]. Recently, Satoh et al. reported 2470 NRF1 target genes, including many estrogen signaling pathway genes, associated with neurodegenerative diseases [<xref ref-type="bibr" rid="B9-ijms-17-02086">9</xref>]. Both neurogenesis and synaptogenesis are controlled by NRF1 regulated genes. A strong association of NRF1 with human fetal brain and neural development has been recently reported [<xref ref-type="bibr" rid="B10-ijms-17-02086">10</xref>]. The effects of EEDs on the brain are varied during the entire life span and far-reaching with many different mechanisms. How a healthy brain responds to EED stressors may help to explain how these stressors disrupt brain cells to produce undesired lesion producing brain diseases. The recent advances in bioinformatics and molecular genetics have provided an opportunity to understand how genes, and genetic and epigenetic changes interact with environmental and stochastic stressors to either preserve health or cause disease [<xref ref-type="bibr" rid="B4-ijms-17-02086">4</xref>]. Keeping in mind the above concepts, first, we reviewed environmental epidemiologic and experimental evidence on brain health with exposure to endogenous estrogen, oral contraceptives, hormonal therapy and then EED compounds such as BPA, PCBs, phthalates, and metalloestrogens: arsenic, cadmium, and manganese. Using bioinformatics, molecular and epidemiologic approaches, we have attempted to review how these ubiquitous EEDs, which are known to disrupt the ovarian and local estrogen function, influence NRF1 transcription factor regulated gene networks, contribute in the development of complex chronic human brain health disorders.</p>
</sec>
<sec id="sec2-ijms-17-02086">
<title>2. Epidemiologic and Experimental Evidence of Brain Health Deficits with Exposure to Estrogenic Endocrine Disruptors (EEDs)</title>
<p><xref ref-type="table" rid="ijms-17-02086-t001">Table 1</xref>, <xref ref-type="table" rid="ijms-17-02086-t002">Table 2</xref> and <xref ref-type="table" rid="ijms-17-02086-t003">Table 3</xref> present epidemiologic and experimental evidence on brain health with exposure to endogenous estrogen, oral contraceptive, hormonal therapy and EED compounds, such as, BPA, PCBs, phthalates, and heavy metals-arsenic, cadmium, and manganese. We have succinctly described below effects of each estrogenic chemical on brain health.</p>
<sec id="sec2dot1-ijms-17-02086">
<title>2.1. Estrogens and Brain Health</title>
<p>Estrogen has a complex role in the body, and been tied to cardiovascular, metabolic, endocrine, reproductive, and neurodegenerative diseases, as well as roles in gene expression and protein synthesis [<xref ref-type="bibr" rid="B11-ijms-17-02086">11</xref>,<xref ref-type="bibr" rid="B12-ijms-17-02086">12</xref>]. Estrogen has been shown to have a role in sexual differentiation in the brain [<xref ref-type="bibr" rid="B12-ijms-17-02086">12</xref>], neuroprotection, and anti-inflammatory effects [<xref ref-type="bibr" rid="B13-ijms-17-02086">13</xref>,<xref ref-type="bibr" rid="B14-ijms-17-02086">14</xref>,<xref ref-type="bibr" rid="B15-ijms-17-02086">15</xref>,<xref ref-type="bibr" rid="B16-ijms-17-02086">16</xref>,<xref ref-type="bibr" rid="B17-ijms-17-02086">17</xref>,<xref ref-type="bibr" rid="B18-ijms-17-02086">18</xref>]. Studies also suggest estrogen plays a significant role in the modulation of neuroplasticity and synaptogenesis [<xref ref-type="bibr" rid="B19-ijms-17-02086">19</xref>,<xref ref-type="bibr" rid="B20-ijms-17-02086">20</xref>,<xref ref-type="bibr" rid="B21-ijms-17-02086">21</xref>,<xref ref-type="bibr" rid="B22-ijms-17-02086">22</xref>,<xref ref-type="bibr" rid="B23-ijms-17-02086">23</xref>,<xref ref-type="bibr" rid="B24-ijms-17-02086">24</xref>]. Estrogens have also been demonstrated to protect and regulate mitochondrial function in the brain [<xref ref-type="bibr" rid="B25-ijms-17-02086">25</xref>,<xref ref-type="bibr" rid="B26-ijms-17-02086">26</xref>,<xref ref-type="bibr" rid="B27-ijms-17-02086">27</xref>].</p>
<p>When assessing the effects of endogenous estrogens on brain health, we observed endogenous estrogen levels were quantified through blood and/or serum levels, or through the use of a surrogate of exposure to estrogen. The surrogates take into account the times at which the human female body is exposed in a lifetime, from the start of menarche to the end of menopause. We examined studies that took into account exogenous estrogen use through either controlling it as a confounder, or using it as an exclusionary criterion, since exogenous estrogen can modify the effects of endogenous estrogens.</p>
<p>Our review identified cross-sectional epidemiological studies that assessed the effects of endogenous estrogen on brain health [<xref ref-type="bibr" rid="B28-ijms-17-02086">28</xref>,<xref ref-type="bibr" rid="B29-ijms-17-02086">29</xref>,<xref ref-type="bibr" rid="B30-ijms-17-02086">30</xref>,<xref ref-type="bibr" rid="B31-ijms-17-02086">31</xref>,<xref ref-type="bibr" rid="B32-ijms-17-02086">32</xref>]. Four of the studies examined the relationship between endogenous estrogen and memory performance [<xref ref-type="bibr" rid="B28-ijms-17-02086">28</xref>,<xref ref-type="bibr" rid="B30-ijms-17-02086">30</xref>,<xref ref-type="bibr" rid="B31-ijms-17-02086">31</xref>,<xref ref-type="bibr" rid="B32-ijms-17-02086">32</xref>] and one study examined the relationship between age of Parkinson’s disease (PD) onset and exposure to endogenous estrogen [<xref ref-type="bibr" rid="B29-ijms-17-02086">29</xref>]. One study examined the effects of endogenous estrogens in males [<xref ref-type="bibr" rid="B32-ijms-17-02086">32</xref>], and the other four studies examined the effects on females [<xref ref-type="bibr" rid="B28-ijms-17-02086">28</xref>,<xref ref-type="bibr" rid="B29-ijms-17-02086">29</xref>,<xref ref-type="bibr" rid="B30-ijms-17-02086">30</xref>,<xref ref-type="bibr" rid="B31-ijms-17-02086">31</xref>].</p>
<p>A study of 393 postmenopausal women did not find any significant associations between endogenous estradiol levels and neuropsychological test performance [<xref ref-type="bibr" rid="B28-ijms-17-02086">28</xref>]. Another study did not find any significant associations between reproductive time as a surrogate of endogenous estrogen exposure and performance on cognitive and memory tests in a cross-sectional study of 760 postmenopausal women [<xref ref-type="bibr" rid="B31-ijms-17-02086">31</xref>]. However, a study by Heys et al., found significant associations between proxies of endogenous estrogen exposure and cognitive delayed recall scores (<italic>p</italic>-value = 0.001, 95% CI, 0.008–0.02) and the mini-mental state exam scores (<italic>p</italic>-value &lt; 0.001, 95% CI, 0.004–0.007) in a cross-sectional study of 11,094 postmenopausal women [<xref ref-type="bibr" rid="B30-ijms-17-02086">30</xref>]. In a cross-sectional study of 181 older men, examining the effects of endogenous estrogen exposure from serum levels and verbal memory assessment scores in men, higher total levels of estradiol were associated with better performance (β = 0.17, <italic>p</italic>-value &lt; 0.02) [<xref ref-type="bibr" rid="B32-ijms-17-02086">32</xref>]. Cereda et al., found that age of PD onset was positively associated with the duration of exposure to endogenous estrogens using reproductive surrogates of endogenous estrogen exposure (7.10, [3.31], <italic>p</italic>-value = 0.032) in a cross-sectional study of 579 females [<xref ref-type="bibr" rid="B29-ijms-17-02086">29</xref>].</p>
<p>We identified case-control studies that assessed the effects of endogenous estrogen exposure on brain health [<xref ref-type="bibr" rid="B33-ijms-17-02086">33</xref>,<xref ref-type="bibr" rid="B34-ijms-17-02086">34</xref>], with one study assessing endogenous estrogen exposure and Alzheimer’s disease (AD) risk using serum estrogen levels [<xref ref-type="bibr" rid="B33-ijms-17-02086">33</xref>] and one study assessing amyotrophic lateral sclerosis (ALS) risk using a lifetime estrogen exposure surrogate [<xref ref-type="bibr" rid="B34-ijms-17-02086">34</xref>]. In a case-control study of 50 AD cases and 93 controls, Manly et al., found women with the lowest endogenous estradiol levels were 4 times as likely to have AD compared to women with the highest estradiol levels (OR = 4.2, 95% CI 1.1–15.6) [<xref ref-type="bibr" rid="B33-ijms-17-02086">33</xref>]. In another case-control study of 131 ALS cases and 430 age-matched controls, De Jong et al. found longer reproductive time-span decrease ALS risk (OR = 0.95, 95% CI 0.91–0.98) and longer endogenous estrogen exposure decreases ALS risk (OR = 0.95, 95% CI 0.89–1.01) [<xref ref-type="bibr" rid="B34-ijms-17-02086">34</xref>].</p>
<p>We identified cohort studies that assessed the effects of endogenous estrogen exposure on brain health [<xref ref-type="bibr" rid="B35-ijms-17-02086">35</xref>,<xref ref-type="bibr" rid="B36-ijms-17-02086">36</xref>,<xref ref-type="bibr" rid="B37-ijms-17-02086">37</xref>]. One study assessed dementia risk and the length of the reproductive period as a surrogate for endogenous estrogen exposure [<xref ref-type="bibr" rid="B35-ijms-17-02086">35</xref>], and two studies assessed AD risk, one using bioavailable estrogen levels [<xref ref-type="bibr" rid="B36-ijms-17-02086">36</xref>], and one using a surrogate measure of endogenous estrogen exposure [<xref ref-type="bibr" rid="B37-ijms-17-02086">37</xref>]. Geerlings et al. found after adjusting for covariates, women with longer reproductive spans had an increased risk of dementia compared to women with the shortest reproductive spans (RR = 1.78, 95% CI 1.12–2.84) and an increased risk of AD (RR = 1.51, 95% CI 0.91–2.50) in a cohort of 3601 postmenopausal women [<xref ref-type="bibr" rid="B35-ijms-17-02086">35</xref>]. The risk was more pronounced in carriers of the APOE allele [<xref ref-type="bibr" rid="B35-ijms-17-02086">35</xref>]. In a cohort study of 119 women with Down’s syndrome, Schupf et al. found women with low bioavailable estrogen were more likely to develop AD (HR = 4.1, 95% CI 1.2–13.9) [<xref ref-type="bibr" rid="B36-ijms-17-02086">36</xref>]. In another cohort study of 133 postmenopausal females, Fox et al. found longer duration of months with endogenous estrogen exposure may have a protective effect against AD risk (<italic>p</italic>-value = 0.0235, 96% CI 0.9907–0.9993) [<xref ref-type="bibr" rid="B37-ijms-17-02086">37</xref>]. The effect is more pronounced when subjects were over the total median number of months (<italic>p</italic>-value = 0.00754, 96% CI 0.004118–0.005289) [<xref ref-type="bibr" rid="B37-ijms-17-02086">37</xref>].</p>
</sec>
<sec id="sec2dot2-ijms-17-02086">
<title>2.2. Oral Contraceptives and Brain Health</title>
<p>Oral contraceptives (OC) containing specifically ethinyl estradiol has been shown to reduce the amount of available endogenous estrogen in the body [<xref ref-type="bibr" rid="B38-ijms-17-02086">38</xref>]. OCs has varying effects brain structure, function, and cognition [<xref ref-type="bibr" rid="B39-ijms-17-02086">39</xref>]. Most recent studies have shown varying effects, However, most recent studies do not differentiate between the various types of contraceptives, making it difficult to find out, if, the contraceptives used contained ethinyl estradiol and inconsistencies are found in the reporting of the type of OC used [<xref ref-type="bibr" rid="B40-ijms-17-02086">40</xref>].</p>
<p>A cross-sectional study examined OC effects on spatial and verbal abilities found OC users to perform better on some cognitive test, but not others and between homogenous groups of specific OC medications [<xref ref-type="bibr" rid="B40-ijms-17-02086">40</xref>]. Another cross-sectional study by Egan and Gleason found OC users to have better performance on cognitive exams compared to non-users [<xref ref-type="bibr" rid="B41-ijms-17-02086">41</xref>]. Griksiene and Ruksenas found OC to negatively affect cognition [<xref ref-type="bibr" rid="B38-ijms-17-02086">38</xref>]. A review by Warren et al., suggest an overall positive effect with OC use and verbal memory [<xref ref-type="bibr" rid="B42-ijms-17-02086">42</xref>].</p>
</sec>
<sec id="sec2dot3-ijms-17-02086">
<title>2.3. Hormonal Replacement Therapy and Brain Health</title>
<p>Hormone replacement therapy (HRT) has been shown to be associated with the onset of neurodegenerative disease, although evidence points to a timeframe dependent response, depending on when the therapy is initiated. As summarized in Maki and Henderson, initial observation studies and analyses with women indicated the use of HRT containing estrogen to be associated with a reduced risk of AD [<xref ref-type="bibr" rid="B43-ijms-17-02086">43</xref>]. Studies suggest that the timing of HRT during parts of the menopausal stage may dictate whether beneficial adverse effects are observed [<xref ref-type="bibr" rid="B44-ijms-17-02086">44</xref>].</p>
<p>Several analytical studies, however, showed associations between the use of HRT and neurodegenerative disease. In the Women’s Health Initiative Memory Study (WHIMS), a randomized, double-blind, placebo-controlled clinical trial, it was found that an HRT treatment of estrogen plus progestin increased the risk for dementia in postmenopausal women and did not prevent cognitive impairment [<xref ref-type="bibr" rid="B45-ijms-17-02086">45</xref>]. In another study from the same trial, it was found that estrogen-only HRT did not reduce the incidence of dementia, or cognitive impairment, and increased the risk for both [<xref ref-type="bibr" rid="B46-ijms-17-02086">46</xref>].</p>
<p>An ancillary to the WHIMS study, the Women’s Health Initiative Study of Cognitive Aging, or WHISCA, further supports HRT’s association with neurodegenerative disease [<xref ref-type="bibr" rid="B47-ijms-17-02086">47</xref>], however, results varied. One finding from Resnick et al. (2006), from the WHISCA study found that a combination of conjugated equine estrogen with medroxyprogesterone acetate (estrogen + progestin) appeared to negatively impact verbal memory, but positively affect figural memory among postmenopausal women, free of probable dementia, and compared to controls [<xref ref-type="bibr" rid="B47-ijms-17-02086">47</xref>]. Another finding from Resnick et al. (2009), showed estrogen alone, as conjugated equine estrogen, did not improve cognitive functioning and lowered certain cognitive functions in women with prior hysterectomy [<xref ref-type="bibr" rid="B48-ijms-17-02086">48</xref>]. Other studies have indicated that no visible improvement has been observed in using estrogen only treatments for cognitive function [<xref ref-type="bibr" rid="B49-ijms-17-02086">49</xref>,<xref ref-type="bibr" rid="B50-ijms-17-02086">50</xref>,<xref ref-type="bibr" rid="B51-ijms-17-02086">51</xref>,<xref ref-type="bibr" rid="B52-ijms-17-02086">52</xref>]. Other studies that administered estrogen only treatments to younger surgically menopausal women have shown benefits to memory [<xref ref-type="bibr" rid="B53-ijms-17-02086">53</xref>,<xref ref-type="bibr" rid="B54-ijms-17-02086">54</xref>], which may show an age-related effect of estrogen only treatments.</p>
<p>New studies and reviews give mixed results. A newer observational study conducted by Shao et al. (2012), showed increased AD risk amongst women who used HRT more than five years after menopause, but observed a decreased risk of AD if used within five years of menopause [<xref ref-type="bibr" rid="B55-ijms-17-02086">55</xref>]. Another recent meta-analysis showed no observable associated between postmenopausal HRT use and AD or dementia [<xref ref-type="bibr" rid="B56-ijms-17-02086">56</xref>]. While another study found that an increased risk in the type of hormonal therapy used and PD risk [<xref ref-type="bibr" rid="B57-ijms-17-02086">57</xref>]. At least one study has examined the relationship between HRT use and brain cancer, where a positive association between HRT use and the diagnosis of meningioma was observed [<xref ref-type="bibr" rid="B58-ijms-17-02086">58</xref>]. In summary, to date, most of the neuroprotective actions of E2 against AD are based on animal models. While animal studies support a beneficial role for E2 in AD, there has been little success in translating this preclinical work to treat AD with estrogens. This may be as a result of species and sex differences, and brain complexity. HRT and anti-estrogen therapy (raloxifene) in AD are focused on circulating estrogens, as measured by blood levels, not based on brain estrogen levels. This is one of the main reasons why endocrine therapies (HRT and anti-estrogen therapy) are unable to produce a significant beneficial effect in human AD [<xref ref-type="bibr" rid="B59-ijms-17-02086">59</xref>]. Also there are negative effects of E2-based therapies, such increased risk of cancer and loss of gray matter in certain regions of brain in older women. </p>
</sec>
<sec id="sec2dot4-ijms-17-02086">
<title>2.4. Bisphenol A and Brain Health</title>
<p>BPA, an EED, is widely used to make polycarbonate plastics and resin [<xref ref-type="bibr" rid="B4-ijms-17-02086">4</xref>,<xref ref-type="bibr" rid="B60-ijms-17-02086">60</xref>]. BPA can be found in many consumer products that contain plastics [<xref ref-type="bibr" rid="B60-ijms-17-02086">60</xref>]. These include water and baby bottles, compact discs, impact-resistant safety equipment, medical devices, food cans, bottle tops, water supply pipes, ATM receipts, dental sealants and composites [<xref ref-type="bibr" rid="B60-ijms-17-02086">60</xref>]. Inhalation, ingestion, and dermal contact are all routes of exposures for BPA [<xref ref-type="bibr" rid="B60-ijms-17-02086">60</xref>]. Additionally, food containers made with BPA can cause BPA to leech into foods and is expedited by the use of high heat [<xref ref-type="bibr" rid="B60-ijms-17-02086">60</xref>]. It is of note that during the 2003–2004 NHANES cycle, BPA was detected in 93% of urine samples from people 6 years of age and older [<xref ref-type="bibr" rid="B61-ijms-17-02086">61</xref>]. BPA has also been demonstrated to show effects at all stages from prenatal to old age [<xref ref-type="bibr" rid="B62-ijms-17-02086">62</xref>]. There is evidence to suggest BPA is released from plastic bottles used to store beverages consumed by consumers, with BPA migration increasing with exposure to heat [<xref ref-type="bibr" rid="B63-ijms-17-02086">63</xref>]. Animal studies have indicated the ability BPA to penetrate the blood brain barrier due to its lipophilic nature [<xref ref-type="bibr" rid="B64-ijms-17-02086">64</xref>,<xref ref-type="bibr" rid="B65-ijms-17-02086">65</xref>].</p>
<p>Numerous studies highlight the link between BPA and neurotoxicity. Synaptogenesis, the formation of synapses between neurons [<xref ref-type="bibr" rid="B66-ijms-17-02086">66</xref>], and neurogenesis, the formation of new neurons [<xref ref-type="bibr" rid="B67-ijms-17-02086">67</xref>], are processes by which the brain can regenerate itself from damage due to trauma and disease. Several animal studies have BPA to significantly affect these processes. Decreased synaptic spinal density and adverse synaptic structures were observed in both male and female species of animals which include rodents [<xref ref-type="bibr" rid="B68-ijms-17-02086">68</xref>,<xref ref-type="bibr" rid="B69-ijms-17-02086">69</xref>,<xref ref-type="bibr" rid="B70-ijms-17-02086">70</xref>,<xref ref-type="bibr" rid="B71-ijms-17-02086">71</xref>,<xref ref-type="bibr" rid="B72-ijms-17-02086">72</xref>,<xref ref-type="bibr" rid="B73-ijms-17-02086">73</xref>] and primates [<xref ref-type="bibr" rid="B74-ijms-17-02086">74</xref>]. Postnatal exposure to BPA was also shown to affect synaptic spinal density and structure in a rodent study [<xref ref-type="bibr" rid="B71-ijms-17-02086">71</xref>]. BPA exposure was also shown to decrease neurogenesis in the hippocampus of postnatal female rats whose mothers were exposed to BPA [<xref ref-type="bibr" rid="B75-ijms-17-02086">75</xref>] as well as young adult mice [<xref ref-type="bibr" rid="B76-ijms-17-02086">76</xref>]. Recently, it has been shown that both BPA and bisphenol S (BPS), a replacement used in BPA-free products, at a very low dose, equally affects neurodevelopment by altering neurogenesis [<xref ref-type="bibr" rid="B77-ijms-17-02086">77</xref>]. Some studies have indicated BPA has a neuroprotective effect on brain cells. In a study using an immortalized clonal mouse hippocampal cell line (HT-22), BPA was found to protect against glutamate and β amyloid protein induced cell death [<xref ref-type="bibr" rid="B78-ijms-17-02086">78</xref>]. Some studies have also indicated that BPA has no effect on neurotoxicity. In a study examining dietary exposure to F1 rat offspring, BPA was shown to have no effect on offspring neurological development and motor activity [<xref ref-type="bibr" rid="B79-ijms-17-02086">79</xref>].</p>
<p>BPA has been found to cause hyperactivity in rats, compared to its derivatives, possibly due to the longer-lasting effect of the parent compound in the brain [<xref ref-type="bibr" rid="B80-ijms-17-02086">80</xref>]. A single dose of BPA administered to neonatal mice was observed to affect cognitive function and alter adult spontaneous behavior, with the effect being seen in mid and high dosed mice [<xref ref-type="bibr" rid="B81-ijms-17-02086">81</xref>]. In utero exposure to BPA in mice was shown to reduce dendritic spine densities in the hippocampal CA1 region, regardless of its dose [<xref ref-type="bibr" rid="B82-ijms-17-02086">82</xref>]. BPA was demonstrated to impair neural ectoderm specification and neural progenitor cells in mouse embryonic stem cells [<xref ref-type="bibr" rid="B83-ijms-17-02086">83</xref>]. In a study using <italic>Caenorhabditis elegans</italic> to examine early embryogenesis exposure to BPA and BPS into adulthood, it was shown that changes in behavior and learning were followed into adulthood [<xref ref-type="bibr" rid="B84-ijms-17-02086">84</xref>]. BPA was shown to decrease the proliferation of multipotent neural progenitor cells and produce cytotoxicity in F1 mice, and in low-doses stimulated neuronal differentiation which might disrupt brain development [<xref ref-type="bibr" rid="B85-ijms-17-02086">85</xref>].</p>
<p>Animal studies have indicated BPA to affect various aspects of memory at lower than the US EPA’s reference safe daily limit of 50 µg/kg/day [<xref ref-type="bibr" rid="B86-ijms-17-02086">86</xref>]. The types of memory affected include spatial memory, visual memory, object recognition, working memory, reference memory and navigational memory [<xref ref-type="bibr" rid="B68-ijms-17-02086">68</xref>,<xref ref-type="bibr" rid="B69-ijms-17-02086">69</xref>,<xref ref-type="bibr" rid="B70-ijms-17-02086">70</xref>,<xref ref-type="bibr" rid="B71-ijms-17-02086">71</xref>,<xref ref-type="bibr" rid="B73-ijms-17-02086">73</xref>,<xref ref-type="bibr" rid="B74-ijms-17-02086">74</xref>,<xref ref-type="bibr" rid="B75-ijms-17-02086">75</xref>,<xref ref-type="bibr" rid="B76-ijms-17-02086">76</xref>,<xref ref-type="bibr" rid="B87-ijms-17-02086">87</xref>,<xref ref-type="bibr" rid="B88-ijms-17-02086">88</xref>]. Animal studies have also indicate affects to locomotor function [<xref ref-type="bibr" rid="B71-ijms-17-02086">71</xref>,<xref ref-type="bibr" rid="B87-ijms-17-02086">87</xref>].</p>
<p>Prenatal BPA exposure has been shown to produce more aggressive and hyperactive behavior in offspring when compared to mothers with lower BPA levels [<xref ref-type="bibr" rid="B89-ijms-17-02086">89</xref>]. This human study is consistent with animal studies that have also shown that prenatal BPA exposure is associated with increased aggression, alterations in the dopaminergic system, and other neurobehavioral effects [<xref ref-type="bibr" rid="B90-ijms-17-02086">90</xref>,<xref ref-type="bibr" rid="B91-ijms-17-02086">91</xref>,<xref ref-type="bibr" rid="B92-ijms-17-02086">92</xref>,<xref ref-type="bibr" rid="B93-ijms-17-02086">93</xref>,<xref ref-type="bibr" rid="B94-ijms-17-02086">94</xref>,<xref ref-type="bibr" rid="B95-ijms-17-02086">95</xref>,<xref ref-type="bibr" rid="B96-ijms-17-02086">96</xref>,<xref ref-type="bibr" rid="B97-ijms-17-02086">97</xref>]. In a study examining early life exposure to BPA, it was found that prenatal urinary BPA concentrations in the mother and child were associated with anxiety, depression, and hyperactivity [<xref ref-type="bibr" rid="B98-ijms-17-02086">98</xref>]. A recent French study of 46 children with autistic spectrum disorders (ASD) and 52 controls reported an association between BPA exposure and ASD in children [<xref ref-type="bibr" rid="B99-ijms-17-02086">99</xref>]. In autistic children, plasma levels of BPA and phthalates were significantly higher compared to controls [<xref ref-type="bibr" rid="B100-ijms-17-02086">100</xref>]. Studies suggest BPA may cause autism by inducing methylation changes in transcriptionally relevant regions of the BDNF gene in the hippocampus of mice [<xref ref-type="bibr" rid="B101-ijms-17-02086">101</xref>]. One study using cross-sectional data from the Canadian Health Measures Survey found children taking psychotropic medications was associated with urinary BPA (OR 1.59; 95% CI 1.05–2.40) [<xref ref-type="bibr" rid="B102-ijms-17-02086">102</xref>]. Another study assessing prenatal exposure to BPA and phthalates and infant neurobehavior at 5 weeks found no associations with BPA and some associations with phthalate exposure and improved possible neurobehavior [<xref ref-type="bibr" rid="B103-ijms-17-02086">103</xref>]. In a prospective cohort study following African-American and Dominican women from pregnancy to children’s age of 7–9, it was found that high prenatal BPA concentrations was associated with increased internalizing and externalizing behaviors in boys with a decrease in internalizing behavior in girls and high postnatal BPA concentrations was associated with increased internalizing and externalizing behaviors in girls than in boys [<xref ref-type="bibr" rid="B104-ijms-17-02086">104</xref>]. Other studies have found a decrease in hyperactivity symptoms in boys and an increase in anxiety, depression, and externalizing behavior in young girls [<xref ref-type="bibr" rid="B89-ijms-17-02086">89</xref>,<xref ref-type="bibr" rid="B105-ijms-17-02086">105</xref>]. Other studies have found no associations among maternal BPA levels, behavior, and autism [<xref ref-type="bibr" rid="B106-ijms-17-02086">106</xref>].</p>
<p>Studies have demonstrated evidence of BPA exposure and associations with brain cancer. In particular, meningioma, which account for 20% of intracranial tumors, may be linked to estrogen sensitivity and genetic predisposition [<xref ref-type="bibr" rid="B107-ijms-17-02086">107</xref>]. BPA exposure has also been implicated to be associated with increased risk of meningioma—a common type of brain tumor—and patients with the highest urine BPA levels were about 1.4 to 1.6 times more likely to have meningioma compared to those with lower concentrations [<xref ref-type="bibr" rid="B108-ijms-17-02086">108</xref>]. BPA at high doses has also been shown to induce cell growth and the production of prolactin in a pituitary tumor cell line [<xref ref-type="bibr" rid="B109-ijms-17-02086">109</xref>]. BPA increases <italic>N</italic>-ras expression in a K. marmortatus model, which shows exposure to BPA can predispose the host to environmental carcinogenesis [<xref ref-type="bibr" rid="B110-ijms-17-02086">110</xref>]. BPA may produce nongenomic estrogenic responses in pituitary tumor cells by detectable ERK phosphorylation [<xref ref-type="bibr" rid="B111-ijms-17-02086">111</xref>]. In rat pituitary GH3 cancer cell lines, BPA interferes with cell proliferation alone or with co-treatment with T3 [<xref ref-type="bibr" rid="B112-ijms-17-02086">112</xref>].</p>
<p>In summary, besides diethylstilbestrol (DES), BPA is one of the widely researched EEDs. BPA is detected in many human fluids and tissues including saliva, serum, urine, amniotic fluid, follicular fluid, placental tissue and breast milk [<xref ref-type="bibr" rid="B99-ijms-17-02086">99</xref>]. From the above studies, it is apparent that BPA exposure has a great potential to impact human brain development and possibly contributes to the increasing prevalence of human neurodevelopmental and behavioral disorders (<xref ref-type="table" rid="ijms-17-02086-t001">Table 1</xref>, <xref ref-type="table" rid="ijms-17-02086-t002">Table 2</xref> and <xref ref-type="table" rid="ijms-17-02086-t003">Table 3</xref>).</p>
</sec>
<sec id="sec2dot5-ijms-17-02086">
<title>2.5. Phthalates and Brain Health</title>
<p>Phthalates, a group of endocrine-disrupting chemicals commonly used to [<xref ref-type="bibr" rid="B4-ijms-17-02086">4</xref>], are used as in plastics to make them flexible and resilient, also known as plasticizers [<xref ref-type="bibr" rid="B113-ijms-17-02086">113</xref>,<xref ref-type="bibr" rid="B114-ijms-17-02086">114</xref>,<xref ref-type="bibr" rid="B115-ijms-17-02086">115</xref>,<xref ref-type="bibr" rid="B116-ijms-17-02086">116</xref>]. Di(2-ethylhexyl) phthalate, or DEHP is the one of the most widely used plasticizers and is found plastic products such as wall coverings, tablecloths, floor tiles, furniture upholstery, shower curtains, garden hoses, swimming pool liners, rainwear, baby pants, dolls, some toys, shoes, automobile upholstery and tops, packaging film and sheets, sheathing for wire and cable, medical tubing, and blood storage bags [<xref ref-type="bibr" rid="B114-ijms-17-02086">114</xref>,<xref ref-type="bibr" rid="B117-ijms-17-02086">117</xref>]. Other commonly used plasticizers are di-<italic>N</italic>-butyl phthalate, found in carpets, paints, glue, insect repellents, hair spray, nail polish, and rocket fuel [<xref ref-type="bibr" rid="B115-ijms-17-02086">115</xref>]; di-<italic>N</italic>-octyl phthalate (DNOP), found in carpet back coating, packaging films, medical tubing and blood storage bags, floor tile, wire, cables, adhesives, cosmetics, and pesticides [<xref ref-type="bibr" rid="B113-ijms-17-02086">113</xref>]; and Diethyl phthalate, in found in products such as toothbrushes, automobile parts, tools, toys, food packaging, cosmetics, insecticides, and aspirin [<xref ref-type="bibr" rid="B116-ijms-17-02086">116</xref>]. Phthalates are not part of the chemical chain that make up the polymers in plastic, allowing them to readily released into the surrounding environment [<xref ref-type="bibr" rid="B113-ijms-17-02086">113</xref>,<xref ref-type="bibr" rid="B114-ijms-17-02086">114</xref>,<xref ref-type="bibr" rid="B115-ijms-17-02086">115</xref>,<xref ref-type="bibr" rid="B116-ijms-17-02086">116</xref>]. Exposure to phthalates comes through ingestion, inhalation, and, to a lesser extent, dermal contact with phthalate-containing products [<xref ref-type="bibr" rid="B117-ijms-17-02086">117</xref>]. Phthalates have also been demonstrated to have the ability to cross the blood brain barrier [<xref ref-type="bibr" rid="B118-ijms-17-02086">118</xref>,<xref ref-type="bibr" rid="B119-ijms-17-02086">119</xref>].</p>
<p>Phthalates have been found to disrupt neuroplasticity. A recent studies using a rat model suggests exposure to phthalates reduces dendritic spine density, neurogenesis, and synaptogenesis in male rats [<xref ref-type="bibr" rid="B120-ijms-17-02086">120</xref>]. A recent review of phthalates and neuroplasticity also suggests phthalates negative effects on neurogenesis and plasticity in animal models [<xref ref-type="bibr" rid="B121-ijms-17-02086">121</xref>,<xref ref-type="bibr" rid="B122-ijms-17-02086">122</xref>].</p>
<p>Phthalate exposure has been associated with various cognitive deficits. Animal studies indicate that specific learning deficits include decreased fear conditioning [<xref ref-type="bibr" rid="B123-ijms-17-02086">123</xref>], impaired spatial memory [<xref ref-type="bibr" rid="B72-ijms-17-02086">72</xref>,<xref ref-type="bibr" rid="B122-ijms-17-02086">122</xref>,<xref ref-type="bibr" rid="B124-ijms-17-02086">124</xref>] and adverse effects to locomotor activity [<xref ref-type="bibr" rid="B72-ijms-17-02086">72</xref>]. A cross-sectional epidemiological study using data from the NHANES 2011–2012 data collection found individuals who had difficulties thinking and remembering had increasing levels of urinary phthalates along with other estrogenic chemicals [<xref ref-type="bibr" rid="B125-ijms-17-02086">125</xref>]. In another study found prenatal maternal exposure to phthalates was inversely associates with child IQ DnBP and DiBP (<italic>b</italic> = −2.69, 95% CI −4.33 to −1.05 and <italic>b</italic> = −2.69, 95% CI −4.22 to −1.16) [<xref ref-type="bibr" rid="B126-ijms-17-02086">126</xref>].</p>
<p>There are a group of studies that have found possible links between phthalates and brain behavioral disorders such as ASD and attention deficit hyperactive disorder (ADHD). One study, examining exposure to estrogenic endocrine disrupting chemicals (EEDCs) and autism and ADHD found intracranial exposure to several classes of EEDCs, which include phthalates, caused significant hyperactivity in neonatal rats [<xref ref-type="bibr" rid="B127-ijms-17-02086">127</xref>]. Altered gene expression was also observed [<xref ref-type="bibr" rid="B127-ijms-17-02086">127</xref>]. A retrospective study followed children 1–6 years of age with a follow-up at 6–8 years of age and found the children with exposure to phthalates from PVC pipe dust were more likely to develop ASD [<xref ref-type="bibr" rid="B128-ijms-17-02086">128</xref>]. Additionally, two other studies looked at both BPA and phthalate levels and neurobehavioral outcomes, with associations found between adverse neurobehavioral outcomes and increasing urinary phthalate levels [<xref ref-type="bibr" rid="B103-ijms-17-02086">103</xref>,<xref ref-type="bibr" rid="B106-ijms-17-02086">106</xref>]</p>
<p>Phthalates are suspected in the development of neurodegenerative diseases [<xref ref-type="bibr" rid="B119-ijms-17-02086">119</xref>]. In an animal study involving a rat model, phthalate exposure was shown to impair cognitive function and increase the level of phspho-Tau, a precursor of AD development, in exposed rat offspring [<xref ref-type="bibr" rid="B129-ijms-17-02086">129</xref>]. Currently no definitive epidemiological studies have been conducted with phthalates and neurodegenerative diseases.</p>
</sec>
<sec id="sec2dot6-ijms-17-02086">
<title>2.6. Polychlorinated Biphenyls and Brain Health</title>
<p>PCBs are synthetic organic chemicals composed in different combinations of 209 different chlorinated compounds, or congeners [<xref ref-type="bibr" rid="B130-ijms-17-02086">130</xref>]. PCBs have been used as coolant and lubricants in transformers, and its manufacture was banned in 1977 because of harmful health effects, however, old products may still contain them [<xref ref-type="bibr" rid="B130-ijms-17-02086">130</xref>]. Many of PCBs congeners produce estrogenic effects [<xref ref-type="bibr" rid="B4-ijms-17-02086">4</xref>]. PCBs have been found to cause cancer in animals [<xref ref-type="bibr" rid="B130-ijms-17-02086">130</xref>]. Routes of exposure included occupational exposure, breathing air near contaminated areas, using older products manufactured before and around 1977, and eating contaminated food [<xref ref-type="bibr" rid="B130-ijms-17-02086">130</xref>]. PCBs bio accumulate in the food chain and remain active in the environment for extended periods of time [<xref ref-type="bibr" rid="B130-ijms-17-02086">130</xref>].</p>
<p>Recent animal and cell studies have shown PCBs to adversely affect brain health. Animal studies have shown exposure to PCBs affect brain health by affecting social behavior [<xref ref-type="bibr" rid="B131-ijms-17-02086">131</xref>], increased hyperactivity [<xref ref-type="bibr" rid="B132-ijms-17-02086">132</xref>], reduction in learning ability [<xref ref-type="bibr" rid="B133-ijms-17-02086">133</xref>], and physiological effects on the brain such as neuronal degradation [<xref ref-type="bibr" rid="B132-ijms-17-02086">132</xref>,<xref ref-type="bibr" rid="B134-ijms-17-02086">134</xref>], neuronal loss and damage [<xref ref-type="bibr" rid="B135-ijms-17-02086">135</xref>], and susceptibility to amyloid stress and reduced expression of synaptic proteins [<xref ref-type="bibr" rid="B134-ijms-17-02086">134</xref>]. In in-vitro models, PCBs have shown to cause neuronal cell death [<xref ref-type="bibr" rid="B136-ijms-17-02086">136</xref>] and interfere with estrogen’s neuroprotective effects on neurons and brain cells [<xref ref-type="bibr" rid="B137-ijms-17-02086">137</xref>]. In a study using ovariectomized, estradiol-replaced ewes, the VEGF/VEGFR systems is affected by PCBs, which therefore affect the production of cerebrospinal fluid [<xref ref-type="bibr" rid="B138-ijms-17-02086">138</xref>].</p>
<p>In a nested case-control study in Finland, serum PCBs were not associated with PD development [<xref ref-type="bibr" rid="B139-ijms-17-02086">139</xref>]. In a retrospective mortality study examining PCB exposure amongst workers in capacitor plants, sex-specific analyses found higher deaths from PD amongst exposed women [<xref ref-type="bibr" rid="B140-ijms-17-02086">140</xref>]. In a case-control study examining post-mortem brain tissue from PD, AD, and control patients, PCB levels were higher in PD groups, and when stratified by age, were higher amongst women [<xref ref-type="bibr" rid="B141-ijms-17-02086">141</xref>].</p>
<p>There are a number of studies that support the hypothesis that exposure to EEDs represent risk factors for ADHD. Lead and PCB exposures have been implicated with ADHD in children [<xref ref-type="bibr" rid="B142-ijms-17-02086">142</xref>]. There are a large number of studies focused on the association between exposures to PCBs and cognitive function. There is ample evidence in human populations to suggest both high and low exposures to PCBs during fetal development may be linked to cognitive deficits. Also alterations in sexually dimorphic behaviors have been reported in humans exposed to PCBs. For example, cross-sectional studies have shown the effects of PCBs on brain health. In children, PCB exposure is associated with lower IQ [<xref ref-type="bibr" rid="B143-ijms-17-02086">143</xref>] and lower visual memory function [<xref ref-type="bibr" rid="B144-ijms-17-02086">144</xref>]. In older populations, PCB exposure is associated with lower verbal learning and memory [<xref ref-type="bibr" rid="B145-ijms-17-02086">145</xref>], lower verbal memory and depressive symptoms [<xref ref-type="bibr" rid="B146-ijms-17-02086">146</xref>], lower score on memory and learning measures [<xref ref-type="bibr" rid="B147-ijms-17-02086">147</xref>] and attenuation of emotional wellbeing and attentional functioning [<xref ref-type="bibr" rid="B148-ijms-17-02086">148</xref>].</p>
</sec>
<sec id="sec2dot7-ijms-17-02086">
<title>2.7. Cadmium and Brain Health</title>
<p>Cadmium is a naturally occurring metal in the earth’s crust and a natural constituent of ocean water. Populations are exposed through food, cigarettes, smoke, drinking water, and air. Cadmium is introduced into the food chain through soil and food contact surfaces, and through foods such as leafy vegetables, grains, legumes, and organ meats. Occupation exposures are highest in occupations involving cadmium-containing products, and occupations involved in alloy, battery, plastics, and coloring production. Current evidence supports cadmium being cytotoxic at high concentrations. At low doses cadmium mimics estrogen (E2) effects both in vitro and in vivo [<xref ref-type="bibr" rid="B149-ijms-17-02086">149</xref>].</p>
<p>Cell models have shown cadmium to have adverse effects on brain health. In a study using hippocampal slides of CA1 neurons, cadmium was shown to affect synaptic transmission and short-term neural plasticity [<xref ref-type="bibr" rid="B150-ijms-17-02086">150</xref>]. In another cell study using PC12 and SH-SY5Y cells, cadmium induced cell apoptosis [<xref ref-type="bibr" rid="B151-ijms-17-02086">151</xref>,<xref ref-type="bibr" rid="B152-ijms-17-02086">152</xref>]. Animal models have shown cadmium to affect different aspects of brain health. In a zebrafish animal model, cadmium has been shown to inhibit neurogenesis in embryonic development [<xref ref-type="bibr" rid="B153-ijms-17-02086">153</xref>]. Cadmium has been shown to negatively affect brain function. Cadmium has been shown to induce apoptosis in vitro in rat cerebellum cortical neurons by affecting by affecting calcium homeostasis [<xref ref-type="bibr" rid="B154-ijms-17-02086">154</xref>] and also has been shown to induce apoptosis in vitro in through damage of mitochondria in rat oligodendrocytes [<xref ref-type="bibr" rid="B155-ijms-17-02086">155</xref>]. Cadmium has been demonstrated to interact with β amyloid peptides which may lead to the development of AD [<xref ref-type="bibr" rid="B156-ijms-17-02086">156</xref>].</p>
<p>Studies on human populations have also shown cadmium’s adverse effects on adult brain function. A cross-sectional study using NHANES III data from 1988 to 1994 compared neurocognitive test scores and urinary cadmium concentrations found individuals with no smoking history, or known occupational cadmium exposure were found to have lower attention/perception scores with increasing urinary cadmium levels [<xref ref-type="bibr" rid="B157-ijms-17-02086">157</xref>]. In a cohort study of rural elderly Chinese persons, it was found that increasing serum cadmium and copper levels was significantly associated with lower composite cognitive scores [<xref ref-type="bibr" rid="B158-ijms-17-02086">158</xref>]. Another study, which examined the cerebrospinal fluid of ALS patients, found elevated levels of various metals, including cadmium, that were higher than the measured blood levels and indicative of bioaccumulation [<xref ref-type="bibr" rid="B159-ijms-17-02086">159</xref>]. A case-control study examining heavy metal levels in a group of Mongolian people found elevated cadmium, as well as other heavy metals in those with Parkinson-like symptoms from their hair samples [<xref ref-type="bibr" rid="B160-ijms-17-02086">160</xref>]. In a study of boiler workers and occupational exposure, exposure to various heavy metals, including cadmium was associated with neurodegenerative-like conditions similar to PD and AD [<xref ref-type="bibr" rid="B161-ijms-17-02086">161</xref>].</p>
</sec>
<sec id="sec2dot8-ijms-17-02086">
<title>2.8. Arsenic and Brain Health</title>
<p>At low doses arsenic acts as a xenoestrogen and modifies estrogen signaling [<xref ref-type="bibr" rid="B149-ijms-17-02086">149</xref>]. Human populations are usually exposed through the air, drinking water, and food, with food being the main source of arsenic in a population, with some areas having naturally high levels of arsenic [<xref ref-type="bibr" rid="B162-ijms-17-02086">162</xref>]. Occupational exposure occurs through individuals working in metal smelting, wood treatment, and those working in the production and application of pesticides and herbicides [<xref ref-type="bibr" rid="B162-ijms-17-02086">162</xref>]. Arsenic is also used in the animal and poultry feed as an antimicrobial additive [<xref ref-type="bibr" rid="B162-ijms-17-02086">162</xref>]. The major routes of exposure are inhalation and oral, with dermal exposure being considered a minor route [<xref ref-type="bibr" rid="B162-ijms-17-02086">162</xref>]. Arsenic has been associated with various health conditions, which include respiratory disorders, cardiovascular outcomes, diabetes, ocular effects, immune response disturbances, impaired neurological function, developmental effects, and cancers [<xref ref-type="bibr" rid="B163-ijms-17-02086">163</xref>]. Genetic polymorphisms are suspected of contributing to the sensitivity towards arsenic [<xref ref-type="bibr" rid="B163-ijms-17-02086">163</xref>].</p>
<p>In animal studies using rats, arsenic exposure through ingest water has been shown to impair neurogenesis, worsened spatial memory, and promote abnormal neural synapses. In addition, animal studies in rats have shown arsenic exposure to affect synaptic plasticity, by affecting the expression of NDMA receptors [<xref ref-type="bibr" rid="B164-ijms-17-02086">164</xref>,<xref ref-type="bibr" rid="B165-ijms-17-02086">165</xref>] and downregulating the PTEN-Akt-Creb signaling pathway and damaging cerebral neurons [<xref ref-type="bibr" rid="B166-ijms-17-02086">166</xref>]. In a cell study conducted by Shavali and Sens (2007), arsenic was found to cause enhanced oxidative stress and cell death in cultured neuronal cells, when administered with dopamine [<xref ref-type="bibr" rid="B167-ijms-17-02086">167</xref>]. In a study using a cholinergic neuronal cell line overexpressing amyloid precursor protein (APP) and exposing it to sodium arsenite and its metabolite, dimethylarsenic acid, it was found to affect cleavage of APP and increase its production [<xref ref-type="bibr" rid="B168-ijms-17-02086">168</xref>].</p>
<p>In a cohort study consisting of 133 men and 201 women from the Project FRONTIER, a rural healthcare study, long-term low level exposure to arsenic from groundwater was found to be associated with poorer scores in language, visuospatial skills, and executive functioning, global cognition, processing speed, and immediate memory [<xref ref-type="bibr" rid="B169-ijms-17-02086">169</xref>]. In another study from Project Frontier, consisting of 526 subjects genotyped according to the AS3MT gene, exposure to higher low level arsenic in groundwater reduced cognitive functioning, but the results differed with amongst the different SNPs [<xref ref-type="bibr" rid="B170-ijms-17-02086">170</xref>]. In a case-control study measuring heavy metal serum levels in 89 Ad patients and 188 cognitively normal controls, there was no difference in serum arsenic levels between the AD group and controls [<xref ref-type="bibr" rid="B171-ijms-17-02086">171</xref>]. Another study conducted by Edwards et al., with a cohort consisting of 733 AD patients, 127 individuals with mild cognitive impairment, and 530 individuals of normal cognition, found that exposure to low level arsenic exposure from groundwater was found to be associated with poorer neuropsychological performance [<xref ref-type="bibr" rid="B172-ijms-17-02086">172</xref>]. A cross-sectional study by Shuie (2015), using NHANES 2011-2012 data, found that individuals who has problems remembering had higher levels of urinary arsenic [<xref ref-type="bibr" rid="B125-ijms-17-02086">125</xref>].</p>
</sec>
<sec id="sec2dot9-ijms-17-02086">
<title>2.9. Manganese and Brain Health</title>
<p>Manganese (Mn) is a naturally abundant environmental trace mineral that is an essential nutrient required as a cofactor for various enzymes and is found naturally in grains and fruit. Manganese, which is found in various industrial processes and products, exposure can occur through inhalation, oral, dermal, and occupational routes. Recently, prepubertal exposure to environmental levels of Mn has been shown to produce precocious mammary gland development through inducing gonadotropin-releasing hormone (GnRH) regulated increases in levels of serum LH and E2 by activating the hypothalamic-pituitary-ovarian axis [<xref ref-type="bibr" rid="B173-ijms-17-02086">173</xref>]. MnCl2 (1.0 µM) is almost 9% as efficient as 17-β estradiol in activating estrogen receptor-mediated transcriptional activity in MCF-7 breast cancer cells. Mn has been show to accumulate in the hypothalamus and induces precocious puberty in rats through activating GnRH peptide release from the basal hypothalamus leading to elevated puberty-related hormones including E2 [<xref ref-type="bibr" rid="B173-ijms-17-02086">173</xref>].</p>
<p>Evidence suggests manganese having a role in neurotoxicity. Chronic manganese exposure has been shown to promote the build-up of the metal in the basal ganglia, white matter, and cortical structures of the brain [<xref ref-type="bibr" rid="B174-ijms-17-02086">174</xref>]. Manganese has also been shown to cause an inhibitory effect on NMDA receptors [<xref ref-type="bibr" rid="B175-ijms-17-02086">175</xref>]. Although manganese is an essential nutrient and has beneficial uses in the human body, increased levels of manganese in the body can lead to PD-like symptoms and developmental exposure has been shown to negatively affect neurological development [<xref ref-type="bibr" rid="B176-ijms-17-02086">176</xref>]. Manganese appears to interfere with dopaminergic synaptic transmission, by possibly impairing presynaptic dopamine release. A study using a monkey model showed manganese exposure caused neurotoxicity by inhibiting dopamine neurotransmission [<xref ref-type="bibr" rid="B177-ijms-17-02086">177</xref>].</p>
<p>In animals chronic exposure of Mn has been shown to produce subtle deficits in spatial working memory, spontaneous activity, manual dexterity, and compulsive-like behavior [<xref ref-type="bibr" rid="B178-ijms-17-02086">178</xref>]. A small cohort study that followed 26 welders exposed to manganese found after a 3.5-year follow-up found worsened olfactory, extrapyramidal, and mood disturbances [<xref ref-type="bibr" rid="B179-ijms-17-02086">179</xref>]. A cohort study following asymptomatic welder trainees with no previous manganese exposure found low-level exposure to cause sub-clinical brain changes in subjects before any measurable learning deficits occur [<xref ref-type="bibr" rid="B180-ijms-17-02086">180</xref>]. In another cross-sectional study assessing children’s intellectual functioning and arsenic and manganese exposure, blood manganese levels were negatively associated with full scale IQ test scores (<italic>p</italic>-value &lt; 0.05), working memory (<italic>p</italic>-value &lt; 0.05), and perceptual memory (<italic>p</italic>-value &lt; 0.05) [<xref ref-type="bibr" rid="B181-ijms-17-02086">181</xref>]. A cross-sectional study by Kim et al. [<xref ref-type="bibr" rid="B182-ijms-17-02086">182</xref>] examining low-level manganese exposure in adults of an Ohio community found subtle subclinical effects in unified PD rating scale and postural sway test for PD. A cross-sectional study of school-aged children in Brazil found inverse scores on executive function and attention tests with manganese levels [<xref ref-type="bibr" rid="B183-ijms-17-02086">183</xref>]. A study amongst school children in Canada found low-level manganese exposure in drinking water was associated with poorer neurobehavioral functions [<xref ref-type="bibr" rid="B184-ijms-17-02086">184</xref>].</p>
<p>Manganese has been shown to produce Parkinsonism [<xref ref-type="bibr" rid="B176-ijms-17-02086">176</xref>,<xref ref-type="bibr" rid="B185-ijms-17-02086">185</xref>]. Recent epidemiological studies have assessed the effects of manganese on brain health. A cross-sectional study by Hozumi et al. [<xref ref-type="bibr" rid="B186-ijms-17-02086">186</xref>], analyzed the cerebrospinal fluid of various neurodegenerative disease patients and found a higher level of manganese among PD patients (<italic>p</italic>-value &lt; 0.05). Koc et al. [<xref ref-type="bibr" rid="B187-ijms-17-02086">187</xref>] found higher levels of metal, including manganese, in hair samples of AD patients compared to controls. A case-control study Miyake et al. [<xref ref-type="bibr" rid="B188-ijms-17-02086">188</xref>], assessing dietary intake of heavy metals amongst PD patients found no association with manganese intake. A case-control study by Roos et al. [<xref ref-type="bibr" rid="B159-ijms-17-02086">159</xref>] found elevated manganese levels in cerebrospinal fluid of ALS patients. A study by Kihira et al. [<xref ref-type="bibr" rid="B189-ijms-17-02086">189</xref>] found elevated manganese levels in ALS patients vs controls from their hair samples. Another study by Arain et al. [<xref ref-type="bibr" rid="B190-ijms-17-02086">190</xref>] found higher levels of manganese and aluminum in hair samples of patients suffering from neurodegenerative disease.</p>
<p>In summary, experimental and epidemiologic studies suggest that exposure to metalloestrogens—Cd, As and Mn may influence brain health and they may be associated in the development of some of the chronic complex brain disorders.</p>
</sec>
</sec>
<sec id="sec3-ijms-17-02086">
<title>3. Mechanisms of Actions of Estrogenic Endocrine Disruptors (EEDs) on Brain Health Deficits</title>
<p>Estrogenic Mechanisms: It is clear through the studies described above that physiologic and pharmacologic forms of estrogen and estrogenic active environmental chemicals affect brain health (<xref ref-type="table" rid="ijms-17-02086-t001">Table 1</xref>, <xref ref-type="table" rid="ijms-17-02086-t002">Table 2</xref> and <xref ref-type="table" rid="ijms-17-02086-t003">Table 3</xref>). Estrogens have long been implicated in influencing brain health disorders, yet the molecular mechanisms underlying brain health effects remain unclear. Estrogens are very intriguing complex chemicals that regulate many of the women and men body’s functions, including development, growth, reproduction, and nervous and immune systems, as well as the way various organs operate. In addition to the primarily produced in ovary in females, estrogens are also produced by many other tissues such as the testis, liver, adrenal glands, brain, breasts and fat cells. For example, estrogen in the testis is produced by Leydig cells and germ cells by aromatization of testosterone. A relatively high concentration of estrogen in rete testis fluid and in semen of several species that exceed even the female vasculature is observed. 17 β estradiol concentration in testis venous blood and lymph is relatively high in all species [<xref ref-type="bibr" rid="B191-ijms-17-02086">191</xref>]. Similarly, in brain, both neurons and glia synthesize E2 through aromatization of testosterone. The neurons of hypothalamus of rhesus monkeys has been shown to produce large amounts of estradiol to regulate release of gonadotropin releasing hormone (GnRH) [<xref ref-type="bibr" rid="B192-ijms-17-02086">192</xref>]. Recently estrogen synthesized in glial cells in Zebra Finch brain under conditions of brain injury have been reported to control inflammation [<xref ref-type="bibr" rid="B193-ijms-17-02086">193</xref>]. Associations between gender specific estrogen levels and brain functions-related health challenges, such as cognition, depression, brain neurodegenerative diseases such as AD and PD and neurodevelopment disorders, such as autism, have raised the importance of estrogens in brain health. It has become apparent that estrogens play very important role in brain health of both sexes. The underlying mechanisms of brain susceptibility to estrogen’s effect remain elusive. In both cell culture and animal studies, estrogen exposure has been shown to have adverse as well as protective effects on neurons, through genomic and non-genomic pathways [<xref ref-type="bibr" rid="B194-ijms-17-02086">194</xref>]. Endogenous estrogens play a role in the growth and regulation of neurons and synaptic plasticity [<xref ref-type="bibr" rid="B19-ijms-17-02086">19</xref>,<xref ref-type="bibr" rid="B20-ijms-17-02086">20</xref>,<xref ref-type="bibr" rid="B21-ijms-17-02086">21</xref>]. How circulating EDEs interact with neural and/or circulatory estrogens in the control of brain structure and function remains to be understood. Maternal PCBs exposure has been reported to accumulate in brain and liver fetal tissues that are strongly associated with PCB levels in adipose tissue [<xref ref-type="bibr" rid="B195-ijms-17-02086">195</xref>]. Other EEDs have been also found in brain. The brain is the fattest tissue (60% fat) in our body. Therefore, once EEDs enter in the body, these compounds can get into the circulation, cross through the blood brain barrier, metabolized, and/or stored by the brain, where their effects can last for long periods of time. The biochemical and molecular mechanisms by which EEDs may affect brain health are not clear. The effects of EEDs on the brain are varied during the entire life span and far-reaching with many different mechanisms. A schematic representation showing how circulatory (c) estrogen produced by ovary or testis, neural (n) estrogen [produced by aromatization of testosterone to 17 β estradiol (E2) by neuronal or glial aromatase in the brain] and EEDs entering into the blood circulation from ingestion, inhalation or dermal exposure may interact in the brain and their impact on brain health (<xref ref-type="fig" rid="ijms-17-02086-f001">Figure 1</xref>). The relationship between neural estradiol and ovarian estrogen or EED feedback is not clear. However, PCBs, BPA, phthalates, Cd, As or Mn, through influencing gonadotropin-releasing hormone (GnRH) regulated increases in levels of serum LH and E2, have been shown to modify the hypothalamic–pituitary-ovarian axis and they also bind to estrogen receptors [<xref ref-type="bibr" rid="B1-ijms-17-02086">1</xref>,<xref ref-type="bibr" rid="B2-ijms-17-02086">2</xref>,<xref ref-type="bibr" rid="B149-ijms-17-02086">149</xref>,<xref ref-type="bibr" rid="B173-ijms-17-02086">173</xref>]. BPA, Phthalates and metalloestrogens—Cd, As and Mn have been shown to cross the blood brain barrier [<xref ref-type="bibr" rid="B1-ijms-17-02086">1</xref>,<xref ref-type="bibr" rid="B64-ijms-17-02086">64</xref>,<xref ref-type="bibr" rid="B65-ijms-17-02086">65</xref>,<xref ref-type="bibr" rid="B118-ijms-17-02086">118</xref>,<xref ref-type="bibr" rid="B119-ijms-17-02086">119</xref>,<xref ref-type="bibr" rid="B149-ijms-17-02086">149</xref>,<xref ref-type="bibr" rid="B173-ijms-17-02086">173</xref>]. Metalloestrogens, such as arsenite, cadmium, mimic the actions of physiological estrogens through binding to estrogen receptors [<xref ref-type="bibr" rid="B196-ijms-17-02086">196</xref>,<xref ref-type="bibr" rid="B197-ijms-17-02086">197</xref>,<xref ref-type="bibr" rid="B198-ijms-17-02086">198</xref>]. We have not discussed existing paradigms of actions of estrogen, BPA and phthalates, because they have been extensively reviewed. The most widely researched paradigm is that effects of estrogens and EEDs are mediated via estrogen receptors (ERa, ERβ, GPER/GPR30), all three of which are widely expressed in the brain [<xref ref-type="bibr" rid="B1-ijms-17-02086">1</xref>,<xref ref-type="bibr" rid="B2-ijms-17-02086">2</xref>,<xref ref-type="bibr" rid="B3-ijms-17-02086">3</xref>,<xref ref-type="bibr" rid="B4-ijms-17-02086">4</xref>] (<xref ref-type="fig" rid="ijms-17-02086-f002">Figure 2</xref>). Excess endogenous estrogens or EEDs produce adverse effects on brain health as a result of aberrant estrogen receptor signaling. In addition to the classical estrogen receptor-mediated signaling, emerging new evidence indicate other mechanisms, such as oxidative stress mediated redox signaling and epigenetic disturbances may be involved with EEDs-associated detrimental brain health outcomes.</p>
<p>Oxidative Stress Mechanisms: There is emerging evidence that exposure to estrogen and EEDs-PCBs, BPA, phthalate produce oxidative stress. Oxidative stress may be one of the mechanisms associated with the adverse effect of EEDs on brain health (<xref ref-type="fig" rid="ijms-17-02086-f002">Figure 2</xref>). Physiologically achievable concentrations of estrogen or estrogen metabolites have been shown to generate reactive oxygen species (ROS). In addition to the direct effect of estrogen on mitochondria and the redox cycling of catechol estrogen, estrogen-induced proinflammatory cytokines, such as interleukin-1β (IL-1β) and tumor necrosis factor α (TNF-α), can also generate ROS. Phthalates—DEHP, DBP, or DEP, have been reported to produce ROS and lipid peroxidation. Epidemiological studies indicated that phthalate metabolites are associated with oxidative stress [<xref ref-type="bibr" rid="B199-ijms-17-02086">199</xref>]. BPA has been shown to modulate neuronal activity by both dependent and independent of estrogen receptors, GPER, or estrogen-related receptor-γ pathways [<xref ref-type="bibr" rid="B200-ijms-17-02086">200</xref>]. BPA can lower cell viability and induce cell death by mediating calcium influx, generation of ROS, and activation of MAPK and caspase 3 [<xref ref-type="bibr" rid="B201-ijms-17-02086">201</xref>]. A similar chemical to BPA, BPAF or Bisphenol AF, was shown to cause hippocampal cell death in mouse neuronal cells (HT-22), by increasing cellular calcium, generation of ROS, and activation of p38, JNK, and caspase 3 [<xref ref-type="bibr" rid="B202-ijms-17-02086">202</xref>]. BPA administered to male rats was found to increase malondiadehyde levels, decrease glutathione and superoxide dismutase activity in the cerebrum and cause upregulation of p53 and CD95-Fas and activation of capsases 3 and 8 causing cell death [<xref ref-type="bibr" rid="B203-ijms-17-02086">203</xref>], with melatonin attenuating the effects of BPA. All three metalloestrogens—Cd, As and Mn produce oxidative stress in both cell lines and animal models [<xref ref-type="bibr" rid="B1-ijms-17-02086">1</xref>,<xref ref-type="bibr" rid="B151-ijms-17-02086">151</xref>,<xref ref-type="bibr" rid="B160-ijms-17-02086">160</xref>,<xref ref-type="bibr" rid="B167-ijms-17-02086">167</xref>]. Different cellular signaling pathways may operate in response to varying levels of estrogen or EED-induced ROS, leading to genotoxic damage, cell apoptosis, or cell growth. At high levels of ROS, cells receiving genotoxic insults, if not repaired, may engage the apoptotic pathways. There is increasing evidence supporting that estrogen or EED-induced alterations in the genome of cells are produced by oxidative attack. Furthermore, ROS generated by estrogen or EED exposure in combination with receptor-mediated proliferation of genetically damaged cells may be involved in pathology of brain diseases. Inhibition of Akt and ERK/CREB/BDNF pathways in the hippocampus by maternal BPA exposure has been suggested to impair object recognition memory in the male offsprings [<xref ref-type="bibr" rid="B204-ijms-17-02086">204</xref>]. In cultured hippocampal neurons, BPA was demonstrated the promote changes in dendritic morphology by the phosphorylation of the NMDA receptor subunit NR2B. BPA was shown to induce ERK1/2 activation at low concentrations in cerebellar granule cells and show neurotoxic effects. Recently, BPA-mediated neurodegeneration has been reported to be a result of modulation of autophagy through involvement of AMPK and mTOR pathways [<xref ref-type="bibr" rid="B205-ijms-17-02086">205</xref>]. BPA has recently been shown to disrupt insulin signaling, where glucose uptake into the CNS was affected, with increase phosphorylated tau and APP observed in male mice. The adverse effects of BPA on insulin signaling and GLUTs may contribute to the increment of p-tau and APP in the brain of adult offspring. Therefore, perinatal BPA exposure might be a risk factor for the long-term neurodegenerative changes in offspring male mice [<xref ref-type="bibr" rid="B206-ijms-17-02086">206</xref>].Phthalates have been demonstrated to induce nuclear transcription factors that are activators of telomerase reverse transcriptase (TERT), which has a role in tumor promotion [<xref ref-type="bibr" rid="B207-ijms-17-02086">207</xref>], increase levels of phospho-tau, a precursor to AD [<xref ref-type="bibr" rid="B129-ijms-17-02086">129</xref>], and affects dendritic spine density [<xref ref-type="bibr" rid="B120-ijms-17-02086">120</xref>]. Recent reviews have also indicated disruption of thyroid homeostasis, disruption of calcium signaling, peroxisome proliferator-activate receptors (PPAR) activation, and adverse lipid metabolism as other potential mechanism [<xref ref-type="bibr" rid="B208-ijms-17-02086">208</xref>].</p>
<p>NRF-1 network genes interacting with individual EED impacting Brain Health: NRF1 (synonyms: α palindromic-binding protein, α-PAL), a mammalian homolog to the P3A2 sea urchin and erect wing (ewg) Drosophila protein, is a redox sensitive transcription factor [<xref ref-type="bibr" rid="B209-ijms-17-02086">209</xref>,<xref ref-type="bibr" rid="B210-ijms-17-02086">210</xref>]. NRF-1 proteins have been shown to interact with a broad spectrum of transcription factors; and the NRF-1 recognition site is one of the seven transcription factor binding sites which are most frequently found in the proximal promoters of ubiquitous genes [<xref ref-type="bibr" rid="B8-ijms-17-02086">8</xref>,<xref ref-type="bibr" rid="B9-ijms-17-02086">9</xref>], indicating a broader spectrum of target genes for NRF-1. NRF-1 mediate oxidative stress responses by regulating the expression of genes involved in cell cycle, DNA repair, cell apoptosis and mitochondrial biogenesis. NRF1 is highly expressed in human fetal brain [<xref ref-type="bibr" rid="B10-ijms-17-02086">10</xref>]. A recent report based on ChIP Seq data from SK-N-SH human neuroblastoma cells showed that NRF1 DNA motif(s) are present in the promoters of 2470 genes [<xref ref-type="bibr" rid="B9-ijms-17-02086">9</xref>]. This study suggested that dysregulation of NRF1 and its targets may be involved in the pathogenesis of neurodegenerative diseases. Seven out of 2470 NRF1 target genes have significant relationships with several neurodegenerative conditions. For examples, NRF1 target genes- PARK2, PARK6 (PINK1), PARK7, PAELR (GPR37) are associated with Parkinson’s disease. NRF1 target genes -PSENEN AND MAPT are involved in Alzheimer’s disease. TAF4, a NRF1 target gene, is associated with Huntington’s disease. NRF1 as a potential important player in AD neighbors with five (CREB1, ESR1, NFE2L2, NOS1 and TP53) genes involved in AD [<xref ref-type="bibr" rid="B211-ijms-17-02086">211</xref>]. Levels of NRF1 and its target gene- transcription factor A of the mitochondria (TFAM) are significantly decreased in hippocampal tissues in AD autopsy brains [<xref ref-type="bibr" rid="B212-ijms-17-02086">212</xref>]. Many estrogen signaling pathway genes are NRF1 target genes, which may be also associated with neurodegenerative diseases [<xref ref-type="bibr" rid="B9-ijms-17-02086">9</xref>]. Therefore, we used the Comparative Toxicogenomics Database (CTD) based on curated information about chemical-gene/protein interactions, chemical-disease and gene-disease relationships, to analyze the gene-EDC interactions associated with both estrogen and NRF1 signaling pathways, and neurodegenerative diseases. Findings of EDCs-modified estrogen signaling and NRF1 signaling genes with exposure to natural estrogen, pharmacological estrogen, PCBs, phthalate, BPA, As, Cd, or Mn are summarized in <xref ref-type="table" rid="ijms-17-02086-t004">Table 4</xref> and <xref ref-type="table" rid="ijms-17-02086-t005">Table 5</xref> and discussed below.</p>
<p>17-β Estradiol interacting genes which are also NRF1 target genes: The CTD search results showed that there were 6695 genes related to 17-β estradiol (E2) (<xref ref-type="fig" rid="ijms-17-02086-f003">Figure 3</xref>). The 724 genes out of the 6695 E2 modified genes are NRF1 target genes (<xref ref-type="app" rid="app1-ijms-17-02086">Tables S1 and 2</xref>, <xref ref-type="fig" rid="ijms-17-02086-f003">Figure 3</xref>). Three of the common E2 and NRF1 target genes, GPR37, MAPT, and PSENEN are associated with neurodegenerative disease ([<xref ref-type="bibr" rid="B9-ijms-17-02086">9</xref>], <xref ref-type="table" rid="ijms-17-02086-t004">Table 4</xref>). <xref ref-type="table" rid="ijms-17-02086-t004">Table 4</xref> showing enriched pathway analysis revealed the top pathways associated with E2 responsive NRF1 target genes, that included: (1) Disease (86 genes); (2) Metabolism (86 genes); (3) Gene Expression (77 genes); (4) Signal Transduction (72 genes); (5) Immune System (67 genes); (6) Cell Cycle (62 genes); (7) Metabolic pathways (62 genes); (8) Metabolism of proteins (48 genes); (9) Developmental Biology (43 genes); and (10) Mitotic M-M/G1 phases (35 genes).</p>
<p>Ethinyl Estradiol Interacting genes common to both E2 and NRF1 target genes: The CTD search revealed that there were 6049 genes related to the active estrogenic chemical in oral contraceptives—ethinyl estradiol (EE) (<xref ref-type="fig" rid="ijms-17-02086-f003">Figure 3</xref>). Out of the 6049 EE modified genes, 800 genes are NRF1 target genes and 331 genes are target genes of both E2 and NRF1 (<xref ref-type="app" rid="app1-ijms-17-02086">Tables S1 and S2</xref>, <xref ref-type="fig" rid="ijms-17-02086-f003">Figure 3</xref>). Two of the genes, MAPT and PSENEN, observed interacting with all three EE, E2 and NRF1 are associated with neurodegenerative disease [<xref ref-type="bibr" rid="B9-ijms-17-02086">9</xref>]. <xref ref-type="table" rid="ijms-17-02086-t004">Table 4</xref> showing enriched pathway analysis revealed the top pathways associated with the number of common E2, E2 and NRF1 target genes, that included: (1) Metabolism (49 genes); (2) Disease (48 genes); (3) Gene Expression (43 genes); (4) Immune System (36 genes); (5) Cell Cycle (35 genes); (6) Metabolic pathways (33 genes); (7) Signal Transduction (33 genes); (8) Metabolism of Proteins (28 genes); (9) Developmental Biology (25 genes); and (10) Cancer Pathways (22 genes).</p>
<p>BPA and Interactions with NRF1 Target Genes: The CTD search revealed there are 19,113 genes related to BPA. Out of the 19,113 interacting genes, 2113 are NRF1 target genes, and 673 are target genes of both BPA and E2 (<xref ref-type="app" rid="app1-ijms-17-02086">Tables S1 and S2</xref>, <xref ref-type="fig" rid="ijms-17-02086-f003">Figure 3</xref>). Three of the genes, <italic>GPR37</italic>, <italic>MAPT</italic> and <italic>PSENEN</italic> observed interacting with all three BPA, E2, and NRF1 are associated with neurodegenerative disease [<xref ref-type="bibr" rid="B9-ijms-17-02086">9</xref>]. Enriched pathway analysis revealed the top pathways associated with number of common BPA/E2/NRF1 target genes, that included: (1) Metabolism (85 genes); (2) Disease (84 genes); (3) Gene Expression (71 genes); (4) Signal Transduction (68 genes); (5) Immune System (66 genes); (6) Cell Cycle (61 genes); (7) Metabolic Pathways (58 genes); (8) Metabolism of Proteins (47 genes); (9) Developmental Biology (41 genes), and Cancer Pathways (34 genes) (<xref ref-type="table" rid="ijms-17-02086-t004">Table 4</xref>).</p>
<p>Phthalates and Interactions with NRF1 Target Genes: The CTD search revealed there were 4816 genes interacting with dibutyl phthalate (DBP) and 1344 genes with diethylhexyl phthalate (DEHP). The 756 DBP interacting genes are NRF1 target genes, whereas 149 DEHP interacting genes are NRF1 target genes. Among DBP responsive genes, there are 309 genes common E2 and NRF1 target genes and 86 DEHP associated genes are common E2 and NRF1 target genes (<xref ref-type="app" rid="app1-ijms-17-02086">Tables S1 and S2</xref>, <xref ref-type="fig" rid="ijms-17-02086-f003">Figure 3</xref>). MAPT, a common DEHP, E2 and NRF1 target genes are associated with neurodegenerative disease [<xref ref-type="bibr" rid="B9-ijms-17-02086">9</xref>]. Enriched pathway analysis revealed the top pathways associated with number of common DBP/E2/NRF1 target genes, that included: (1) Metabolism (56 genes); (2) Disease (45 genes); (3) Gene Expression (39 genes); (4) Metabolic Pathways (38 genes); (5) Cell Cycle (34 genes); (6) Signal Transduction (32 genes); (7) Immune System (31 genes); (8) Metabolism of Proteins (25 genes); (9) Mitotic M-M/G1 phases (23 genes), and Developmental Biology (21 genes). Enriched pathway analysis of E2/NRF1/DEHP-responsive genes revealed the top pathways for gene involvement that includes: (1) Metabolism (21 genes); (2) Metabolic pathways (15 genes); (3) Disease (15 genes); (4) Immune System (12 genes), (5) Metabolism of proteins (11 genes); (6) Cell Cycle (9 genes); (7) Cellular response to stress (8 genes); (8) Cancer Pathways (8 genes); (9) Developmental Biology (8 genes); and (10) Cell cycle (5 genes) (<xref ref-type="table" rid="ijms-17-02086-t004">Table 4</xref>).</p>
<p>Polychlorinated Biphenyls and Interactions with NRF1 Target Genes: There were 648 genes interacting with polychlorinated biphenyls (PCBs). The 433 PCBs genes are NRF1 target genes, and the 53 PCBs genes are common E2 and NRF1 target genes (<xref ref-type="app" rid="app1-ijms-17-02086">Tables S1 and S2</xref>, <xref ref-type="fig" rid="ijms-17-02086-f003">Figure 3</xref>). Enriched pathway analysis of common PCBs/E2/NRF1-associated genes revealed the top pathways for gene involvement that included: (1) Cell Cycle (13 genes); (2) Mitotic M-M/G1 phases (9 genes); (3) DNA replication (4 genes); (4) Cell Cycle (4 genes); (5) DNA replication and repair (3 genes); and (6) Pancreatic cancer (3 genes) (<xref ref-type="table" rid="ijms-17-02086-t004">Table 4</xref>).</p>
<p>Cadmium and Interactions with NRF1 Target Genes: Using CTD search we found 2458 genes interacting with cadmium (Cd). The 263 Cd interacting genes are NRF1 target genes and 143 interacting genes are common E2 and NRF1 target genes (<xref ref-type="app" rid="app1-ijms-17-02086">Tables S1 and S2</xref>, <xref ref-type="fig" rid="ijms-17-02086-f003">Figure 3</xref>). <italic>GPR37</italic> gene, a common Cd/E2/NRF1 gene, is associated with neurodegenerative disease [<xref ref-type="bibr" rid="B9-ijms-17-02086">9</xref>]. Enriched pathway analysis of Cd/E2/NRF1 common genes revealed the top pathways that included: (1) Metabolism (26 genes); (2) Gene Expression (25 genes); (3) Disease (24 genes); (4) Signal Transduction (21 genes); (5) Metabolic pathways (20 genes); (6) Immune System (18 genes); (7) Cell Cycle (17 genes); (8) Cancer Pathways (15 genes); (9) Developmental Biology (15 genes) and (10) Metabolism of proteins (12 genes) (<xref ref-type="table" rid="ijms-17-02086-t004">Table 4</xref>).</p>
<p>Arsenic and Interactions with NRF1 Target Genes: The CTD search revealed there were 4037 genes related to arsenic (As). The 520 As interacting genes are NRF1 target genes and the 190 as interacting genes are common E2 and NRF1 target genes (<xref ref-type="app" rid="app1-ijms-17-02086">Tables S1 and S2</xref>, <xref ref-type="fig" rid="ijms-17-02086-f003">Figure 3</xref>). Enriched pathway analysis of As/E2/NRF1 common genes revealed the top pathways that included: (1) Metabolism (33 genes); (2) Immune System (30 genes); (3) Disease (27 genes); (4) Signal Transduction (24 genes); (5) Developmental Biology (22 genes); (6) Metabolic pathways (20 genes); (7) Cell Cycle (19 genes); (8) Gene Expression (19 genes); (9) Cancer Pathways (17 genes); and (10) Cellular responses to stress (16 genes) (<xref ref-type="table" rid="ijms-17-02086-t004">Table 4</xref>).</p>
<p>Manganese and Interactions with NRF1 Target Genes: Using CTD search we found 462 genes interacting with manganese (Mn). The 50 Mn interacting genes are NRF1 target genes and the 30 Mn interacting genes are common E2 and NRF1 target genes (<xref ref-type="app" rid="app1-ijms-17-02086">Tables S1 and S2</xref>, <xref ref-type="fig" rid="ijms-17-02086-f003">Figure 3</xref>). Enriched pathway analysis of common Mn/E2/NRF1 genes revealed the top pathways that included: (1) Cellular responses to stress (6 genes); (2) Developmental Biology (5 genes); (3) Tuberculosis (4 genes); (4) p53 signaling pathway (3 genes), Small cell lung cancer (3 genes), Apoptosis (3 genes), Cell cycle (3 genes) (<xref ref-type="table" rid="ijms-17-02086-t004">Table 4</xref>).</p>
<p>Association of EED interacting genes common to both E2 and NRF1 targets with Neurodegenerative Diseases: <xref ref-type="table" rid="ijms-17-02086-t005">Table 5</xref> as well as <xref ref-type="app" rid="app1-ijms-17-02086">Tables S1 and S2</xref> summarize EEDs modified genes, which are common E2 and NRF1 target genes and their involvement with the specific type of brain disease, such as AD, PD, HD, ALS, Autism Spectrum Disorder, and Brain Neoplasms. Out of the 6643 E2 interacting genes, there were 1413 genes associated with nervous system disease.</p>
<p>The CTD search of E2 interacting genes in AD revealed 61 genes: <italic>ACE</italic>, <italic>ACHE</italic>, <italic>AMFR</italic>, <italic>APBB2</italic>, <italic>APOE</italic>, <italic>APP</italic>, <italic>ARC</italic>, <italic>ATP5A1</italic>, <italic>BAX</italic>, <italic>BCHE</italic>, <italic>BCL2</italic>, <italic>BDNF</italic>, <italic>BIN1</italic>, <italic>CALM1</italic>, <italic>CASP3</italic>, <italic>CHRNA7</italic>, <italic>CHRNB2</italic>, <italic>CLU</italic>, <italic>CRH</italic>, <italic>CYP46A1</italic>, <italic>DHCR24</italic>, <italic>DPYSL2</italic>, <italic>EIF2S1</italic>, <italic>ENO1</italic>, <italic>EPHA1</italic>, <italic>ESR1</italic>, <italic>F2</italic>, <italic>GAPDHS</italic>, <italic>GSK3B</italic>, <italic>HFE</italic>, <italic>HMOX1</italic>, <italic>IGF1</italic>, <italic>IGF1R</italic>, <italic>IGF2</italic>, <italic>IGF2R</italic>, <italic>IL1B</italic>, <italic>INS</italic>, <italic>INSR</italic>, <italic>LEP</italic>, <italic>MAOB</italic>, <italic>MAPT</italic>, <italic>MIR146A</italic>, <italic>MPO</italic>, <italic>NOS3</italic>, <italic>NPY</italic>, <italic>PAXIP1</italic>, <italic>PICALM</italic>, <italic>PLAU</italic>, <italic>PPARG</italic>, <italic>PRNP</italic>, <italic>PSEN2</italic>, <italic>SLC2A4</italic>, <italic>SOD2</italic>, <italic>SORL1</italic>, <italic>TF</italic>, <italic>TFAM</italic>, <italic>TNF</italic>, <italic>TPI1</italic>, <italic>TREM2</italic>, <italic>VEGFA</italic>, <italic>VSNL</italic>. The bold indicates E2 interacting genes which are NRF1 target genes. With AD, the six E2-responsive genes are NRF1 target genes: <italic>APBB2</italic>, <italic>DPYSL2</italic>, <italic>EIF2S1</italic>, <italic>ENO1</italic>, <italic>MAPT</italic>, and <italic>PAXIP1</italic>. These genes are also responsive to the following EEDCs: ethinyl estradiol (<italic>APBB2</italic>, <italic>DPYSL2</italic>, <italic>EIF2S1</italic>, <italic>ENO1</italic>, <italic>MAPT</italic>, and <italic>PAXIP1</italic>), BPA (<italic>APBB2</italic>, <italic>EIF2S1</italic>, <italic>ENO1</italic>, <italic>MAPT</italic>, and <italic>PAXIP1</italic>), dibutyl phthalate (<italic>DPYSL2</italic>, <italic>EIF2S1</italic>, <italic>ENO1</italic>), diethylhexyl phthalate (<italic>DPYSL2</italic> and <italic>MAPT</italic>), cadmium (<italic>ENO1</italic>), arsenic (<italic>ENO1</italic> and <italic>MAPT</italic>), and manganese (<italic>MAPT</italic>) (<xref ref-type="table" rid="ijms-17-02086-t005">Table 5</xref>).</p>
<p>With PD, the 8 E2-responsive NRF1 target genes are: <italic>GAK</italic>, <italic>HSPA9</italic>, <italic>MAPT</italic>, <italic>PARK2</italic>, <italic>PARK7</italic>, <italic>PINK1</italic>, <italic>RPL14</italic>, <italic>AND VPS35</italic>. These genes are also responsive to the following EEDCs: ethinyl estradiol (<italic>HSPA9, MAPT</italic>), BPA (<italic>HSPA9</italic>, <italic>MAPT</italic>, <italic>RPL14</italic>), dibutyl phthalate (<italic>HSPA9</italic>, <italic>RPL14</italic>), diethylhexyl phthalate (<italic>HSPA9</italic>, <italic>MAPT</italic>), cadmium (<italic>RPL14</italic>), and arsenic <italic>(HSPA9</italic>, <italic>MAPT</italic>) (<xref ref-type="table" rid="ijms-17-02086-t005">Table 5</xref>). The CTD search revealed that PCBs-interacting 9 genes: <italic>HMOX1</italic>, <italic>IL6</italic>, <italic>NQO1</italic>, <italic>RPS8</italic>, <italic>SLC18A2</italic>, <italic>SNCA</italic>, <italic>SOD1</italic>, <italic>SOD2</italic>, <italic>TNF</italic> are associated with Parkinson Disease. Both SOD and TNF E2 interacting genes are NRF1 target genes.</p>
<p>With HD, the 2 E2-responsive NRF1 target genes are: <italic>AIFM1</italic> and <italic>IP6K2</italic>. These genes are also responsive to the following EEDCs: ethinyl estradiol (<italic>AIFM1</italic>), BPA (<italic>AIFM1</italic> and <italic>IP6K2</italic>), dibutyl phthalate (<italic>IP6K2</italic>), cadmium (<italic>AIFM1</italic>), and arsenic (<italic>IP6K2</italic>) (<xref ref-type="table" rid="ijms-17-02086-t005">Table 5</xref>).</p>
<p>With ALS, the E2-responsive NRF1 target genes are <italic>CHMP2B</italic> and <italic>GSR</italic>. These genes are also responsive to the following EEDCs: ethinyl estradiol (<italic>GSR</italic>), BPA (<italic>GSR</italic> and <italic>CHMP2B</italic>), dibutyl phthalate (<italic>GSR</italic>), diethylhexyl phthalate (<italic>GSR</italic>), cadmium (<italic>GSR</italic>), and arsenic (<italic>GSR</italic>) (<xref ref-type="table" rid="ijms-17-02086-t005">Table 5</xref>).</p>
<p>With ASD, the E2-responsive NRF1 target genes are <italic>CIRBP</italic>, <italic>PCDH9</italic>, and <italic>GTF2I</italic>. These genes are also responsive to the following EEDCs: ethinyl estradiol (<italic>CIRBP</italic> and <italic>GTF2I</italic>), BPA (<italic>CIRBP</italic>, <italic>GTF2I</italic>, and <italic>PCDH9</italic>), polychlorinated biphenyls (<italic>CIRBP</italic>), cadmium (<italic>CIRBP</italic>), and arsenic (<italic>PCDH9</italic>) (<xref ref-type="table" rid="ijms-17-02086-t005">Table 5</xref>).</p>
<p>With brain neoplasms, the E2-responsive NRF1 target genes are <italic>PCNA</italic>, <italic>PTCH1</italic>, and <italic>RELA</italic>. These genes are also responsive to the following EEDCs: ethinyl estradiol (<italic>PCNA</italic> and <italic>PTCH1</italic>), BPA (<italic>PCNA</italic> and <italic>RELA</italic>), dibutyl phthalate (<italic>PCNA</italic> and <italic>PTCH1</italic>), cadmium (<italic>RELA</italic>), arsenic (<italic>PCNA</italic> and <italic>PTCH1</italic>), and manganese (<italic>RELA</italic>) (<xref ref-type="table" rid="ijms-17-02086-t005">Table 5</xref>).</p>
<sec id="sec3dot1-ijms-17-02086">
<title>3.1. NRF1, Mitochondrial Dysfunction, and Neurodegenerative Diseases</title>
<p>Mitochondria are known as the powerhouses of cells. They are important for cell viability and function [<xref ref-type="bibr" rid="B213-ijms-17-02086">213</xref>]. They control cell process such as energy production, calcium signaling, and apoptosis [<xref ref-type="bibr" rid="B213-ijms-17-02086">213</xref>]. Research has suggested that mitochondrial dysfunction is a cause and not a result of neurodegenerative diseases [<xref ref-type="bibr" rid="B214-ijms-17-02086">214</xref>]. It is suggested mitochondrial dysfunction plays a major role, in AD, PD, HD, and ALS through the oxidative phosphorylation dysfunction [<xref ref-type="bibr" rid="B202-ijms-17-02086">202</xref>]. Mitochondrial dysfunction may also increase ROS generation, cause abnormal protein-protein interactions, and may lead to loss of cellular integrity and cell death [<xref ref-type="bibr" rid="B215-ijms-17-02086">215</xref>]. There is also evidence to suggest mitochondrial dysfunction may play a role in neuronal plasticity and maintenance [<xref ref-type="bibr" rid="B215-ijms-17-02086">215</xref>]. Sex steroids have been observed to regulate mitochondrial function [<xref ref-type="bibr" rid="B216-ijms-17-02086">216</xref>], and provide targets for EEDs such as BPA, phthalates, polychlorinated biphenyls, metals, oral contraceptives, and hormonal replacement therapies [<xref ref-type="bibr" rid="B5-ijms-17-02086">5</xref>]. NRF1 regulates the expression of nuclear genes that encode that encode mitochondrial proteins that function in metabolic pathways such as the trichloroacetic acid cycle (TCA), oxidative phosphorylation, heme synthesis, and in mitochondrial DNA replication and transcription (e.g., mitochondrial transcription factor A [Tfam] [<xref ref-type="bibr" rid="B9-ijms-17-02086">9</xref>,<xref ref-type="bibr" rid="B217-ijms-17-02086">217</xref>]. For example, NRF1 and NRF2 are regulators of all 13 COX subunit genes in neurons which are integral to mitochondrial function [<xref ref-type="bibr" rid="B218-ijms-17-02086">218</xref>]. By generating energy (ATP), and regulating subcellular Ca<sup>2+</sup> and redox homoeostasis through modulating mitochondria biogenesis genes as well as neuroplasticity regulating genes, NRF1 may play important roles in controlling fundamental processes in neuroplasticity, including neural differentiation, neurite outgrowth, neurotransmitter release and dendritic remodeling. Since mitochondrial dysfunction has been implicated as a possible pathway for neurodegenerative diseases [<xref ref-type="bibr" rid="B214-ijms-17-02086">214</xref>], gene targets of NRF-1 directly affect brain health and may provide insight into mechanisms of these diseases. PGC1α acts as a master inducer of mitochondrial biogenesis and respiration through regulating NRF1. PGC1α has also been implicated in Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and Duchenne muscular dystrophy. In ALS patients and mice, significant alterations in mRNA expression of PGC-1α, NRF1, NRF2, and Tfam were observed [<xref ref-type="bibr" rid="B219-ijms-17-02086">219</xref>]. The PGC-1 transcription impairment in the striatum and a significant decrease of PGC-1 and PGC-1A but unchanged NRF-1 and Tfam mRNA expression in muscle tissue have been reported in HD patients [<xref ref-type="bibr" rid="B220-ijms-17-02086">220</xref>,<xref ref-type="bibr" rid="B221-ijms-17-02086">221</xref>]. In a mouse model of HD, decreased mRNA expression of PGC-1 and Tfam in muscle tissue correlated with reduced numbers of mitochondria, whereas PGC-1A, NRF-1, and further downstream target genes were not significantly reduced [<xref ref-type="bibr" rid="B220-ijms-17-02086">220</xref>]. These observations have led to the suggestion that the progressive muscle atrophy and morphologic abnormalities of neuromuscular junctions that occur in HD mice could be a consequence of impaired PGC-1 and target gene expression [<xref ref-type="bibr" rid="B220-ijms-17-02086">220</xref>]. PGC-1, NRF1, and MnSOD are mainly localized in neurons suggests that these protective effects are of neuronal rather than glial origin. Expression of PGC1α is reduced in AD patients and in the transgenic 2576 mouse model of AD [<xref ref-type="bibr" rid="B222-ijms-17-02086">222</xref>,<xref ref-type="bibr" rid="B223-ijms-17-02086">223</xref>,<xref ref-type="bibr" rid="B224-ijms-17-02086">224</xref>,<xref ref-type="bibr" rid="B225-ijms-17-02086">225</xref>]. Importantly, PGC1α in cell models of AD ameliorates their phenotype [<xref ref-type="bibr" rid="B212-ijms-17-02086">212</xref>,<xref ref-type="bibr" rid="B224-ijms-17-02086">224</xref>]. Since levels of NRF1 are significantly decreased in both Alzheimer’s disease hippocampal tissues and AD-causing amyloid precursor protein mutant cells, impaired mitochondrial biogenesis is implicated to contribute to mitochondrial dysfunction in Alzheimer’s disease. NRF-1 has the ability to distinctly co-ordinate mitochondrial functions by tailoring nucleo-mitochondrial interactions to a specific cellular context, such as differentiation, stress stimulus and cell lineage. Furthermore, expression of PGC1-α, NRF1, NRF2, and transcription factor A were found to be significantly reduced in both AD hippocampal tissue as well as APPswe M17 cells which overexpress APP protein, which supports impaired mitochondrial biogenesis likely contributes to mitochondrial dysfunction [<xref ref-type="bibr" rid="B212-ijms-17-02086">212</xref>]. When mtDNA contained within mitochondria undergoing phagocytosis is considered into account, it appears that total hippocampal neuron mtDNA may actually increase [<xref ref-type="bibr" rid="B226-ijms-17-02086">226</xref>]. Increased mitochondrial mass or mitochondrial mass markers have been observed in the AD hippocampus of the healthiest remaining neurons that paradoxically appear to be increased [<xref ref-type="bibr" rid="B227-ijms-17-02086">227</xref>]. Considering these disparate findings suggesting that neuron mitochondrial mass or mitochondrial mass markers increase with advancing age, Swerdlow suggested a physiologic difference between brain aging and the AD brain, which is the ability of healthy hippocampal neurons to adapt to mitochondrial stress by mounting a compensatory mitochondrial biogenesis response [<xref ref-type="bibr" rid="B228-ijms-17-02086">228</xref>,<xref ref-type="bibr" rid="B229-ijms-17-02086">229</xref>,<xref ref-type="bibr" rid="B230-ijms-17-02086">230</xref>].</p>
</sec>
<sec id="sec3dot2-ijms-17-02086">
<title>3.2. NRF1-Mediated Regulation of Neurogenesis and Synaptogenesis</title>
<p>Estrogen has been demonstrated to have a significant role in controlling neural progenitors in the developing embryonic brain. Estrogen has been shown to induce proliferation and differentiation of neural progenitor [<xref ref-type="bibr" rid="B231-ijms-17-02086">231</xref>,<xref ref-type="bibr" rid="B232-ijms-17-02086">232</xref>,<xref ref-type="bibr" rid="B233-ijms-17-02086">233</xref>]. Neural progenitors have also been demonstrated to express estrogen receptors [<xref ref-type="bibr" rid="B232-ijms-17-02086">232</xref>,<xref ref-type="bibr" rid="B233-ijms-17-02086">233</xref>], which provide a site in EEDCs to exert their effects. EEDCs have been shown to cross the placental and blood brain barrier [<xref ref-type="bibr" rid="B6-ijms-17-02086">6</xref>], but the mechanisms regarding the effects on the early stages of neural development are largely not known. Studies suggest neural development is affected by exposures to EEDCs. Low-dose exposure to BPA and BPS has been shown to induce hypothalamic neurogenesis in an embryonic zebrafish at a point in time analogous to the second trimester of human development [<xref ref-type="bibr" rid="B77-ijms-17-02086">77</xref>]. Several classes of phthalates were shown to prevent neural stem cell proliferation in a rat mesencephalic stem cell model [<xref ref-type="bibr" rid="B234-ijms-17-02086">234</xref>]. Polychlorinated biphenyls have also been demonstrated to interfere with neuronal cell differentiation in a rat embryonic neural stem cell model [<xref ref-type="bibr" rid="B235-ijms-17-02086">235</xref>]. Arsenic was shown to substantially inhibit neuronal differentiation in human embryonic neural stem cells [<xref ref-type="bibr" rid="B236-ijms-17-02086">236</xref>]. Manganese has also been demonstrated to cause cell death in a rat neural stem cell model through a mitochondrial-mediated pathway [<xref ref-type="bibr" rid="B237-ijms-17-02086">237</xref>]. Both neurogenesis and synaptogenesis are controlled by NRF1 regulated genes. We now know that multipotent adult neural stem cells (NSCs) have differentiation potential to give rise to all three main neuronal cell types, the neurons, astrocytes and oligodendrocytes. Multipotent adult neuronal stem cells (NSCs) through neurogenesis (birth of brain cells or the process by which brain cells are generated from neural stem cells and progenitor cells) replenish loss of cells in discrete regions of the human brain. A decreased rate of neurogenesis as a result of impairment in NSCs with increasing age in the adult brains of human is considered to contribute to the neurodegenerative process and subsequently resulting in memory deficits and learning impediments during the pathogenesis of Alzheimer’s disease. Cholinergic neurons of the forebrain are most affected by the neurodegenerative process during the pathogenesis of Alzheimer’s disease. Neuronal loss is one of the neuropathological hallmarks of AD. The control of stem cell homeostasis within tissues such as the balance between proliferation, differentiation, apoptosis and senescence is strictly linked to the regulation of tissue repair and regeneration. It has been recently reported that estrogen helps in growth, survival and differentiation of either embryonic stem cells or tissue-specific stem/progenitor cells. New adult stem cells (ASCs) replenishing losses due to neurodegenerative processes underlying AD. EEDs may interfere with new neural stem cells generation. The generation of new neurons from neural progenitor stem cells, the growth of axons and dendrites and the formation and reorganization of synapses are examples of neuroplasticity. All these processes seem to be regulated by nuclear respiratory factor 1 (NRF1) target network genes. For example, recently, it has been shown that NRF1 regulates neurite outgrowth—a critical process in neuronal development in neuroblastoma cells and hippocampal neurons by regulating its target gene, Synapsin 1 [<xref ref-type="bibr" rid="B238-ijms-17-02086">238</xref>]. Another fifteen genes involved in different biological processes of neurons, cell cycle-related genes—<italic>MAPRE3</italic>, <italic>NPDC1</italic>, <italic>SUV39H2</italic>, <italic>SKA3</italic>, transport-related genes—<italic>RAB3IP</italic>, <italic>TRAPPC3</italic>, signal transduction-related genes—<italic>SMAD5</italic>, <italic>PIP5K1A</italic>, <italic>USP10</italic>, <italic>SPRY4</italic>, transcription-related genes—<italic>GTF2F2</italic>, <italic>NR1D1</italic>, and regulation of GTPase activity-related genes—<italic>RHOA</italic>, <italic>RAPGEF6</italic>, <italic>SMAP1</italic>, have been reported to contain NRF1 binding motif(s) in their promoters and mRNA levels of 12 of these genes are regulated by NRF-1 [<xref ref-type="bibr" rid="B239-ijms-17-02086">239</xref>]. Overexpression or knockdown of MAPRE3, NPDC1, SMAD5, USP10, SPRY4, GTF2F2, SKA3, RAPGEF6 positively regulates, where as RHOA and SMAP1 negatively regulates neurite outgrowth. Three hypothetical genes—<italic>FAM134C</italic>, <italic>C3orf10</italic>, and <italic>ENOX1</italic> involved in neurite outgrowth are regulated by NRF1. FAM134C positively regulates and C3orf10 negatively regulates neurite outgrowth [<xref ref-type="bibr" rid="B240-ijms-17-02086">240</xref>]. In summary, it appears that NRF-1 regulates neurite outgrowth through cell cycle-, transport-, signal transduction-, transcription-, regulation of GTPase activity-related genes and hypothetical genes. This suggests that NRF1 regulates neuronal differentiation through a variety of biological processes.</p>
<p>NMDA receptors are very important for regulating neuronal plasticity including learning and memory. Soluble β-amyloid (Aβ) oligomers (Aβ), considered to be involved in the pathogenesis of Alzheimer’s disease (AD), have been reported to influence synaptic dysfunction through interacting with glutamatergic receptors of the NMDA type responsible for maintaining glutamate homeostasis such as uptake and release [<xref ref-type="bibr" rid="B241-ijms-17-02086">241</xref>]. There is a clinical relevance of above interactions based on the NMDA receptor antagonist- memantine. This NMDA receptor antagonist is used clinically in the treatment of AD. NRF1 has recently been shown to functionally regulate important subunits of NMDA receptors—NR1 and NR2b (Grin1 and Grin2b) and AMPA receptor subunit 2 (GluR2) [<xref ref-type="bibr" rid="B242-ijms-17-02086">242</xref>] in response to changing neuronal activity. NRF1 and NRF2 have been shown to concurrently regulate both GRIN1 and GRIN2B [<xref ref-type="bibr" rid="B243-ijms-17-02086">243</xref>]. The <italic>GRIN2B</italic> gene which encodes NMDA receptor subunit NR2B has been suspected to play a role in the development of AD [<xref ref-type="bibr" rid="B244-ijms-17-02086">244</xref>] which makes its relationship with NRF1 a possible route of neurodegeneration. Evidence suggests that the DNA methylation competes with transcriptions factors [<xref ref-type="bibr" rid="B245-ijms-17-02086">245</xref>], which may indicate a possible mechanism for neurodegenerative conditions to take place, if NRF1 binding is affected. NRF1 has also been demonstrated to interact with macroH2A histone which stabilizes and positions nucleosomes and reduces transcriptional variability [<xref ref-type="bibr" rid="B246-ijms-17-02086">246</xref>]. NRF1 has also been shown to work with chromosomal conformations to facilitate the expression of GRIN2B, which when affected, results in impairments in working memory [<xref ref-type="bibr" rid="B247-ijms-17-02086">247</xref>]. NRF1 also has a role in the transport of NMDA receptors to dendrites by regulating the Kif17 gene [<xref ref-type="bibr" rid="B248-ijms-17-02086">248</xref>]. This suggests that NRF1 is actively involved in the regulation of glutamatergic synaptic transmission in neurons and also possibly in brain diseases.</p>
<p>In vitro and in vivo BPA exposure via disrupting a chloride ion transporter Kcc2 gene expression in neurons through epigenetic mechanisms involving NRF1 target gene- Methyl-CpG binding protein 2 (MeCp2) is considered to be involved neurodevelopmental toxicity. This could possibly help to explain a NRF1 role in BPA-associated pathogenesis of human neurodevelopmental disorders [<xref ref-type="bibr" rid="B249-ijms-17-02086">249</xref>].</p>
<p>In a study examining the effects of manganese exposure with HT disease pathology, manganese exposure adversely affects medium spiny neuron dendritic length and spine density which is associated with a decrease brain-derived neurotrophic factor which caused alterations in the Htt gene which causes HT [<xref ref-type="bibr" rid="B250-ijms-17-02086">250</xref>]. In study using a monkey model, exposure to manganese was shown to promote α-synuclein positive cells, which indicate the development of PD and dementia [<xref ref-type="bibr" rid="B251-ijms-17-02086">251</xref>]. Another study using a monkey model found the amyloid-β precursor-like protein 1 (APLP1), and indicator in the development of AD, was upregulated when exposed to manganese [<xref ref-type="bibr" rid="B252-ijms-17-02086">252</xref>]</p>
<p>The accumulation of the β-amyloid protein outside neurons and an abnormal form of the protein tau inside neurons are considered to contribute to the development of Alzheimer’s. During the progression of Alzheimer’s disease, chemical transfer at synapses begins to fail, the number of synapses declines, and neurons eventually die. All these processes seem to be regulated by nuclear respiratory factor 1 (NRF1) target network genes. In addition to the regulation of neuroplasticity controlling genes, PSENEN (PEN2), a component of the γ-secretase complex, APLP1 (an isoform of APP) and MAPT (tau) are three principal NRF1 target genes directly associated with the development Alzheimer’s [<xref ref-type="bibr" rid="B9-ijms-17-02086">9</xref>]. All three proteins—APP, presenilin-1 and tau are considered to play important roles in developmental and synaptic plasticity, and alterations in these proteins have been shown to modulate neurogenesis and synaptic plasticity [<xref ref-type="bibr" rid="B253-ijms-17-02086">253</xref>]. The suppression of NRF-1 activity can induce neurodegeneration through growth arrest and increases in apoptosis and reduces growth and survival of neural stem cells. Therefore, NRF1 is an emerging potential target for therapeutic intervention for brain diseases, including AD.</p>
</sec>
<sec id="sec3dot3-ijms-17-02086">
<title>3.3. Understanding Sex Bias and NRF1 Regulated Genes-EEDs Interactions in AD</title>
<p>Sex differences in nervous system diseases, such as multiple sclerosis, Parkinson’s disease, and Alzheimer’s disease, exist in prevalence, severity, and progression of pathologies and consequently has become a major obstacle for the treatment. Cognitive disturbances are frequent in brain health deficit-related disease. Men show greater cognitive impairment in schizophrenia, whereas women show more severe dementia and cognitive decline with Alzheimer’s disease. Low dose of raloxifene exposure to BPA alters the expression of hypothalamic ERα and ERβ (Esr1 and Esr2) expression in a sex-specific manner in the developing brain [<xref ref-type="bibr" rid="B254-ijms-17-02086">254</xref>].</p>
<p>Menopausal hormone therapy (HT; 0.625 mg/day conjugated equine estrogens (CEE) therapy alone (CEE-Alone) and in combination with 2.5 mg/day medroxyprogesterone acetate (CEE + MPA)) has recently been shown to produce significant Gray Matter (GM) losses compared to the placebo groups in the anterior cingulate and the adjacent medial frontal gyrus, and the orbitofrontal cortex and risk for cognitive impairment and dementia in older women [<xref ref-type="bibr" rid="B255-ijms-17-02086">255</xref>].</p>
<p>Alzheimer’s disease (AD) disproportionally affects women (F:M = 2:1) and the total number of Americans aged 65 y with AD is projected to increase from 5.1 million to 13.8 million by 2050. Despite tremendous progress in understanding the pathogenesis of AD, the molecular basis underlying the sex-dependent differences in AD remains largely unknown and consequently has become a major obstacle for the development of new sex-based molecular targets of AD. Hormone replacement therapy (HRT) and anti-estrogen therapy (raloxifene) are focused on circulating estrogens, as measured by blood levels, but not based on brain estrogen levels. This is one of the main reasons why such endocrine therapy is unable to produce a significant beneficial effect in human AD [<xref ref-type="bibr" rid="B256-ijms-17-02086">256</xref>]. There is only one study in which human brain levels of estrogens have been measured; and these hormones do not change significantly with age in postmenopausal women, rather estradiol (E2) showed an increasing trend from age 60–100 years [<xref ref-type="bibr" rid="B257-ijms-17-02086">257</xref>]. There is no change in brain levels of E2 in the male 60–79 years age range. In contrast, preclinical data are ample and unequivocal that brain estrogen deficiency induces Alzheimer’s pathology, and early E2 treatment, not late treatment, prevents AD pathologies in APP transgenic mice [<xref ref-type="bibr" rid="B258-ijms-17-02086">258</xref>]. It is not clear why a sex-specific bias occurs in AD, even though brain hormone levels are similar between the two sexes. NRF1 targets have been shown to have roles in the development of AD. The NMDA receptor subunit GRIN1 and GRIN2B, have been shown to be regulated by NRF-1 [<xref ref-type="bibr" rid="B243-ijms-17-02086">243</xref>]. GRIN1 and PSD-95 protein were found to be significantly increased in AD cases compared to controls and were found in areas of the brain that were reactive for anti-tau antibody AD2 [<xref ref-type="bibr" rid="B259-ijms-17-02086">259</xref>]. A variant of GRIN2B was found to be overexpressed in AD patients and individuals with mild cognitive impairment [<xref ref-type="bibr" rid="B260-ijms-17-02086">260</xref>] and may induce lower GRIN2B transcriptional activity as well as NR2B protein expression, which are associated with AD [<xref ref-type="bibr" rid="B261-ijms-17-02086">261</xref>]. Other studies support this connection where AB peptides were shown to decrease the number and activity of NMDA receptors [<xref ref-type="bibr" rid="B262-ijms-17-02086">262</xref>]. Another study found neurons from AD cases had significantly less mtDNA gene copy numbers from PCR methods compared to controls as well as lessened gene expression of mitobiogenesis factors such as NRF1, NRF2, EER α, and TFAM and the master regulator PGC1 α [<xref ref-type="bibr" rid="B263-ijms-17-02086">263</xref>]. Another NRF1 target, prsenilin-2 (PSEN2), an AD-related gene was shown to have increased activity when an overexpression of EGR-1 is takes place [<xref ref-type="bibr" rid="B264-ijms-17-02086">264</xref>]. This provides the evidence that NRF1 may also have a role in the regulation of PSEN2. Evidence also suggests the regulation of the transcription factor EGR-1 may be regulated by APP, which may play a role in AD development and memory formation [<xref ref-type="bibr" rid="B265-ijms-17-02086">265</xref>]. Mutations in NRF1 targets PSEN1 and PSEN2 may also lead to the development of neurodegenerative disease [<xref ref-type="bibr" rid="B266-ijms-17-02086">266</xref>,<xref ref-type="bibr" rid="B267-ijms-17-02086">267</xref>,<xref ref-type="bibr" rid="B268-ijms-17-02086">268</xref>]. In addition PSEN1 and PSEN2 transcription, expression, promoter activity, and mRNA levels are influenced by the PARKIN protein [<xref ref-type="bibr" rid="B269-ijms-17-02086">269</xref>]. PARKIN inactivation as well as PGC-1 α and NRF1 repression is a possible mechanism for neurodegeneration [<xref ref-type="bibr" rid="B270-ijms-17-02086">270</xref>].</p>
<p>Many genes modified by EEDs are common targets of both (E2) and NRF1 and some of these genes are involved with the specified brain diseases. Therefore, using NRF1-EDC interacting genes identified from CTD (<xref ref-type="table" rid="ijms-17-02086-t004">Table 4</xref>), we focused our efforts on AD and conducted enrichment pathway analysis, which revealed that many of the NRF1 target genes interacting with each specific EEDC and they are part of pathway of AD (<xref ref-type="fig" rid="ijms-17-02086-f004">Figure 4</xref>, <xref ref-type="fig" rid="ijms-17-02086-f005">Figure 5</xref>, <xref ref-type="fig" rid="ijms-17-02086-f006">Figure 6</xref>, <xref ref-type="fig" rid="ijms-17-02086-f007">Figure 7</xref>, <xref ref-type="fig" rid="ijms-17-02086-f008">Figure 8</xref>, <xref ref-type="fig" rid="ijms-17-02086-f009">Figure 9</xref> and <xref ref-type="fig" rid="ijms-17-02086-f010">Figure 10</xref>). Enrichment pathway analysis was performed using Cytoscape and Genemania. The search of enriched pathways showed that top 10 E2 interacting genes in AD: <italic>APOE</italic>, <italic>APP</italic>, <italic>ATP5A1</italic>, <italic>CALM1</italic>, <italic>CASP3</italic>, <italic>GSK3B</italic>, <italic>IL1B</italic>, <italic>MAPT</italic>, <italic>PSEN2</italic> and <italic>TNF</italic> underlie the enrichment of the Kyoto Encyclopedia of Genes and Genomes (KEGG) Alzheimer’s disease pathway. With AD, the six E2-responsive genes are NRF1 target genes: <italic>APBB2</italic>, <italic>DPYSL2</italic>, <italic>EIF2S1</italic>, <italic>ENO1</italic>, <italic>MAPT</italic>, and <italic>PAXIP1</italic>. These genes are also responsive to the following EEDs: ethinyl estradiol (<italic>APBB2</italic>, <italic>DPYSL2</italic>, <italic>EIF2S1</italic>, <italic>ENO1</italic>, <italic>MAPT</italic>, and <italic>PAXIP1</italic>) <italic>BPA</italic> (<italic>APBB2</italic>, <italic>EIF2S1</italic>, <italic>ENO1</italic>, <italic>MAPT</italic>, and <italic>PAXIP1</italic>), dibutyl phthalate (<italic>DPYSL2</italic>, <italic>EIF2S1</italic>, <italic>ENO1</italic>), diethylhexyl phthalate (<italic>DPYSL2</italic> and <italic>MAPT</italic>), dibutyl phthalate (<italic>DPYSL2</italic>, <italic>EIF2S1</italic>, <italic>ENO1</italic>) (<xref ref-type="fig" rid="ijms-17-02086-f005">Figure 5</xref>, <xref ref-type="fig" rid="ijms-17-02086-f006">Figure 6</xref>, <xref ref-type="fig" rid="ijms-17-02086-f007">Figure 7</xref>, <xref ref-type="fig" rid="ijms-17-02086-f008">Figure 8</xref>, <xref ref-type="fig" rid="ijms-17-02086-f009">Figure 9</xref> and <xref ref-type="fig" rid="ijms-17-02086-f010">Figure 10</xref>, <xref ref-type="table" rid="ijms-17-02086-t005">Table 5</xref>). GO annotations of E2 and NRF1 enrichment network genes of EEDs revealed multiple common E2 and NRF1 genes associated with carbohydrate metabolic pathways, which was common among all EEDs (<xref ref-type="fig" rid="ijms-17-02086-f004">Figure 4</xref>, <xref ref-type="fig" rid="ijms-17-02086-f005">Figure 5</xref>, <xref ref-type="fig" rid="ijms-17-02086-f006">Figure 6</xref>, <xref ref-type="fig" rid="ijms-17-02086-f007">Figure 7</xref>, <xref ref-type="fig" rid="ijms-17-02086-f008">Figure 8</xref>, <xref ref-type="fig" rid="ijms-17-02086-f009">Figure 9</xref> and <xref ref-type="fig" rid="ijms-17-02086-f010">Figure 10</xref>). Other two biological process pathways showing association with multiple common E2 and NRF1 genes interacting with E2, EE, BPA or phthalates were translation (translation initiation, translation initiation factory activity and translation factory activity, nucleic acid binding) and glial/oligodendrocytes growth and differentiation (<xref ref-type="fig" rid="ijms-17-02086-f004">Figure 4</xref>, <xref ref-type="fig" rid="ijms-17-02086-f005">Figure 5</xref>, <xref ref-type="fig" rid="ijms-17-02086-f006">Figure 6</xref>, <xref ref-type="fig" rid="ijms-17-02086-f007">Figure 7</xref> and <xref ref-type="fig" rid="ijms-17-02086-f008">Figure 8</xref>). To validate findings from CTD curated data, we conducted Bayesian network (BN) analysis [<xref ref-type="bibr" rid="B271-ijms-17-02086">271</xref>] of microarray data of 79 subjects of male (15 AD patients, 17 control) and female (17 AD patients, 30 controls) from Gene Expression Omnibus (GEO) database [<xref ref-type="bibr" rid="B272-ijms-17-02086">272</xref>] showed that the female NRF1 gene network is completely different from male human AD patients (<xref ref-type="fig" rid="ijms-17-02086-f011">Figure 11</xref>). For BN analysis, we have first identified 827 genes that showed significant correlations with NRF1 gene expression pattern among 79 subjects.</p>
<p>We used Banjo [<xref ref-type="bibr" rid="B273-ijms-17-02086">273</xref>] to identify the most likely BN given the male and female data. <xref ref-type="fig" rid="ijms-17-02086-f011">Figure 11</xref> shows the summarized BN where for each gene, State 0, 1, and 2 represent low expression, no change, and high expression respectively; and for Alzheimer, State 0 and 1 represent a control subject and a subject with AD respectively. When we analyzed only hippocampal microarray, we observed that both gender and NRF1 were associated with AD (<xref ref-type="fig" rid="ijms-17-02086-f012">Figure 12</xref> and <xref ref-type="fig" rid="ijms-17-02086-f013">Figure 13</xref>). The invertebrate NRF1 homologue, EWG, controls transcription of neuronal genes in Drosophila embryos [<xref ref-type="bibr" rid="B210-ijms-17-02086">210</xref>]. A strong association of NRF1with human fetal brain and neural development has been recently reported [<xref ref-type="bibr" rid="B208-ijms-17-02086">208</xref>]. NRF1 regulates neurite outgrowth. NRF1 regulates important subunits of NMDA receptors—NR1 and NR2b (Grin1 and Grin2b) and AMPA receptor subunit 2 (GluR2). These findings suggest that NRF1 may be involved in the regulation of brain and neural development [<xref ref-type="bibr" rid="B10-ijms-17-02086">10</xref>,<xref ref-type="bibr" rid="B274-ijms-17-02086">274</xref>].The neurotoxic amyloid β-peptide (Aβ), the major constituent of senile plaques in AD brains is generated by proteolytic cleavages of the amyloid precursor protein (APP), and the amyloid precursor-like proteins 1 and 2 (APLP1 and APLP2) by β- and γ-Secretases. PSEN2, and presenilin enhancer 2 (PEN2) subunits of γ-Secretase complex, involved in the formation of Aβ, MAPT (tau) and insulin-degrading enzyme (IDE) which degrades Aβ are NRF1 target genes [<xref ref-type="bibr" rid="B9-ijms-17-02086">9</xref>]. Accumulation of Aβ is dependent on Aβ formation by MAPT, APP, PSEN2, and PEN2; and loss of IDE (Aβ degrading enzyme). AD-associated NRF1 target genes -APLP1, APP, GRIN1, GRIN2B, MAPT, PSEN2, PEN2, and IDE are also regulated by E2. These NRF-1 regulatable genes alone, or in concert with others, may contribute to the sex-dependent differences in the brain NRF1 network and the molecular mechanisms of prevention of AD by E2.</p>
</sec>
</sec>
<sec id="sec4-ijms-17-02086">
<title>4. Conclusions</title>
<p>A large number of genes (approximately 300) are considered to be altered during the development of complex chronic brain diseases. For example, a minimum of six to eight gene mutations and gene activation by genetic/epigenetic mechanisms is needed for the development of glioblastoma [<xref ref-type="bibr" rid="B275-ijms-17-02086">275</xref>]. Similarly, in AD, there are a minimum of 6–8 genes that are involved in the causation of this disease. During the development of an individual from a single cell to prenatal stages to adolescent to adulthood and through the complete life span, humans are exposed to countless environmental and stochastic factors. Environment constitutes everything that surrounds us both internally and externally, including toxicants, hormones, diet, psychosocial behaviors, and life-styles. Like genes, these environmental factors also interact among themselves. It takes 5–15 years to develop the most sporadic brain cancers and other complex chronic brain diseases. A single exposure to an internal or external environmental factor alone cannot explain the development of a complex chronic brain disease, rather it appears that exposure to multiple environmental and stochastic factors across the lifespan and their interactions influence the development of a chronic disease in an individual. The old paradigm is that an orderly progression of changes in disease stem cells through a recognizable series of intermediate states leads toward a predictable endpoint, the disease, in equilibrium with the prevailing environment. In contrast, a more recent view of complex malignant or nonmalignant complex chronic lesion development is based on adaptations of independent disease stem cells. Transitions between a series of different states of disease stem cells are disorderly and unpredictable resulting from probabilistic processes such as death and survival of disease stem cells which make up a malignant or nonmalignant complex chronic lesion. This reflects inherent variability observed in behaviors of different types of cells present in the malignant or nonmalignant complex chronic lesion and the uncertainty of environmental and stochastic factors. In particular, it allows for succession of alternative pathways and endpoints dependent on the chance outcome of interactions among gene–gene, environment-environment, gene–environment and between cells and their environment. These concepts may help in explaining tremendous inter-individual variability in the response to environmental and stochastic stressors, which has hindered our understanding of why a certain individual develops a brain disease when exposed to environmental factors and others remain healthy. EEDs effects on brain go beyond known mechanisms to disrupt the circulatory and neural estrogen function and estrogen-mediated signaling. Bioinformatics analysis of gene-EEDs interactions and brain disease associations identified numerous NRF1 regulated genes that were altered by exposure to estrogen, phthalate or BPA or other EEDCs (<italic>APP</italic>, <italic>APLP1</italic>, <italic>MAPT</italic>, <italic>PEN2</italic>, <italic>PSEN2</italic>, <italic>PARH2</italic>, <italic>PINK1</italic>, <italic>PARK7</italic>, <italic>VDAC2</italic>, <italic>NR1</italic> and <italic>2b</italic>). EEDs -modified genes in brain health deficits are part of estrogen and NRF1 signaling pathways. NRF1 regulates targets genes with diverse functions, including involved in cell growth (<italic>CKS2</italic>, <italic>CDC6</italic>, <italic>CDC7</italic>, <italic>CDC23</italic>, <italic>CDC25C</italic>, <italic>NPAT</italic>, <italic>GTSE1</italic>, <italic>SMC4L1</italic>, <italic>KIF22</italic>, <italic>PPP5C</italic>, <italic>CCNB1</italic>, <italic>CCNG2</italic>, <italic>RAD54B</italic>, <italic>PRC1</italic>), <italic>apoptosis/autophagy</italic> (<italic>BNIP3</italic>, <italic>PINK1</italic>, <italic>Parkin</italic>), mitochondrial biogenesis/respiration (mtTFA, ABCB6, MRP63, MRPL18, TIMM8A, CytC), and neurogenesis/neuroplasticity/synaptogenesis (<italic>Synapsin 1</italic>, <italic>MAPRE3</italic>, <italic>NPDC1</italic>, <italic>SUV39H2</italic>, <italic>SKA3</italic>, <italic>RAB3IP</italic>, <italic>TRAPPC3</italic>, <italic>PIP5K1A</italic>, <italic>USP10</italic>, <italic>SPRY4</italic>, <italic>GTF2F2</italic>, <italic>NR1D1</italic>, <italic>RHOA</italic>, <italic>RAPGEF6</italic>, <italic>SMAP1</italic>, <italic>NPDC1</italic>, <italic>SMAD5</italic>, <italic>USP10</italic>, <italic>FAM134C</italic>, <italic>C3orf10</italic>, and <italic>ENOX1</italic>) (<xref ref-type="fig" rid="ijms-17-02086-f014">Figure 14</xref>). Both phosphorylation and acetylation of NRF-1 by two independent signaling molecules control NRF-1 activation. Activation of a redox sensitive signaling pathway regulates NRF-1 phosphorylation and acetylation events. These two events enhance its activating function by increasing its localization close to nuclear targets and its affinity for promoters of target genes.</p>
<p>This, in turn, may contribute to the susceptibility of normal brain cells to develop disease phenotype. NRF-1 is phosphorylated by cyclin D1-dependent kinase, p38MAPK, ERK and AKT (reviewed in [<xref ref-type="bibr" rid="B8-ijms-17-02086">8</xref>]). All of these are redox sensitive kinases. Consistent with the redox-sensitivity of AKT, 4-OH-E2- or H2O2-induced NRF-1 phosphorylation was inhibited by the glutathione peroxidase mimic, ebselen. AKT activity depends on its phosphorylation, which is positively regulated by PI3K and negatively regulated by a class of protein phosphatases [<xref ref-type="bibr" rid="B52-ijms-17-02086">52</xref>]. AKT controls translocation of NRF-1 to the nucleus, because translocation of NRF-1 to the nucleus does not occur in PTEN deficient cells. The ability of E2 and H<sub>2</sub>O<sub>2</sub> to activate AKT may be attributed to the inactivation of cysteine-based phosphatases by ROS [<xref ref-type="bibr" rid="B8-ijms-17-02086">8</xref>]. The reversible inactivation of phosphatase—PTEN, by estrogen-induced ROS may be a key component of AKT activation. Together, these data suggest that estrogen effects on brain cells may be in part mediated through ROS signaling biomolecules that regulate estrogen-induced NRF-1 activation. This, in turn, may control the expression of NRF-1-regulatable genes. These data implicated that ROS induced DNA synthesis, increased phosphorylation of kinases, and activated transcription factors, e.g., AP-1, CREB, E2F, NF-κB, and NRF1 of non-genomic pathways which are responsive to oxidants, estrogen and EEDs. Estrogen or EED-induced ROS by increasing genomic instability and by transducing signal through influencing redox sensitive transcription factors may play important role(s) in neurogenesis and synaptogenesis (<xref ref-type="fig" rid="ijms-17-02086-f002">Figure 2</xref>). It is envisioned that estrogen or EED induced ROS mediated signaling is a key complementary mechanism that drives the brain disorders. ROS mediated signaling, however, may occur in the context of other estrogen induced pathways such as ER-mediated signaling. NRF1 regulates targets genes with diverse functions, including cell growth, apoptosis/autophagy, mitochondrial biogenesis, genomic instability, neurogenesis, neuroplasticity, synaptogenesis, and senescence (<xref ref-type="fig" rid="ijms-17-02086-f014">Figure 14</xref>). By activating or repressing the genes involved in cell proliferation, growth suppression, DNA damage/repair, apoptosis/autophagy, angiogenesis, estrogen signaling, neurogenesis, synaptogenesis, and senescence, and inducing a wide range of DNA damage, genomic instability and DNA methylation and transcriptional repression, NRF1 may act as a major regulator of EEDs-induced brain health deficits. Our findings suggest that in addition to estrogen signaling, EED chemicals influencing NRF1-regulated communities of genes across genomic and epigenomic multiple networks may contribute to the development of complex chronic human brain health deficits.</p>
</sec>
</body>
<back>
<app-group>
<app id="app1-ijms-17-02086">
<title>Supplementary Materials</title>
<p>Supplementary materials can be found at <uri xlink:href="www.mdpi.com/1422-0067/17/12/2086/s1" xlink:type="simple">www.mdpi.com/1422-0067/17/12/2086/s1</uri>.</p>
<supplementary-material content-type="local-data" id="ijms-17-02086-s001">
<media xlink:href="ijms-17-02086-s001.zip">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</app>
</app-group>
<notes>
<title>Author Contributions</title>
<p>Deodutta Roy designed the study; Mark Preciados and Changwon Yoo and Deodutta Roy collected, analyzed bioinformatic data, and wrote the paper.</p>
</notes>
<notes notes-type="COI-statement">
<title>Conflicts of Interest</title>
<p>The authors declare no conflict of interest.</p>
</notes>
<ref-list>
<title>References</title>
<ref id="B1-ijms-17-02086">
<label>1.</label>
<element-citation publication-type="book">
<person-group person-group-type="author"><collab>UNEP/WHO</collab></person-group>
<source/>State of the Science of Endocrine Disrupting Chemicals—2012
<person-group person-group-type="editor"><name><surname>Bergman</surname><given-names>A.</given-names></name><name><surname>Heindel</surname><given-names>J.J.</given-names></name><name><surname>Jobling</surname><given-names>S.</given-names></name><name><surname>Kidd</surname><given-names>K.A.</given-names></name><name><surname>Zoeller</surname><given-names>R.T.</given-names></name></person-group>
<publisher-name>WHO Press</publisher-name>
<publisher-loc>Geneva, Switzerland</publisher-loc>
<year>2013</year>
<fpage>1</fpage>
<lpage>272</lpage>
</element-citation>
</ref>
<ref id="B2-ijms-17-02086">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Roy</surname><given-names>D.</given-names></name><name><surname>Palangat</surname><given-names>M.</given-names></name><name><surname>Chen</surname><given-names>C.W.</given-names></name><name><surname>Thomas</surname><given-names>R.T.</given-names></name><name><surname>Colerangle</surname><given-names>J.C.</given-names></name><name><surname>Atkinson</surname><given-names>A.</given-names></name><name><surname>Yan</surname><given-names>Z.J.</given-names></name></person-group>
<article-title>Biochemical and molecular changes at the cellular levels in response to exposure of environmental estrogen-like chemicals</article-title>
<source/>J. Toxicol. Environ. Health
<year>1997</year>
<volume>49</volume>
<fpage>101</fpage>
<lpage>129</lpage>
</element-citation>
</ref>
<ref id="B3-ijms-17-02086">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Diamanti-Kandarakis</surname><given-names>E.</given-names></name><name><surname>Bourguignon</surname><given-names>J.-P.</given-names></name><name><surname>Giudice</surname><given-names>L.C.</given-names></name><name><surname>Hauser</surname><given-names>R.</given-names></name><name><surname>Prins</surname><given-names>G.S.</given-names></name><name><surname>Soto</surname><given-names>A.M.</given-names></name><name><surname>Zoeller</surname><given-names>R.T.</given-names></name><name><surname>Gore</surname><given-names>A.C.</given-names></name></person-group>
<article-title>Endocrine-disrupting chemicals: An Endocrine Society scientific statement</article-title>
<source/>Endocr. Rev.
<year>2009</year>
<volume>30</volume>
<fpage>293</fpage>
<lpage>342</lpage>
<pub-id pub-id-type="doi">10.1210/er.2009-0002</pub-id>
<pub-id pub-id-type="pmid">19502515</pub-id></element-citation>
</ref>
<ref id="B4-ijms-17-02086">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Roy</surname><given-names>D.</given-names></name><name><surname>Morgan</surname><given-names>M.</given-names></name><name><surname>Yoo</surname><given-names>C.</given-names></name><name><surname>Deoraj</surname><given-names>A.</given-names></name><name><surname>Roy</surname><given-names>S.</given-names></name><name><surname>Yadav</surname><given-names>V.K.</given-names></name><name><surname>Garoub</surname><given-names>M.</given-names></name><name><surname>Assaggaf</surname><given-names>H.</given-names></name><name><surname>Doke</surname><given-names>M.</given-names></name></person-group>
<article-title>Integrated bioinformatics, environmental epidemiologic and genomic approaches to identify environmental and molecular links between endometriosis and breast cancer</article-title>
<source/>Int. J. Mol. Sci.
<year>2015</year>
<volume>16</volume>
<fpage>25285</fpage>
<lpage>25322</lpage>
<pub-id pub-id-type="doi">10.3390/ijms161025285</pub-id>
<pub-id pub-id-type="pmid">26512648</pub-id></element-citation>
</ref>
<ref id="B5-ijms-17-02086">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McCarthy</surname><given-names>M.M.</given-names></name></person-group>
<article-title>Estradiol and the developing brain</article-title>
<source/>Physiol. Rev.
<year>2008</year>
<volume>88</volume>
<fpage>91</fpage>
<lpage>124</lpage>
<pub-id pub-id-type="doi">10.1152/physrev.00010.2007</pub-id>
<pub-id pub-id-type="pmid">18195084</pub-id></element-citation>
</ref>
<ref id="B6-ijms-17-02086">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kajta</surname><given-names>M.</given-names></name><name><surname>Wojtowicz</surname><given-names>A.K.</given-names></name></person-group>
<article-title>Impact of endocrine-disrupting chemicals on neural development and the onset of neurological disorders</article-title>
<source/>Pharmacol. Rep.
<year>2013</year>
<volume>65</volume>
<fpage>1632</fpage>
<lpage>1639</lpage>
<pub-id pub-id-type="doi">10.1016/S1734-1140(13)71524-X</pub-id>
<pub-id pub-id-type="pmid">24553011</pub-id></element-citation>
</ref>
<ref id="B7-ijms-17-02086">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Masuo</surname><given-names>Y.</given-names></name><name><surname>Ishido</surname><given-names>M.</given-names></name></person-group>
<article-title>Neurotoxicity of endocrine disruptors: Possible involvement in brain development and neurodegeneration</article-title>
<source/>J. Toxicol. Environ. Health B Crit. Rev.
<year>2011</year>
<volume>14</volume>
<fpage>346</fpage>
<lpage>369</lpage>
<pub-id pub-id-type="doi">10.1080/10937404.2011.578557</pub-id>
<pub-id pub-id-type="pmid">21790316</pub-id></element-citation>
</ref>
<ref id="B8-ijms-17-02086">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Okoh</surname><given-names>V.</given-names></name><name><surname>Deoraj</surname><given-names>A.</given-names></name><name><surname>Roy</surname><given-names>D.</given-names></name></person-group>
<article-title>Estrogen-induced ROS mediated redox signaling contributes in the development of breast cancer</article-title>
<source/>Biochem. Biophys. Acta
<year>2011</year>
<volume>1815</volume>
<fpage>115</fpage>
<lpage>133</lpage>
<pub-id pub-id-type="pmid">21036202</pub-id></element-citation>
</ref>
<ref id="B9-ijms-17-02086">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Satoh</surname><given-names>J.I.</given-names></name><name><surname>Kawana</surname><given-names>N.</given-names></name><name><surname>Yamamoto</surname><given-names>Y.</given-names></name></person-group>
<article-title>Pathway analysis of ChIP-Seq-Based NRF1 target genes suggests a logical hypothesis of their Involvement in the pathogenesis of neurodegenerative diseases</article-title>
<source/>Gene Regul. Syst. Biol.
<year>2013</year>
<volume>2013</volume>
<fpage>139</fpage>
<lpage>152</lpage>
<pub-id pub-id-type="doi">10.4137/GRSB.S13204</pub-id>
<pub-id pub-id-type="pmid">24250222</pub-id></element-citation>
</ref>
<ref id="B10-ijms-17-02086">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pennacchio</surname><given-names>L.A.</given-names></name><name><surname>Loots</surname><given-names>G.G.</given-names></name><name><surname>Nobrega</surname><given-names>M.A.</given-names></name><name><surname>Ovcharenko</surname><given-names>I.</given-names></name></person-group>
<article-title>Predicting tissue-specific enhancers in the human genome</article-title>
<source/>Genome Res.
<year>2007</year>
<volume>17</volume>
<fpage>201</fpage>
<lpage>211</lpage>
<pub-id pub-id-type="doi">10.1101/gr.5972507</pub-id>
<pub-id pub-id-type="pmid">17210927</pub-id></element-citation>
</ref>
<ref id="B11-ijms-17-02086">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Burns</surname><given-names>K.A.</given-names></name><name><surname>Korach</surname><given-names>K.S.</given-names></name></person-group>
<article-title>Estrogen receptors and human disease: An update</article-title>
<source/>Arch. Toxicol.
<year>2012</year>
<volume>86</volume>
<fpage>1491</fpage>
<lpage>1504</lpage>
<pub-id pub-id-type="doi">10.1007/s00204-012-0868-5</pub-id>
<pub-id pub-id-type="pmid">22648069</pub-id></element-citation>
</ref>
<ref id="B12-ijms-17-02086">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gillies</surname><given-names>G.E.</given-names></name><name><surname>McArthur</surname><given-names>S.</given-names></name></person-group>
<article-title>Estrogen actions in the brain and the basis for differential action in men and women: A case for sex-specific medicines</article-title>
<source/>Pharmacol. Rev.
<year>2010</year>
<volume>62</volume>
<fpage>155</fpage>
<lpage>198</lpage>
<pub-id pub-id-type="doi">10.1124/pr.109.002071</pub-id>
<pub-id pub-id-type="pmid">20392807</pub-id></element-citation>
</ref>
<ref id="B13-ijms-17-02086">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Arevalo</surname><given-names>M.-A.</given-names></name><name><surname>Azcoitia</surname><given-names>I.</given-names></name><name><surname>Garcia-Segura</surname><given-names>L.M.</given-names></name></person-group>
<article-title>The neuroprotective actions of oestradiol and oestrogen receptors</article-title>
<source/>Neuroscience
<year>2015</year>
<volume>16</volume>
<fpage>17</fpage>
<lpage>29</lpage>
<pub-id pub-id-type="doi">10.1038/nrn3856</pub-id>
<pub-id pub-id-type="pmid">25423896</pub-id></element-citation>
</ref>
<ref id="B14-ijms-17-02086">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chakrabarti</surname><given-names>M.</given-names></name><name><surname>Haque</surname><given-names>A.</given-names></name><name><surname>Banik</surname><given-names>N.L.</given-names></name><name><surname>Nagarkatti</surname><given-names>P.</given-names></name><name><surname>Nagarkatti</surname><given-names>M.</given-names></name><name><surname>Ray</surname><given-names>S.K.</given-names></name></person-group>
<article-title>Estrogen receptor agonists for attenuation of neuroinflammation and neurodegeneration</article-title>
<source/>Brain Res. Bull.
<year>2014</year>
<volume>109</volume>
<fpage>22</fpage>
<lpage>31</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainresbull.2014.09.004</pub-id>
<pub-id pub-id-type="pmid">25245209</pub-id></element-citation>
</ref>
<ref id="B15-ijms-17-02086">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Green</surname><given-names>P.S.</given-names></name><name><surname>Simpkins</surname><given-names>J.W.</given-names></name></person-group>
<article-title>Neuroprotective effects of estrogens: Potential mechanisms of action</article-title>
<source/>Int. J. Dev. Neurosci.
<year>2000</year>
<volume>18</volume>
<fpage>347</fpage>
<lpage>358</lpage>
<pub-id pub-id-type="doi">10.1016/S0736-5748(00)00017-4</pub-id>
<pub-id pub-id-type="pmid">10817919</pub-id></element-citation>
</ref>
<ref id="B16-ijms-17-02086">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hristian</surname><given-names>C.</given-names></name><name><surname>Ruber</surname><given-names>J.G.</given-names></name><name><surname>Alter</surname><given-names>W.</given-names></name><name><surname>Schugguel</surname><given-names>T.</given-names></name><name><surname>Chneeberger</surname><given-names>S.</given-names></name><name><surname>Ohannes</surname><given-names>J.</given-names></name><name><surname>Uber</surname><given-names>C.H.</given-names></name></person-group>
<article-title>Production and actions of estrogens</article-title>
<source/>N. Engl. J. Med.
<year>2002</year>
<volume>346</volume>
<fpage>340</fpage>
<lpage>352</lpage>
<pub-id pub-id-type="pmid">11821512</pub-id></element-citation>
</ref>
<ref id="B17-ijms-17-02086">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pozzi</surname><given-names>S.</given-names></name><name><surname>Benedusi</surname><given-names>V.</given-names></name><name><surname>Maggi</surname><given-names>A.</given-names></name><name><surname>Vegeto</surname><given-names>E.</given-names></name></person-group>
<article-title>Estrogen action in neuroprotection and brain inflammation</article-title>
<source/>Ann. N. Y. Acad. Sci.
<year>2006</year>
<volume>1089</volume>
<fpage>302</fpage>
<lpage>323</lpage>
<pub-id pub-id-type="doi">10.1196/annals.1386.035</pub-id>
<pub-id pub-id-type="pmid">17261778</pub-id></element-citation>
</ref>
<ref id="B18-ijms-17-02086">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wise</surname><given-names>P.M.</given-names></name><name><surname>Dubal</surname><given-names>D.B.</given-names></name><name><surname>Wilson</surname><given-names>M.E.</given-names></name><name><surname>Rau</surname><given-names>S.W.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name></person-group>
<article-title>Estrogens: Trophic and protective factors in the adult brain</article-title>
<source/>Front. Neuroendocrinol.
<year>2001</year>
<volume>22</volume>
<fpage>33</fpage>
<lpage>66</lpage>
<pub-id pub-id-type="doi">10.1006/frne.2000.0207</pub-id>
<pub-id pub-id-type="pmid">11141318</pub-id></element-citation>
</ref>
<ref id="B19-ijms-17-02086">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hojo</surname><given-names>Y.</given-names></name><name><surname>Murakami</surname><given-names>G.</given-names></name><name><surname>Mukai</surname><given-names>H.</given-names></name><name><surname>Higo</surname><given-names>S.</given-names></name><name><surname>Hatanaka</surname><given-names>Y.</given-names></name><name><surname>Ogiue-Ikeda</surname><given-names>M.</given-names></name><name><surname>Ishii</surname><given-names>H.</given-names></name><name><surname>Kimoto</surname><given-names>T.</given-names></name><name><surname>Kawato</surname><given-names>S.</given-names></name></person-group>
<article-title>Estrogen synthesis in the brain-role in synaptic plasticity and memory</article-title>
<source/>Stud. Surf. Sci. Catal.
<year>2008</year>
<volume>77</volume>
<fpage>105</fpage>
<lpage>110</lpage>
<pub-id pub-id-type="doi">10.1016/j.mce.2008.04.017</pub-id>
<pub-id pub-id-type="pmid">18541362</pub-id></element-citation>
</ref>
<ref id="B20-ijms-17-02086">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ogiue-Ikeda</surname><given-names>M.</given-names></name><name><surname>Tanabe</surname><given-names>N.</given-names></name><name><surname>Mukai</surname><given-names>H.</given-names></name><name><surname>Hojo</surname><given-names>Y.</given-names></name><name><surname>Murakami</surname><given-names>G.</given-names></name><name><surname>Tsurugizawa</surname><given-names>T.</given-names></name><name><surname>Takata</surname><given-names>N.</given-names></name><name><surname>Kimoto</surname><given-names>T.</given-names></name><name><surname>Kawato</surname><given-names>S.</given-names></name></person-group>
<article-title>Rapid modulation of synaptic plasticity by estrogens as well as endocrine disrupters in hippocampal neurons</article-title>
<source/>Brain Res. Rev.
<year>2008</year>
<volume>57</volume>
<fpage>363</fpage>
<lpage>375</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainresrev.2007.06.010</pub-id>
<pub-id pub-id-type="pmid">17822775</pub-id></element-citation>
</ref>
<ref id="B21-ijms-17-02086">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mukai</surname><given-names>H.</given-names></name><name><surname>Kimoto</surname><given-names>T.</given-names></name><name><surname>Hojo</surname><given-names>Y.</given-names></name><name><surname>Kawato</surname><given-names>S.</given-names></name><name><surname>Murakami</surname><given-names>G.</given-names></name><name><surname>Higo</surname><given-names>S.</given-names></name><name><surname>Hatanaka</surname><given-names>Y.</given-names></name><name><surname>Ogiue-Ikeda</surname><given-names>M.</given-names></name></person-group>
<article-title>Modulation of synaptic plasticity by brain estrogen in the hippocampus</article-title>
<source/>Biochim. Biophys. Acta—Gen. Subj.
<year>2010</year>
<volume>1800</volume>
<fpage>1030</fpage>
<lpage>1044</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbagen.2009.11.002</pub-id>
<pub-id pub-id-type="pmid">19909788</pub-id></element-citation>
</ref>
<ref id="B22-ijms-17-02086">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Parducz</surname><given-names>A.</given-names></name><name><surname>Hajszan</surname><given-names>T.</given-names></name><name><surname>MacLusky</surname><given-names>N.J.</given-names></name><name><surname>Hoyk</surname><given-names>Z.</given-names></name><name><surname>Csakvari</surname><given-names>E.</given-names></name><name><surname>Kurunczi</surname><given-names>A.</given-names></name><name><surname>Prange-Kiel</surname><given-names>J.</given-names></name><name><surname>Leranth</surname><given-names>C.</given-names></name></person-group>
<article-title>Synaptic remodeling induced by gonadal hormones: Neuronal plasticity as a mediator of neuroendocrine and behavioral responses to steroids</article-title>
<source/>Neuroscience
<year>2006</year>
<volume>138</volume>
<fpage>977</fpage>
<lpage>985</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2005.07.008</pub-id>
<pub-id pub-id-type="pmid">16310961</pub-id></element-citation>
</ref>
<ref id="B23-ijms-17-02086">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Leranth</surname><given-names>C.</given-names></name><name><surname>Petnehazy</surname><given-names>O.</given-names></name><name><surname>MacLusky</surname><given-names>N.J.</given-names></name></person-group>
<article-title>Gonadal hormones affect spine synaptic density in the CA1 hippocampal subfield of male rats</article-title>
<source/>J. Neurosci.
<year>2003</year>
<volume>23</volume>
<fpage>1588</fpage>
<lpage>1592</lpage>
<pub-id pub-id-type="pmid">12629162</pub-id></element-citation>
</ref>
<ref id="B24-ijms-17-02086">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>MacLusky</surname><given-names>N.J.</given-names></name><name><surname>Hajszan</surname><given-names>T.</given-names></name><name><surname>Prange-Kiel</surname><given-names>J.</given-names></name><name><surname>Leranth</surname><given-names>C.</given-names></name></person-group>
<article-title>Androgen modulation of hippocampal synaptic plasticity</article-title>
<source/>Neuroscience
<year>2006</year>
<volume>138</volume>
<fpage>957</fpage>
<lpage>965</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2005.12.054</pub-id>
<pub-id pub-id-type="pmid">16488544</pub-id></element-citation>
</ref>
<ref id="B25-ijms-17-02086">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Arnold</surname><given-names>S.</given-names></name><name><surname>Beyer</surname><given-names>C.</given-names></name></person-group>
<article-title>Neuroprotection by estrogen in the brain: The mitochondrial compartment as presumed therapeutic target</article-title>
<source/>J. Neurochem.
<year>2009</year>
<volume>110</volume>
<fpage>1</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.2009.06133.x</pub-id>
<pub-id pub-id-type="pmid">19457121</pub-id></element-citation>
</ref>
<ref id="B26-ijms-17-02086">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Grimm</surname><given-names>A.</given-names></name><name><surname>Schmitt</surname><given-names>K.</given-names></name><name><surname>Lang</surname><given-names>U.E.</given-names></name><name><surname>Mensah-Nyagan</surname><given-names>A.G.</given-names></name><name><surname>Eckert</surname><given-names>A.</given-names></name></person-group>
<article-title>Improvement of neuronal bioenergetics by neurosteroids: Implications for age-related neurodegenerative disorders</article-title>
<source/>Biochim. Biophys. Acta—Mol. Basis Dis.
<year>2014</year>
<volume>1842</volume>
<fpage>2427</fpage>
<lpage>2438</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbadis.2014.09.013</pub-id>
<pub-id pub-id-type="pmid">25281013</pub-id></element-citation>
</ref>
<ref id="B27-ijms-17-02086">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Simpkins</surname><given-names>J.W.</given-names></name><name><surname>Yi</surname><given-names>K.D.</given-names></name><name><surname>Yang</surname><given-names>S.</given-names></name><name><surname>Dykens</surname><given-names>J.A.</given-names></name></person-group>
<article-title>Mitochondrial mechanisms of estrogen neuroprotection</article-title>
<source/>Biochim. Biophys. Acta
<year>2011</year>
<volume>1800</volume>
<fpage>1113</fpage>
<lpage>1120</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbagen.2009.11.013</pub-id>
<pub-id pub-id-type="pmid">19931595</pub-id></element-citation>
</ref>
<ref id="B28-ijms-17-02086">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Barrett-Connor</surname><given-names>E.</given-names></name><name><surname>Goodman-Gruen</surname><given-names>D.</given-names></name></person-group>
<article-title>Cognitive function and endogenous sex hormones in older women</article-title>
<source/>J. Am. Geriatr. Soc.
<year>1999</year>
<volume>47</volume>
<fpage>1289</fpage>
<lpage>1293</lpage>
<pub-id pub-id-type="doi">10.1111/j.1532-5415.1999.tb07427.x</pub-id>
<pub-id pub-id-type="pmid">10573435</pub-id></element-citation>
</ref>
<ref id="B29-ijms-17-02086">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cereda</surname><given-names>E.</given-names></name><name><surname>Barichella</surname><given-names>M.</given-names></name><name><surname>Cassani</surname><given-names>E.</given-names></name><name><surname>Caccialanza</surname><given-names>R.</given-names></name><name><surname>Pezzoli</surname><given-names>G.</given-names></name></person-group>
<article-title>Reproductive factors and clinical features of Parkinson’s disease</article-title>
<source/>Parkinsonism Relat. Disord.
<year>2013</year>
<volume>19</volume>
<fpage>1094</fpage>
<lpage>1099</lpage>
<pub-id pub-id-type="doi">10.1016/j.parkreldis.2013.07.020</pub-id>
<pub-id pub-id-type="pmid">23931933</pub-id></element-citation>
</ref>
<ref id="B30-ijms-17-02086">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Heys</surname><given-names>M.</given-names></name><name><surname>Jiang</surname><given-names>C.</given-names></name><name><surname>Cheng</surname><given-names>K.K.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Yeung</surname><given-names>S.L.A.</given-names></name><name><surname>Lam</surname><given-names>T.H.</given-names></name><name><surname>Leung</surname><given-names>G.M.</given-names></name><name><surname>Schooling</surname><given-names>C.M.</given-names></name></person-group>
<article-title>Life long endogenous estrogen exposure and later adulthood cognitive function in a population of naturally postmenopausal women from Southern China: The Guangzhou biobank cohort study</article-title>
<source/>Psychoneuroendocrinology
<year>2011</year>
<volume>36</volume>
<fpage>864</fpage>
<lpage>873</lpage>
<pub-id pub-id-type="doi">10.1016/j.psyneuen.2010.11.009</pub-id>
<pub-id pub-id-type="pmid">21185655</pub-id></element-citation>
</ref>
<ref id="B31-ijms-17-02086">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Low</surname><given-names>L.F.</given-names></name></person-group>
<article-title>Reproductive period and cognitive function in a representative sample of naturally postmenopausal women aged 60–64 years</article-title>
<source/>Climacteric
<year>2005</year>
<volume>8</volume>
<fpage>380</fpage>
<lpage>389</lpage>
<pub-id pub-id-type="doi">10.1080/13697130500345240</pub-id>
<pub-id pub-id-type="pmid">16390773</pub-id></element-citation>
</ref>
<ref id="B32-ijms-17-02086">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zimmerman</surname><given-names>M.E.</given-names></name><name><surname>Lipton</surname><given-names>R.B.</given-names></name><name><surname>Santoro</surname><given-names>N.</given-names></name><name><surname>McConnell</surname><given-names>D.S.</given-names></name><name><surname>Derby</surname><given-names>C.A.</given-names></name><name><surname>Katz</surname><given-names>M.J.</given-names></name><name><surname>Baigi</surname><given-names>K.</given-names></name><name><surname>Saunders-Pullman</surname><given-names>R.</given-names></name></person-group>
<article-title>Endogenous estradiol is associated with verbal memory in nondemented older men</article-title>
<source/>Brain Cogn.
<year>2011</year>
<volume>76</volume>
<fpage>158</fpage>
<lpage>165</lpage>
<pub-id pub-id-type="doi">10.1016/j.bandc.2011.01.011</pub-id>
<pub-id pub-id-type="pmid">21354686</pub-id></element-citation>
</ref>
<ref id="B33-ijms-17-02086">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Manly</surname><given-names>J.J.</given-names></name><name><surname>Merchant</surname><given-names>C.A.</given-names></name><name><surname>Jacobs</surname><given-names>D.M.</given-names></name><name><surname>Small</surname><given-names>S.A.</given-names></name><name><surname>Bell</surname><given-names>K.</given-names></name><name><surname>Ferin</surname><given-names>M.</given-names></name><name><surname>Mayeux</surname><given-names>R.</given-names></name></person-group>
<article-title>Endogenous estrogen levels and Alzheimer’s disease among postmenopausal women</article-title>
<source/>Neurology
<year>2000</year>
<volume>54</volume>
<fpage>833</fpage>
<lpage>837</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.54.4.833</pub-id>
<pub-id pub-id-type="pmid">10690972</pub-id></element-citation>
</ref>
<ref id="B34-ijms-17-02086">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>De Jong</surname><given-names>S.</given-names></name><name><surname>Huisman</surname><given-names>M.</given-names></name><name><surname>Sutedja</surname><given-names>N.</given-names></name><name><surname>van Der Kooi</surname><given-names>A.</given-names></name><name><surname>de Visser</surname><given-names>M.</given-names></name><name><surname>Schelhaas</surname><given-names>J.</given-names></name><name><surname>van Der Schouw</surname><given-names>Y.</given-names></name><name><surname>Veldink</surname><given-names>J.</given-names></name><name><surname>van Den Berg</surname><given-names>L.</given-names></name></person-group>
<article-title>Endogenous female reproductive hormones and the risk of amyotrophic lateral sclerosis</article-title>
<source/>J. Neurol.
<year>2013</year>
<volume>260</volume>
<fpage>507</fpage>
<lpage>512</lpage>
<pub-id pub-id-type="doi">10.1007/s00415-012-6665-5</pub-id>
<pub-id pub-id-type="pmid">22972621</pub-id></element-citation>
</ref>
<ref id="B35-ijms-17-02086">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Geerlings</surname><given-names>M.I.</given-names></name><name><surname>Ruitenberg</surname><given-names>A.</given-names></name><name><surname>Witteman</surname><given-names>J.C.</given-names></name><name><surname>van Swieten</surname><given-names>J.C.</given-names></name><name><surname>Hofman</surname><given-names>A.</given-names></name><name><surname>van Duijn</surname><given-names>C.M.</given-names></name><name><surname>Breteler</surname><given-names>M.M.</given-names></name><name><surname>Launer</surname><given-names>L.J.</given-names></name></person-group>
<article-title>Reproductive period and risk of dementia in postmenopausal women</article-title>
<source/>JAMA
<year>2001</year>
<volume>285</volume>
<fpage>1475</fpage>
<lpage>1481</lpage>
<pub-id pub-id-type="doi">10.1001/jama.285.11.1475</pub-id>
<pub-id pub-id-type="pmid">11255424</pub-id></element-citation>
</ref>
<ref id="B36-ijms-17-02086">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schupf</surname><given-names>N.</given-names></name><name><surname>Winsten</surname><given-names>S.</given-names></name><name><surname>Patel</surname><given-names>B.</given-names></name><name><surname>Pang</surname><given-names>D.</given-names></name><name><surname>Ferin</surname><given-names>M.</given-names></name><name><surname>Zigman</surname><given-names>W.B.</given-names></name><name><surname>Silverman</surname><given-names>W.</given-names></name><name><surname>Mayeux</surname><given-names>R.</given-names></name></person-group>
<article-title>Bioavailable estradiol and age at onset of Alzheimer’s disease in postmenopausal women with Down syndrome</article-title>
<source/>Neurosci. Lett.
<year>2006</year>
<volume>406</volume>
<fpage>298</fpage>
<lpage>302</lpage>
<pub-id pub-id-type="doi">10.1016/j.neulet.2006.07.062</pub-id>
<pub-id pub-id-type="pmid">16926067</pub-id></element-citation>
</ref>
<ref id="B37-ijms-17-02086">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fox</surname><given-names>M.</given-names></name><name><surname>Berzuini</surname><given-names>C.</given-names></name><name><surname>Knapp</surname><given-names>L.A.</given-names></name></person-group>
<article-title>Cumulative estrogen exposure, number of menstrual cycles, and Alzheimer’s risk in a cohort of British women</article-title>
<source/>Psychoneuroendocrinology
<year>2013</year>
<volume>38</volume>
<fpage>2973</fpage>
<lpage>2982</lpage>
<pub-id pub-id-type="doi">10.1016/j.psyneuen.2013.08.005</pub-id>
<pub-id pub-id-type="pmid">24064221</pub-id></element-citation>
</ref>
<ref id="B38-ijms-17-02086">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Griksiene</surname><given-names>R.</given-names></name><name><surname>Ruksenas</surname><given-names>O.</given-names></name></person-group>
<article-title>Effects of hormonal contraceptives on mental rotation and verbal fluency</article-title>
<source/>Psychoneuroendocrinology
<year>2011</year>
<volume>36</volume>
<fpage>1239</fpage>
<lpage>1248</lpage>
<pub-id pub-id-type="doi">10.1016/j.psyneuen.2011.03.001</pub-id>
<pub-id pub-id-type="pmid">21454017</pub-id></element-citation>
</ref>
<ref id="B39-ijms-17-02086">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pletzer</surname><given-names>B.A.</given-names></name><name><surname>Kerschbaum</surname><given-names>H.H.</given-names></name></person-group>
<article-title>50 years of hormonal contraception—Time to find out, what it does to our brain</article-title>
<source/>Front. Neurosci.
<year>2014</year>
<volume>8</volume>
<fpage>256</fpage>
<pub-id pub-id-type="doi">10.3389/fnins.2014.00256</pub-id>
<pub-id pub-id-type="pmid">25191220</pub-id></element-citation>
</ref>
<ref id="B40-ijms-17-02086">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Beltz</surname><given-names>A.M.</given-names></name><name><surname>Hampson</surname><given-names>E.</given-names></name><name><surname>Berenbaum</surname><given-names>S.A.</given-names></name></person-group>
<article-title>Oral contraceptives and cognition: A role for ethinyl estradiol</article-title>
<source/>Horm. Behav.
<year>2015</year>
<volume>74</volume>
<fpage>209</fpage>
<lpage>217</lpage>
<pub-id pub-id-type="doi">10.1016/j.yhbeh.2015.06.012</pub-id>
<pub-id pub-id-type="pmid">26122296</pub-id></element-citation>
</ref>
<ref id="B41-ijms-17-02086">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Egan</surname><given-names>K.R.</given-names></name><name><surname>Gleason</surname><given-names>C.E.</given-names></name></person-group>
<article-title>Longer duration of hormonal contraceptive use predicts better cognitive outcomes later in life</article-title>
<source/>J. Women’s Health
<year>2012</year>
<volume>21</volume>
<fpage>1259</fpage>
<lpage>1266</lpage>
<pub-id pub-id-type="doi">10.1089/jwh.2012.3522</pub-id>
<pub-id pub-id-type="pmid">22994984</pub-id></element-citation>
</ref>
<ref id="B42-ijms-17-02086">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Warren</surname><given-names>A.M.</given-names></name><name><surname>Gurvich</surname><given-names>C.</given-names></name><name><surname>Worsley</surname><given-names>R.</given-names></name><name><surname>Kulkarni</surname><given-names>J.</given-names></name></person-group>
<article-title>A systematic review of the impact of oral contraceptives on cognition</article-title>
<source/>Contraception
<year>2014</year>
<volume>90</volume>
<fpage>111</fpage>
<lpage>116</lpage>
<pub-id pub-id-type="doi">10.1016/j.contraception.2014.03.015</pub-id>
<pub-id pub-id-type="pmid">24856205</pub-id></element-citation>
</ref>
<ref id="B43-ijms-17-02086">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Maki</surname><given-names>P.M.</given-names></name><name><surname>Henderson</surname><given-names>V.W.</given-names></name></person-group>
<article-title>Hormone therapy, dementia, and cognition: The Women’s Health Initiative ten years on</article-title>
<source/>Climacteric
<year>2012</year>
<volume>15</volume>
<fpage>256</fpage>
<lpage>262</lpage>
<pub-id pub-id-type="doi">10.3109/13697137.2012.660613</pub-id>
<pub-id pub-id-type="pmid">22612612</pub-id></element-citation>
</ref>
<ref id="B44-ijms-17-02086">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xiao</surname><given-names>M.</given-names></name><name><surname>Cao</surname><given-names>G.L.</given-names></name><name><surname>Marshall</surname><given-names>C.</given-names></name><name><surname>Hu</surname><given-names>G.</given-names></name></person-group>
<article-title>Hypothesis: Multiple factors are associated with the lack of any beneficial effects of oestrogen-replacement therapy in the late postmenopausal stage</article-title>
<source/>Clin. Exp. Pharmacol. Physiol.
<year>2010</year>
<volume>37</volume>
<fpage>873</fpage>
<lpage>876</lpage>
<pub-id pub-id-type="doi">10.1111/j.1440-1681.2010.05400.x</pub-id>
<pub-id pub-id-type="pmid">20456422</pub-id></element-citation>
</ref>
<ref id="B45-ijms-17-02086">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shumaker</surname><given-names>S.A.</given-names></name><name><surname>Legault</surname><given-names>C.</given-names></name><name><surname>Rapp</surname><given-names>S.R.</given-names></name><name><surname>Thal</surname><given-names>L.</given-names></name><name><surname>Wallace</surname><given-names>R.B.</given-names></name><name><surname>Ockene</surname><given-names>J.K.</given-names></name><name><surname>Hendrix</surname><given-names>S.L.</given-names></name><name><surname>Jackson</surname><given-names>R.D.</given-names></name><name><surname>Kotchen</surname><given-names>J.M.</given-names></name><name><surname>Wassertheil-Smoller</surname><given-names>S.</given-names></name><etal></etal></person-group>
<article-title>Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women</article-title>
<source/>JAMA
<year>2003</year>
<volume>289</volume>
<fpage>2651</fpage>
<lpage>2662</lpage>
<pub-id pub-id-type="doi">10.1001/jama.289.20.2651</pub-id>
<pub-id pub-id-type="pmid">12771112</pub-id></element-citation>
</ref>
<ref id="B46-ijms-17-02086">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shumaker</surname><given-names>S.A.</given-names></name><name><surname>Legault</surname><given-names>C.</given-names></name><name><surname>Kuller</surname><given-names>L.</given-names></name><name><surname>Rapp</surname><given-names>S.R.</given-names></name><name><surname>Thal</surname><given-names>L.</given-names></name><name><surname>Lane</surname><given-names>D.S.</given-names></name><name><surname>Fillit</surname><given-names>H.</given-names></name><name><surname>Stefanick</surname><given-names>M.L.</given-names></name><name><surname>Hendrix</surname><given-names>S.L.</given-names></name><name><surname>Lewis</surname><given-names>C.E.</given-names></name><etal></etal></person-group>
<article-title>Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women’s Health Initiative Memory Study</article-title>
<source/>JAMA
<year>2004</year>
<volume>291</volume>
<fpage>2947</fpage>
<lpage>2958</lpage>
<pub-id pub-id-type="doi">10.1001/jama.291.24.2947</pub-id>
<pub-id pub-id-type="pmid">15213206</pub-id></element-citation>
</ref>
<ref id="B47-ijms-17-02086">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Resnick</surname><given-names>S.M.</given-names></name><name><surname>Maki</surname><given-names>P.M.</given-names></name><name><surname>Rapp</surname><given-names>S.R.</given-names></name><name><surname>Espeland</surname><given-names>M.</given-names></name><name><surname>Brunner</surname><given-names>R.</given-names></name><name><surname>Coker</surname><given-names>L.H.</given-names></name><name><surname>Granek</surname><given-names>I.</given-names></name><name><surname>Hogan</surname><given-names>P.</given-names></name><name><surname>Ockene</surname><given-names>J.K.</given-names></name><name><surname>Shumaker</surname><given-names>S.</given-names></name></person-group>
<article-title>Effects of combination estrogen plus progestin hormone treatment on cognition and affect</article-title>
<source/>J. Clin. Endocrinol. Metab.
<year>2006</year>
<volume>91</volume>
<fpage>1802</fpage>
<lpage>1810</lpage>
<pub-id pub-id-type="doi">10.1210/jc.2005-2097</pub-id>
<pub-id pub-id-type="pmid">16522699</pub-id></element-citation>
</ref>
<ref id="B48-ijms-17-02086">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Resnick</surname><given-names>S.M.</given-names></name><name><surname>Espeland</surname><given-names>M.A.</given-names></name><name><surname>An</surname><given-names>Y.</given-names></name><name><surname>Maki</surname><given-names>P.M.</given-names></name><name><surname>Coker</surname><given-names>L.H.</given-names></name><name><surname>Jackson</surname><given-names>R.</given-names></name><name><surname>Stefanick</surname><given-names>M.L.</given-names></name><name><surname>Wallace</surname><given-names>R.</given-names></name><name><surname>Rapp</surname><given-names>S.R.</given-names></name></person-group>
<article-title>Effects of conjugated equine estrogens on cognition and affect in postmenopausal women with prior hysterectomy</article-title>
<source/>J. Clin. Endocrinol. Metab.
<year>2009</year>
<volume>94</volume>
<fpage>4152</fpage>
<lpage>4161</lpage>
<pub-id pub-id-type="doi">10.1210/jc.2009-1340</pub-id>
<pub-id pub-id-type="pmid">19850684</pub-id></element-citation>
</ref>
<ref id="B49-ijms-17-02086">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yaffe</surname><given-names>K.</given-names></name><name><surname>Vittinghoff</surname><given-names>E.</given-names></name><name><surname>Ensrud</surname><given-names>K.E.</given-names></name><name><surname>Johnson</surname><given-names>K.C.</given-names></name><name><surname>Diem</surname><given-names>S.</given-names></name><name><surname>Hanes</surname><given-names>V.</given-names></name><name><surname>Grady</surname><given-names>D.</given-names></name></person-group>
<article-title>Effects of ultra-low-dose transdermal estradiol on cognition and health-related quality of life</article-title>
<source/>Arch. Neurol.
<year>2006</year>
<volume>63</volume>
<fpage>945</fpage>
<lpage>950</lpage>
<pub-id pub-id-type="doi">10.1001/archneur.63.7.945</pub-id>
<pub-id pub-id-type="pmid">16831962</pub-id></element-citation>
</ref>
<ref id="B50-ijms-17-02086">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Viscoli</surname><given-names>C.M.</given-names></name><name><surname>Brass</surname><given-names>L.M.</given-names></name><name><surname>Kernan</surname><given-names>W.N.</given-names></name><name><surname>Sarrel</surname><given-names>P.M.</given-names></name><name><surname>Suissa</surname><given-names>S.</given-names></name><name><surname>Horwitz</surname><given-names>R.I.</given-names></name></person-group>
<article-title>Estrogen therapy and risk of cognitive decline: Results from the Women’s Estrogen for Stroke Trial (WEST)</article-title>
<source/>Am. J. Obstet. Gynecol.
<year>2005</year>
<volume>192</volume>
<fpage>387</fpage>
<lpage>393</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajog.2004.08.017</pub-id>
<pub-id pub-id-type="pmid">15695976</pub-id></element-citation>
</ref>
<ref id="B51-ijms-17-02086">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Almeida</surname><given-names>O.P.</given-names></name><name><surname>Lautenschlager</surname><given-names>N.T.</given-names></name><name><surname>Vasikaran</surname><given-names>S.</given-names></name><name><surname>Leedman</surname><given-names>P.</given-names></name><name><surname>Gelavis</surname><given-names>A.</given-names></name><name><surname>Flicker</surname><given-names>L.</given-names></name></person-group>
<article-title>A 20-week randomized controlled trial of estradiol replacement therapy for women aged 70 years and older: Effect on mood, cognition and quality of life</article-title>
<source/>Neurobiology
<year>2006</year>
<volume>27</volume>
<fpage>141</fpage>
<lpage>149</lpage>
<pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2004.12.012</pub-id>
<pub-id pub-id-type="pmid">16298249</pub-id></element-citation>
</ref>
<ref id="B52-ijms-17-02086">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pefanco</surname><given-names>M.A.</given-names></name><name><surname>Kenny</surname><given-names>A.M.</given-names></name><name><surname>Kaplan</surname><given-names>R.F.</given-names></name><name><surname>Kuchel</surname><given-names>G.</given-names></name><name><surname>Walsh</surname><given-names>S.</given-names></name><name><surname>Kleppinger</surname><given-names>A.</given-names></name><name><surname>Prestwood</surname><given-names>K.</given-names></name></person-group>
<article-title>The effect of 3-year treatment with 0.25 mg/day of micronized 17 β-estradiol on cognitive function in older postmenopausal women</article-title>
<source/>J. Am. Geriatr. Soc.
<year>2007</year>
<volume>55</volume>
<fpage>426</fpage>
<lpage>431</lpage>
<pub-id pub-id-type="doi">10.1111/j.1532-5415.2007.01085.x</pub-id>
<pub-id pub-id-type="pmid">17341247</pub-id></element-citation>
</ref>
<ref id="B53-ijms-17-02086">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Phillips</surname><given-names>S.M.</given-names></name><name><surname>Sherwin</surname><given-names>B.B.</given-names></name></person-group>
<article-title>Effects of estrogen on memory function in surgically menopausal women</article-title>
<source/>Psychoneuroendocrinology
<year>1992</year>
<volume>17</volume>
<fpage>485</fpage>
<lpage>495</lpage>
<pub-id pub-id-type="doi">10.1016/0306-4530(92)90007-T</pub-id>
<pub-id pub-id-type="pmid">1484915</pub-id></element-citation>
</ref>
<ref id="B54-ijms-17-02086">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sherwin</surname><given-names>B.B.</given-names></name></person-group>
<article-title>Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women</article-title>
<source/>Psychoneuroendocrinology
<year>1988</year>
<volume>13</volume>
<fpage>345</fpage>
<lpage>357</lpage>
<pub-id pub-id-type="doi">10.1016/0306-4530(88)90060-1</pub-id>
<pub-id pub-id-type="pmid">3067252</pub-id></element-citation>
</ref>
<ref id="B55-ijms-17-02086">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shao</surname><given-names>H.</given-names></name><name><surname>Breitner</surname><given-names>J.C.S.</given-names></name><name><surname>Whitmer</surname><given-names>R.A.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Hayden</surname><given-names>K.</given-names></name><name><surname>Wengreen</surname><given-names>H.</given-names></name><name><surname>Corcoran</surname><given-names>C.</given-names></name><name><surname>Tschanz</surname><given-names>J.</given-names></name><name><surname>Norton</surname><given-names>M.</given-names></name><name><surname>Munger</surname><given-names>R.</given-names></name><etal></etal></person-group>
<article-title>Hormone therapy and Alzheimer disease dementia: New findings from the Cache County Study</article-title>
<source/>Neurology
<year>2012</year>
<volume>79</volume>
<fpage>1846</fpage>
<lpage>1852</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.0b013e318271f823</pub-id>
<pub-id pub-id-type="pmid">23100399</pub-id></element-citation>
</ref>
<ref id="B56-ijms-17-02086">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>O’Brien</surname><given-names>J.</given-names></name><name><surname>Jackson</surname><given-names>J.W.</given-names></name><name><surname>Grodstein</surname><given-names>F.</given-names></name><name><surname>Blacker</surname><given-names>D.</given-names></name><name><surname>Weuve</surname><given-names>J.</given-names></name></person-group>
<article-title>Postmenopausal hormone therapy is not associated with risk of all-cause dementia and Alzheimer’s disease</article-title>
<source/>Epidemiol. Rev.
<year>2014</year>
<volume>36</volume>
<fpage>83</fpage>
<lpage>103</lpage>
<pub-id pub-id-type="doi">10.1093/epirev/mxt008</pub-id>
<pub-id pub-id-type="pmid">24042430</pub-id></element-citation>
</ref>
<ref id="B57-ijms-17-02086">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lundin</surname><given-names>J.I.</given-names></name><name><surname>Ton</surname><given-names>T.G.</given-names></name><name><surname>LaCroix</surname><given-names>A.Z.</given-names></name><name><surname>Longstreth</surname><given-names>W.</given-names></name><name><surname>Franklin</surname><given-names>G.M.</given-names></name><name><surname>Swanson</surname><given-names>P.D.</given-names></name><name><surname>Smith-Weller</surname><given-names>T.</given-names></name><name><surname>Racette</surname><given-names>B.A.</given-names></name><name><surname>Checkoway</surname><given-names>H.</given-names></name></person-group>
<article-title>Formulations of hormone therapy and risk of Parkinson’s disease</article-title>
<source/>Mov. Disord.
<year>2014</year>
<volume>29</volume>
<fpage>1631</fpage>
<lpage>1636</lpage>
<pub-id pub-id-type="doi">10.1002/mds.26037</pub-id>
<pub-id pub-id-type="pmid">25255692</pub-id></element-citation>
</ref>
<ref id="B58-ijms-17-02086">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Blitshteyn</surname><given-names>S.</given-names></name><name><surname>Crook</surname><given-names>J.E.</given-names></name><name><surname>Jaeckle</surname><given-names>K.A.</given-names></name></person-group>
<article-title>Is there an association between meningioma and hormone replacement therapy?</article-title>
<source/>J. Clin. Oncol.
<year>2008</year>
<volume>26</volume>
<fpage>279</fpage>
<lpage>282</lpage>
<pub-id pub-id-type="doi">10.1200/JCO.2007.14.2133</pub-id>
<pub-id pub-id-type="pmid">18182668</pub-id></element-citation>
</ref>
<ref id="B59-ijms-17-02086">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Henderson</surname><given-names>V.W.</given-names></name><name><surname>Ala</surname><given-names>T.</given-names></name><name><surname>Sainani</surname><given-names>K.L.</given-names></name><name><surname>Bernstein</surname><given-names>A.L.</given-names></name><name><surname>Stephenson</surname><given-names>B.S.</given-names></name><name><surname>Rosen</surname><given-names>A.C.</given-names></name><name><surname>Farlow</surname><given-names>M.R.</given-names></name></person-group>
<article-title>Raloxifene for women with Alzheimer disease: A randomized controlled pilot trial</article-title>
<source/>Neurology
<year>2015</year>
<volume>85</volume>
<fpage>1937</fpage>
<lpage>1944</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.0000000000002171</pub-id>
<pub-id pub-id-type="pmid">26537053</pub-id></element-citation>
</ref>
<ref id="B60-ijms-17-02086">
<label>60.</label>
<element-citation publication-type="book">
<person-group person-group-type="author"><collab>Agency for Toxic Substances and Disease Registry (ATSDR)</collab></person-group>
<source/>ATSDR Toxicological Profile for Phenol
<publisher-name>Agency for Toxic Substances and Disease Registry (ATSDR)</publisher-name>
<publisher-loc>Atlanta, GA, USA</publisher-loc>
<year>2008</year>
<fpage>1</fpage>
<lpage>269</lpage>
</element-citation>
</ref>
<ref id="B61-ijms-17-02086">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Calafat</surname><given-names>A.M.</given-names></name><name><surname>Ye</surname><given-names>X.</given-names></name><name><surname>Wong</surname><given-names>L.Y.</given-names></name><name><surname>Reidy</surname><given-names>J.A.</given-names></name><name><surname>Needham</surname><given-names>L.L.</given-names></name></person-group>
<article-title>Exposure of the U.S. population to Bisphenol A and 4-tertiary-octylphenol: 2003–2004</article-title>
<source/>Environ. Health Perspect.
<year>2008</year>
<volume>116</volume>
<fpage>39</fpage>
<lpage>44</lpage>
<pub-id pub-id-type="doi">10.1289/ehp.10753</pub-id>
<pub-id pub-id-type="pmid">18197297</pub-id></element-citation>
</ref>
<ref id="B62-ijms-17-02086">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rubin</surname><given-names>B.S.</given-names></name></person-group>
<article-title>Bisphenol A: An endocrine disruptor with widespread exposure and multiple effects</article-title>
<source/>J. Steroid Biochem. Mol. Biol.
<year>2011</year>
<volume>127</volume>
<fpage>27</fpage>
<lpage>34</lpage>
<pub-id pub-id-type="doi">10.1016/j.jsbmb.2011.05.002</pub-id>
<pub-id pub-id-type="pmid">21605673</pub-id></element-citation>
</ref>
<ref id="B63-ijms-17-02086">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Le</surname><given-names>H.H.</given-names></name><name><surname>Carlson</surname><given-names>E.M.</given-names></name><name><surname>Chua</surname><given-names>J.P.</given-names></name><name><surname>Belcher</surname><given-names>S.M.</given-names></name></person-group>
<article-title>Bisphenol A is released from polycarbonate drinking bottles and mimics the neurotoxic actions of estrogen in developing cerebellar neurons</article-title>
<source/>Toxicol. Lett.
<year>2008</year>
<volume>176</volume>
<fpage>149</fpage>
<lpage>156</lpage>
<pub-id pub-id-type="doi">10.1016/j.toxlet.2007.11.001</pub-id>
<pub-id pub-id-type="pmid">18155859</pub-id></element-citation>
</ref>
<ref id="B64-ijms-17-02086">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sun</surname><given-names>Y.</given-names></name><name><surname>Nakashima</surname><given-names>M.N.</given-names></name><name><surname>Takahashi</surname><given-names>M.</given-names></name><name><surname>Kuroda</surname><given-names>N.</given-names></name><name><surname>Nakashima</surname><given-names>K.</given-names></name></person-group>
<article-title>Determination of bisphenol A in rat brain by microdialysis and column switching high-performance liquid chromatography with fluorescence detection</article-title>
<source/>Biomed. Chromatogr.
<year>2002</year>
<volume>16</volume>
<fpage>319</fpage>
<lpage>326</lpage>
<pub-id pub-id-type="doi">10.1002/bmc.161</pub-id>
<pub-id pub-id-type="pmid">12210505</pub-id></element-citation>
</ref>
<ref id="B65-ijms-17-02086">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kim</surname><given-names>C.S.</given-names></name><name><surname>Sapienza</surname><given-names>P.P.</given-names></name><name><surname>Ross</surname><given-names>I.A.</given-names></name><name><surname>Johnson</surname><given-names>W.</given-names></name><name><surname>Luu</surname><given-names>H.M.D.</given-names></name><name><surname>Hutter</surname><given-names>J.C.</given-names></name></person-group>
<article-title>Distribution of bisphenol A in the neuroendocrine organs of female rats</article-title>
<source/>Toxicol. Ind. Health
<year>2004</year>
<volume>20</volume>
<fpage>41</fpage>
<lpage>50</lpage>
<pub-id pub-id-type="doi">10.1191/0748233704th186oa</pub-id>
<pub-id pub-id-type="pmid">15807407</pub-id></element-citation>
</ref>
<ref id="B66-ijms-17-02086">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Huttenlocher</surname><given-names>P.R.</given-names></name><name><surname>Dabholkar</surname><given-names>A.S.</given-names></name></person-group>
<article-title>Regional differences in synaptogenesis in human cerebral cortex</article-title>
<source/>J. Comp. Neurol.
<year>1997</year>
<volume>387</volume>
<fpage>167</fpage>
<lpage>178</lpage>
<pub-id pub-id-type="doi">10.1002/(SICI)1096-9861(19971020)387:2&lt;167::AID-CNE1&gt;3.0.CO;2-Z</pub-id>
<pub-id pub-id-type="pmid">9336221</pub-id></element-citation>
</ref>
<ref id="B67-ijms-17-02086">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Eriksson</surname><given-names>P.S.</given-names></name><name><surname>Perfilieva</surname><given-names>E.</given-names></name><name><surname>Björk-Eriksson</surname><given-names>T.</given-names></name><name><surname>Alborn</surname><given-names>A.M.</given-names></name><name><surname>Nordborg</surname><given-names>C.</given-names></name><name><surname>Peterson</surname><given-names>D.A.</given-names></name><name><surname>Gage</surname><given-names>F.H.</given-names></name></person-group>
<article-title>Neurogenesis in the adult human hippocampus</article-title>
<source/>Nat. Med.
<year>1998</year>
<volume>4</volume>
<fpage>1313</fpage>
<lpage>1317</lpage>
<pub-id pub-id-type="doi">10.1038/3305</pub-id>
<pub-id pub-id-type="pmid">9809557</pub-id></element-citation>
</ref>
<ref id="B68-ijms-17-02086">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bowman</surname><given-names>R.E.</given-names></name><name><surname>Luine</surname><given-names>V.</given-names></name><name><surname>Diaz Weinstein</surname><given-names>S.</given-names></name><name><surname>Khandaker</surname><given-names>H.</given-names></name><name><surname>DeWolf</surname><given-names>S.</given-names></name><name><surname>Frankfurt</surname><given-names>M.</given-names></name></person-group>
<article-title>Bisphenol-A exposure during adolescence leads to enduring alterations in cognition and dendritic spine density in adult male and female rats</article-title>
<source/>Horm. Behav.
<year>2015</year>
<volume>69</volume>
<fpage>89</fpage>
<lpage>97</lpage>
<pub-id pub-id-type="doi">10.1016/j.yhbeh.2014.12.007</pub-id>
<pub-id pub-id-type="pmid">25554518</pub-id></element-citation>
</ref>
<ref id="B69-ijms-17-02086">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Eilam-Stock</surname><given-names>T.</given-names></name><name><surname>Serrano</surname><given-names>P.</given-names></name><name><surname>Frankfurt</surname><given-names>M.</given-names></name><name><surname>Luine</surname><given-names>V.</given-names></name></person-group>
<article-title>Bisphenol-A impairs memory and reduces dendritic spine density in adult male rats</article-title>
<source/>Behav. Neurosci.
<year>2012</year>
<volume>126</volume>
<fpage>175</fpage>
<lpage>185</lpage>
<pub-id pub-id-type="doi">10.1037/a0025959</pub-id>
<pub-id pub-id-type="pmid">22004261</pub-id></element-citation>
</ref>
<ref id="B70-ijms-17-02086">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Inagaki</surname><given-names>T.</given-names></name><name><surname>Frankfurt</surname><given-names>M.</given-names></name><name><surname>Luine</surname><given-names>V.</given-names></name></person-group>
<article-title>Estrogen-induced memory enhancements are blocked by acute bisphenol A in adult female rats: Role of dendritic spines</article-title>
<source/>Endocrinology
<year>2012</year>
<volume>153</volume>
<fpage>3357</fpage>
<lpage>3367</lpage>
<pub-id pub-id-type="doi">10.1210/en.2012-1121</pub-id>
<pub-id pub-id-type="pmid">22569790</pub-id></element-citation>
</ref>
<ref id="B71-ijms-17-02086">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Niu</surname><given-names>R.</given-names></name><name><surname>Zhu</surname><given-names>Y.</given-names></name><name><surname>Han</surname><given-names>H.</given-names></name><name><surname>Luo</surname><given-names>G.</given-names></name><name><surname>Zhou</surname><given-names>B.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name></person-group>
<article-title>Changes in memory and synaptic plasticity induced in male rats after maternal exposure to bisphenol A</article-title>
<source/>Toxicology
<year>2014</year>
<volume>322</volume>
<fpage>51</fpage>
<lpage>60</lpage>
<pub-id pub-id-type="doi">10.1016/j.tox.2014.05.001</pub-id>
<pub-id pub-id-type="pmid">24820113</pub-id></element-citation>
</ref>
<ref id="B72-ijms-17-02086">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dai</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name></person-group>
<article-title>Effects of uterine and lactational exposure to di-(2-ethylhexyl) phthalate on spatial memory and NMDA receptor of hippocampus in mice</article-title>
<source/>Horm. Behav.
<year>2015</year>
<volume>71</volume>
<fpage>41</fpage>
<lpage>48</lpage>
<pub-id pub-id-type="doi">10.1016/j.yhbeh.2015.03.008</pub-id>
<pub-id pub-id-type="pmid">25870019</pub-id></element-citation>
</ref>
<ref id="B73-ijms-17-02086">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Zhang</surname><given-names>G.</given-names></name><name><surname>Lu</surname><given-names>Y.</given-names></name><name><surname>Ruan</surname><given-names>Q.</given-names></name><name><surname>Dong</surname><given-names>F.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name></person-group>
<article-title>Sex-specific effects of bisphenol-A on memory and synaptic structural modification in hippocampus of adult mice</article-title>
<source/>Horm. Behav.
<year>2013</year>
<volume>63</volume>
<fpage>766</fpage>
<lpage>775</lpage>
<pub-id pub-id-type="doi">10.1016/j.yhbeh.2013.03.004</pub-id>
<pub-id pub-id-type="pmid">23523742</pub-id></element-citation>
</ref>
<ref id="B74-ijms-17-02086">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Elsworth</surname><given-names>J.D.</given-names></name><name><surname>Jentsch</surname><given-names>J.D.</given-names></name><name><surname>Groman</surname><given-names>S.M.</given-names></name><name><surname>Roth</surname><given-names>R.H.</given-names></name><name><surname>Redmond</surname><given-names>E.D.</given-names></name><name><surname>Leranth</surname><given-names>C.</given-names></name></person-group>
<article-title>Low circulating levels of bisphenol-A induce cognitive deficits and loss of asymmetric spine synapses in dorsolateral prefrontal cortex and hippocampus of adult male monkeys</article-title>
<source/>J. Comp. Neurol.
<year>2015</year>
<volume>523</volume>
<fpage>1248</fpage>
<lpage>1257</lpage>
<pub-id pub-id-type="doi">10.1002/cne.23735</pub-id>
<pub-id pub-id-type="pmid">25557059</pub-id></element-citation>
</ref>
<ref id="B75-ijms-17-02086">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jang</surname><given-names>Y.J.</given-names></name><name><surname>Park</surname><given-names>H.R.</given-names></name><name><surname>Kim</surname><given-names>T.H.</given-names></name><name><surname>Yang</surname><given-names>W.J.</given-names></name><name><surname>Lee</surname><given-names>J.J.</given-names></name><name><surname>Choi</surname><given-names>S.Y.</given-names></name><name><surname>Oh</surname><given-names>S.B.</given-names></name><name><surname>Lee</surname><given-names>E.</given-names></name><name><surname>Park</surname><given-names>J.H.</given-names></name><name><surname>Kim</surname><given-names>H.P.</given-names></name><etal></etal></person-group>
<article-title>High dose bisphenol A impairs hippocampal neurogenesis in female mice across generations</article-title>
<source/>Toxicology
<year>2012</year>
<volume>296</volume>
<fpage>73</fpage>
<lpage>82</lpage>
<pub-id pub-id-type="doi">10.1016/j.tox.2012.03.007</pub-id>
<pub-id pub-id-type="pmid">22484357</pub-id></element-citation>
</ref>
<ref id="B76-ijms-17-02086">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kim</surname><given-names>M.E.</given-names></name><name><surname>Park</surname><given-names>H.R.</given-names></name><name><surname>Gong</surname><given-names>E.J.</given-names></name><name><surname>Choi</surname><given-names>S.Y.</given-names></name><name><surname>Kim</surname><given-names>H.S.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name></person-group>
<article-title>Exposure to bisphenol A appears to impair hippocampal neurogenesis and spatial learning and memory</article-title>
<source/>Food Chem. Toxicol.
<year>2011</year>
<volume>49</volume>
<fpage>3383</fpage>
<lpage>3389</lpage>
<pub-id pub-id-type="doi">10.1016/j.fct.2011.09.017</pub-id>
<pub-id pub-id-type="pmid">21959526</pub-id></element-citation>
</ref>
<ref id="B77-ijms-17-02086">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kinch</surname><given-names>C.D.</given-names></name><name><surname>Ibhazehiebo</surname><given-names>K.</given-names></name><name><surname>Jeong</surname><given-names>J.-H.</given-names></name><name><surname>Habibi</surname><given-names>H.R.</given-names></name><name><surname>Kurrasch</surname><given-names>D.M.</given-names></name></person-group>
<article-title>Low-dose exposure to bisphenol A and replacement bisphenol S induces precocious hypothalamic neurogenesis in embryonic zebrafish</article-title>
<source/>Proc. Natl. Acad. Sci. USA
<year>2015</year>
<volume>112</volume>
<fpage>1475</fpage>
<lpage>1480</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1417731112</pub-id>
<pub-id pub-id-type="pmid">25583509</pub-id></element-citation>
</ref>
<ref id="B78-ijms-17-02086">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gursoy</surname><given-names>E.</given-names></name><name><surname>Cardounel</surname><given-names>A.</given-names></name><name><surname>Kalimi</surname><given-names>M.</given-names></name></person-group>
<article-title>The environmental estrogenic compound bisphenol A exerts estrogenic effects on mouse hippocampal (HT-22) cells: Neuroprotection against glutamate and amyloid β protein toxicity</article-title>
<source/>Neurochem. Int.
<year>2001</year>
<volume>38</volume>
<fpage>181</fpage>
<lpage>186</lpage>
<pub-id pub-id-type="doi">10.1016/S0197-0186(00)00072-3</pub-id>
<pub-id pub-id-type="pmid">11137887</pub-id></element-citation>
</ref>
<ref id="B79-ijms-17-02086">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stump</surname><given-names>D.G.</given-names></name><name><surname>Beck</surname><given-names>M.J.</given-names></name><name><surname>Radovsky</surname><given-names>A.</given-names></name><name><surname>Garman</surname><given-names>R.H.</given-names></name><name><surname>Freshwater</surname><given-names>L.L.</given-names></name><name><surname>Sheets</surname><given-names>L.P.</given-names></name><name><surname>Marty</surname><given-names>M.S.</given-names></name><name><surname>Waechter</surname><given-names>J.M.</given-names></name><name><surname>Dimond</surname><given-names>S.S.</given-names></name><name><surname>van Miller</surname><given-names>J.P.</given-names></name><etal></etal></person-group>
<article-title>Developmental neurotoxicity study of dietary bisphenol A in Sprague-Dawley rats</article-title>
<source/>Toxicol. Sci.
<year>2010</year>
<volume>115</volume>
<fpage>167</fpage>
<lpage>182</lpage>
<pub-id pub-id-type="doi">10.1093/toxsci/kfq025</pub-id>
<pub-id pub-id-type="pmid">20164145</pub-id></element-citation>
</ref>
<ref id="B80-ijms-17-02086">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ishido</surname><given-names>M.</given-names></name><name><surname>Masuo</surname><given-names>Y.</given-names></name><name><surname>Terasaki</surname><given-names>M.</given-names></name><name><surname>Morita</surname><given-names>M.</given-names></name></person-group>
<article-title>Rat hyperactivity by bisphenol A, but not by its derivatives, 3-hydroxybisphenol A or bisphenol A 3,4-quinone</article-title>
<source/>Toxicol. Lett.
<year>2011</year>
<volume>206</volume>
<fpage>300</fpage>
<lpage>305</lpage>
<pub-id pub-id-type="doi">10.1016/j.toxlet.2011.08.011</pub-id>
<pub-id pub-id-type="pmid">21884766</pub-id></element-citation>
</ref>
<ref id="B81-ijms-17-02086">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Viberg</surname><given-names>H.</given-names></name><name><surname>Fredriksson</surname><given-names>A.</given-names></name><name><surname>Buratovic</surname><given-names>S.</given-names></name><name><surname>Eriksson</surname><given-names>P.</given-names></name></person-group>
<article-title>Dose-dependent behavioral disturbances after a single neonatal Bisphenol A dose</article-title>
<source/>Toxicology
<year>2011</year>
<volume>290</volume>
<fpage>188</fpage>
<lpage>195</lpage>
<pub-id pub-id-type="doi">10.1016/j.tox.2011.09.006</pub-id>
<pub-id pub-id-type="pmid">21971502</pub-id></element-citation>
</ref>
<ref id="B82-ijms-17-02086">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kimura</surname><given-names>E.</given-names></name><name><surname>Matsuyoshi</surname><given-names>C.</given-names></name><name><surname>Miyazaki</surname><given-names>W.</given-names></name><name><surname>Benner</surname><given-names>S.</given-names></name><name><surname>Hosokawa</surname><given-names>M.</given-names></name><name><surname>Yokoyama</surname><given-names>K.</given-names></name><name><surname>Kakeyama</surname><given-names>M.</given-names></name><name><surname>Tohyama</surname><given-names>C.</given-names></name></person-group>
<article-title>Prenatal exposure to bisphenol A impacts neuronal morphology in the hippocampal CA1 region in developing and aged mice</article-title>
<source/>Arch. Toxicol.
<year>2016</year>
<volume>90</volume>
<fpage>691</fpage>
<lpage>700</lpage>
<pub-id pub-id-type="doi">10.1007/s00204-015-1485-x</pub-id>
<pub-id pub-id-type="pmid">25804199</pub-id></element-citation>
</ref>
<ref id="B83-ijms-17-02086">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yin</surname><given-names>N.</given-names></name><name><surname>Yao</surname><given-names>X.</given-names></name><name><surname>Qin</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>Y.L.</given-names></name><name><surname>Faiola</surname><given-names>F.</given-names></name></person-group>
<article-title>Assessment of Bisphenol A (BPA) neurotoxicity in vitro with mouse embryonic stem cells</article-title>
<source/>J. Environ. Sci.
<year>2015</year>
<volume>36</volume>
<fpage>181</fpage>
<lpage>187</lpage>
<pub-id pub-id-type="doi">10.1016/j.jes.2015.06.004</pub-id>
<pub-id pub-id-type="pmid">26456621</pub-id></element-citation>
</ref>
<ref id="B84-ijms-17-02086">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mersha</surname><given-names>M.D.</given-names></name><name><surname>Patel</surname><given-names>B.M.</given-names></name><name><surname>Patel</surname><given-names>D.</given-names></name><name><surname>Richardson</surname><given-names>B.N.</given-names></name><name><surname>Dhillon</surname><given-names>H.S.</given-names></name></person-group>
<article-title>Effects of BPA and BPS exposure limited to early embryogenesis persist to impair non-associative learning in adults</article-title>
<source/>Behav. Brain Funct.
<year>2015</year>
<volume>11</volume>
<fpage>1</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="doi">10.1186/s12993-015-0071-y</pub-id>
<pub-id pub-id-type="pmid">25595193</pub-id></element-citation>
</ref>
<ref id="B85-ijms-17-02086">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kim</surname><given-names>K.</given-names></name><name><surname>Son</surname><given-names>T.G.</given-names></name><name><surname>Park</surname><given-names>H.R.</given-names></name><name><surname>Kim</surname><given-names>S.J.</given-names></name><name><surname>Kim</surname><given-names>H.S.</given-names></name><name><surname>Kim</surname><given-names>H.S.</given-names></name><name><surname>Kim</surname><given-names>T.S.</given-names></name><name><surname>Jung</surname><given-names>K.K.</given-names></name><name><surname>Han</surname><given-names>S.Y.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name></person-group>
<article-title>Potencies of bisphenol A on the neuronal differentiation and hippocampal neurogenesis</article-title>
<source/>J. Toxicol. Environ. Health A
<year>2009</year>
<volume>72</volume>
<fpage>1343</fpage>
<lpage>1351</lpage>
<pub-id pub-id-type="doi">10.1080/15287390903212501</pub-id>
<pub-id pub-id-type="pmid">20077206</pub-id></element-citation>
</ref>
<ref id="B86-ijms-17-02086">
<label>86.</label>
<element-citation publication-type="book">
<person-group person-group-type="author"><collab>U.S. Environmental Protection Agency</collab></person-group>
<source/>Bisphenol A
<gov>CASRN 80-05-7</gov>
<publisher-name>U.S. Environmental Protection Agency</publisher-name>
<publisher-loc>Washington, DC, USA</publisher-loc>
<year>1988</year>
<fpage>1</fpage>
<lpage>7</lpage>
</element-citation>
</ref>
<ref id="B87-ijms-17-02086">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Diaz Weinstein</surname><given-names>S.</given-names></name><name><surname>Villafane</surname><given-names>J.J.</given-names></name><name><surname>Juliano</surname><given-names>N.</given-names></name><name><surname>Bowman</surname><given-names>R.E.</given-names></name></person-group>
<article-title>Adolescent exposure to Bisphenol-A increases anxiety and sucrose preference but impairs spatial memory in rats independent of sex</article-title>
<source/>Brain Res.
<year>2013</year>
<volume>1529</volume>
<fpage>56</fpage>
<lpage>65</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainres.2013.07.018</pub-id>
<pub-id pub-id-type="pmid">23872220</pub-id></element-citation>
</ref>
<ref id="B88-ijms-17-02086">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Johnson</surname><given-names>S.A.</given-names></name><name><surname>Javurek</surname><given-names>A.B.</given-names></name><name><surname>Painter</surname><given-names>M.S.</given-names></name><name><surname>Ellersieck</surname><given-names>M.R.</given-names></name><name><surname>Welsh</surname><given-names>T.H.</given-names></name><name><surname>Camacho</surname><given-names>L.</given-names></name><name><surname>Lewis</surname><given-names>S.M.</given-names></name><name><surname>Vanlandingham</surname><given-names>M.M.</given-names></name><name><surname>Ferguson</surname><given-names>S.A.</given-names></name><name><surname>Rosenfeld</surname><given-names>C.S.</given-names></name></person-group>
<article-title>Effects of developmental exposure to bisphenol A on spatial navigational learning and memory in rats: A CLARITY-BPA study</article-title>
<source/>Horm. Behav.
<year>2016</year>
<volume>80</volume>
<fpage>139</fpage>
<lpage>148</lpage>
<pub-id pub-id-type="doi">10.1016/j.yhbeh.2015.09.005</pub-id>
<pub-id pub-id-type="pmid">26436835</pub-id></element-citation>
</ref>
<ref id="B89-ijms-17-02086">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Braun</surname><given-names>J.M.</given-names></name><name><surname>Yolton</surname><given-names>K.</given-names></name><name><surname>Dietrich</surname><given-names>K.N.</given-names></name><name><surname>Hornung</surname><given-names>R.</given-names></name><name><surname>Ye</surname><given-names>X.</given-names></name><name><surname>Calafat</surname><given-names>A.M.</given-names></name><name><surname>Lanphear</surname><given-names>B.P.</given-names></name></person-group>
<article-title>Prenatal bisphenol A exposure and early childhood behavior</article-title>
<source/>Environ. Health Perspect.
<year>2009</year>
<volume>117</volume>
<fpage>1945</fpage>
<lpage>1952</lpage>
<pub-id pub-id-type="doi">10.1289/ehp.0900979</pub-id>
<pub-id pub-id-type="pmid">20049216</pub-id></element-citation>
</ref>
<ref id="B90-ijms-17-02086">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rebuli</surname><given-names>M.E.</given-names></name><name><surname>Camacho</surname><given-names>L.</given-names></name><name><surname>Adonay</surname><given-names>M.E.</given-names></name><name><surname>Reif</surname><given-names>D.M.</given-names></name><name><surname>Aylor</surname><given-names>D.L.</given-names></name><name><surname>Patisaul</surname><given-names>H.B.</given-names></name></person-group>
<article-title>Impact of low-dose oral exposure to bisphenol A (BPA) on Juvenile and adult rat exploratory and anxiety behavior: A CLARITY-BPA Consortium Study</article-title>
<source/>Toxicol. Sci.
<year>2015</year>
<volume>148</volume>
<fpage>341</fpage>
<lpage>354</lpage>
<pub-id pub-id-type="doi">10.1093/toxsci/kfv163</pub-id>
<pub-id pub-id-type="pmid">26209558</pub-id></element-citation>
</ref>
<ref id="B91-ijms-17-02086">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Luo</surname><given-names>G.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Wei</surname><given-names>R.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Niu</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name></person-group>
<article-title>Maternal bisphenol a diet induces anxiety-like behavior in female juvenile with neuroimmune activation</article-title>
<source/>Toxicol. Sci.
<year>2014</year>
<volume>140</volume>
<fpage>364</fpage>
<lpage>373</lpage>
<pub-id pub-id-type="doi">10.1093/toxsci/kfu085</pub-id>
<pub-id pub-id-type="pmid">24824810</pub-id></element-citation>
</ref>
<ref id="B92-ijms-17-02086">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Carr</surname><given-names>R.</given-names></name><name><surname>Bertasi</surname><given-names>F.</given-names></name><name><surname>Betancourt</surname><given-names>A.</given-names></name><name><surname>Bowers</surname><given-names>S.</given-names></name><name><surname>Gandy</surname><given-names>B.S.</given-names></name><name><surname>Ryan</surname><given-names>P.</given-names></name><name><surname>Willard</surname><given-names>S.</given-names></name></person-group>
<article-title>Effect of neonatal rat bisphenol a exposure on performance in the Morris water maze</article-title>
<source/>J. Toxicol. Environ. Health A
<year>2003</year>
<volume>66</volume>
<fpage>2077</fpage>
<lpage>2088</lpage>
<pub-id pub-id-type="doi">10.1080/713853983</pub-id>
<pub-id pub-id-type="pmid">14555403</pub-id></element-citation>
</ref>
<ref id="B93-ijms-17-02086">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Miyagawa</surname><given-names>K.</given-names></name><name><surname>Narita</surname><given-names>M.</given-names></name><name><surname>Narita</surname><given-names>M.</given-names></name><name><surname>Akama</surname><given-names>H.</given-names></name><name><surname>Suzuki</surname><given-names>T.</given-names></name></person-group>
<article-title>Memory impairment associated with a dysfunction of the hippocampal cholinergic system induced by prenatal and neonatal exposures to bisphenol-A</article-title>
<source/>Neurosci. Lett.
<year>2007</year>
<volume>418</volume>
<fpage>236</fpage>
<lpage>241</lpage>
<pub-id pub-id-type="doi">10.1016/j.neulet.2007.01.088</pub-id>
<pub-id pub-id-type="pmid">17467901</pub-id></element-citation>
</ref>
<ref id="B94-ijms-17-02086">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kawai</surname><given-names>K.</given-names></name><name><surname>Nozaki</surname><given-names>T.</given-names></name><name><surname>Nishikata</surname><given-names>H.</given-names></name><name><surname>Aou</surname><given-names>S.</given-names></name><name><surname>Takii</surname><given-names>M.</given-names></name><name><surname>Kubo</surname><given-names>C.</given-names></name></person-group>
<article-title>Aggressive behavior and serum testosterone concentration during the maturation process of male mice: The effects of fetal exposure to bisphenol A</article-title>
<source/>Environ. Health Perspect.
<year>2003</year>
<volume>111</volume>
<fpage>175</fpage>
<lpage>178</lpage>
<pub-id pub-id-type="doi">10.1289/ehp.5440</pub-id>
<pub-id pub-id-type="pmid">12573901</pub-id></element-citation>
</ref>
<ref id="B95-ijms-17-02086">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nagao</surname><given-names>T.</given-names></name><name><surname>Saito</surname><given-names>Y.</given-names></name><name><surname>Usumi</surname><given-names>K.</given-names></name><name><surname>Kuwagata</surname><given-names>M.</given-names></name><name><surname>Imai</surname><given-names>K.</given-names></name></person-group>
<article-title>Reproductive function in rats exposed neonatally to bisphenol A and estradiol benzoate</article-title>
<source/>Reprod. Toxicol.
<year>1999</year>
<volume>13</volume>
<fpage>303</fpage>
<lpage>311</lpage>
<pub-id pub-id-type="doi">10.1016/S0890-6238(99)00017-9</pub-id>
<pub-id pub-id-type="pmid">10453915</pub-id></element-citation>
</ref>
<ref id="B96-ijms-17-02086">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Narita</surname><given-names>M.</given-names></name><name><surname>Miyagawa</surname><given-names>K.</given-names></name><name><surname>Mizuo</surname><given-names>K.</given-names></name><name><surname>Yoshida</surname><given-names>T.</given-names></name><name><surname>Suzuki</surname><given-names>T.</given-names></name></person-group>
<article-title>Prenatal and neonatal exposure to low-dose of bisphenol-A enhance the morphine-induced hyperlocomotion and rewarding effect</article-title>
<source/>Neurosci. Lett.
<year>2006</year>
<volume>402</volume>
<fpage>249</fpage>
<lpage>252</lpage>
<pub-id pub-id-type="doi">10.1016/j.neulet.2006.04.014</pub-id>
<pub-id pub-id-type="pmid">16678967</pub-id></element-citation>
</ref>
<ref id="B97-ijms-17-02086">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Narita</surname><given-names>M.</given-names></name><name><surname>Miyagawa</surname><given-names>K.</given-names></name><name><surname>Mizuo</surname><given-names>K.</given-names></name><name><surname>Yoshida</surname><given-names>T.</given-names></name><name><surname>Suzuki</surname><given-names>T.</given-names></name></person-group>
<article-title>Changes in central dopaminergic systems and morphine reward by prenatal and neonatal exposure to bisphenol-A in mice: Evidence for the importance of exposure period</article-title>
<source/>Addict. Biol.
<year>2007</year>
<volume>12</volume>
<fpage>167</fpage>
<lpage>172</lpage>
<pub-id pub-id-type="doi">10.1111/j.1369-1600.2007.00048.x</pub-id>
<pub-id pub-id-type="pmid">17508988</pub-id></element-citation>
</ref>
<ref id="B98-ijms-17-02086">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Harley</surname><given-names>K.G.</given-names></name><name><surname>Gunier</surname><given-names>R.B.</given-names></name><name><surname>Kogut</surname><given-names>K.</given-names></name><name><surname>Johnson</surname><given-names>C.</given-names></name><name><surname>Bradman</surname><given-names>A.</given-names></name><name><surname>Calafat</surname><given-names>A.M.</given-names></name><name><surname>Eskenazi</surname><given-names>B.</given-names></name></person-group>
<article-title>Prenatal and early childhood bisphenol A concentrations and behavior in school-aged children</article-title>
<source/>Environ. Res.
<year>2013</year>
<volume>126</volume>
<fpage>43</fpage>
<lpage>50</lpage>
<pub-id pub-id-type="doi">10.1016/j.envres.2013.06.004</pub-id>
<pub-id pub-id-type="pmid">23870093</pub-id></element-citation>
</ref>
<ref id="B99-ijms-17-02086">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sarrouilhe</surname><given-names>D.</given-names></name><name><surname>Dejean</surname><given-names>C.</given-names></name></person-group>
<article-title>Autism spectrum disorders and bisphenol A: Is serotonin the lacking link in the chain?</article-title>
<source/>Encephale
<year>2016</year>
<pub-id pub-id-type="doi">10.1016/j.encep.2016.04.007</pub-id>
</element-citation>
</ref>
<ref id="B100-ijms-17-02086">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kondolot</surname><given-names>M.</given-names></name><name><surname>Ozmert</surname><given-names>E.N.</given-names></name><name><surname>Ascı</surname><given-names>A.</given-names></name><name><surname>Erkekoglu</surname><given-names>P.</given-names></name><name><surname>Oztop</surname><given-names>D.B.</given-names></name><name><surname>Gumus</surname><given-names>H.</given-names></name><name><surname>Kocer-Gumusel</surname><given-names>B.</given-names></name><name><surname>Yurdakok</surname><given-names>K.</given-names></name></person-group>
<article-title>Plasma phthalate and bisphenol a levels and oxidant-antioxidant status in autistic children</article-title>
<source/>Environ. Toxicol. Pharmacol.
<year>2016</year>
<volume>43</volume>
<fpage>149</fpage>
<lpage>158</lpage>
<pub-id pub-id-type="doi">10.1016/j.etap.2016.03.006</pub-id>
<pub-id pub-id-type="pmid">26991849</pub-id></element-citation>
</ref>
<ref id="B101-ijms-17-02086">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Repossi</surname><given-names>G.</given-names></name><name><surname>Dain</surname><given-names>A.</given-names></name><name><surname>Tarres</surname><given-names>M.C.</given-names></name><name><surname>Das</surname><given-names>U.N.</given-names></name><name><surname>Eynard</surname><given-names>A.R.</given-names></name></person-group>
<article-title>Beneficial action of resveratrol: How and why?</article-title>
<source/>Nutrition
<year>2015</year>
<volume>32</volume>
<fpage>1</fpage>
<lpage>5</lpage>
</element-citation>
</ref>
<ref id="B102-ijms-17-02086">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Arbuckle</surname><given-names>T.E.</given-names></name><name><surname>Davis</surname><given-names>K.</given-names></name><name><surname>Boylan</surname><given-names>K.</given-names></name><name><surname>Fisher</surname><given-names>M.</given-names></name><name><surname>Fu</surname><given-names>J.</given-names></name></person-group>
<article-title>Bisphenol A, phthalates and lead and learning and behavioral problems in Canadian children 6–11 years of age: CHMS 2007–2009</article-title>
<source/>Neurotoxicology
<year>2016</year>
<volume>54</volume>
<fpage>89</fpage>
<lpage>98</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuro.2016.03.014</pub-id>
<pub-id pub-id-type="pmid">27021348</pub-id></element-citation>
</ref>
<ref id="B103-ijms-17-02086">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yolton</surname><given-names>K.</given-names></name><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Strauss</surname><given-names>D.</given-names></name><name><surname>Altaye</surname><given-names>M.</given-names></name><name><surname>Calafat</surname><given-names>A.M.</given-names></name><name><surname>Khoury</surname><given-names>J.</given-names></name></person-group>
<article-title>Prenatal exposure to bisphenol A and phthalates and infant neurobehavior</article-title>
<source/>Neurotoxicol. Teratol.
<year>2011</year>
<volume>33</volume>
<fpage>558</fpage>
<lpage>566</lpage>
<pub-id pub-id-type="doi">10.1016/j.ntt.2011.08.003</pub-id>
<pub-id pub-id-type="pmid">21854843</pub-id></element-citation>
</ref>
<ref id="B104-ijms-17-02086">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Roen</surname><given-names>E.L.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Calafat</surname><given-names>A.M.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Margolis</surname><given-names>A.</given-names></name><name><surname>Herbstman</surname><given-names>J.</given-names></name><name><surname>Hoepner</surname><given-names>L.A.</given-names></name><name><surname>Rauh</surname><given-names>V.</given-names></name><name><surname>Perera</surname><given-names>F.P.</given-names></name></person-group>
<article-title>Bisphenol A exposure and behavioral problems among inner city children at 7–9 years of age</article-title>
<source/>Environ. Res.
<year>2015</year>
<volume>142</volume>
<fpage>739</fpage>
<lpage>745</lpage>
<pub-id pub-id-type="doi">10.1016/j.envres.2015.01.014</pub-id>
<pub-id pub-id-type="pmid">25724466</pub-id></element-citation>
</ref>
<ref id="B105-ijms-17-02086">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Braun</surname><given-names>J.M.</given-names></name><name><surname>Kalkbrenner</surname><given-names>A.E.</given-names></name><name><surname>Calafat</surname><given-names>A.M.</given-names></name><name><surname>Yolton</surname><given-names>K.</given-names></name><name><surname>Ye</surname><given-names>X.</given-names></name><name><surname>Dietrich</surname><given-names>K.N.</given-names></name><name><surname>Lanphear</surname><given-names>B.P.</given-names></name></person-group>
<article-title>Impact of early-life bisphenol A exposure on behavior and executive function in children</article-title>
<source/>Pediatrics
<year>2011</year>
<volume>128</volume>
<fpage>873</fpage>
<lpage>882</lpage>
<pub-id pub-id-type="doi">10.1542/peds.2011-1335</pub-id>
<pub-id pub-id-type="pmid">22025598</pub-id></element-citation>
</ref>
<ref id="B106-ijms-17-02086">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Miodovnik</surname><given-names>A.</given-names></name><name><surname>Engel</surname><given-names>S.M.</given-names></name><name><surname>Zhu</surname><given-names>C.</given-names></name><name><surname>Ye</surname><given-names>X.</given-names></name><name><surname>Soorya</surname><given-names>L.V.</given-names></name><name><surname>Silva</surname><given-names>M.J.</given-names></name><name><surname>Calafat</surname><given-names>A.M.</given-names></name><name><surname>Wolff</surname><given-names>M.S.</given-names></name></person-group>
<article-title>Endocrine disruptors and childhood social impairment</article-title>
<source/>Neurotoxicology
<year>2011</year>
<volume>32</volume>
<fpage>261</fpage>
<lpage>267</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuro.2010.12.009</pub-id>
<pub-id pub-id-type="pmid">21182865</pub-id></element-citation>
</ref>
<ref id="B107-ijms-17-02086">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bondy</surname><given-names>M.</given-names></name><name><surname>Lee Ligon</surname><given-names>B.</given-names></name></person-group>
<article-title>Epidemiology and etiology of intracranial meningiomas: A review</article-title>
<source/>J. Neurooncol.
<year>1996</year>
<volume>29</volume>
<fpage>197</fpage>
<lpage>205</lpage>
<pub-id pub-id-type="doi">10.1007/BF00165649</pub-id>
<pub-id pub-id-type="pmid">8858525</pub-id></element-citation>
</ref>
<ref id="B108-ijms-17-02086">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Duan</surname><given-names>B.</given-names></name><name><surname>Hu</surname><given-names>X.</given-names></name><name><surname>Zhao</surname><given-names>H.</given-names></name><name><surname>Qin</surname><given-names>J.</given-names></name><name><surname>Luo</surname><given-names>J.</given-names></name></person-group>
<article-title>The relationship between urinary bisphenol A levels and meningioma in Chinese adults</article-title>
<source/>Int. J. Clin. Oncol.
<year>2013</year>
<volume>18</volume>
<fpage>492</fpage>
<lpage>497</lpage>
<pub-id pub-id-type="doi">10.1007/s10147-012-0408-6</pub-id>
<pub-id pub-id-type="pmid">22527848</pub-id></element-citation>
</ref>
<ref id="B109-ijms-17-02086">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chun</surname><given-names>T.Y.</given-names></name><name><surname>Gorski</surname><given-names>J.</given-names></name></person-group>
<article-title>High concentrations of bisphenol A induce cell growth and prolactin secretion in an estrogen-responsive pituitary tumor cell line</article-title>
<source/>Toxicol. Appl. Pharmacol.
<year>2000</year>
<volume>162</volume>
<fpage>161</fpage>
<lpage>165</lpage>
<pub-id pub-id-type="doi">10.1006/taap.1999.8840</pub-id>
<pub-id pub-id-type="pmid">10652244</pub-id></element-citation>
</ref>
<ref id="B110-ijms-17-02086">
<label>110.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lee</surname><given-names>Y.M.</given-names></name><name><surname>Raisuddin</surname><given-names>S.</given-names></name><name><surname>Rhee</surname><given-names>J.S.</given-names></name><name><surname>Ki</surname><given-names>J.S.</given-names></name><name><surname>Kim</surname><given-names>I.C.</given-names></name><name><surname>Lee</surname><given-names>J.S.</given-names></name></person-group>
<article-title>Modulatory effect of environmental endocrine disruptors on N-ras oncogene expression in the hermaphroditic fish, <italic>Kryptolebias marmoratus</italic></article-title>
<source/>Comp. Biochem. Physiol.—C Toxicol. Pharmacol.
<year>2008</year>
<volume>147</volume>
<fpage>299</fpage>
<lpage>305</lpage>
<pub-id pub-id-type="doi">10.1016/j.cbpc.2007.11.006</pub-id>
<pub-id pub-id-type="pmid">18248853</pub-id></element-citation>
</ref>
<ref id="B111-ijms-17-02086">
<label>111.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mikhail</surname><given-names>Y.</given-names></name><name><surname>Cheryl</surname><given-names>S.</given-names></name></person-group>
<article-title>Alkylphenol xenoestrogens with varying carbon chain lengths differentially and potently activate signaling and functional responses in GH3/B6/F10 somatomam</article-title>
<source/>Environ. Health Perspect.
<year>2009</year>
<volume>117</volume>
<fpage>723</fpage>
<pub-id pub-id-type="pmid">19479013</pub-id></element-citation>
</ref>
<ref id="B112-ijms-17-02086">
<label>112.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ghisari</surname><given-names>M.</given-names></name><name><surname>Bonefeld-Jorgensen</surname><given-names>E.C.</given-names></name></person-group>
<article-title>Impact of environmental chemicals on the thyroid hormone function in pituitary rat GH3 cells</article-title>
<source/>Mol. Cell. Endocrinol.
<year>2005</year>
<volume>244</volume>
<fpage>31</fpage>
<lpage>41</lpage>
<pub-id pub-id-type="doi">10.1016/j.mce.2005.01.013</pub-id>
<pub-id pub-id-type="pmid">16221524</pub-id></element-citation>
</ref>
<ref id="B113-ijms-17-02086">
<label>113.</label>
<element-citation publication-type="book">
<person-group person-group-type="author"><collab>Agency for Toxic Substances and Disease Registry (ATSDR)</collab></person-group>
<source/>Toxicological Profile for Di-N-Octylphthalate
<publisher-name>Agency for Toxic Substances and Disease Registry (ATSDR)</publisher-name>
<publisher-loc>Atlanta, GA, USA</publisher-loc>
<year>1997</year>
</element-citation>
</ref>
<ref id="B114-ijms-17-02086">
<label>114.</label>
<element-citation publication-type="book">
<person-group person-group-type="author"><collab>Agency for Toxic Substances and Disease Registry (ATSDR)</collab></person-group>
<source/>Toxicological Profile: Di-(2-Ethylhexyl) Phthalate (DEHP)
<publisher-name>Agency for Toxic Substances and Disease Registry (ATSDR)</publisher-name>
<publisher-loc>Atlanta, GA, USA</publisher-loc>
<year>2002</year>
</element-citation>
</ref>
<ref id="B115-ijms-17-02086">
<label>115.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><collab>Agency for Toxic Substances and Disease Registry (ATSDR)</collab></person-group>
<article-title>Toxicological profile for di-<italic>N</italic>-butyl phthalate</article-title>
<source/>Agency Toxic Subst. Dis. Regist.
<year>2001</year>
<volume>18</volume>
<fpage>187</fpage>
<lpage>191</lpage>
</element-citation>
</ref>
<ref id="B116-ijms-17-02086">
<label>116.</label>
<element-citation publication-type="book">
<person-group person-group-type="author"><collab>Agency for Toxic Substances and Disease Registry (ATSDR)</collab></person-group>
<source/>Toxicological Profile for Diethyl Phthalate
<publisher-name>Agency for Toxic Substances and Disease Registry (ATSDR)</publisher-name>
<publisher-loc>Atlanta, GA, USA</publisher-loc>
<year>1995</year>
<fpage>1</fpage>
<lpage>158</lpage>
</element-citation>
</ref>
<ref id="B117-ijms-17-02086">
<label>117.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Heudorf</surname><given-names>U.</given-names></name><name><surname>Mersch-Sundermann</surname><given-names>V.</given-names></name><name><surname>Angerer</surname><given-names>J.</given-names></name></person-group>
<article-title>Phthalates: Toxicology and exposure</article-title>
<source/>Int. J. Hyg. Environ. Health
<year>2007</year>
<volume>210</volume>
<fpage>623</fpage>
<lpage>634</lpage>
<pub-id pub-id-type="doi">10.1016/j.ijheh.2007.07.011</pub-id>
<pub-id pub-id-type="pmid">17889607</pub-id></element-citation>
</ref>
<ref id="B118-ijms-17-02086">
<label>118.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ma</surname><given-names>N.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Gao</surname><given-names>P.</given-names></name><name><surname>Cao</surname><given-names>P.</given-names></name><name><surname>Xu</surname><given-names>H.</given-names></name></person-group>
<article-title>Effect of diisobutyl phthalate on learning and memory behavior and apoptosis of hippocampus cells in mice</article-title>
<source/>Wei Sheng Yan Jiu
<year>2013</year>
<volume>42</volume>
<fpage>57</fpage>
<lpage>60</lpage>
<comment>(In Chinese)</comment>
<pub-id pub-id-type="pmid">23596708</pub-id></element-citation>
</ref>
<ref id="B119-ijms-17-02086">
<label>119.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zeliger</surname><given-names>H.I.</given-names></name></person-group>
<article-title>Exposure to lipophilic chemicals as a cause of neurological impairments, neurodevelopmental disorders and neurodegenerative diseases</article-title>
<source/>Interdiscip. Toxicol.
<year>2013</year>
<volume>6</volume>
<fpage>103</fpage>
<lpage>110</lpage>
<pub-id pub-id-type="doi">10.2478/intox-2013-0018</pub-id>
<pub-id pub-id-type="pmid">24678247</pub-id></element-citation>
</ref>
<ref id="B120-ijms-17-02086">
<label>120.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Smith</surname><given-names>C.A.</given-names></name><name><surname>Holahan</surname><given-names>M.R.</given-names></name></person-group>
<article-title>Reduced hippocampal dendritic spine density and BDNF expression following acute postnatal exposure to di-(2-ethylhexyl) phthalate in male long evans rats</article-title>
<source/>PLoS ONE
<year>2014</year>
<volume>9</volume>
<elocation-id>e109522</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0109522</pub-id>
<pub-id pub-id-type="pmid">25295592</pub-id></element-citation>
</ref>
<ref id="B121-ijms-17-02086">
<label>121.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Holahan</surname><given-names>M.R.</given-names></name><name><surname>Smith</surname><given-names>C.A.</given-names></name></person-group>
<article-title>Phthalates and neurotoxic effects on hippocampal network plasticity</article-title>
<source/>Neurotoxicology
<year>2015</year>
<volume>48</volume>
<fpage>21</fpage>
<lpage>34</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuro.2015.02.008</pub-id>
<pub-id pub-id-type="pmid">25749100</pub-id></element-citation>
</ref>
<ref id="B122-ijms-17-02086">
<label>122.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>X.J.</given-names></name><name><surname>Jiang</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>H.S.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name></person-group>
<article-title>Neurotoxicity of dibutyl phthalate in brain development following perinatal exposure: A study in rats</article-title>
<source/>Environ. Toxicol. Pharmacol.
<year>2013</year>
<volume>36</volume>
<fpage>392</fpage>
<lpage>402</lpage>
<pub-id pub-id-type="doi">10.1016/j.etap.2013.05.001</pub-id>
<pub-id pub-id-type="pmid">23736097</pub-id></element-citation>
</ref>
<ref id="B123-ijms-17-02086">
<label>123.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Betz</surname><given-names>A.J.</given-names></name><name><surname>Jayatilaka</surname><given-names>S.</given-names></name><name><surname>Joshi</surname><given-names>J.</given-names></name><name><surname>Ramanan</surname><given-names>S.</given-names></name><name><surname>Debartolo</surname><given-names>D.</given-names></name><name><surname>Pylypiw</surname><given-names>H.</given-names></name><name><surname>Franke</surname><given-names>E.</given-names></name></person-group>
<article-title>Chronic exposure to benzyl butyl phthalate (BBP) alters social interaction and fear conditioning in male adult rats: Alterations in amygdalar MeCP2, ERK1/2 and ER??</article-title>
<source/>Neuroendocrinol. Lett.
<year>2013</year>
<volume>34</volume>
<fpage>347</fpage>
<lpage>358</lpage>
<pub-id pub-id-type="pmid">23922038</pub-id></element-citation>
</ref>
<ref id="B124-ijms-17-02086">
<label>124.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lin</surname><given-names>H.</given-names></name><name><surname>Yuan</surname><given-names>K.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Hu</surname><given-names>G.</given-names></name><name><surname>Lian</surname><given-names>Q.Q.</given-names></name><name><surname>Ge</surname><given-names>R.S.</given-names></name></person-group>
<article-title>In utero exposure to diethylhexyl phthalate affects rat brain development: A behavioral and genomic approach</article-title>
<source/>Int. J. Environ. Res. Public Health
<year>2015</year>
<volume>12</volume>
<fpage>13696</fpage>
<lpage>13710</lpage>
<pub-id pub-id-type="doi">10.3390/ijerph121113696</pub-id>
<pub-id pub-id-type="pmid">26516888</pub-id></element-citation>
</ref>
<ref id="B125-ijms-17-02086">
<label>125.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shiue</surname><given-names>I.</given-names></name></person-group>
<article-title>Arsenic, heavy metals, phthalates, pesticides, hydrocarbons and polyfluorinated compounds but not parabens or phenols are associated with adult remembering condition: US NHANES, 2011–2012</article-title>
<source/>Environ. Sci. Pollut. Res. Int.
<year>2015</year>
<volume>22</volume>
<fpage>6381</fpage>
<lpage>6386</lpage>
<pub-id pub-id-type="doi">10.1007/s11356-015-4261-9</pub-id>
<pub-id pub-id-type="pmid">25744817</pub-id></element-citation>
</ref>
<ref id="B126-ijms-17-02086">
<label>126.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Factor-Litvak</surname><given-names>P.</given-names></name><name><surname>Insel</surname><given-names>B.</given-names></name><name><surname>Calafat</surname><given-names>A.M.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Perera</surname><given-names>F.</given-names></name><name><surname>Rauh</surname><given-names>V.A.</given-names></name><name><surname>Whyatt</surname><given-names>R.M.</given-names></name></person-group>
<article-title>Persistent associations between maternal prenatal exposure to phthalates on child IQ at age 7 years</article-title>
<source/>PLoS ONE
<year>2014</year>
<volume>9</volume>
<fpage>1</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0114003</pub-id>
<pub-id pub-id-type="pmid">25493564</pub-id></element-citation>
</ref>
<ref id="B127-ijms-17-02086">
<label>127.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Masuo</surname><given-names>Y.</given-names></name><name><surname>Morita</surname><given-names>M.</given-names></name><name><surname>Oka</surname><given-names>S.</given-names></name><name><surname>Ishido</surname><given-names>M.</given-names></name></person-group>
<article-title>Motor hyperactivity caused by a deficit in dopaminergic neurons and the effects of endocrine disruptors: A study inspired by the physiological roles of PACAP in the brain</article-title>
<source/>Regul. Pept.
<year>2004</year>
<volume>123</volume>
<fpage>225</fpage>
<lpage>234</lpage>
<pub-id pub-id-type="doi">10.1016/j.regpep.2004.05.010</pub-id>
<pub-id pub-id-type="pmid">15518916</pub-id></element-citation>
</ref>
<ref id="B128-ijms-17-02086">
<label>128.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Larsson</surname><given-names>M.</given-names></name><name><surname>Weiss</surname><given-names>B.</given-names></name><name><surname>Janson</surname><given-names>S.</given-names></name><name><surname>Sundell</surname><given-names>J.</given-names></name><name><surname>Bornehag</surname><given-names>C.G.</given-names></name></person-group>
<article-title>Associations between indoor environmental factors and parental-reported autistic spectrum disorders in children 6–8 years of age</article-title>
<source/>Neurotoxicology
<year>2009</year>
<volume>30</volume>
<fpage>822</fpage>
<lpage>831</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuro.2009.01.011</pub-id>
<pub-id pub-id-type="pmid">19822263</pub-id></element-citation>
</ref>
<ref id="B129-ijms-17-02086">
<label>129.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sun</surname><given-names>W.</given-names></name><name><surname>Ban</surname><given-names>J.-B.</given-names></name><name><surname>Zhang</surname><given-names>N.</given-names></name><name><surname>Zu</surname><given-names>Y.-K.</given-names></name><name><surname>Sun</surname><given-names>W.-X.</given-names></name></person-group>
<article-title>Perinatal exposure to di-(2-ethylhexyl)-phthalate leads to cognitive dysfunction and phospho-tau level increase in aged rats</article-title>
<source/>Environ. Toxicol.
<year>2014</year>
<volume>29</volume>
<fpage>596</fpage>
<lpage>603</lpage>
<pub-id pub-id-type="doi">10.1002/tox.21785</pub-id>
<pub-id pub-id-type="pmid">22610992</pub-id></element-citation>
</ref>
<ref id="B130-ijms-17-02086">
<label>130.</label>
<element-citation publication-type="book">
<person-group person-group-type="author"><collab>Agency for Toxic Substances and Disease Registry (ATSDR)</collab></person-group>
<source/>Toxicological Profile for Polychlorinated Biphenyls (PCBs)
<publisher-name>Agency for Toxic Substances and Disease Registry (ATSDR)</publisher-name>
<publisher-loc>Atlanta, GA, USA</publisher-loc>
<year>2000</year>
<fpage>1</fpage>
<lpage>948</lpage>
</element-citation>
</ref>
<ref id="B131-ijms-17-02086">
<label>131.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Reilly</surname><given-names>M.P.</given-names></name><name><surname>Weeks</surname><given-names>C.D.</given-names></name><name><surname>Topper</surname><given-names>V.Y.</given-names></name><name><surname>Thompson</surname><given-names>L.M.</given-names></name><name><surname>Crews</surname><given-names>D.</given-names></name><name><surname>Gore</surname><given-names>A.C.</given-names></name></person-group>
<article-title>The effects of prenatal PCBs on adult female paced mating reproductive behaviors in rats</article-title>
<source/>Horm. Behav.
<year>2007</year>
<volume>51</volume>
<fpage>364</fpage>
<lpage>372</lpage>
<pub-id pub-id-type="pmid">17274994</pub-id></element-citation>
</ref>
<ref id="B132-ijms-17-02086">
<label>132.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lee</surname><given-names>D.W.</given-names></name><name><surname>Notter</surname><given-names>S.A.</given-names></name><name><surname>Thiruchelvam</surname><given-names>M.</given-names></name><name><surname>Dever</surname><given-names>D.P.</given-names></name><name><surname>Fitzpatrick</surname><given-names>R.</given-names></name><name><surname>Kostyniak</surname><given-names>P.J.</given-names></name><name><surname>Cory-slechta</surname><given-names>D.A.</given-names></name><name><surname>Opanashuk</surname><given-names>L.A.</given-names></name></person-group>
<article-title>Subchronic polychlorinated biphenyl (aroclor 1254) exposure produces oxidative damage and neuronal death of ventral midbrain dopaminergic systems</article-title>
<source/>Toxicol. Sci.
<year>2012</year>
<volume>125</volume>
<fpage>496</fpage>
<lpage>508</lpage>
<pub-id pub-id-type="doi">10.1093/toxsci/kfr313</pub-id>
<pub-id pub-id-type="pmid">22094459</pub-id></element-citation>
</ref>
<ref id="B133-ijms-17-02086">
<label>133.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zahara</surname><given-names>A.R.D.</given-names></name><name><surname>Michel</surname><given-names>N.L.</given-names></name><name><surname>Flahr</surname><given-names>L.M.</given-names></name><name><surname>Ejack</surname><given-names>L.E.</given-names></name><name><surname>Morrissey</surname><given-names>C.A.</given-names></name></person-group>
<article-title>Latent cognitive effects from low-level polychlorinated biphenyl exposure in juvenile European starlings (<italic>Sturnus vulgaris</italic>)</article-title>
<source/>Environ. Toxicol. Chem.
<year>2015</year>
<volume>34</volume>
<fpage>2513</fpage>
<lpage>2520</lpage>
<pub-id pub-id-type="doi">10.1002/etc.3084</pub-id>
<pub-id pub-id-type="pmid">26033510</pub-id></element-citation>
</ref>
<ref id="B134-ijms-17-02086">
<label>134.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Elnar</surname><given-names>A.A.</given-names></name><name><surname>Allouche</surname><given-names>A.</given-names></name><name><surname>Desor</surname><given-names>F.</given-names></name><name><surname>Yen</surname><given-names>F.T.</given-names></name><name><surname>Soulimani</surname><given-names>R.</given-names></name><name><surname>Oster</surname><given-names>T.</given-names></name></person-group>
<article-title>Lactational exposure of mice to low levels of non-dioxin-like polychlorinated biphenyls increases susceptibility to neuronal stress at a mature age</article-title>
<source/>Neurotoxicology
<year>2015</year>
<volume>53</volume>
<fpage>314</fpage>
<lpage>320</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuro.2015.10.003</pub-id>
<pub-id pub-id-type="pmid">26480858</pub-id></element-citation>
</ref>
<ref id="B135-ijms-17-02086">
<label>135.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hilgier</surname><given-names>W.</given-names></name><name><surname>Łazarewicz</surname><given-names>J.W.</given-names></name><name><surname>Strużynska</surname><given-names>L.</given-names></name><name><surname>Frontczak-Baniewicz</surname><given-names>M.</given-names></name><name><surname>Albrecht</surname><given-names>J.</given-names></name></person-group>
<article-title>Repeated exposure of adult rats to Aroclor 1254 induces neuronal injury and impairs the neurochemical manifestations of the NMDA receptor-mediated intracellular signaling in the hippocampus</article-title>
<source/>Neurotoxicology
<year>2012</year>
<volume>33</volume>
<fpage>16</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuro.2011.10.005</pub-id>
<pub-id pub-id-type="pmid">22044768</pub-id></element-citation>
</ref>
<ref id="B136-ijms-17-02086">
<label>136.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Formisano</surname><given-names>L.</given-names></name><name><surname>Guida</surname><given-names>N.</given-names></name><name><surname>Laudati</surname><given-names>G.</given-names></name><name><surname>Mascolo</surname><given-names>L.</given-names></name><name><surname>Di Renzo</surname><given-names>G.</given-names></name><name><surname>Canzoniero</surname><given-names>L.M.T.</given-names></name></person-group>
<article-title>MS-275 inhibits aroclor 1254-induced SH-SY5Y neuronal cell toxicity by preventing the formation of the HDAC3/REST complex on the synapsin-1 promoter</article-title>
<source/>J. Pharmacol. Exp. Ther.
<year>2015</year>
<volume>352</volume>
<fpage>236</fpage>
<lpage>243</lpage>
<pub-id pub-id-type="doi">10.1124/jpet.114.219345</pub-id>
<pub-id pub-id-type="pmid">25467131</pub-id></element-citation>
</ref>
<ref id="B137-ijms-17-02086">
<label>137.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bang</surname><given-names>Y.</given-names></name><name><surname>Lim</surname><given-names>J.</given-names></name><name><surname>Kim</surname><given-names>S.S.</given-names></name><name><surname>Jeong</surname><given-names>H.M.</given-names></name><name><surname>Jung</surname><given-names>K.K.</given-names></name><name><surname>Kang</surname><given-names>I.H.</given-names></name><name><surname>Lee</surname><given-names>K.Y.</given-names></name><name><surname>Choi</surname><given-names>H.J.</given-names></name></person-group>
<article-title>Aroclor1254 interferes with estrogen receptor-mediated neuroprotection against β-amyloid toxicity in cholinergic SN56 cells</article-title>
<source/>Neurochem. Int.
<year>2011</year>
<volume>59</volume>
<fpage>582</fpage>
<lpage>590</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuint.2011.04.006</pub-id>
<pub-id pub-id-type="pmid">21693151</pub-id></element-citation>
</ref>
<ref id="B138-ijms-17-02086">
<label>138.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Szczepkowska</surname><given-names>A.</given-names></name><name><surname>Lagaraine</surname><given-names>C.</given-names></name><name><surname>Robert</surname><given-names>V.</given-names></name><name><surname>Młynarczuk</surname><given-names>J.</given-names></name><name><surname>Dufourny</surname><given-names>L.</given-names></name><name><surname>Thiéry</surname><given-names>J.C.</given-names></name><name><surname>Skipor</surname><given-names>J.</given-names></name></person-group>
<article-title>PCB153 (2,2′,4,4′,5,5′-hexachlorobiphenyl) differentially affects the VEGF/VEGFR system depending on photoperiod in the ovine choroid plexus</article-title>
<source/>Ecotoxicol. Environ. Saf.
<year>2016</year>
<volume>124</volume>
<fpage>303</fpage>
<lpage>308</lpage>
<pub-id pub-id-type="doi">10.1016/j.ecoenv.2015.11.007</pub-id>
<pub-id pub-id-type="pmid">26580897</pub-id></element-citation>
</ref>
<ref id="B139-ijms-17-02086">
<label>139.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Weisskopf</surname><given-names>M.</given-names></name><name><surname>Knekt</surname><given-names>P.</given-names></name><name><surname>O’Reilly</surname><given-names>E.</given-names></name><name><surname>Lyytinen</surname><given-names>J.</given-names></name><name><surname>Reunanen</surname><given-names>A.</given-names></name><name><surname>Laden</surname><given-names>F.</given-names></name><name><surname>Altshul</surname><given-names>L.</given-names></name><name><surname>Ascherio</surname><given-names>A.</given-names></name></person-group>
<article-title>Polychlorinated biphenyls in prospectively collected serum and parkinson’s disease risk</article-title>
<source/>Mov. Disord.
<year>2012</year>
<volume>27</volume>
<fpage>1659</fpage>
<lpage>1665</lpage>
<pub-id pub-id-type="doi">10.1002/mds.25217</pub-id>
<pub-id pub-id-type="pmid">23044514</pub-id></element-citation>
</ref>
<ref id="B140-ijms-17-02086">
<label>140.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Steenland</surname><given-names>K.</given-names></name><name><surname>Hein</surname><given-names>M.J.</given-names></name><name><surname>Cassinelli</surname><given-names>R.T.</given-names></name><name><surname>Prince</surname><given-names>M.M.</given-names></name><name><surname>Nilsen</surname><given-names>N.B.</given-names></name><name><surname>Whelan</surname><given-names>E.A.</given-names></name><name><surname>Waters</surname><given-names>M.A.</given-names></name><name><surname>Ruder</surname><given-names>A.M.</given-names></name><name><surname>Schnorr</surname><given-names>T.M.</given-names></name></person-group>
<article-title>Polychlorinated biphenyls and neurodegenerative disease mortality in an occupational cohort</article-title>
<source/>Epidemiology
<year>2006</year>
<volume>17</volume>
<fpage>8</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="doi">10.1097/01.ede.0000190707.51536.2b</pub-id>
<pub-id pub-id-type="pmid">16357589</pub-id></element-citation>
</ref>
<ref id="B141-ijms-17-02086">
<label>141.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hatcher-Martin</surname><given-names>J.M.</given-names></name><name><surname>Gearing</surname><given-names>M.</given-names></name><name><surname>Steenland</surname><given-names>K.</given-names></name><name><surname>Levey</surname><given-names>A.I.</given-names></name><name><surname>Miller</surname><given-names>G.W.</given-names></name><name><surname>Pennell</surname><given-names>K.D.</given-names></name></person-group>
<article-title>Association between polychlorinated biphenyls and Parkinson’s disease neuropathology</article-title>
<source/>Neurotoxicology
<year>2012</year>
<volume>33</volume>
<fpage>1298</fpage>
<lpage>1304</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuro.2012.08.002</pub-id>
<pub-id pub-id-type="pmid">22906799</pub-id></element-citation>
</ref>
<ref id="B142-ijms-17-02086">
<label>142.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Eubig</surname><given-names>P.A.</given-names></name><name><surname>Aguiar</surname><given-names>A.</given-names></name><name><surname>Schantz</surname><given-names>S.L.</given-names></name></person-group>
<article-title>Lead and PCBs as risk factors for attention defcit/hyperactivity disorder</article-title>
<source/>Environ. Health Perspect.
<year>2010</year>
<volume>118</volume>
<fpage>1654</fpage>
<lpage>1667</lpage>
<pub-id pub-id-type="doi">10.1289/ehp.0901852</pub-id>
<pub-id pub-id-type="pmid">20829149</pub-id></element-citation>
</ref>
<ref id="B143-ijms-17-02086">
<label>143.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Orenstein</surname><given-names>S.T.C.</given-names></name><name><surname>Thurston</surname><given-names>S.W.</given-names></name><name><surname>Bellinger</surname><given-names>D.C.</given-names></name><name><surname>Schwartz</surname><given-names>J.D.</given-names></name><name><surname>Amarasiriwardena</surname><given-names>C.J.</given-names></name><name><surname>Altshul</surname><given-names>L.M.</given-names></name><name><surname>Korrick</surname><given-names>S.A.</given-names></name></person-group>
<article-title>Prenatal organochlorine and methylmercury exposure and memory and learning in school-age children in communities near the new bedford harbor superfund site, Massachusetts</article-title>
<source/>Environ. Health Perspect.
<year>2014</year>
<volume>122</volume>
<fpage>1253</fpage>
<lpage>1259</lpage>
<pub-id pub-id-type="doi">10.1289/ehp.1307804</pub-id>
<pub-id pub-id-type="pmid">25062363</pub-id></element-citation>
</ref>
<ref id="B144-ijms-17-02086">
<label>144.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Boucher</surname><given-names>O.</given-names></name><name><surname>Muckle</surname><given-names>G.</given-names></name><name><surname>Jacobson</surname><given-names>J.L.</given-names></name><name><surname>Carter</surname><given-names>R.C.</given-names></name><name><surname>Kaplan-Estrin</surname><given-names>M.</given-names></name><name><surname>Ayotte</surname><given-names>P.</given-names></name><name><surname>Dewailly</surname><given-names>É.</given-names></name><name><surname>Jacobson</surname><given-names>S.W.</given-names></name></person-group>
<article-title>Domain-specific effects of prenatal exposure to PCBs, mercury, and lead on infant cognition: Results from the environmental contaminants and child development study in nunavik</article-title>
<source/>Environ. Health Perspect.
<year>2014</year>
<volume>122</volume>
<fpage>310</fpage>
<lpage>316</lpage>
<pub-id pub-id-type="doi">10.1289/ehp.1206323</pub-id>
<pub-id pub-id-type="pmid">24441767</pub-id></element-citation>
</ref>
<ref id="B145-ijms-17-02086">
<label>145.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fitzgerald</surname><given-names>E.F.</given-names></name><name><surname>Shrestha</surname><given-names>S.</given-names></name><name><surname>Gomez</surname><given-names>M.I.</given-names></name><name><surname>McCaffrey</surname><given-names>R.J.</given-names></name><name><surname>Zimmerman</surname><given-names>E.A.</given-names></name><name><surname>Kannan</surname><given-names>K.</given-names></name><name><surname>Hwang</surname><given-names>S.</given-names></name></person-group>
<article-title>An polybrominated diphenyl ethers (PBDEs), polychlorinated biphenyls (PCBs) and neuropsychological status among older adults in New York</article-title>
<source/>Neurotoxicology
<year>2012</year>
<volume>33</volume>
<fpage>8</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuro.2011.10.011</pub-id>
<pub-id pub-id-type="pmid">22079442</pub-id></element-citation>
</ref>
<ref id="B146-ijms-17-02086">
<label>146.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fitzgerald</surname><given-names>E.F.</given-names></name><name><surname>Belanger</surname><given-names>E.E.</given-names></name><name><surname>Gomez</surname><given-names>M.I.</given-names></name><name><surname>Cayo</surname><given-names>M.</given-names></name><name><surname>McCaffrey</surname><given-names>R.J.</given-names></name><name><surname>Seegal</surname><given-names>R.F.</given-names></name><name><surname>Jansing</surname><given-names>R.L.</given-names></name><name><surname>Hwang</surname><given-names>S.A.</given-names></name><name><surname>Hicka</surname><given-names>H.E.</given-names></name></person-group>
<article-title>Polychlorinated biphenyl exposure and neuropsychological status among older residents of upper Hudson River communities</article-title>
<source/>Environ. Health Perspect.
<year>2008</year>
<volume>116</volume>
<fpage>209</fpage>
<lpage>215</lpage>
<pub-id pub-id-type="doi">10.1289/ehp.10432</pub-id>
<pub-id pub-id-type="pmid">18288320</pub-id></element-citation>
</ref>
<ref id="B147-ijms-17-02086">
<label>147.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schantz</surname><given-names>S.L.</given-names></name><name><surname>Gasior</surname><given-names>D.M.</given-names></name><name><surname>Polverejan</surname><given-names>E.</given-names></name><name><surname>McCaffrey</surname><given-names>R.J.</given-names></name><name><surname>Sweeney</surname><given-names>A.M.</given-names></name><name><surname>Humphrey</surname><given-names>H.E.B.</given-names></name><name><surname>Gardiner</surname><given-names>J.C.</given-names></name></person-group>
<article-title>Impairments of memory and learning in older adults exposed to polychlorinated biphenyls via consumption of Great Lakes Fish</article-title>
<source/>Environ. Health Perspect.
<year>2001</year>
<volume>109</volume>
<fpage>605</fpage>
<lpage>611</lpage>
<pub-id pub-id-type="doi">10.1289/ehp.01109605</pub-id>
<pub-id pub-id-type="pmid">11445515</pub-id></element-citation>
</ref>
<ref id="B148-ijms-17-02086">
<label>148.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Peper</surname><given-names>M.</given-names></name><name><surname>Klett</surname><given-names>M.</given-names></name><name><surname>Morgenstern</surname><given-names>R.</given-names></name></person-group>
<article-title>Neuropsychological effects of chronic low-dose exposure to polychlorinated biphenyls (PCBs): A cross-sectional study</article-title>
<source/>Environ. Health
<year>2005</year>
<volume>4</volume>
<fpage>1</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="doi">10.1186/1476-069X-4-22</pub-id>
<pub-id pub-id-type="pmid">15679885</pub-id></element-citation>
</ref>
<ref id="B149-ijms-17-02086">
<label>149.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ronchetti</surname><given-names>S.A.</given-names></name><name><surname>Novack</surname><given-names>G.V.</given-names></name><name><surname>Bianchi</surname><given-names>M.S.</given-names></name><name><surname>Crocco</surname><given-names>M.C.</given-names></name><name><surname>Duvilanski</surname><given-names>B.H.</given-names></name><name><surname>Cabilla</surname><given-names>J.P.</given-names></name></person-group>
<article-title>In vivo xenoestrogenic actions of cadmium and arsenic in anterior pituitary and uterus</article-title>
<source/>Reproduction
<year>2016</year>
<volume>152</volume>
<fpage>1</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="doi">10.1530/REP-16-0115</pub-id>
<pub-id pub-id-type="pmid">27256631</pub-id></element-citation>
</ref>
<ref id="B150-ijms-17-02086">
<label>150.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Hu</surname><given-names>P.</given-names></name><name><surname>Wang</surname><given-names>H.-L.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Chen</surname><given-names>J.-T.</given-names></name><name><surname>Tang</surname><given-names>J.-L.</given-names></name><name><surname>Ruan</surname><given-names>D.-Y.</given-names></name></person-group>
<article-title>Effects of Cd<sup>2+</sup> on AMPA receptor-mediated synaptic transmission in rat hippocampal CA1 area</article-title>
<source/>Toxicol. Lett.
<year>2008</year>
<volume>176</volume>
<fpage>215</fpage>
<lpage>222</lpage>
<pub-id pub-id-type="doi">10.1016/j.toxlet.2007.11.008</pub-id>
<pub-id pub-id-type="pmid">18248923</pub-id></element-citation>
</ref>
<ref id="B151-ijms-17-02086">
<label>151.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Luo</surname><given-names>Y.</given-names></name><name><surname>Huang</surname><given-names>S.</given-names></name></person-group>
<article-title>MAPK and mTOR pathways are involved in cadmium-induced neuronal apoptosis</article-title>
<source/>J. Neurochem.
<year>2008</year>
<volume>105</volume>
<fpage>251</fpage>
<lpage>261</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.2007.05133.x</pub-id>
<pub-id pub-id-type="pmid">18021293</pub-id></element-citation>
</ref>
<ref id="B152-ijms-17-02086">
<label>152.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jiang</surname><given-names>J.H.</given-names></name><name><surname>Ge</surname><given-names>G.</given-names></name><name><surname>Gao</surname><given-names>K.</given-names></name><name><surname>Pang</surname><given-names>Y.</given-names></name><name><surname>Chai</surname><given-names>R.C.</given-names></name><name><surname>Jia</surname><given-names>X.H.</given-names></name><name><surname>Kong</surname><given-names>J.G.</given-names></name><name><surname>Yu</surname><given-names>A.C.-H.</given-names></name></person-group>
<article-title>Calcium signaling involvement in cadmium-induced astrocyte cytotoxicity and cell death through activation of MAPK and PI3K/Akt signaling pathways</article-title>
<source/>Neurochem. Res.
<year>2015</year>
<volume>40</volume>
<fpage>1929</fpage>
<lpage>1944</lpage>
<pub-id pub-id-type="doi">10.1007/s11064-015-1686-y</pub-id>
<pub-id pub-id-type="pmid">26248512</pub-id></element-citation>
</ref>
<ref id="B153-ijms-17-02086">
<label>153.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chow</surname><given-names>E.S.H.</given-names></name><name><surname>Hui</surname><given-names>M.N.Y.</given-names></name><name><surname>Lin</surname><given-names>C.C.</given-names></name><name><surname>Cheng</surname><given-names>S.H.</given-names></name></person-group>
<article-title>Cadmium inhibits neurogenesis in zebrafish embryonic brain development</article-title>
<source/>Aquat. Toxicol.
<year>2008</year>
<volume>87</volume>
<fpage>157</fpage>
<lpage>169</lpage>
<pub-id pub-id-type="doi">10.1016/j.aquatox.2008.01.019</pub-id>
<pub-id pub-id-type="pmid">18342959</pub-id></element-citation>
</ref>
<ref id="B154-ijms-17-02086">
<label>154.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yuan</surname><given-names>Y.</given-names></name><name><surname>Jiang</surname><given-names>C.</given-names></name><name><surname>Xu</surname><given-names>H.</given-names></name><name><surname>Sun</surname><given-names>Y.</given-names></name><name><surname>Hu</surname><given-names>F.</given-names></name><name><surname>Bian</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Gu</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name></person-group>
<article-title>Cadmium-induced apoptosis in primary rat cerebral cortical neurons culture is mediated by a calcium signaling pathway</article-title>
<source/>PLoS ONE
<year>2013</year>
<volume>8</volume>
<elocation-id>e64330</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0064330</pub-id>
<pub-id pub-id-type="pmid">23741317</pub-id></element-citation>
</ref>
<ref id="B155-ijms-17-02086">
<label>155.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hossain</surname><given-names>S.</given-names></name><name><surname>Liu</surname><given-names>H.-N.</given-names></name><name><surname>Nguyen</surname><given-names>M.</given-names></name><name><surname>Shore</surname><given-names>G.</given-names></name><name><surname>Almazan</surname><given-names>G.</given-names></name></person-group>
<article-title>Cadmium exposure induces mitochondria-dependent apoptosis in oligodendrocytes</article-title>
<source/>Neurotoxicology
<year>2009</year>
<volume>30</volume>
<fpage>544</fpage>
<lpage>554</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuro.2009.06.001</pub-id>
<pub-id pub-id-type="pmid">19523979</pub-id></element-citation>
</ref>
<ref id="B156-ijms-17-02086">
<label>156.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Notarachille</surname><given-names>G.</given-names></name><name><surname>Arnesano</surname><given-names>F.</given-names></name><name><surname>Calò</surname><given-names>V.</given-names></name><name><surname>Meleleo</surname><given-names>D.</given-names></name></person-group>
<article-title>Heavy metals toxicity: Effect of cadmium ions on amyloid β protein 1–42. Possible implications for Alzheimer’s disease</article-title>
<source/>Biometals
<year>2014</year>
<volume>27</volume>
<fpage>371</fpage>
<lpage>388</lpage>
<pub-id pub-id-type="doi">10.1007/s10534-014-9719-6</pub-id>
<pub-id pub-id-type="pmid">24557150</pub-id></element-citation>
</ref>
<ref id="B157-ijms-17-02086">
<label>157.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ciesielski</surname><given-names>T.</given-names></name><name><surname>Bellinger</surname><given-names>D.C.</given-names></name><name><surname>Schwartz</surname><given-names>J.</given-names></name><name><surname>Hauser</surname><given-names>R.</given-names></name><name><surname>Wright</surname><given-names>R.O.</given-names></name></person-group>
<article-title>Associations between cadmium exposure and neurocognitive test scores in a cross-sectional study of US adults</article-title>
<source/>Environ. Health
<year>2013</year>
<volume>12</volume>
<fpage>214</fpage>
<lpage>221</lpage>
<pub-id pub-id-type="doi">10.1186/1476-069X-12-13</pub-id>
<pub-id pub-id-type="pmid">23379984</pub-id></element-citation>
</ref>
<ref id="B158-ijms-17-02086">
<label>158.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gao</surname><given-names>S.</given-names></name><name><surname>Jin</surname><given-names>Y.</given-names></name><name><surname>Unverzagt</surname><given-names>F.W.</given-names></name><name><surname>Ma</surname><given-names>F.</given-names></name><name><surname>Hall</surname><given-names>K.S.</given-names></name><name><surname>Murrell</surname><given-names>J.R.</given-names></name><name><surname>Cheng</surname><given-names>Y.</given-names></name><name><surname>Shen</surname><given-names>J.</given-names></name><name><surname>Ying</surname><given-names>B.</given-names></name><name><surname>Ji</surname><given-names>R.</given-names></name><etal></etal></person-group>
<article-title>Trace element levels and cognitive function in rural elderly Chinese</article-title>
<source/>J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
<year>2008</year>
<volume>63</volume>
<fpage>635</fpage>
<lpage>641</lpage>
<pub-id pub-id-type="doi">10.1093/gerona/63.6.635</pub-id>
<pub-id pub-id-type="pmid">18559640</pub-id></element-citation>
</ref>
<ref id="B159-ijms-17-02086">
<label>159.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Roos</surname><given-names>P.M.</given-names></name><name><surname>Vesterberg</surname><given-names>O.</given-names></name><name><surname>Syversen</surname><given-names>T.</given-names></name><name><surname>Flaten</surname><given-names>T.P.</given-names></name><name><surname>Nordberg</surname><given-names>M.</given-names></name></person-group>
<article-title>Metal concentrations in cerebrospinal fluid and blood plasma from patients with amyotrophic lateral sclerosis</article-title>
<source/>Biol. Trace Elem. Res.
<year>2013</year>
<volume>151</volume>
<fpage>159</fpage>
<lpage>170</lpage>
<pub-id pub-id-type="doi">10.1007/s12011-012-9547-x</pub-id>
<pub-id pub-id-type="pmid">23225075</pub-id></element-citation>
</ref>
<ref id="B160-ijms-17-02086">
<label>160.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Komatsu</surname><given-names>F.</given-names></name><name><surname>Kagawa</surname><given-names>Y.</given-names></name><name><surname>Kawabata</surname><given-names>T.</given-names></name><name><surname>Kaneko</surname><given-names>Y.</given-names></name><name><surname>Chimedregzen</surname><given-names>U.</given-names></name><name><surname>Purvee</surname><given-names>B.</given-names></name><name><surname>Otgon</surname><given-names>J.</given-names></name></person-group>
<article-title>A high accumulation of hair minerals in Mongolian people: 2nd report; influence of manganese, iron, lead, cadmium and aluminum to oxidative stress, Parkinsonism and arthritis</article-title>
<source/>Curr. Aging Sci.
<year>2011</year>
<volume>4</volume>
<fpage>42</fpage>
<lpage>56</lpage>
<pub-id pub-id-type="doi">10.2174/1874609811104010042</pub-id>
<pub-id pub-id-type="pmid">21204778</pub-id></element-citation>
</ref>
<ref id="B161-ijms-17-02086">
<label>161.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jumpponen</surname><given-names>M.</given-names></name><name><surname>Rönkkömäki</surname><given-names>H.</given-names></name><name><surname>Pasanen</surname><given-names>P.</given-names></name><name><surname>Laitinen</surname><given-names>J.</given-names></name></person-group>
<article-title>Occupational exposure to solid chemical agents in biomass-fired power plants and associated health effects</article-title>
<source/>Chemosphere
<year>2014</year>
<volume>104</volume>
<fpage>25</fpage>
<lpage>31</lpage>
<pub-id pub-id-type="doi">10.1016/j.chemosphere.2013.10.025</pub-id>
<pub-id pub-id-type="pmid">24289933</pub-id></element-citation>
</ref>
<ref id="B162-ijms-17-02086">
<label>162.</label>
<element-citation publication-type="book">
<person-group person-group-type="author"><collab>Agency for Toxic Substances and Disease Registry (ATSDR)</collab></person-group>
<source/>Toxicological Profile for Arsenic. Health Effects
<publisher-name>Agency for Toxic Substances and Disease Registry (ATSDR)</publisher-name>
<publisher-loc>Atlanta, GA, USA</publisher-loc>
<year>2007</year>
</element-citation>
</ref>
<ref id="B163-ijms-17-02086">
<label>163.</label>
<element-citation publication-type="book">
<person-group person-group-type="author"><collab>Agency for Toxic Substances and Disease Registry (ATSDR)</collab></person-group>
<source/>Toxicological Profile for Arsenic
<publisher-name>Agency for Toxic Substances and Disease Registry (ATSDR)</publisher-name>
<publisher-loc>Atlanta, GA, USA</publisher-loc>
<year>2013</year>
</element-citation>
</ref>
<ref id="B164-ijms-17-02086">
<label>164.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Luo</surname><given-names>J.</given-names></name><name><surname>Qiu</surname><given-names>Z.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Shu</surname><given-names>W.</given-names></name></person-group>
<article-title>Arsenite exposure altered the expression of NMDA receptor and postsynaptic signaling proteins in rat hippocampus</article-title>
<source/>Toxicol. Lett.
<year>2012</year>
<volume>211</volume>
<fpage>39</fpage>
<lpage>44</lpage>
<pub-id pub-id-type="doi">10.1016/j.toxlet.2012.02.021</pub-id>
<pub-id pub-id-type="pmid">22421273</pub-id></element-citation>
</ref>
<ref id="B165-ijms-17-02086">
<label>165.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Luo</surname><given-names>J.</given-names></name><name><surname>Qiu</surname><given-names>Z.</given-names></name><name><surname>Shu</surname><given-names>W.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name></person-group>
<article-title>Effects of arsenic exposure from drinking water on spatial memory, ultra-structures and NMDAR gene expression of hippocampus in rats</article-title>
<source/>Toxicol. Lett.
<year>2009</year>
<volume>184</volume>
<fpage>121</fpage>
<lpage>125</lpage>
<pub-id pub-id-type="doi">10.1016/j.toxlet.2008.10.029</pub-id>
<pub-id pub-id-type="pmid">19041379</pub-id></element-citation>
</ref>
<ref id="B166-ijms-17-02086">
<label>166.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Qu</surname><given-names>L.</given-names></name><name><surname>Gao</surname><given-names>Y.</given-names></name><name><surname>Sun</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Sun</surname><given-names>D.</given-names></name></person-group>
<article-title>Role of PTEN-Akt-CREB signaling pathway in nervous system impairment of rats with chronic arsenite exposure</article-title>
<source/>Biol. Trace Elem. Res.
<year>2016</year>
<volume>170</volume>
<fpage>1</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1007/s12011-015-0478-1</pub-id>
<pub-id pub-id-type="pmid">26179085</pub-id></element-citation>
</ref>
<ref id="B167-ijms-17-02086">
<label>167.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shavali</surname><given-names>S.</given-names></name><name><surname>Sens</surname><given-names>D.A.</given-names></name></person-group>
<article-title>Synergistic neurotoxic effects of arsenic and dopamine in human dopaminergic neuroblastoma SH-SY5Y cells</article-title>
<source/>Toxicol. Sci.
<year>2007</year>
<volume>102</volume>
<fpage>254</fpage>
<lpage>261</lpage>
<pub-id pub-id-type="doi">10.1093/toxsci/kfm302</pub-id>
<pub-id pub-id-type="pmid">18079140</pub-id></element-citation>
</ref>
<ref id="B168-ijms-17-02086">
<label>168.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zarazúa</surname><given-names>S.</given-names></name><name><surname>Bürger</surname><given-names>S.</given-names></name><name><surname>Delgado</surname><given-names>J.M.</given-names></name><name><surname>Jiménez-Capdeville</surname><given-names>M.E.</given-names></name><name><surname>Schliebs</surname><given-names>R.</given-names></name></person-group>
<article-title>Arsenic affects expression and processing of amyloid precursor protein (APP) in primary neuronal cells overexpressing the Swedish mutation of human APP</article-title>
<source/>Int. J. Dev. Neurosci.
<year>2011</year>
<volume>29</volume>
<fpage>389</fpage>
<lpage>396</lpage>
<pub-id pub-id-type="doi">10.1016/j.ijdevneu.2011.03.004</pub-id>
<pub-id pub-id-type="pmid">21440049</pub-id></element-citation>
</ref>
<ref id="B169-ijms-17-02086">
<label>169.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>O’Bryant</surname><given-names>S.E.</given-names></name><name><surname>Edwards</surname><given-names>M.</given-names></name><name><surname>Menon</surname><given-names>C.</given-names></name><name><surname>Gong</surname><given-names>G.</given-names></name><name><surname>Barber</surname><given-names>R.</given-names></name></person-group>
<article-title>Long-term low-level arsenic exposure is associated with poorer neuropsychological functioning: A project frontier study</article-title>
<source/>Int. J. Environ. Res. Public Health
<year>2011</year>
<volume>8</volume>
<fpage>861</fpage>
<lpage>874</lpage>
<pub-id pub-id-type="doi">10.3390/ijerph8030861</pub-id>
<pub-id pub-id-type="pmid">21556183</pub-id></element-citation>
</ref>
<ref id="B170-ijms-17-02086">
<label>170.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Edwards</surname><given-names>M.</given-names></name><name><surname>Hall</surname><given-names>J.</given-names></name><name><surname>Gong</surname><given-names>G.</given-names></name><name><surname>O’Bryant</surname><given-names>S.E.</given-names></name></person-group>
<article-title>Arsenic exposure, AS3MT polymorphism, and neuropsychological functioning among rural dwelling adults and elders: A cross-sectional study</article-title>
<source/>Environ. Health
<year>2014</year>
<volume>13</volume>
<fpage>225</fpage>
<pub-id pub-id-type="doi">10.1186/1476-069X-13-15</pub-id>
<pub-id pub-id-type="pmid">24621105</pub-id></element-citation>
</ref>
<ref id="B171-ijms-17-02086">
<label>171.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Park</surname><given-names>J.-H.</given-names></name><name><surname>Lee</surname><given-names>D.-W.</given-names></name><name><surname>Park</surname><given-names>K.S.</given-names></name><name><surname>Joung</surname><given-names>H.</given-names></name></person-group>
<article-title>Serum trace metal levels in Alzheimer’s disease and normal control groups</article-title>
<source/>Am. J. Alzheimers Dis. Other Dement.
<year>2014</year>
<volume>29</volume>
<fpage>76</fpage>
<lpage>83</lpage>
<pub-id pub-id-type="doi">10.1177/1533317513506778</pub-id>
<pub-id pub-id-type="pmid">24164932</pub-id></element-citation>
</ref>
<ref id="B172-ijms-17-02086">
<label>172.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Edwards</surname><given-names>M.</given-names></name><name><surname>Johnson</surname><given-names>L.</given-names></name><name><surname>Mauer</surname><given-names>C.</given-names></name><name><surname>Barber</surname><given-names>R.</given-names></name><name><surname>Hall</surname><given-names>J.</given-names></name><name><surname>O’Bryant</surname><given-names>S.</given-names></name></person-group>
<article-title>Regional specific groundwater arsenic levels and neuropsychological functioning: A cross-sectional study</article-title>
<source/>Int. J. Environ. Health Res.
<year>2014</year>
<volume>24</volume>
<fpage>546</fpage>
<lpage>557</lpage>
<pub-id pub-id-type="doi">10.1080/09603123.2014.883591</pub-id>
<pub-id pub-id-type="pmid">24506178</pub-id></element-citation>
</ref>
<ref id="B173-ijms-17-02086">
<label>173.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dearth</surname><given-names>R.K.</given-names></name><name><surname>Hiney</surname><given-names>J.K.</given-names></name><name><surname>Srivastava</surname><given-names>V.K.</given-names></name><name><surname>Hamilton</surname><given-names>A.M.</given-names></name><name><surname>Dees</surname><given-names>W.L.</given-names></name></person-group>
<article-title>Prepubertal exposure to elevated manganese results in estradiol regulated mammary gland ductal differentiation and hyperplasia in female rats</article-title>
<source/>Exp. Biol. Med.
<year>2014</year>
<volume>239</volume>
<fpage>871</fpage>
<lpage>882</lpage>
<pub-id pub-id-type="doi">10.1177/1535370214531865</pub-id>
<pub-id pub-id-type="pmid">24845367</pub-id></element-citation>
</ref>
<ref id="B174-ijms-17-02086">
<label>174.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Guilarte</surname><given-names>T.R.</given-names></name><name><surname>McGlothan</surname><given-names>J.L.</given-names></name><name><surname>Degaonkar</surname><given-names>M.</given-names></name><name><surname>Chen</surname><given-names>M.-K.</given-names></name><name><surname>Barker</surname><given-names>P.B.</given-names></name><name><surname>Syversen</surname><given-names>T.</given-names></name><name><surname>Schneider</surname><given-names>J.S.</given-names></name></person-group>
<article-title>Evidence for cortical dysfunction and widespread manganese accumulation in the nonhuman primate brain following chronic manganese exposure: A 1H-MRS and MRI study</article-title>
<source/>Toxicol. Sci.
<year>2006</year>
<volume>94</volume>
<fpage>351</fpage>
<lpage>358</lpage>
<pub-id pub-id-type="doi">10.1093/toxsci/kfl106</pub-id>
<pub-id pub-id-type="pmid">16968886</pub-id></element-citation>
</ref>
<ref id="B175-ijms-17-02086">
<label>175.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Guilarte</surname><given-names>T.R.</given-names></name><name><surname>Chen</surname><given-names>M.K.</given-names></name></person-group>
<article-title>Manganese inhibits NMDA receptor channel function: Implications to psychiatric and cognitive effects</article-title>
<source/>Neurotoxicology
<year>2007</year>
<volume>28</volume>
<fpage>1147</fpage>
<lpage>1152</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuro.2007.06.005</pub-id>
<pub-id pub-id-type="pmid">17662456</pub-id></element-citation>
</ref>
<ref id="B176-ijms-17-02086">
<label>176.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Neal</surname><given-names>A.P.</given-names></name><name><surname>Guilarte</surname><given-names>T.R.</given-names></name></person-group>
<article-title>Mechanisms of lead and manganese neurotoxicity</article-title>
<source/>Toxicol. Res.
<year>2013</year>
<volume>2</volume>
<fpage>99</fpage>
<lpage>114</lpage>
<pub-id pub-id-type="doi">10.1039/c2tx20064c</pub-id>
<pub-id pub-id-type="pmid">25722848</pub-id></element-citation>
</ref>
<ref id="B177-ijms-17-02086">
<label>177.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Guilarte</surname><given-names>T.R.</given-names></name><name><surname>Burton</surname><given-names>N.C.</given-names></name><name><surname>McGlothan</surname><given-names>J.L.</given-names></name><name><surname>Verina</surname><given-names>T.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Alexander</surname><given-names>M.</given-names></name><name><surname>Pham</surname><given-names>L.</given-names></name><name><surname>Griswold</surname><given-names>M.</given-names></name><name><surname>Wong</surname><given-names>D.F.</given-names></name><name><surname>Syversen</surname><given-names>T.</given-names></name><etal></etal></person-group>
<article-title>Impairment of nigrostriatal dopamine neurotransmission by manganese is mediated by pre-synaptic mechanism(s): Implications to manganese-induced parkinsonism</article-title>
<source/>J. Neurochem.
<year>2008</year>
<volume>107</volume>
<fpage>1236</fpage>
<lpage>1247</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.2008.05695.x</pub-id>
<pub-id pub-id-type="pmid">18808452</pub-id></element-citation>
</ref>
<ref id="B178-ijms-17-02086">
<label>178.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schneider</surname><given-names>J.S.</given-names></name><name><surname>Decamp</surname><given-names>E.</given-names></name><name><surname>Koser</surname><given-names>A.J.</given-names></name><name><surname>Fritz</surname><given-names>S.</given-names></name><name><surname>Gonczi</surname><given-names>H.</given-names></name><name><surname>Syversen</surname><given-names>T.</given-names></name><name><surname>Guilarte</surname><given-names>T.R.</given-names></name></person-group>
<article-title>Effects of chronic manganese exposure on cognitive and motor functioning in non-human primates</article-title>
<source/>Brain Res.
<year>2006</year>
<volume>1118</volume>
<fpage>222</fpage>
<lpage>231</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainres.2006.08.054</pub-id>
<pub-id pub-id-type="pmid">16978592</pub-id></element-citation>
</ref>
<ref id="B179-ijms-17-02086">
<label>179.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bowler</surname><given-names>R.M.</given-names></name><name><surname>Gocheva</surname><given-names>V.</given-names></name><name><surname>Harris</surname><given-names>M.</given-names></name><name><surname>Ngo</surname><given-names>L.</given-names></name><name><surname>Abdelouahab</surname><given-names>N.</given-names></name><name><surname>Wilkinson</surname><given-names>J.</given-names></name><name><surname>Doty</surname><given-names>R.L.</given-names></name><name><surname>Park</surname><given-names>R.</given-names></name><name><surname>Roels</surname><given-names>H.A.</given-names></name></person-group>
<article-title>Prospective study on neurotoxic effects in manganese-exposed bridge construction welders</article-title>
<source/>Neurotoxicology
<year>2011</year>
<volume>32</volume>
<fpage>596</fpage>
<lpage>605</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuro.2011.06.004</pub-id>
<pub-id pub-id-type="pmid">21762725</pub-id></element-citation>
</ref>
<ref id="B180-ijms-17-02086">
<label>180.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Baker</surname><given-names>M.G.</given-names></name><name><surname>Criswell</surname><given-names>S.R.</given-names></name><name><surname>Racette</surname><given-names>B.A.</given-names></name><name><surname>Simpson</surname><given-names>C.D.</given-names></name><name><surname>Sheppard</surname><given-names>L.</given-names></name><name><surname>Checkoway</surname><given-names>H.</given-names></name><name><surname>Sheppard</surname><given-names>L.</given-names></name></person-group>
<article-title>Neurological outcomes associated with low-level manganese exposure in an inception cohort of asymptomatic welding trainees</article-title>
<source/>Scand. J. Work. Environ. Health
<year>2015</year>
<volume>41</volume>
<fpage>94</fpage>
<lpage>101</lpage>
<pub-id pub-id-type="doi">10.5271/sjweh.3466</pub-id>
<pub-id pub-id-type="pmid">25380186</pub-id></element-citation>
</ref>
<ref id="B181-ijms-17-02086">
<label>181.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wasserman</surname><given-names>G.A.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Parvez</surname><given-names>F.</given-names></name><name><surname>Factor-Litvak</surname><given-names>P.</given-names></name><name><surname>Ahsan</surname><given-names>H.</given-names></name><name><surname>Levy</surname><given-names>D.</given-names></name><name><surname>Kline</surname><given-names>J.</given-names></name><name><surname>van Geen</surname><given-names>A.</given-names></name><name><surname>Mey</surname><given-names>J.</given-names></name><name><surname>Slavkovich</surname><given-names>V.</given-names></name><etal></etal></person-group>
<article-title>Arsenic and manganese exposure and children’s intellectual function</article-title>
<source/>Neurotoxicology
<year>2011</year>
<volume>32</volume>
<fpage>450</fpage>
<lpage>457</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuro.2011.03.009</pub-id>
<pub-id pub-id-type="pmid">21453724</pub-id></element-citation>
</ref>
<ref id="B182-ijms-17-02086">
<label>182.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kim</surname><given-names>Y.</given-names></name><name><surname>Bowler</surname><given-names>R.M.</given-names></name><name><surname>Abdelouahab</surname><given-names>N.</given-names></name><name><surname>Harris</surname><given-names>M.</given-names></name><name><surname>Gocheva</surname><given-names>V.</given-names></name><name><surname>Roels</surname><given-names>H.A.</given-names></name></person-group>
<article-title>Motor function in adults of an Ohio community with environmental manganese exposure</article-title>
<source/>Neurotoxicology
<year>2011</year>
<volume>32</volume>
<fpage>606</fpage>
<lpage>614</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuro.2011.07.011</pub-id>
<pub-id pub-id-type="pmid">21840336</pub-id></element-citation>
</ref>
<ref id="B183-ijms-17-02086">
<label>183.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Carvalho</surname><given-names>C.F.</given-names></name><name><surname>Menezes-Filho</surname><given-names>J.A.</given-names></name><name><surname>de Matos</surname><given-names>V.P.</given-names></name><name><surname>Bessa</surname><given-names>J.R.</given-names></name><name><surname>Coelho-Santos</surname><given-names>J.</given-names></name><name><surname>Viana</surname><given-names>G.F.S.</given-names></name><name><surname>Argollo</surname><given-names>N.</given-names></name><name><surname>Abreu</surname><given-names>N.</given-names></name></person-group>
<article-title>Elevated airborne manganese and low executive function in school-aged children in Brazil</article-title>
<source/>Neurotoxicology
<year>2014</year>
<volume>45</volume>
<fpage>301</fpage>
<lpage>308</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuro.2013.11.006</pub-id>
<pub-id pub-id-type="pmid">24308913</pub-id></element-citation>
</ref>
<ref id="B184-ijms-17-02086">
<label>184.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Oulhote</surname><given-names>Y.</given-names></name><name><surname>Mergler</surname><given-names>D.</given-names></name><name><surname>Barbeau</surname><given-names>B.</given-names></name><name><surname>Bellinger</surname><given-names>D.C.</given-names></name><name><surname>Bouffard</surname><given-names>T.</given-names></name><name><surname>Brodeur</surname><given-names>M.-È.</given-names></name><name><surname>Saint-Amour</surname><given-names>D.</given-names></name><name><surname>Legrand</surname><given-names>M.</given-names></name><name><surname>Sauvé</surname><given-names>S.</given-names></name><name><surname>Bouchard</surname><given-names>M.F.</given-names></name></person-group>
<article-title>Neurobehavioral function in school-age children exposed to manganese in drinking water</article-title>
<source/>Environ. Health Perspect.
<year>2014</year>
<volume>122</volume>
<fpage>1343</fpage>
<lpage>1350</lpage>
<pub-id pub-id-type="doi">10.1289/ehp.1307918</pub-id>
<pub-id pub-id-type="pmid">25260096</pub-id></element-citation>
</ref>
<ref id="B185-ijms-17-02086">
<label>185.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Guilarte</surname><given-names>T.R.</given-names></name></person-group>
<article-title>Manganese and Parkinson’s disease: A critical review and new findings</article-title>
<source/>Environ. Health Perspect.
<year>2010</year>
<volume>118</volume>
<fpage>1071</fpage>
<lpage>1080</lpage>
<pub-id pub-id-type="doi">10.1289/ehp.0901748</pub-id>
<pub-id pub-id-type="pmid">20403794</pub-id></element-citation>
</ref>
<ref id="B186-ijms-17-02086">
<label>186.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hozumi</surname><given-names>I.</given-names></name><name><surname>Hasegawa</surname><given-names>T.</given-names></name><name><surname>Honda</surname><given-names>A.</given-names></name><name><surname>Ozawa</surname><given-names>K.</given-names></name><name><surname>Hayashi</surname><given-names>Y.</given-names></name><name><surname>Hashimoto</surname><given-names>K.</given-names></name><name><surname>Yamada</surname><given-names>M.</given-names></name><name><surname>Koumura</surname><given-names>A.</given-names></name><name><surname>Sakurai</surname><given-names>T.</given-names></name><name><surname>Kimura</surname><given-names>A.</given-names></name><etal></etal></person-group>
<article-title>Patterns of levels of biological metals in CSF differ among neurodegenerative diseases</article-title>
<source/>J. Neurol. Sci.
<year>2011</year>
<volume>303</volume>
<fpage>95</fpage>
<lpage>99</lpage>
<pub-id pub-id-type="doi">10.1016/j.jns.2011.01.003</pub-id>
<pub-id pub-id-type="pmid">21292280</pub-id></element-citation>
</ref>
<ref id="B187-ijms-17-02086">
<label>187.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Koc</surname><given-names>E.R.</given-names></name><name><surname>Ilhan</surname><given-names>A.</given-names></name><name><surname>Ayturk</surname><given-names>Z.</given-names></name><name><surname>Acar</surname><given-names>B.</given-names></name><name><surname>Gurler</surname><given-names>M.</given-names></name><name><surname>Altuntas</surname><given-names>A.</given-names></name><name><surname>Karapirli</surname><given-names>M.</given-names></name><name><surname>Bodur</surname><given-names>A.S.</given-names></name></person-group>
<article-title>A comparison of hair and serum trace elements in patients with Alzheimer disease and healthy participants</article-title>
<source/>Turk. J. Med. Sci.
<year>2015</year>
<volume>45</volume>
<fpage>1034</fpage>
<lpage>1039</lpage>
<pub-id pub-id-type="doi">10.3906/sag-1407-67</pub-id>
<pub-id pub-id-type="pmid">26738344</pub-id></element-citation>
</ref>
<ref id="B188-ijms-17-02086">
<label>188.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Miyake</surname><given-names>Y.</given-names></name><name><surname>Tanaka</surname><given-names>K.</given-names></name><name><surname>Fukushima</surname><given-names>W.</given-names></name><name><surname>Sasaki</surname><given-names>S.</given-names></name><name><surname>Kiyohara</surname><given-names>C.</given-names></name><name><surname>Tsuboi</surname><given-names>Y.</given-names></name><name><surname>Yamada</surname><given-names>T.</given-names></name><name><surname>Oeda</surname><given-names>T.</given-names></name><name><surname>Miki</surname><given-names>T.</given-names></name><name><surname>Kawamura</surname><given-names>N.</given-names></name><etal></etal></person-group>
<article-title>Dietary intake of metals and risk of Parkinson’s disease: A case-control study in Japan</article-title>
<source/>J. Neurol. Sci.
<year>2011</year>
<volume>306</volume>
<fpage>98</fpage>
<lpage>102</lpage>
<pub-id pub-id-type="doi">10.1016/j.jns.2011.03.035</pub-id>
<pub-id pub-id-type="pmid">21497832</pub-id></element-citation>
</ref>
<ref id="B189-ijms-17-02086">
<label>189.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kihira</surname><given-names>T.</given-names></name><name><surname>Sakurai</surname><given-names>I.</given-names></name><name><surname>Yoshida</surname><given-names>S.</given-names></name><name><surname>Wakayama</surname><given-names>I.</given-names></name><name><surname>Takamiya</surname><given-names>K.</given-names></name><name><surname>Okumura</surname><given-names>R.</given-names></name><name><surname>Iinuma</surname><given-names>Y.</given-names></name><name><surname>Iwai</surname><given-names>K.</given-names></name><name><surname>Kajimoto</surname><given-names>Y.</given-names></name><name><surname>Hiwatani</surname><given-names>Y.</given-names></name><etal></etal></person-group>
<article-title>Neutron activation analysis of scalp hair from ALS patients and residents in the Kii Peninsula, Japan</article-title>
<source/>Biol. Trace Elem. Res.
<year>2015</year>
<volume>164</volume>
<fpage>36</fpage>
<lpage>42</lpage>
<pub-id pub-id-type="doi">10.1007/s12011-014-0202-6</pub-id>
<pub-id pub-id-type="pmid">25524522</pub-id></element-citation>
</ref>
<ref id="B190-ijms-17-02086">
<label>190.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Arain</surname><given-names>M.S.</given-names></name><name><surname>Afridi</surname><given-names>H.I.</given-names></name><name><surname>Kazi</surname><given-names>T.G.</given-names></name><name><surname>Talpur</surname><given-names>F.N.</given-names></name><name><surname>Arain</surname><given-names>M.B.</given-names></name><name><surname>Kazi</surname><given-names>A.</given-names></name><name><surname>Arain</surname><given-names>S.A.</given-names></name><name><surname>Ali</surname><given-names>J.</given-names></name></person-group>
<article-title>Correlation of aluminum and manganese concentration in scalp hair samples of patients having neurological disorders</article-title>
<source/>Environ. Monit. Assess.
<year>2015</year>
<volume>187</volume>
<fpage>4172</fpage>
<pub-id pub-id-type="doi">10.1007/s10661-014-4172-0</pub-id>
<pub-id pub-id-type="pmid">25618568</pub-id></element-citation>
</ref>
<ref id="B191-ijms-17-02086">
<label>191.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hess</surname><given-names>R.A.</given-names></name><name><surname>Carnes</surname><given-names>K.</given-names></name></person-group>
<article-title>The role of estrogen in testis and the male reproductive tract: A review and species comparison</article-title>
<source/>Anim. Reprod.
<year>2004</year>
<volume>1</volume>
<fpage>5</fpage>
<lpage>30</lpage>
</element-citation>
</ref>
<ref id="B192-ijms-17-02086">
<label>192.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kenealy</surname><given-names>B.P.</given-names></name><name><surname>Kapoor</surname><given-names>A.</given-names></name><name><surname>Guerriero</surname><given-names>K.A.</given-names></name><name><surname>Keen</surname><given-names>K.L.</given-names></name><name><surname>Garcia</surname><given-names>J.P.</given-names></name><name><surname>Kurian</surname><given-names>J.R.</given-names></name><name><surname>Ziegler</surname><given-names>T.E.</given-names></name><name><surname>Terasawa</surname><given-names>E.</given-names></name></person-group>
<article-title>Neuroestradiol in the hypothalamus contributes to the regulation of gonadotropin releasing hormone release</article-title>
<source/>J. Neurosci.
<year>2013</year>
<volume>33</volume>
<fpage>19051</fpage>
<lpage>19059</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.3878-13.2013</pub-id>
<pub-id pub-id-type="pmid">24305803</pub-id></element-citation>
</ref>
<ref id="B193-ijms-17-02086">
<label>193.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pedersen</surname><given-names>A.L.</given-names></name><name><surname>Nelson</surname><given-names>L.H.</given-names></name><name><surname>Saldanha</surname><given-names>C.J.</given-names></name></person-group>
<article-title>Centrally synthesized estradiol is a potent anti-inflammatory in the injured zebra finch brain</article-title>
<source/>Endocrinology
<year>2016</year>
<volume>157</volume>
<fpage>2041</fpage>
<lpage>2051</lpage>
<pub-id pub-id-type="doi">10.1210/en.2015-1991</pub-id>
<pub-id pub-id-type="pmid">26963472</pub-id></element-citation>
</ref>
<ref id="B194-ijms-17-02086">
<label>194.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brann</surname><given-names>D.W.</given-names></name><name><surname>Dhandapani</surname><given-names>K.</given-names></name><name><surname>Wakade</surname><given-names>C.</given-names></name><name><surname>Mahesh</surname><given-names>V.B.</given-names></name><name><surname>Khan</surname><given-names>M.M.</given-names></name></person-group>
<article-title>Neurotrophic and neuroprotective actions of estrogen: Basic mechanisms and clinical implications</article-title>
<source/>Steroids
<year>2007</year>
<volume>72</volume>
<fpage>381</fpage>
<lpage>405</lpage>
<pub-id pub-id-type="doi">10.1016/j.steroids.2007.02.003</pub-id>
<pub-id pub-id-type="pmid">17379265</pub-id></element-citation>
</ref>
<ref id="B195-ijms-17-02086">
<label>195.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lanting</surname><given-names>C.I.</given-names></name><name><surname>Huisman</surname><given-names>M.</given-names></name><name><surname>Muskiet</surname><given-names>F.A.J.</given-names></name><name><surname>van der Paauw</surname><given-names>C.G.</given-names></name><name><surname>Essed</surname><given-names>C.E.</given-names></name><name><surname>Boersma</surname><given-names>E.R.</given-names></name></person-group>
<article-title>Polychlorinated biphenyls in adipose tissue, liver, and brain from nine stillborns of varying gestational Ages</article-title>
<source/>Pediatr. Res.
<year>1998</year>
<volume>44</volume>
<fpage>222</fpage>
<lpage>225</lpage>
<pub-id pub-id-type="doi">10.1203/00006450-199808000-00014</pub-id>
<pub-id pub-id-type="pmid">9702918</pub-id></element-citation>
</ref>
<ref id="B196-ijms-17-02086">
<label>196.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Darbre</surname><given-names>P.D.</given-names></name></person-group>
<article-title>Metalloestrogens: An emerging class of inorganic xenoestrogens with potential to add to the oestrogenic burden of the human breast</article-title>
<source/>J. Appl. Toxicol.
<year>2006</year>
<volume>26</volume>
<fpage>191</fpage>
<lpage>197</lpage>
<pub-id pub-id-type="doi">10.1002/jat.1135</pub-id>
<pub-id pub-id-type="pmid">16489580</pub-id></element-citation>
</ref>
<ref id="B197-ijms-17-02086">
<label>197.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wallace</surname><given-names>D.R.</given-names></name></person-group>
<article-title>Nanotoxicology and metalloestrogens: Possible involvement in breast cancer</article-title>
<source/>Toxics
<year>2015</year>
<volume>3</volume>
<fpage>390</fpage>
<lpage>413</lpage>
<pub-id pub-id-type="doi">10.3390/toxics3040390</pub-id>
</element-citation>
</ref>
<ref id="B198-ijms-17-02086">
<label>198.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Harvey</surname><given-names>P.W.</given-names></name><name><surname>Everett</surname><given-names>D.J.</given-names></name></person-group>
<article-title>Regulation of endocrine-disrupting chemicals: Critical overview and deficiencies in toxicology and risk assessment for human health</article-title>
<source/>Best Pract. Res. Clin. Endocrinol.
<year>2006</year>
<volume>20</volume>
<fpage>145</fpage>
<lpage>165</lpage>
<pub-id pub-id-type="doi">10.1016/j.beem.2005.09.008</pub-id>
<pub-id pub-id-type="pmid">16522525</pub-id></element-citation>
</ref>
<ref id="B199-ijms-17-02086">
<label>199.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jeng</surname><given-names>H.A.</given-names></name></person-group>
<article-title>Exposure to endocrine disrupting chemicals and male reproductive health</article-title>
<source/>Front. Public Health
<year>2014</year>
<volume>2</volume>
<fpage>18033</fpage>
<lpage>18037</lpage>
<pub-id pub-id-type="doi">10.3389/fpubh.2014.00055</pub-id>
<pub-id pub-id-type="pmid">24926476</pub-id></element-citation>
</ref>
<ref id="B200-ijms-17-02086">
<label>200.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Klenke</surname><given-names>U.</given-names></name><name><surname>Constantin</surname><given-names>S.</given-names></name><name><surname>Wray</surname><given-names>S.</given-names></name></person-group>
<article-title>BPA directly decreases GnRH neuronal activity via non-canonical pathway</article-title>
<source/>Endocrinology
<year>2016</year>
<volume>157</volume>
<fpage>1980</fpage>
<lpage>1990</lpage>
<pub-id pub-id-type="doi">10.1210/en.2015-1924</pub-id>
<pub-id pub-id-type="pmid">26934298</pub-id></element-citation>
</ref>
<ref id="B201-ijms-17-02086">
<label>201.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>Suk</surname><given-names>K.</given-names></name><name><surname>Kim</surname><given-names>I.K.</given-names></name><name><surname>Jang</surname><given-names>I.S.</given-names></name><name><surname>Park</surname><given-names>J.W.</given-names></name><name><surname>Johnson</surname><given-names>V.J.</given-names></name><name><surname>Kwon</surname><given-names>T.K.</given-names></name><name><surname>Choi</surname><given-names>B.J.</given-names></name><name><surname>Kim</surname><given-names>S.H.</given-names></name></person-group>
<article-title>Signaling pathways of bisphenol A-induced apoptosis in hippocampal neuronal cells: Role of calcium-induced reactive oxygen species, mitogen-activated protein kinases, and nuclear factor-κB</article-title>
<source/>J. Neurosci. Res.
<year>2008</year>
<volume>86</volume>
<fpage>2932</fpage>
<lpage>2942</lpage>
<pub-id pub-id-type="doi">10.1002/jnr.21739</pub-id>
<pub-id pub-id-type="pmid">18521933</pub-id></element-citation>
</ref>
<ref id="B202-ijms-17-02086">
<label>202.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>Kim</surname><given-names>Y.K.</given-names></name><name><surname>Shin</surname><given-names>T.Y.</given-names></name><name><surname>Kim</surname><given-names>S.H.</given-names></name></person-group>
<article-title>Neurotoxic effects of bisphenol AF on calcium-induced ROS and MAPKs</article-title>
<source/>Neurotox. Res.
<year>2013</year>
<volume>23</volume>
<fpage>249</fpage>
<lpage>259</lpage>
<pub-id pub-id-type="doi">10.1007/s12640-012-9353-4</pub-id>
<pub-id pub-id-type="pmid">22996013</pub-id></element-citation>
</ref>
<ref id="B203-ijms-17-02086">
<label>203.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>El-Missiry</surname><given-names>M.A.</given-names></name><name><surname>Othman</surname><given-names>A.I.</given-names></name><name><surname>Al-Abdan</surname><given-names>M.A.</given-names></name><name><surname>El-Sayed</surname><given-names>A.A.</given-names></name></person-group>
<article-title>Melatonin ameliorates oxidative stress, modulates death receptor pathway proteins, and protects the rat cerebrum against bisphenol-A-induced apoptosis</article-title>
<source/>J. Neurol. Sci.
<year>2014</year>
<volume>347</volume>
<fpage>251</fpage>
<lpage>256</lpage>
<pub-id pub-id-type="doi">10.1016/j.jns.2014.10.009</pub-id>
<pub-id pub-id-type="pmid">25454643</pub-id></element-citation>
</ref>
<ref id="B204-ijms-17-02086">
<label>204.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Han</surname><given-names>H.</given-names></name><name><surname>Luo</surname><given-names>G.</given-names></name><name><surname>Zhou</surname><given-names>B.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name></person-group>
<article-title>Impairment of object recognition memory by maternal bisphenol A exposure is associated with inhibition of Akt and ERK/CREB/BDNF pathway in the male offspring hippocampus</article-title>
<source/>Toxicology
<year>2016</year>
<volume>341–343</volume>
<fpage>56</fpage>
<lpage>64</lpage>
<pub-id pub-id-type="doi">10.1016/j.tox.2016.01.010</pub-id>
<pub-id pub-id-type="pmid">26827910</pub-id></element-citation>
</ref>
<ref id="B205-ijms-17-02086">
<label>205.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Agarwal</surname><given-names>S.</given-names></name><name><surname>Tiwari</surname><given-names>S.K.</given-names></name><name><surname>Seth</surname><given-names>B.</given-names></name><name><surname>Yadav</surname><given-names>A.</given-names></name><name><surname>Singh</surname><given-names>A.</given-names></name><name><surname>Mudawal</surname><given-names>A.</given-names></name><name><surname>Chauhan</surname><given-names>L.K.S.</given-names></name><name><surname>Gupta</surname><given-names>S.K.</given-names></name><name><surname>Choubey</surname><given-names>V.</given-names></name><name><surname>Tripathi</surname><given-names>A.</given-names></name><etal></etal></person-group>
<article-title>Activation of autophagic flux against xenoestrogen bisphenol-A-induced hippocampal neurodegeneration via AMP kinase (AMPK)/mammalian target of rapamycin (mTOR) pathways</article-title>
<source/>J. Biol. Chem.
<year>2015</year>
<volume>290</volume>
<fpage>21163</fpage>
<lpage>21184</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M115.648998</pub-id>
<pub-id pub-id-type="pmid">26139607</pub-id></element-citation>
</ref>
<ref id="B206-ijms-17-02086">
<label>206.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Fang</surname><given-names>F.</given-names></name><name><surname>Chen</surname><given-names>D.</given-names></name><name><surname>Gao</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Gao</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Xiao</surname><given-names>H.</given-names></name></person-group>
<article-title>Bisphenol A disrupts glucose transport and neurophysiological role of IR/IRS/AKT/GSK3β axis in the brain of male mice</article-title>
<source/>Environ. Toxicol. Pharmacol.
<year>2016</year>
<volume>43</volume>
<fpage>7</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="doi">10.1016/j.etap.2015.11.025</pub-id>
<pub-id pub-id-type="pmid">26923231</pub-id></element-citation>
</ref>
<ref id="B207-ijms-17-02086">
<label>207.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Scinicariello</surname><given-names>F.</given-names></name><name><surname>Feroe</surname><given-names>A.G.</given-names></name><name><surname>Attanasio</surname><given-names>R.</given-names></name></person-group>
<article-title>Urinary phthalates and leukocyte telomere length: An analysis of NHANES 1999–2002</article-title>
<source/>EBioMedicine
<year>2015</year>
<volume>6</volume>
<fpage>96</fpage>
<lpage>102</lpage>
<pub-id pub-id-type="doi">10.1016/j.ebiom.2016.02.027</pub-id>
<pub-id pub-id-type="pmid">27211552</pub-id></element-citation>
</ref>
<ref id="B208-ijms-17-02086">
<label>208.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Miodovnik</surname><given-names>A.</given-names></name><name><surname>Edwards</surname><given-names>A.</given-names></name><name><surname>Bellinger</surname><given-names>D.C.</given-names></name><name><surname>Hauser</surname><given-names>R.</given-names></name></person-group>
<article-title>Developmental neurotoxicity of ortho-phthalate diesters: Review of human and experimental evidence</article-title>
<source/>Neurotoxicology
<year>2014</year>
<volume>41</volume>
<fpage>112</fpage>
<lpage>122</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuro.2014.01.007</pub-id>
<pub-id pub-id-type="pmid">24486776</pub-id></element-citation>
</ref>
<ref id="B209-ijms-17-02086">
<label>209.</label>
<element-citation publication-type="webpage">
<person-group person-group-type="author"><name><surname>Roy</surname><given-names>D.</given-names></name><name><surname>Tamuli</surname><given-names>R.</given-names></name></person-group>
<article-title>NRF1 (Nuclear Respiratory Factor 1). Atlas Genet Cytogenet Oncol Haematol</article-title>
<year>2008</year>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://AtlasGeneticsOncology.org/Genes/NRF1ID44233ch7q32.html">http://AtlasGeneticsOncology.org/Genes/NRF1ID44233ch7q32.html</ext-link></comment>
<date-in-citation>(accessed on 12 September 2016)</date-in-citation>
</element-citation>
</ref>
<ref id="B210-ijms-17-02086">
<label>210.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Okoh</surname><given-names>V.O.</given-names></name><name><surname>Garba</surname><given-names>N.A.</given-names></name><name><surname>Penney</surname><given-names>R.B.</given-names></name><name><surname>Das</surname><given-names>J.</given-names></name><name><surname>Deoraj</surname><given-names>A.</given-names></name><name><surname>Singh</surname><given-names>K.P.</given-names></name><name><surname>Sarkar</surname><given-names>S.</given-names></name><name><surname>Felty</surname><given-names>Q.</given-names></name><name><surname>Yoo</surname><given-names>C.</given-names></name><name><surname>Jackson</surname><given-names>R.M.</given-names></name><etal></etal></person-group>
<article-title>Redox signalling to nuclear regulatory proteins by reactive oxygen species contributes to oestrogen-induced growth of breast cancer cells</article-title>
<source/>Br. J. Cancer
<year>2015</year>
<volume>112</volume>
<fpage>1687</fpage>
<lpage>1702</lpage>
<pub-id pub-id-type="doi">10.1038/bjc.2014.586</pub-id>
<pub-id pub-id-type="pmid">25965299</pub-id></element-citation>
</ref>
<ref id="B211-ijms-17-02086">
<label>211.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chandrasekaran</surname><given-names>S.</given-names></name><name><surname>Bonchev</surname><given-names>D.</given-names></name></person-group>
<article-title>Network topology analysis of post-mortem brain microarrays identifies more Alzheimer’s related genes and MicroRNAs and points to novel routes for fighting with the disease</article-title>
<source/>PLoS ONE
<year>2016</year>
<volume>11</volume>
<elocation-id>e0144052</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0144052</pub-id>
<pub-id pub-id-type="pmid">26784894</pub-id></element-citation>
</ref>
<ref id="B212-ijms-17-02086">
<label>212.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sheng</surname><given-names>B.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Su</surname><given-names>B.</given-names></name><name><surname>Lee</surname><given-names>H.</given-names></name><name><surname>Casadesus</surname><given-names>G.</given-names></name><name><surname>Perry</surname><given-names>G.</given-names></name><name><surname>Zhu</surname><given-names>X.</given-names></name></person-group>
<article-title>Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer’s disease</article-title>
<source/>J. Neurochem.
<year>2012</year>
<volume>120</volume>
<fpage>419</fpage>
<lpage>429</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.2011.07581.x</pub-id>
<pub-id pub-id-type="pmid">22077634</pub-id></element-citation>
</ref>
<ref id="B213-ijms-17-02086">
<label>213.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Osellame</surname><given-names>L.D.</given-names></name><name><surname>Blacker</surname><given-names>T.S.</given-names></name><name><surname>Duchen</surname><given-names>M.R.</given-names></name></person-group>
<article-title>Cellular and molecular mechanisms of mitochondrial function</article-title>
<source/>Best Pract. Res. Clin. Endocrinol. Metab.
<year>2012</year>
<volume>26</volume>
<fpage>711</fpage>
<lpage>723</lpage>
<pub-id pub-id-type="doi">10.1016/j.beem.2012.05.003</pub-id>
<pub-id pub-id-type="pmid">23168274</pub-id></element-citation>
</ref>
<ref id="B214-ijms-17-02086">
<label>214.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Johri</surname><given-names>A.</given-names></name><name><surname>Beal</surname><given-names>F.</given-names></name></person-group>
<article-title>Mitochondrial dysfunction in neurodegenerative diseases</article-title>
<source/>J. Pharmacol. Exp. Ther.
<year>2012</year>
<volume>342</volume>
<fpage>619</fpage>
<lpage>630</lpage>
<pub-id pub-id-type="doi">10.1124/jpet.112.192138</pub-id>
<pub-id pub-id-type="pmid">22700435</pub-id></element-citation>
</ref>
<ref id="B215-ijms-17-02086">
<label>215.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Corona</surname><given-names>J.C.</given-names></name><name><surname>Duchen</surname><given-names>M.R.</given-names></name></person-group>
<article-title>Impaired mitochondrial homeostasis and neurodegeneration: Towards new therapeutic targets?</article-title>
<source/>J. Bioenerg. Biomembr.
<year>2014</year>
<volume>47</volume>
<fpage>89</fpage>
<lpage>99</lpage>
<pub-id pub-id-type="doi">10.1007/s10863-014-9576-6</pub-id>
<pub-id pub-id-type="pmid">25216534</pub-id></element-citation>
</ref>
<ref id="B216-ijms-17-02086">
<label>216.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Velarde</surname><given-names>M.C.</given-names></name></person-group>
<article-title>Mitochondrial and sex steroid hormone crosstalk during aging</article-title>
<source/>Longev. Healthspan
<year>2014</year>
<volume>3</volume>
<fpage>1</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="doi">10.1186/2046-2395-3-2</pub-id>
<pub-id pub-id-type="pmid">24472138</pub-id></element-citation>
</ref>
<ref id="B217-ijms-17-02086">
<label>217.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Scarpulla</surname><given-names>R.</given-names></name></person-group>
<article-title>Transcriptional paradigms in mammalian mitochondrial biogenesis and function</article-title>
<source/>Physiol. Rev.
<year>2008</year>
<volume>88</volume>
<fpage>611</fpage>
<lpage>638</lpage>
<pub-id pub-id-type="doi">10.1152/physrev.00025.2007</pub-id>
<pub-id pub-id-type="pmid">18391175</pub-id></element-citation>
</ref>
<ref id="B218-ijms-17-02086">
<label>218.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dhar</surname><given-names>S.S.</given-names></name><name><surname>Johar</surname><given-names>K.</given-names></name><name><surname>Wong-Riley</surname><given-names>M.T.T.</given-names></name></person-group>
<article-title>Bigenomic transcriptional regulation of all thirteen cytochrome c oxidase subunit genes by specificity protein 1</article-title>
<source/>Open Biol.
<year>2013</year>
<volume>3</volume>
<fpage>142</fpage>
<lpage>150</lpage>
<pub-id pub-id-type="doi">10.1098/rsob.120176</pub-id>
<pub-id pub-id-type="pmid">23516108</pub-id></element-citation>
</ref>
<ref id="B219-ijms-17-02086">
<label>219.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Thau</surname><given-names>N.</given-names></name><name><surname>Knippenberg</surname><given-names>S.</given-names></name><name><surname>Körner</surname><given-names>S.</given-names></name><name><surname>Rath</surname><given-names>K.J.</given-names></name><name><surname>Dengler</surname><given-names>R.</given-names></name><name><surname>Petri</surname><given-names>S.</given-names></name></person-group>
<article-title>Decreased mRNA expression of PGC-1α and PGC-1α-regulated factors in the SOD1G93A ALS mouse model and in human sporadic ALS</article-title>
<source/>J. Neuropathol. Exp. Neurol.
<year>2012</year>
<volume>71</volume>
<fpage>1064</fpage>
<lpage>1074</lpage>
<pub-id pub-id-type="doi">10.1097/NEN.0b013e318275df4b</pub-id>
<pub-id pub-id-type="pmid">23147503</pub-id></element-citation>
</ref>
<ref id="B220-ijms-17-02086">
<label>220.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chaturvedi</surname><given-names>R.K.</given-names></name><name><surname>Adhihetty</surname><given-names>P.</given-names></name><name><surname>Shukla</surname><given-names>S.</given-names></name><name><surname>Hennessy</surname><given-names>T.</given-names></name><name><surname>Calingasan</surname><given-names>N.</given-names></name><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Starkov</surname><given-names>A.</given-names></name><name><surname>Kiaei</surname><given-names>M.</given-names></name><name><surname>Cannella</surname><given-names>M.</given-names></name><name><surname>Sassone</surname><given-names>J.</given-names></name><etal></etal></person-group>
<article-title>Impaired PGC-1α function in muscle in Huntington’s disease</article-title>
<source/>Hum. Mol. Genet.
<year>2009</year>
<volume>18</volume>
<fpage>3048</fpage>
<lpage>3065</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddp243</pub-id>
<pub-id pub-id-type="pmid">19460884</pub-id></element-citation>
</ref>
<ref id="B221-ijms-17-02086">
<label>221.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Weydt</surname><given-names>P.</given-names></name><name><surname>Pineda</surname><given-names>V.V.</given-names></name><name><surname>Torrence</surname><given-names>A.E.</given-names></name><name><surname>Libby</surname><given-names>R.T.</given-names></name><name><surname>Satterfield</surname><given-names>T.F.</given-names></name><name><surname>Lazarowski</surname><given-names>E.</given-names></name><name><surname>Gilbert</surname><given-names>M.L.</given-names></name><name><surname>Morton</surname><given-names>G.J.</given-names></name><name><surname>Bammler</surname><given-names>T.K.</given-names></name><name><surname>Strand</surname><given-names>A.D.</given-names></name><etal></etal></person-group>
<article-title>Thermoregulatory and metabolic defects in Huntington’s disease transgenic mice implicate PGC-1α in Huntington’s disease neurodegeneration</article-title>
<source/>Cell Metab.
<year>2006</year>
<volume>4</volume>
<fpage>349</fpage>
<lpage>362</lpage>
<pub-id pub-id-type="doi">10.1016/j.cmet.2006.10.004</pub-id>
<pub-id pub-id-type="pmid">17055784</pub-id></element-citation>
</ref>
<ref id="B222-ijms-17-02086">
<label>222.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gong</surname><given-names>B.</given-names></name><name><surname>Chen</surname><given-names>F.</given-names></name><name><surname>Pan</surname><given-names>Y.</given-names></name><name><surname>Arrieta-Cruz</surname><given-names>I.</given-names></name><name><surname>Yoshida</surname><given-names>Y.</given-names></name><name><surname>Haroutunian</surname><given-names>V.</given-names></name><name><surname>Pasinetti</surname><given-names>G.M.</given-names></name></person-group>
<article-title>SCFFbx2-E3-ligase-mediated degradation of BACE1 attenuates Alzheimer’s disease amyloidosis and improves synaptic function</article-title>
<source/>Aging Cell
<year>2010</year>
<volume>9</volume>
<fpage>1018</fpage>
<lpage>1031</lpage>
<pub-id pub-id-type="doi">10.1111/j.1474-9726.2010.00632.x</pub-id>
<pub-id pub-id-type="pmid">20854419</pub-id></element-citation>
</ref>
<ref id="B223-ijms-17-02086">
<label>223.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Qin</surname><given-names>W.</given-names></name><name><surname>Haroutunian</surname><given-names>V.</given-names></name><name><surname>Katsel</surname><given-names>P.</given-names></name><name><surname>Cardozo</surname><given-names>C.P.</given-names></name><name><surname>Ho</surname><given-names>L.</given-names></name><name><surname>Buxbaum</surname><given-names>J.D.</given-names></name><name><surname>Pasinetti</surname><given-names>G.M.</given-names></name></person-group>
<article-title>PGC-1α expression decreases in the Alzheimer disease brain as a function of dementia</article-title>
<source/>Arch. Neurol.
<year>2009</year>
<volume>66</volume>
<fpage>352</fpage>
<lpage>361</lpage>
<pub-id pub-id-type="doi">10.1001/archneurol.2008.588</pub-id>
<pub-id pub-id-type="pmid">19273754</pub-id></element-citation>
</ref>
<ref id="B224-ijms-17-02086">
<label>224.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hagl</surname><given-names>S.</given-names></name><name><surname>Grewal</surname><given-names>R.</given-names></name><name><surname>Ciobanu</surname><given-names>I.</given-names></name><name><surname>Helal</surname><given-names>A.</given-names></name><name><surname>Khayyal</surname><given-names>M.T.</given-names></name><name><surname>Muller</surname><given-names>W.E.</given-names></name><name><surname>Eckert</surname><given-names>G.P.</given-names></name></person-group>
<article-title>Rice bran extract compensates mitochondrial dysfunction in a cellular model of early Alzheimer’s disease</article-title>
<source/>J. Alzheimers Dis.
<year>2015</year>
<volume>43</volume>
<fpage>927</fpage>
<lpage>938</lpage>
<pub-id pub-id-type="pmid">25125472</pub-id></element-citation>
</ref>
<ref id="B225-ijms-17-02086">
<label>225.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Austin</surname><given-names>S.</given-names></name><name><surname>St-Pierre</surname><given-names>J.</given-names></name></person-group>
<article-title>PGC1α and mitochondrial metabolism–emerging concepts and relevance in ageing and neurodegenerative disorders</article-title>
<source/>J. Cell Sci.
<year>2012</year>
<volume>12</volume>
<fpage>4963</fpage>
<lpage>4971</lpage>
<pub-id pub-id-type="doi">10.1242/jcs.113662</pub-id>
<pub-id pub-id-type="pmid">23277535</pub-id></element-citation>
</ref>
<ref id="B226-ijms-17-02086">
<label>226.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hirai</surname><given-names>K.</given-names></name><name><surname>Aliev</surname><given-names>G.</given-names></name><name><surname>Nunomura</surname><given-names>A.</given-names></name><name><surname>Fujioka</surname><given-names>H.</given-names></name><name><surname>Russell</surname><given-names>R.L.</given-names></name><name><surname>Atwood</surname><given-names>C.S.</given-names></name><name><surname>Johnson</surname><given-names>A.B.</given-names></name><name><surname>Kress</surname><given-names>Y.</given-names></name><name><surname>Vinters</surname><given-names>H.V.</given-names></name><name><surname>Tabaton</surname><given-names>M.</given-names></name><etal></etal></person-group>
<article-title>Mitochondrial abnormalities in Alzheimer’s disease</article-title>
<source/>J. Neurosci.
<year>2001</year>
<volume>21</volume>
<fpage>3017</fpage>
<lpage>3023</lpage>
<pub-id pub-id-type="pmid">11312286</pub-id></element-citation>
</ref>
<ref id="B227-ijms-17-02086">
<label>227.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nagy</surname><given-names>Z.</given-names></name><name><surname>Esiri</surname><given-names>M.M.</given-names></name><name><surname>LeGris</surname><given-names>M.</given-names></name><name><surname>Matthews</surname><given-names>P.M.</given-names></name></person-group>
<article-title>Mitochondrial enzyme expression in the hippocampus in relation to Alzheimer-type pathology</article-title>
<source/>Acta Neuropathol.
<year>1999</year>
<volume>97</volume>
<fpage>346</fpage>
<lpage>354</lpage>
<pub-id pub-id-type="doi">10.1007/s004010050997</pub-id>
<pub-id pub-id-type="pmid">10208273</pub-id></element-citation>
</ref>
<ref id="B228-ijms-17-02086">
<label>228.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Swerdlow</surname><given-names>R.H.</given-names></name></person-group>
<article-title>Brain aging, Alzheimer’s disease, and mitochondria</article-title>
<source/>Biochim. Biophys. Acta
<year>2011</year>
<volume>1812</volume>
<fpage>1630</fpage>
<lpage>1639</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbadis.2011.08.012</pub-id>
<pub-id pub-id-type="pmid">21920438</pub-id></element-citation>
</ref>
<ref id="B229-ijms-17-02086">
<label>229.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Swerdlow</surname><given-names>R.H.</given-names></name></person-group>
<article-title>Mitochondria and cell bioenergetics: Increasingly recognized components and a possible etiologic cause of Alzheimer’s disease</article-title>
<source/>Antioxid. Redox Signal.
<year>2012</year>
<volume>16</volume>
<fpage>1434</fpage>
<lpage>1455</lpage>
<pub-id pub-id-type="doi">10.1089/ars.2011.4149</pub-id>
<pub-id pub-id-type="pmid">21902597</pub-id></element-citation>
</ref>
<ref id="B230-ijms-17-02086">
<label>230.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Swerdlow</surname><given-names>R.H.</given-names></name></person-group>
<article-title>β-Apptists and tauists, it is time for sermon from the book of biogenesis</article-title>
<source/>J. Neurochem.
<year>2012</year>
<volume>120</volume>
<fpage>347</fpage>
<lpage>349</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.2011.07561.x</pub-id>
<pub-id pub-id-type="pmid">22035261</pub-id></element-citation>
</ref>
<ref id="B231-ijms-17-02086">
<label>231.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brannval</surname><given-names>K.</given-names></name><name><surname>Korhonen</surname><given-names>L.</given-names></name><name><surname>Lindholm</surname><given-names>D.</given-names></name></person-group>
<article-title>Estrogen-receptor-dependent regulation of neural stem cell proliferation and differentiation</article-title>
<source/>Mol. Cell. Neurosci.
<year>2002</year>
<volume>21</volume>
<fpage>512</fpage>
<lpage>520</lpage>
<pub-id pub-id-type="doi">10.1006/mcne.2002.1194</pub-id>
<pub-id pub-id-type="pmid">12498791</pub-id></element-citation>
</ref>
<ref id="B232-ijms-17-02086">
<label>232.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Okada</surname><given-names>M.</given-names></name><name><surname>Murase</surname><given-names>K.</given-names></name><name><surname>Makino</surname><given-names>A.</given-names></name><name><surname>Nakajima</surname><given-names>M.</given-names></name><name><surname>Kaku</surname><given-names>T.</given-names></name><name><surname>Furukawa</surname><given-names>S.</given-names></name><name><surname>Furukawa</surname><given-names>Y.</given-names></name></person-group>
<article-title>Effects of estrogens on proliferation and differentiation of neural stem/progenitor cells</article-title>
<source/>Biomed. Res.
<year>2008</year>
<volume>29</volume>
<fpage>163</fpage>
<lpage>170</lpage>
<pub-id pub-id-type="doi">10.2220/biomedres.29.163</pub-id>
<pub-id pub-id-type="pmid">18614850</pub-id></element-citation>
</ref>
<ref id="B233-ijms-17-02086">
<label>233.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Okada</surname><given-names>M.</given-names></name><name><surname>Makino</surname><given-names>A.</given-names></name><name><surname>Nakajima</surname><given-names>M.</given-names></name><name><surname>Okuyama</surname><given-names>S.</given-names></name><name><surname>Furukawa</surname><given-names>S.</given-names></name><name><surname>Furukawa</surname><given-names>Y.</given-names></name></person-group>
<article-title>Estrogen stimulates proliferation and differentiation of neural stem/progenitor cells through different signal transduction pathways</article-title>
<source/>Int. J. Mol. Sci.
<year>2010</year>
<volume>11</volume>
<fpage>4114</fpage>
<lpage>4123</lpage>
<pub-id pub-id-type="doi">10.3390/ijms11104114</pub-id>
<pub-id pub-id-type="pmid">21152324</pub-id></element-citation>
</ref>
<ref id="B234-ijms-17-02086">
<label>234.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ishido</surname><given-names>M.</given-names></name><name><surname>Suzuki</surname><given-names>J.</given-names></name></person-group>
<article-title>Classification of phthalates based on an in vitro neurosphere assay using rat mesencephalic neural stem cells</article-title>
<source/>J. Toxicol. Sci.
<year>2014</year>
<volume>39</volume>
<fpage>25</fpage>
<lpage>32</lpage>
<pub-id pub-id-type="doi">10.2131/jts.39.25</pub-id>
<pub-id pub-id-type="pmid">24418706</pub-id></element-citation>
</ref>
<ref id="B235-ijms-17-02086">
<label>235.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tofighi</surname><given-names>R.</given-names></name><name><surname>Wan Ibrahim</surname><given-names>W.N.</given-names></name><name><surname>Rebellato</surname><given-names>P.</given-names></name><name><surname>Andersson</surname><given-names>P.L.</given-names></name><name><surname>Uhlén</surname><given-names>P.</given-names></name><name><surname>Ceccatelli</surname><given-names>S.</given-names></name></person-group>
<article-title>Non-dioxin-like polychlorinated biphenyls interfere with neuronal differentiation of embryonic neural stem cells</article-title>
<source/>Toxicol. Sci.
<year>2011</year>
<volume>124</volume>
<fpage>192</fpage>
<lpage>201</lpage>
<pub-id pub-id-type="doi">10.1093/toxsci/kfr221</pub-id>
<pub-id pub-id-type="pmid">21908764</pub-id></element-citation>
</ref>
<ref id="B236-ijms-17-02086">
<label>236.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ivanov</surname><given-names>V.N.</given-names></name><name><surname>Hei</surname><given-names>T.K.</given-names></name></person-group>
<article-title>Induction of apoptotic death and retardation of neuronal differentiation of human neural stem cells by sodium arsenite treatment</article-title>
<source/>Exp. Cell Res.
<year>2013</year>
<volume>319</volume>
<fpage>875</fpage>
<lpage>887</lpage>
<pub-id pub-id-type="doi">10.1016/j.yexcr.2012.11.019</pub-id>
<pub-id pub-id-type="pmid">23219847</pub-id></element-citation>
</ref>
<ref id="B237-ijms-17-02086">
<label>237.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tamm</surname><given-names>C.</given-names></name><name><surname>Sabri</surname><given-names>F.</given-names></name><name><surname>Ceccatelli</surname><given-names>S.</given-names></name></person-group>
<article-title>Mitochondrial-mediated apoptosis in neural stem cells exposed to manganese</article-title>
<source/>Toxicol. Sci.
<year>2008</year>
<volume>101</volume>
<fpage>310</fpage>
<lpage>320</lpage>
<pub-id pub-id-type="doi">10.1093/toxsci/kfm267</pub-id>
<pub-id pub-id-type="pmid">17977900</pub-id></element-citation>
</ref>
<ref id="B238-ijms-17-02086">
<label>238.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>J.L.</given-names></name><name><surname>Chang</surname><given-names>W.T.</given-names></name><name><surname>Tong</surname><given-names>C.W.</given-names></name><name><surname>Kohno</surname><given-names>K.</given-names></name><name><surname>Huang</surname><given-names>A.M.</given-names></name></person-group>
<article-title>Human synapsin I mediates the function of nuclear respiratory factor 1 in neurite outgrowth in neuroblastoma IMR-32 cells</article-title>
<source/>J. Neurosci. Res.
<year>2009</year>
<volume>87</volume>
<fpage>2255</fpage>
<lpage>2263</lpage>
<pub-id pub-id-type="doi">10.1002/jnr.22059</pub-id>
<pub-id pub-id-type="pmid">19301426</pub-id></element-citation>
</ref>
<ref id="B239-ijms-17-02086">
<label>239.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tong</surname><given-names>C.W.</given-names></name><name><surname>Wang</surname><given-names>J.L.</given-names></name><name><surname>Jiang</surname><given-names>M.S.</given-names></name><name><surname>Hsu</surname><given-names>C.H.</given-names></name><name><surname>Chang</surname><given-names>W.T.</given-names></name><name><surname>Huang</surname><given-names>A.M.</given-names></name></person-group>
<article-title>Novel genes that mediate nuclear respiratory factor 1-regualted neurite outgrowth in neuroblastoma IMR-32 cells</article-title>
<source/>Gene
<year>2013</year>
<volume>515</volume>
<fpage>62</fpage>
<lpage>70</lpage>
<pub-id pub-id-type="doi">10.1016/j.gene.2012.11.026</pub-id>
<pub-id pub-id-type="pmid">23219993</pub-id></element-citation>
</ref>
<ref id="B240-ijms-17-02086">
<label>240.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>J.L.</given-names></name><name><surname>Tong</surname><given-names>C.W.</given-names></name><name><surname>Chang</surname><given-names>W.T.</given-names></name><name><surname>Huang</surname><given-names>A.M.</given-names></name></person-group>
<article-title>Novel genes FAM134C, C3orf10 and ENOX1 are regulated by NRF-1 and differentially regulate neurite outgrowth in neuroblastoma cells and hippocampal neurons</article-title>
<source/>Gene
<year>2013</year>
<volume>529</volume>
<fpage>7</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="doi">10.1016/j.gene.2013.08.006</pub-id>
<pub-id pub-id-type="pmid">23939472</pub-id></element-citation>
</ref>
<ref id="B241-ijms-17-02086">
<label>241.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Danysz</surname><given-names>W.</given-names></name><name><surname>Parsons</surname><given-names>C.G.</given-names></name></person-group>
<article-title>Alzheimer’s disease, β-amyloid, glutamate, NMDA receptors and memantine—Searching for the connections</article-title>
<source/>Br. J. Pharmacol.
<year>2012</year>
<volume>167</volume>
<fpage>324</fpage>
<lpage>352</lpage>
<pub-id pub-id-type="doi">10.1111/j.1476-5381.2012.02057.x</pub-id>
<pub-id pub-id-type="pmid">22646481</pub-id></element-citation>
</ref>
<ref id="B242-ijms-17-02086">
<label>242.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dhar</surname><given-names>S.S.</given-names></name><name><surname>Liang</surname><given-names>H.L.</given-names></name><name><surname>Wong-Riley</surname><given-names>M.T.T.</given-names></name></person-group>
<article-title>Nuclear respiratory factor 1 co-regulates AMPA glutamate receptor subunit 2 and cytochrome c oxidase: Tight coupling of glutamatergic transmission and energy metabolism in neurons</article-title>
<source/>J. Neurochem.
<year>2009</year>
<volume>108</volume>
<fpage>1595</fpage>
<lpage>1606</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.2009.05929.x</pub-id>
<pub-id pub-id-type="pmid">19166514</pub-id></element-citation>
</ref>
<ref id="B243-ijms-17-02086">
<label>243.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Priya</surname><given-names>A.</given-names></name><name><surname>Johar</surname><given-names>K.</given-names></name><name><surname>Wong-Riley</surname><given-names>M.T.T.</given-names></name></person-group>
<article-title>Nuclear respiratory factor 2 regulates the expression of the same NMDA receptor subunit genes as NRF-1: Both factors act by a concurrent and parallel mechanism to couple energy metabolism and synaptic transmission</article-title>
<source/>Biochim. Biophys. Acta—Mol. Cell Res.
<year>2013</year>
<volume>1833</volume>
<fpage>48</fpage>
<lpage>58</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbamcr.2012.10.014</pub-id>
<pub-id pub-id-type="pmid">23085505</pub-id></element-citation>
</ref>
<ref id="B244-ijms-17-02086">
<label>244.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Andreoli</surname><given-names>V.</given-names></name><name><surname>De Marco</surname><given-names>E.V.</given-names></name><name><surname>Trecroci</surname><given-names>F.</given-names></name><name><surname>Cittadella</surname><given-names>R.</given-names></name><name><surname>Di Palma</surname><given-names>G.</given-names></name><name><surname>Gambardella</surname><given-names>A.</given-names></name></person-group>
<article-title>Potential involvement of GRIN2B encoding the NMDA receptor subunit NR2B in the spectrum of Alzheimer’s disease</article-title>
<source/>J. Neural Transm.
<year>2014</year>
<volume>121</volume>
<fpage>533</fpage>
<lpage>542</lpage>
<pub-id pub-id-type="doi">10.1007/s00702-013-1125-7</pub-id>
<pub-id pub-id-type="pmid">24292895</pub-id></element-citation>
</ref>
<ref id="B245-ijms-17-02086">
<label>245.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Domcke</surname><given-names>S.</given-names></name><name><surname>Bardet</surname><given-names>A.F.</given-names></name><name><surname>Adrian Ginno</surname><given-names>P.</given-names></name><name><surname>Hartl</surname><given-names>D.</given-names></name><name><surname>Burger</surname><given-names>L.</given-names></name><name><surname>Schübeler</surname><given-names>D.</given-names></name></person-group>
<article-title>Competition between DNA methylation and transcription factors determines binding of NRF1</article-title>
<source/>Nature
<year>2015</year>
<volume>528</volume>
<fpage>575</fpage>
<lpage>579</lpage>
<pub-id pub-id-type="doi">10.1038/nature16462</pub-id>
<pub-id pub-id-type="pmid">26675734</pub-id></element-citation>
</ref>
<ref id="B246-ijms-17-02086">
<label>246.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lavigne</surname><given-names>M.D.</given-names></name><name><surname>Vatsellas</surname><given-names>G.</given-names></name><name><surname>Polyzos</surname><given-names>A.</given-names></name><name><surname>Mantouvalou</surname><given-names>E.</given-names></name><name><surname>Sianidis</surname><given-names>G.</given-names></name><name><surname>Maraziotis</surname><given-names>I.</given-names></name><name><surname>Agelopoulos</surname><given-names>M.</given-names></name><name><surname>Thanos</surname><given-names>D.</given-names></name></person-group>
<article-title>Composite macroH2A/NRF-1 nucleosomes suppress noise and generate robustness in gene expression</article-title>
<source/>Cell Rep.
<year>2015</year>
<volume>11</volume>
<fpage>1090</fpage>
<lpage>1101</lpage>
<pub-id pub-id-type="doi">10.1016/j.celrep.2015.04.022</pub-id>
<pub-id pub-id-type="pmid">25959814</pub-id></element-citation>
</ref>
<ref id="B247-ijms-17-02086">
<label>247.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bharadwaj</surname><given-names>R.</given-names></name><name><surname>Peter</surname><given-names>C.J.</given-names></name><name><surname>Jiang</surname><given-names>Y.</given-names></name><name><surname>Roussos</surname><given-names>P.</given-names></name><name><surname>Vogel-Ciernia</surname><given-names>A.</given-names></name><name><surname>Shen</surname><given-names>E.Y.</given-names></name><name><surname>Mitchell</surname><given-names>A.C.</given-names></name><name><surname>Mao</surname><given-names>W.</given-names></name><name><surname>Whittle</surname><given-names>C.</given-names></name><name><surname>Dincer</surname><given-names>A.</given-names></name><etal></etal></person-group>
<article-title>Conserved higher-order chromatin regulates NMDA receptor gene expression and cognition</article-title>
<source/>Neuron
<year>2014</year>
<volume>84</volume>
<fpage>997</fpage>
<lpage>1008</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2014.10.032</pub-id>
<pub-id pub-id-type="pmid">25467983</pub-id></element-citation>
</ref>
<ref id="B248-ijms-17-02086">
<label>248.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dhar</surname><given-names>S.S.</given-names></name><name><surname>Wong-Riley</surname><given-names>M.T.T.</given-names></name></person-group>
<article-title>The kinesin superfamily protein KIF17 is regulated by the same transcription factor (NRF-1) as its cargo NR2B in neurons</article-title>
<source/>Biochim. Biophys. Acta—Mol. Cell Res.
<year>2011</year>
<volume>1813</volume>
<fpage>403</fpage>
<lpage>411</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbamcr.2010.12.013</pub-id>
<pub-id pub-id-type="pmid">21172391</pub-id></element-citation>
</ref>
<ref id="B249-ijms-17-02086">
<label>249.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yeo</surname><given-names>M.</given-names></name><name><surname>Berglund</surname><given-names>K.</given-names></name><name><surname>Hanna</surname><given-names>M.</given-names></name><name><surname>Guo</surname><given-names>J.U.</given-names></name><name><surname>Kittur</surname><given-names>J.</given-names></name><name><surname>Torres</surname><given-names>M.D.</given-names></name><name><surname>Abramowitz</surname><given-names>J.</given-names></name><name><surname>Busciglio</surname><given-names>J.</given-names></name><name><surname>Gao</surname><given-names>Y.</given-names></name><name><surname>Birnbaumer</surname><given-names>L.</given-names></name><etal></etal></person-group>
<article-title>Bisphenol A delays the perinatal chloride shift in cortical neurons by epigenetic effects on the Kcc2 promoter</article-title>
<source/>Proc. Natl. Acad. Sci. USA
<year>2013</year>
<volume>110</volume>
<fpage>4315</fpage>
<lpage>4320</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1300959110</pub-id>
<pub-id pub-id-type="pmid">23440186</pub-id></element-citation>
</ref>
<ref id="B250-ijms-17-02086">
<label>250.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stansfield</surname><given-names>K.H.</given-names></name><name><surname>Bichell</surname><given-names>T.J.</given-names></name><name><surname>Bowman</surname><given-names>A.B.</given-names></name><name><surname>Guilarte</surname><given-names>T.R.</given-names></name></person-group>
<article-title>BDNF and Huntingtin protein modifications by manganese: Implications for striatal medium spiny neuron pathology in manganese neurotoxicity</article-title>
<source/>J. Neurochem.
<year>2014</year>
<volume>131</volume>
<fpage>655</fpage>
<lpage>666</lpage>
<pub-id pub-id-type="doi">10.1111/jnc.12926</pub-id>
<pub-id pub-id-type="pmid">25099302</pub-id></element-citation>
</ref>
<ref id="B251-ijms-17-02086">
<label>251.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Verina</surname><given-names>T.</given-names></name><name><surname>Schneider</surname><given-names>J.S.</given-names></name><name><surname>Guilarte</surname><given-names>T.R.</given-names></name></person-group>
<article-title>Manganese exposure induces α-synuclein aggregation in the frontal cortex of non-human primates</article-title>
<source/>Toxicol. Lett.
<year>2013</year>
<volume>217</volume>
<fpage>177</fpage>
<lpage>183</lpage>
<pub-id pub-id-type="doi">10.1016/j.toxlet.2012.12.006</pub-id>
<pub-id pub-id-type="pmid">23262390</pub-id></element-citation>
</ref>
<ref id="B252-ijms-17-02086">
<label>252.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Guilarte</surname><given-names>T.R.</given-names></name><name><surname>Burton</surname><given-names>N.C.</given-names></name><name><surname>Verina</surname><given-names>T.</given-names></name><name><surname>Prabhu</surname><given-names>V.V.</given-names></name><name><surname>Becker</surname><given-names>K.G.</given-names></name><name><surname>Syversen</surname><given-names>T.</given-names></name><name><surname>Schneider</surname><given-names>J.S.</given-names></name></person-group>
<article-title>Increased APLP1 expression and neurodegeneration in the frontal cortex of manganese-exposed non-human primates</article-title>
<source/>J. Neurochem.
<year>2008</year>
<volume>105</volume>
<fpage>1948</fpage>
<lpage>1959</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.2008.05295.x</pub-id>
<pub-id pub-id-type="pmid">18284614</pub-id></element-citation>
</ref>
<ref id="B253-ijms-17-02086">
<label>253.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cheng</surname><given-names>A.</given-names></name><name><surname>Hou</surname><given-names>Y.</given-names></name><name><surname>Mattson</surname><given-names>M.P.</given-names></name></person-group>
<article-title>Mitochondria and neuroplasticity</article-title>
<source/>ASN Neuro
<year>2010</year>
<volume>2</volume>
<fpage>243</fpage>
<lpage>256</lpage>
<pub-id pub-id-type="doi">10.1042/AN20100019</pub-id>
<pub-id pub-id-type="pmid">20957078</pub-id></element-citation>
</ref>
<ref id="B254-ijms-17-02086">
<label>254.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Arambula</surname><given-names>S.E.</given-names></name><name><surname>Belcher</surname><given-names>S.M.</given-names></name><name><surname>Planchart</surname><given-names>A.</given-names></name><name><surname>Turner</surname><given-names>S.D.</given-names></name><name><surname>Patisaul</surname><given-names>H.B.</given-names></name></person-group>
<article-title>Impact of low dose oral exposure to bisphenol a (BPA) on the neonatal rat hypothalamic and hippocampal transcriptome: A CLARITY-BPA consortium study</article-title>
<source/>Endocrinology
<year>2016</year>
<volume>157</volume>
<fpage>3856</fpage>
<lpage>3872</lpage>
<pub-id pub-id-type="doi">10.1210/en.2016-1339</pub-id>
<pub-id pub-id-type="pmid">27571134</pub-id></element-citation>
</ref>
<ref id="B255-ijms-17-02086">
<label>255.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>T.</given-names></name><name><surname>Casanova</surname><given-names>R.</given-names></name><name><surname>Resnick</surname><given-names>S.M.</given-names></name><name><surname>Manson</surname><given-names>J.E.</given-names></name><name><surname>Baker</surname><given-names>L.D.</given-names></name><name><surname>Padual</surname><given-names>C.B.</given-names></name><name><surname>Kuller</surname><given-names>L.H.</given-names></name><name><surname>Bryan</surname><given-names>R.N.</given-names></name><name><surname>Espeland</surname><given-names>M.A.</given-names></name><name><surname>Davatzikos</surname><given-names>C.</given-names></name></person-group>
<article-title>Effects of hormone therapy on brain volumes changes of postmenopausal women revealed by optimally-discriminative voxel-based morphometry</article-title>
<source/>PLoS ONE
<year>2016</year>
<volume>11</volume>
<elocation-id>e0150834</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0150834</pub-id>
<pub-id pub-id-type="pmid">26974440</pub-id></element-citation>
</ref>
<ref id="B256-ijms-17-02086">
<label>256.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Henderson</surname><given-names>V.W.</given-names></name><name><surname>John</surname><given-names>J.A.</given-names></name><name><surname>Hodis</surname><given-names>H.N.</given-names></name><name><surname>McCleary</surname><given-names>C.A.</given-names></name><name><surname>Stanczyk</surname><given-names>F.Z.</given-names></name><name><surname>Shoupe</surname><given-names>D.</given-names></name><name><surname>Kono</surname><given-names>N.</given-names></name><name><surname>Dustin</surname><given-names>L.</given-names></name><name><surname>Allayee</surname><given-names>H.</given-names></name><name><surname>Mack</surname><given-names>W.J.</given-names></name></person-group>
<article-title>Cognitive effects of estradiol after menopause: A randomized trial of the timing hypothesis</article-title>
<source/>Neurology
<year>2016</year>
<volume>87</volume>
<fpage>699</fpage>
<lpage>708</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.0000000000002980</pub-id>
<pub-id pub-id-type="pmid">27421538</pub-id></element-citation>
</ref>
<ref id="B257-ijms-17-02086">
<label>257.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rosario</surname><given-names>E.R.</given-names></name><name><surname>Chang</surname><given-names>L.</given-names></name><name><surname>Head</surname><given-names>E.H.</given-names></name><name><surname>Stanczyk</surname><given-names>F.Z.</given-names></name><name><surname>Pike</surname><given-names>C.J.</given-names></name></person-group>
<article-title>Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer’s disease</article-title>
<source/>Neurobiol. Aging
<year>2011</year>
<volume>32</volume>
<fpage>604</fpage>
<lpage>613</lpage>
<pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2009.04.008</pub-id>
<pub-id pub-id-type="pmid">19428144</pub-id></element-citation>
</ref>
<ref id="B258-ijms-17-02086">
<label>258.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Foy</surname><given-names>M.R.</given-names></name><name><surname>Baudry</surname><given-names>M.</given-names></name><name><surname>Diaz Brinton</surname><given-names>R.</given-names></name><name><surname>Thompson</surname><given-names>R.F.</given-names></name></person-group>
<article-title>Estrogen and hippocampal plasticity in rodent models</article-title>
<source/>J. Alzheimers. Dis.
<year>2008</year>
<volume>15</volume>
<fpage>589</fpage>
<lpage>603</lpage>
<pub-id pub-id-type="pmid">19096158</pub-id></element-citation>
</ref>
<ref id="B259-ijms-17-02086">
<label>259.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Leuba</surname><given-names>G.</given-names></name><name><surname>Vernay</surname><given-names>A.</given-names></name><name><surname>Kraftsik</surname><given-names>R.</given-names></name><name><surname>Tardif</surname><given-names>E.</given-names></name><name><surname>Riederer</surname><given-names>B.M.</given-names></name><name><surname>Savioz</surname><given-names>A.</given-names></name></person-group>
<article-title>Pathological reorganization of NMDA receptors subunits and postsynaptic protein PSD-95 distribution in Alzheimer’s disease</article-title>
<source/>Curr. Alzheimer Res.
<year>2014</year>
<volume>11</volume>
<fpage>86</fpage>
<lpage>96</lpage>
<pub-id pub-id-type="doi">10.2174/15672050113106660170</pub-id>
<pub-id pub-id-type="pmid">24156266</pub-id></element-citation>
</ref>
<ref id="B260-ijms-17-02086">
<label>260.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stein</surname><given-names>J.L.</given-names></name><name><surname>Hua</surname><given-names>X.</given-names></name><name><surname>Morra</surname><given-names>J.H.</given-names></name><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>Hibar</surname><given-names>D.P.</given-names></name><name><surname>Ho</surname><given-names>A.J.</given-names></name><name><surname>Leow</surname><given-names>A.D.</given-names></name><name><surname>Toga</surname><given-names>A.W.</given-names></name><name><surname>Sul</surname><given-names>J.H.</given-names></name><name><surname>Kang</surname><given-names>H.M.</given-names></name><etal></etal></person-group>
<article-title>Genome-wide analysis reveals novel genes influencing temporal lobe structure with relevance to neurodegeneration in Alzheimer’s disease</article-title>
<source/>Neuroimage
<year>2010</year>
<volume>51</volume>
<fpage>542</fpage>
<lpage>554</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroimage.2010.02.068</pub-id>
<pub-id pub-id-type="pmid">20197096</pub-id></element-citation>
</ref>
<ref id="B261-ijms-17-02086">
<label>261.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jiang</surname><given-names>H.</given-names></name><name><surname>Jia</surname><given-names>J.</given-names></name></person-group>
<article-title>Association between NR2B subunit gene (GRIN2B) promoter polymorphisms and sporadic Alzheimer’s disease in the North Chinese population</article-title>
<source/>Neurosci. Lett.
<year>2009</year>
<volume>450</volume>
<fpage>356</fpage>
<lpage>360</lpage>
<pub-id pub-id-type="doi">10.1016/j.neulet.2008.10.075</pub-id>
<pub-id pub-id-type="pmid">18983893</pub-id></element-citation>
</ref>
<ref id="B262-ijms-17-02086">
<label>262.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Snyder</surname><given-names>E.M.</given-names></name><name><surname>Nong</surname><given-names>Y.</given-names></name><name><surname>Almeida</surname><given-names>C.G.</given-names></name><name><surname>Paul</surname><given-names>S.</given-names></name><name><surname>Moran</surname><given-names>T.</given-names></name><name><surname>Choi</surname><given-names>E.Y.</given-names></name><name><surname>Nairn</surname><given-names>A.C.</given-names></name><name><surname>Salter</surname><given-names>M.W.</given-names></name><name><surname>Lombroso</surname><given-names>P.J.</given-names></name><name><surname>Gouras</surname><given-names>G.K.</given-names></name><etal></etal></person-group>
<article-title>Regulation of NMDA receptor trafficking by amyloid-β</article-title>
<source/>Nat. Neurosci.
<year>2005</year>
<volume>8</volume>
<fpage>1051</fpage>
<lpage>1058</lpage>
<pub-id pub-id-type="doi">10.1038/nn1503</pub-id>
<pub-id pub-id-type="pmid">16025111</pub-id></element-citation>
</ref>
<ref id="B263-ijms-17-02086">
<label>263.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rice</surname><given-names>A.C.</given-names></name><name><surname>Keeney</surname><given-names>P.M.</given-names></name><name><surname>Algarzae</surname><given-names>N.K.</given-names></name><name><surname>Ladd</surname><given-names>A.C.</given-names></name><name><surname>Thomas</surname><given-names>R.R.</given-names></name><name><surname>Bennett</surname><given-names>J.P.</given-names><suffix>Jr.</suffix></name></person-group>
<article-title>Mitochondrial DNA copy numbers in pyramidal neurons are decreased and mitochondrial biogenesis transcriptome signaling is disrupted in Alzheimer’s Disease hippocampi</article-title>
<source/>J. Alzheimer’s Dis.
<year>2014</year>
<volume>40</volume>
<fpage>319</fpage>
<lpage>330</lpage>
<pub-id pub-id-type="pmid">24448779</pub-id></element-citation>
</ref>
<ref id="B264-ijms-17-02086">
<label>264.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Renbaum</surname><given-names>P.</given-names></name><name><surname>Beeri</surname><given-names>R.</given-names></name><name><surname>Gabai</surname><given-names>E.</given-names></name><name><surname>Amiel</surname><given-names>M.</given-names></name><name><surname>Gal</surname><given-names>M.</given-names></name><name><surname>Ehrengruber</surname><given-names>M.U.</given-names></name><name><surname>Levy-Lahad</surname><given-names>E.</given-names></name></person-group>
<article-title>Egr-1 upregulates the Alzheimer’s disease presenilin-2 gene in neuronal cells</article-title>
<source/>Gene
<year>2003</year>
<volume>318</volume>
<fpage>113</fpage>
<lpage>124</lpage>
<pub-id pub-id-type="doi">10.1016/S0378-1119(03)00766-2</pub-id>
<pub-id pub-id-type="pmid">14585504</pub-id></element-citation>
</ref>
<ref id="B265-ijms-17-02086">
<label>265.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hendrickx</surname><given-names>A.</given-names></name><name><surname>Pierrot</surname><given-names>N.</given-names></name><name><surname>Tasiaux</surname><given-names>B.</given-names></name><name><surname>Schakman</surname><given-names>O.</given-names></name><name><surname>Brion</surname><given-names>J.P.</given-names></name><name><surname>Kienlen-Campard</surname><given-names>P.</given-names></name><name><surname>De Smet</surname><given-names>C.</given-names></name><name><surname>Octave</surname><given-names>J.N.</given-names></name></person-group>
<article-title>Epigenetic induction of EGR-1 expression by the amyloid precursor protein during exposure to novelty</article-title>
<source/>PLoS ONE
<year>2013</year>
<volume>8</volume>
<fpage>1</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0074305</pub-id>
<pub-id pub-id-type="pmid">24066134</pub-id></element-citation>
</ref>
<ref id="B266-ijms-17-02086">
<label>266.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Atwood</surname><given-names>C.S.</given-names></name><name><surname>Bowen</surname><given-names>R.L.</given-names></name></person-group>
<article-title>A Unified hypothesis of early- and late-onset Alzheimer’s disease pathogenesis</article-title>
<source/>J. Alzheimer’s Dis.
<year>2015</year>
<volume>47</volume>
<fpage>33</fpage>
<lpage>47</lpage>
<pub-id pub-id-type="doi">10.3233/JAD-143210</pub-id>
<pub-id pub-id-type="pmid">26402752</pub-id></element-citation>
</ref>
<ref id="B267-ijms-17-02086">
<label>267.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cai</surname><given-names>Y.</given-names></name><name><surname>An</surname><given-names>S.S.A.</given-names></name><name><surname>Kim</surname><given-names>S.</given-names></name></person-group>
<article-title>Mutations in presenilin 2 and its implications in Alzheimer’s disease and other dementia-associated disorders</article-title>
<source/>Clin. Interv. Aging
<year>2015</year>
<volume>10</volume>
<fpage>1163</fpage>
<lpage>1172</lpage>
<pub-id pub-id-type="pmid">26203236</pub-id></element-citation>
</ref>
<ref id="B268-ijms-17-02086">
<label>268.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>H.</given-names></name><name><surname>Iqbal</surname><given-names>M.</given-names></name><name><surname>Zheng</surname><given-names>J.</given-names></name><name><surname>Wines-Samuelson</surname><given-names>M.</given-names></name><name><surname>Shen</surname><given-names>J.</given-names></name></person-group>
<article-title>Partial loss of presenilin impairs age-dependent neuronal survival in the cerebral cortex</article-title>
<source/>J. Neurosci.
<year>2014</year>
<volume>34</volume>
<fpage>15912</fpage>
<lpage>15922</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.3261-14.2014</pub-id>
<pub-id pub-id-type="pmid">25429133</pub-id></element-citation>
</ref>
<ref id="B269-ijms-17-02086">
<label>269.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Duplan</surname><given-names>E.</given-names></name><name><surname>Sevalle</surname><given-names>J.</given-names></name><name><surname>Viotti</surname><given-names>J.</given-names></name><name><surname>Goiran</surname><given-names>T.</given-names></name><name><surname>Bauer</surname><given-names>C.</given-names></name><name><surname>Renbaum</surname><given-names>P.</given-names></name><name><surname>Levy-Lahad</surname><given-names>E.</given-names></name><name><surname>Gautier</surname><given-names>C.A.</given-names></name><name><surname>Corti</surname><given-names>O.</given-names></name><name><surname>Leroudier</surname><given-names>N.</given-names></name><etal></etal></person-group>
<article-title>Parkin differently regulates presenilin-1 and presenilin-2 functions by direct control of their promoter transcription</article-title>
<source/>J. Mol. Cell Biol.
<year>2013</year>
<volume>5</volume>
<fpage>132</fpage>
<lpage>142</lpage>
<pub-id pub-id-type="doi">10.1093/jmcb/mjt003</pub-id>
<pub-id pub-id-type="pmid">23359614</pub-id></element-citation>
</ref>
<ref id="B270-ijms-17-02086">
<label>270.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shin</surname><given-names>J.H.</given-names></name><name><surname>Ko</surname><given-names>H.S.</given-names></name><name><surname>Kang</surname><given-names>H.</given-names></name><name><surname>Lee</surname><given-names>Y.</given-names></name><name><surname>Lee</surname><given-names>Y.I.L.</given-names></name><name><surname>Pletinkova</surname><given-names>O.</given-names></name><name><surname>Troconso</surname><given-names>J.C.</given-names></name><name><surname>Dawson</surname><given-names>V.L.</given-names></name><name><surname>Dawson</surname><given-names>T.M.</given-names></name></person-group>
<article-title>PARIS (ZNF746) repression of PGC-1α contributes to neurodegeneration in parkinson’s disease</article-title>
<source/>Cell
<year>2011</year>
<volume>144</volume>
<fpage>689</fpage>
<lpage>702</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2011.02.010</pub-id>
<pub-id pub-id-type="pmid">21376232</pub-id></element-citation>
</ref>
<ref id="B271-ijms-17-02086">
<label>271.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Charniak</surname><given-names>E.</given-names></name></person-group>
<article-title>Bayesian networks without tears</article-title>
<source/>AI Mag.
<year>1991</year>
<volume>12</volume>
<fpage>50</fpage>
<lpage>63</lpage>
</element-citation>
</ref>
<ref id="B272-ijms-17-02086">
<label>272.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hokama</surname><given-names>M.</given-names></name><name><surname>Oka</surname><given-names>S.</given-names></name><name><surname>Leon</surname><given-names>J.</given-names></name><name><surname>Ninomiya</surname><given-names>T.</given-names></name><name><surname>Honda</surname><given-names>H.</given-names></name><name><surname>Sasaki</surname><given-names>K.</given-names></name><name><surname>Iwaki</surname><given-names>T.</given-names></name><name><surname>Ohara</surname><given-names>T.</given-names></name><name><surname>Sasaki</surname><given-names>T.</given-names></name><name><surname>LaFerla</surname><given-names>F.M.</given-names></name><etal></etal></person-group>
<article-title>Altered expression of diabetes-related genes in Alzheimer’s disease brains: The Hisayama study</article-title>
<source/>Cereb. Cortex
<year>2014</year>
<volume>24</volume>
<fpage>2476</fpage>
<lpage>2488</lpage>
<pub-id pub-id-type="doi">10.1093/cercor/bht101</pub-id>
<pub-id pub-id-type="pmid">23595620</pub-id></element-citation>
</ref>
<ref id="B273-ijms-17-02086">
<label>273.</label>
<element-citation publication-type="confproc">
<person-group person-group-type="author"><name><surname>Silander</surname><given-names>T.</given-names></name><name><surname>Myllymaki</surname><given-names>P.</given-names></name></person-group>
<article-title>A simple approach for finding the globally optimal Bayesian network structure</article-title>
<source/>Proceedings of the Twenty-Second Conference on Uncertainty in Artificial Intelligence
<conf-loc>Cambridge, MA, USA</conf-loc>
<conf-date>13–16 July 2006</conf-date>
</element-citation>
</ref>
<ref id="B274-ijms-17-02086">
<label>274.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cheng</surname><given-names>A.</given-names></name><name><surname>Wan</surname><given-names>R.</given-names></name><name><surname>Yang</surname><given-names>J.L.</given-names></name><name><surname>Kamimura</surname><given-names>N.</given-names></name><name><surname>Son</surname><given-names>T.G.</given-names></name><name><surname>Ouyang</surname><given-names>X.</given-names></name><name><surname>Luo</surname><given-names>Y.</given-names></name><name><surname>Okun</surname><given-names>E.</given-names></name></person-group>
<article-title>Involvement of PGC-1α in the formation and maintenance of neuronal dendritic spines</article-title>
<source/>Nat. Commun.
<year>2012</year>
<volume>3</volume>
<fpage>1250</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms2238</pub-id>
<pub-id pub-id-type="pmid">23212379</pub-id></element-citation>
</ref>
<ref id="B275-ijms-17-02086">
<label>275.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kunkle</surname><given-names>B.W.</given-names></name><name><surname>Yoo</surname><given-names>C.</given-names></name><name><surname>Roy</surname><given-names>D.</given-names></name></person-group>
<article-title>Reverse engineering of modified genes by bayesian network analysis defines molecular determinants critical to the development of glioblastoma</article-title>
<source/>PLoS ONE
<year>2013</year>
<volume>8</volume>
<elocation-id>e64140</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0064140</pub-id>
<pub-id pub-id-type="pmid">23737970</pub-id></element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="ijms-17-02086-f001" position="float">
<label>Figure 1</label>
<caption>
<p>A schematic representation showing how circulatory (c) estrogen produced by ovary or testis, neural (n) estrogen (produced by aromatization of testosterone to 17 β estradiol (E2) by neuronal or glial aromatase in the brain) and estrogenic Endocrine Disruptors (EEDs) entering into the blood circulation from ingestion, inhalation or dermal exposure may interact in the brain and their impact on brain health. Neural estradiol and ovarian estradiol feedback remains to be ascertained.</p>
</caption>
<graphic xlink:href="ijms-17-02086-g001"></graphic>
</fig>
<fig id="ijms-17-02086-f002" position="float">
<label>Figure 2</label>
<caption>
<p>Possible mechanisms of estrogen or EED action. Genomic mechanism involves the nuclear form of estrogen receptors ER-α or ER-β which associates with either the estrogen response element (ERE) or Fos/Jun heterodimers that bind, in turn to activator protein-1 (AP-1) sites, whereas plasma membrane bound ER-mediated mechanisms include the activation of an ER linked to the phosphatidylinositol 3-kinase (PI3-K)/Akt, ERK1/2 mitogen-activated protein kinase (MAPK) pathways, protein kinase C (PKC), and cAMP/protein kinase A (PKA) converging with the genomic pathway. Actions of neurotrophins are influenced by estrogens or EEDs and vice versa. These pathways are also activated by reactive oxygen species (ROS). ROS mediated redox signaling leading to the activation of Akt/ERK/PKC pathways modulates nuclear transcription factors (e.g., ER, CREB, c-Fos/c-Jun, NRF1) binding to their DNA motifs in the regulatory regions in DNA sequences of genes associated with growth and survival of brain cells, neurogenesis and neuroplasticity, synaptogenesis and synaptic plasticity and cognitive function. Estrogenic effects mediated through these pathways are inhibited by antioxidants.</p>
</caption>
<graphic xlink:href="ijms-17-02086-g002"></graphic>
</fig>
<fig id="ijms-17-02086-f003" position="float">
<label>Figure 3</label>
<caption>
<p>A Venn diagram showing the individual pharmacological estrogen or estrogenic Endocrine Disruptor (EED) modified genes common to both NRF1 and/or estrogen signaling pathways. NRF1 target genes were mapped between 17-β estradiol (E2) and pharmacological estrogen-ethinyl estradiol or PCBs or BPA or phthalates or Cd or As or Mn.</p>
</caption>
<graphic xlink:href="ijms-17-02086-g003"></graphic>
</fig>
<fig id="ijms-17-02086-f004" position="float">
<label>Figure 4</label>
<caption>
<p>Gene set pathway enrichment analysis of 17-β estradiol (E2) responsive NRF1 target genes associated with Alzheimer’s Disease (AD). The network includes the top 30 E2 related genes in AD in gray. E2 responsive NRF1 genes are in black. Right panel show GO annotations of NRF1 enrichment network genes of E2 associated with biological process pathways involving multiple E2 and NRF1 genes and <italic>Q</italic>-value as a probability showing number of genes out of the total genes annotated to each GO term.</p>
</caption>
<graphic xlink:href="ijms-17-02086-g004"></graphic>
</fig>
<fig id="ijms-17-02086-f005" position="float">
<label>Figure 5</label>
<caption>
<p>Gene set pathway enrichment analysis of ethinyl estradiol responsive E2 and NRF1 common target genes associated with Alzheimer’s Disease (AD). The network includes the top 30 ethinyl estradiol-associated genes in AD in gray. Ethinyl estradiol responsive NRF1 genes are in black and * genes denoted by a diamond-shaped node are E2 and NRF1. Right panel show GO annotations of E2 and NRF1 enrichment network genes of ethinyl estradiol associated with biological process pathways involving multiple E2 and NRF1 genes and <italic>Q</italic>-value as a probability showing number of genes out of the total genes annotated to each GO term.</p>
</caption>
<graphic xlink:href="ijms-17-02086-g005"></graphic>
</fig>
<fig id="ijms-17-02086-f006" position="float">
<label>Figure 6</label>
<caption>
<p>Gene set pathway enrichment analysis of bisphenol-A (BPA) responsive R2 and NRF1common target genes associated with Alzheimer’s Disease (AD). The network includes the top 30 BPA-related genes in AD in gray. Bisphenol-A responsive NRF1 genes are in black. Genes denoted by a diamond-shaped node and * are E2 and NRF1 responsive. Right panel show GO annotations of E2 and NRF1 enrichment network genes of BPA associated with biological process pathways involving multiple E2 and NRF1 genes and <italic>Q</italic>-value as a probability showing number of genes out of the total genes annotated to each GO term.</p>
</caption>
<graphic xlink:href="ijms-17-02086-g006"></graphic>
</fig>
<fig id="ijms-17-02086-f007" position="float">
<label>Figure 7</label>
<caption>
<p>Gene set pathway enrichment analysis of dibutyl phthalate modified E2 and NRF1 common target genes associated with Alzheimer’s Disease (AD). The network includes the top 30 dibutyl phthalate related genes in AD in gray. Dibutyl phthalate responsive NRF1 genes are in black. Genes denoted by a diamond-shaped node and * are E2 and NRF1 responsive. Right panel show GO annotations of E2 and NRF1 enrichment network genes of dibutyl phthalate associated with biological process pathways involving multiple E2 and NRF1 genes and <italic>Q</italic>-value as a probability showing number of genes out of the total genes annotated to each GO term.</p>
</caption>
<graphic xlink:href="ijms-17-02086-g007"></graphic>
</fig>
<fig id="ijms-17-02086-f008" position="float">
<label>Figure 8</label>
<caption>
<p>Gene set pathway enrichment analysis of diethylhexyl phthalate responsive E2 and NRF1 common target genes associated with Alzheimer’s Disease (AD). The network includes the top 30 diethylhexyl phthalate related genes in AD in gray. Diethylhexyl phthalate responsive NRF1 genes are in black. Genes denoted by a diamond-shaped node and * are E2 and NRF1 responsive. Right panel show GO annotations of E2 and NRF1 enrichment network genes of diethylhexyl phthalate associated with biological process pathways involving multiple E2 and NRF1 genes and <italic>Q</italic>-value as a probability showing number of genes out of the total genes annotated to each GO term.</p>
</caption>
<graphic xlink:href="ijms-17-02086-g008"></graphic>
</fig>
<fig id="ijms-17-02086-f009" position="float">
<label>Figure 9</label>
<caption>
<p>Gene set pathway enrichment analysis of cadmium responsive E2 and NRF1 common target genes associated with Alzheimer’s Disease (AD). The network includes the top 30 Cd related genes in AD in gray. Cadmium responsive NRF1 genes are in black. Genes denoted by a diamond-shaped node and * are E2 and NRF1 responsive. The network includes the top 30 related genes in gray. Right panel show GO annotations of E2 and NRF1 enrichment network genes of cadmium associated with biological process pathways involving multiple E2 and NRF1 genes and <italic>Q</italic>-value as a probability showing number of genes out of the total genes annotated to each GO term.</p>
</caption>
<graphic xlink:href="ijms-17-02086-g009"></graphic>
</fig>
<fig id="ijms-17-02086-f010" position="float">
<label>Figure 10</label>
<caption>
<p>Gene set pathway enrichment analysis of arsenic responsive E2 and NRF1 common target genes associated with Alzheimer’s Disease (AD). The network includes the top 30 arsenic related genes in AD in gray. Arsenic responsive NRF1 genes are in black. Genes denoted by a diamond-shaped node and * are E2 and NRF1 responsive. Right panel show GO annotations of E2 and NRF1 enrichment network genes of arsenic associated with biological process pathways involving multiple E2 and NRF1 genes and <italic>Q</italic>-value as a probability showing number of genes out of the total genes annotated to each GO term.</p>
</caption>
<graphic xlink:href="ijms-17-02086-g010"></graphic>
</fig>
<fig id="ijms-17-02086-f011" position="float">
<label>Figure 11</label>
<caption>
<p>Gender differences in NRF1 network in AD of brain microarray data of 79 subjects of male (15 AD patients, 17 control) and female (17 AD patients, 30 controls) from GEO database [<xref ref-type="bibr" rid="B272-ijms-17-02086">272</xref>].</p>
</caption>
<graphic xlink:href="ijms-17-02086-g011"></graphic>
</fig>
<fig id="ijms-17-02086-f012" position="float">
<label>Figure 12</label>
<caption>
<p>Bene network showing gender and NRF1 association with AD in hippocampal microarray [<xref ref-type="bibr" rid="B272-ijms-17-02086">272</xref>].</p>
</caption>
<graphic xlink:href="ijms-17-02086-g012"></graphic>
</fig>
<fig id="ijms-17-02086-f013" position="float">
<label>Figure 13</label>
<caption>
<p>Causal network analysis of gender and NRF1 association with AD in hippocampal microarray [<xref ref-type="bibr" rid="B272-ijms-17-02086">272</xref>].</p>
</caption>
<graphic xlink:href="ijms-17-02086-g013"></graphic>
</fig>
<fig id="ijms-17-02086-f014" position="float">
<label>Figure 14</label>
<caption>
<p>NRF1 regulating targets genes with diverse functions. NRF1 is depicted to recognize the palindromic sequence defined as YGCGCAYGCGCR, where Y and R indicate a pyrimidine or purine nucleotide, respectively, to recruit factors for the transcription of target genes, which are involved in many cellular processes.</p>
</caption>
<graphic xlink:href="ijms-17-02086-g014"></graphic>
</fig>
<table-wrap id="ijms-17-02086-t001" position="float">
<object-id pub-id-type="pii">ijms-17-02086-t001_Table 1</object-id>
<label>Table 1</label>
<caption>
<p>Epidemiological studies summarizing association between endogenous estrogen, hormonal replacement therapy, phthalates, polychlorinated biphenyls, cadmium, arsenic and manganese and neurodegenerative diseases—Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), and dementia.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Study Reference</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">EDC</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Year</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Epidemiological Study Type</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Effect on Brain</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Brain Disease</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Manly et al., 2000</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Endogenous estrogen</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2000</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Case-control</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Lower estradiol levels in women associated with greater risk of AD.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">AD</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Geerlings et al., 2001</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Endogenous estrogen</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2001</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Prospective cohort</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Longer exposure to endogenous estrogen associated with AD and dementia.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Dementia and AD</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Schupf et al., 2006</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Endogenous estrogen</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2006</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Prospective-cohort</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Women with low bioavailable estrogen were more likely to develop AD.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">AD</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">De Jong et al., 2012</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Endogenous estrogen</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2012</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Case-Control</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Longer reproductive time-span and exposure to endogenous estrogen decreases ALS risk.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">ALS</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Fox et al., 2013</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Endogenous estrogen</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2013</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Retrospective cohort study</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Longer duration of endogenous estrogen exposure may have a protective effect against AD risk.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">AD</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cereda et al., 2013</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Endogenous estrogen</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2013</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cross-sectional</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Age of PD onset was positively associated with duration of exposure to endogenous estrogens.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">PD</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Shumaker et al., 2003</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Hormonal replacement therapy</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2003</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Clinical trial</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Estrogen progestin HRT increased risk for dementia and did not prevent cognitive impairment.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Dementia</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Shumaker et al., 2004</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Hormonal replacement therapy</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2004</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Clinical trial</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Estrogen only HRT increased risk of dementia and cognitive impairment.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Dementia</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Shao et al., 2012</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Hormonal replacement therapy</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2012</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cohort study</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Increased Alzheimer’s disease risk amongst women who used HRT more than five years after menopause, but observed a decreased risk of AD if used within five years of menopause.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">AD</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Lundin et al., 2014</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Hormonal replacement therapy</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2014</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cohort study</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Increased in PD risk observed depending on type of hormonal therapy.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">PD</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Weisskopf et al., 2012</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Polychlorinated biphenyls</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2012</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Nested case-control</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">PCB exposure not associated with PD development.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">PD</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Steenland et al., 2006</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Polychlorinated biphenyls</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2006</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Retrospective mortality study</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">In PCB exposed plant workers, higher death rates from PD were observed in women.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">PD</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Hatcher-Martin et al., 2012</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Polychlorinated biphenyls</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2012</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Case-control</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">In post-mortem brain tissue from PD, AD, and controls, PCB levels were higher in PD brain tissue.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">PD</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Roos et al., 2013</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cadmium</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2013</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cross-sectional</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Elevated heavy metals, including cadmium, were higher in ALS patients.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">ALS</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Komatsu et al., 2011</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cadmium</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2011</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Case-control</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Elevated cadmium hair levels were associated with Parkinson-like symptoms.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">PD</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Park et al., 2014</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Arsenic</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2014</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cross-sectional</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">No difference in serum arsenic levels in AD patients and controls.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">AD</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Hozumi et al., 2011</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Manganese</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2011</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cross-sectional</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Higher levels of manganese found among PD patients.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">PD</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Koc et al., 2015</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Manganese</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2015</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cross-sectional</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Higher manganese levels found in hair samples of AD patients compared to controls.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">AD</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Miyake et al., 2011</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Manganese</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2011</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Case-control</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">In PD patients, no association found with increased manganese intake.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">PD</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Roos et al., 2013</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Manganese</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2013</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Case-control</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Elevated manganese levels observed in ALS patients.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">ALS</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Kumudini et al., 2014</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Manganese</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2014</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Case-control</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">No association between blood manganese levels in PD patients’ vs. controls.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">PD</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Garzillo et al., 2014</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Manganese</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2014</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Case-control</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">No association between blood manganese levels in ALS patients’ vs. controls.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">ALS</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Kihira et al., 2015</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Manganese</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2015</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Case-control</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Elevated manganese levels in hair observed in ALS patients’ vs. controls.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">ALS</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Arain et al., 2015</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Manganese</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2015</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Case-control</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Higher levels of manganese and aluminum in those suffering from neurodegenerative disease.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Neurodegenerative disease.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Baker et al., 2015</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Manganese</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2015</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Prospective cohort</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Low level manganese exposure causes sub-clinical brain changes before symptoms occur.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Neurodegenerative disease</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="ijms-17-02086-t002" position="float">
<object-id pub-id-type="pii">ijms-17-02086-t002_Table 2</object-id>
<label>Table 2</label>
<caption>
<p>Epidemiological studies summarizing association between endogenous estrogen, hormonal replacement therapy, bisphenol-A, and phthalates and memory performance, child behavior, and IQ.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Study Reference</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">EDC</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Year</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Epidemiological Study Type</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Study Population</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Measurement of Exposure</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Outcome</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Results</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Confounders</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Comments</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Brain Health Indicator</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Barret-Connor and Goodman-Gruen, 1999</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Endogenous estrogen</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">1999</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cross-sectional</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">393 females (ages 55 to 89).</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Serum estradiol and estrone levels. Bioavailable and total.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Partial correlation (<italic>p</italic>-value) and Linear Regression (β, <italic>p</italic>-value).</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">No associations between neuropsychological tests and endogenous estrogen exposure.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Smoking status, alcohol use, body mass index, mood, age, education.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Does not account for past exogenous estrogen use, only present use.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Memory performance</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Low et al., 2005</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Endogenous estrogen</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2005</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cross-sectional</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">760 women (ages 60–64).</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Reproductive time period as a surrogate of endogenous estrogen exposure.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Linear regression (β, <italic>p</italic>-value).</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">No significant associations found between performance on cognitive and memory tests and endogenous estrogen exposure.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Age, education, verbal intelligence, health and mood variables, lifestyle variables, reproductive variables.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Study accounts for exogenous estrogen use.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Memory performance</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Heys et al., 2011</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Endogenous estrogen</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2011</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cross-sectional</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">11094 women (age &gt; 50 years).</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Proxies of endogenous estrogen exposure.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Multivariate Linear regression (<italic>p</italic>-value, 95% CI).</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Longer reproductive period associated with higher cognitive delayed recall scores (<italic>p</italic>-value = 0.001; 95% CI, 0.008–0.02) and mini-mental state exam sores (<italic>p</italic>-value &lt; 0.001; 95% CI, 0.04–0.07.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Age, education, childhood and adulthood socio-economic position and physical activity.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Accounts for exogenous estrogen use.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Memory performance</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Zimmerman et al., 2011</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Endogenous estrogen</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2011</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cross-sectional</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">181 men (mean age = 81 years).</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Estradiol and testosterone levels.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Linear Regression (β, <italic>p</italic>-value).</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Men with higher levels of total estradiol performed better on verbal memory assessments (β = 0.17, <italic>p</italic>-value &lt; 0.02), compared to men with lower levels of total estradiol.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Age, education, body mass index, and cardiovascular comorbidities.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Accounts for exogenous estrogen use.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Memory performance</td>
</tr>
<tr>
<td align="center" colspan="11" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>Oral Contraceptives and Memory Performance</bold>
</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Beltz et al., 2015</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Ethinyl estradiol</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2015</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cross-sectional</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">136 men, 93 normally cycling women, 148 OC users. 18–30 years of age.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">History of OC use.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Hierarchal Regression.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Ethinyl estradiol was found to affect memory, but only amongst homogenous groups of OC users.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Age and vocabulary.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Study does not account for endogenous estrogen exposure.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Memory Performance</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Egan and Gleason, 2012</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Ethinyl estradiol</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2012</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cross-sectional</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">261 cognitively normal women, 40–65 years of age.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">History of OC use.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">MANCOVA (<italic>u</italic>, CI, <italic>p</italic>-value).</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">OC users performed better on Visuo-spatial ability (<italic>u</italic> = 0.75, CI 0.23–1.28, <italic>p</italic> = 0.005) and speed and flexibility (<italic>u</italic> = 0.52, CI 0.16–1.04, <italic>p</italic> = 0.007).</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Age, years of education, socioeconomic status.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Study compares OC users to non-users.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Memory Performance</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Griksiene and Ruksenas, 2011</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Ethinyl estradiol</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2011</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cross-sectional</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">43 females, 23 OC users, 20 non-users, ages 19 to 24 years of age.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Salivary 17- β estradiol and progesterone levels.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">ANOVA.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">OC use negatively affects verbal and spatial abilities.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Not stated.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Does not differentiate between the type of OC.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Memory Performance</td>
</tr>
<tr>
<td align="center" colspan="11" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>Hormone Replacement Therapy and Memory Performance</bold>
</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Resnick et al., 2006</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Hormonal replacement therapy</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2006</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Randomized, double-blind, placebo–controlled clinical trial</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">1416 postmenopausal women, 65 years of age and older.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Estrogen + Progestin (CEE + MPA) or Placebo.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Change is cognitive function and affect. Generalized Linear Models (<italic>p</italic>-value).</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">CEE + MPA had a negative effect on verbal memory (<italic>p</italic> &lt; 0.01) and positive effect on figural memory (<italic>p</italic> = 0.012) compared to placebo. No significant influence on positive affect, negative affect, or depressive symptoms.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Age, time at enrollment, education, race, BMI, smoking status, alcoholic drinks/week, history of cardiovascular disease, hypertension, diabetes, prior HT use.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Beneficial and detrimental effects observed.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Memory Performance</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Resnick et al., 2009</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Hormonal replacement therapy</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2009</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Randomized, double-blind, placebo-controlled clinical trial</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">866 postmenopausal women with prior hysterectomy, 65 years of age and older, free of probable dementia.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.625 mg of CEE daily or placebo.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Annual rates of change in specific cognitive functions and affects. Linear Mixed Models (<italic>p</italic>-value).</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Compared with placebo, CEE treatment was associated with lower spatial rotational ability (<italic>p</italic> &lt; 0.01) which diminished over time. CEE did not affect other cognitive functions and affects.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Age, time at enrollment, education, race, BMI, smoking status, alcoholic drinks/week, history of cardiovascular disease, hypertension, diabetes, prior HT use.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">No improvements in memory over time.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Memory performance</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Almeida et al., 2006</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Hormonal replacement therapy.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2006</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Randomized, double-blind, placebo-controlled trial</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">115 Postmenopausal women, 65 years of age and older.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2 mg estradiol or placebo.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Changes in cognitive function and affect.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Higher dosages of estradiol containing HRT treatment did not improve cognitive function.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Age, marital status, education, previous HRT use, daily living, age at menarche, age at menopause, cognitive factors and complaints, plasma estradiol and homocysteine levels.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">No significant improvements in memory.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Memory performance.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Pefanco et al., 2007</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Hormonal replacement therapy</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2007</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Randomized, placebo-controlled trial</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">57 postmenopausal women, 65 years of age and older.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.20 mg of micronized 17-β estradiol or placebo.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Neuropsychological measures of memory, language, mood, and executive function Repeated Measures Analysis (<italic>p</italic>-value).</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">No differences were found between ET and placebo on any of the neurocognitive measures or depression instruments, nor were there any differences when the groups were stratified according to age.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Age, education, income, daily living, estradiol levels, estrone levels, hysterectomy.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">No significant improvements in memory.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Memory performance.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Viscoli et al., 2005</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Hormone replacement therapy.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2005</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Randomized, double-blind trial.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">644 postmenopausal women.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">1 mg of 17-β estradiol or placebo.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Results of MMSE and domain measures. Generalized Linear Models (<italic>p</italic>-values).</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Estrogen therapy did not have a significant effect on cognitive measures over time.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Age, race, education level, chronic diseases, prior estrogen therapy use, hysterectomy, depression, stroke.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">No significant improvement in memory.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Memory performance.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Yaffe et al., 2006</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Hormone replacement therapy.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2006</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Randomized, placebo-controlled, double-blind trial</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">417 postmenopausal women, 60 to 80 years of age.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Weekly transdermal patch of 0.014 mg/day estradiol or placebo.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Results of global cognitive function, verbal and visuospatial memory, language, executive function, and semantic memory. Linear mixed models (<italic>p</italic>-value).</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Estrogen therapy did not have a significant effect on cognitive measures over time.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Age, education level, race, BMI, smoking status, depression status, presence of hot flashes, current estradiol level.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">No significant improvement in memory.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Memory performance.</td>
</tr>
<tr>
<td align="center" colspan="11" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>Bisphenol A, Maternal Exposure, and Child Behavior</bold>
</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Harley et al., 2013</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Bisphenol-A</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2013</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Prospective Cohort Study</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">592 mothers and their children, followed prenatally up to 9 years of age.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Urinary BPA concentrations (µg/L). Child and maternal exposure.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Child behavior assessment results. Multivariable linear regression (β, 95% CI).</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Prenatal urinary BPA concentrations were associated with increased internalizing problems in boys at age 7 (β = 1.8, 95% CI: 0.3–3.3). Childhood urinary exposure was associated with increased externalizing behavior in girls at age 7 (β = 1.2, 95% CI: 0.3–2.1 and β = 1.0, 95% CI: 0.1–2.0) and increased inattention and hyperactivity behaviors in both boys and girls at age 7.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Maternal age, race/ethnicity, education level, marital status, country of birth, years of US residency, number siblings, family income, maternal depression, pesticide metabolites.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Behavioral results from both teacher and mother reported.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Behavior</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Braun et al., 2009</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Bisphenol-A</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2009</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Prospective Cohort Study</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">249 mothers and their children followed prenatally up to 2 years of age.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Urinary BPA concentrations (µg/L). Child and maternal exposure.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Child behavior assessment. Multivariable linear regression (β, 95% CI).</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Prenatal BPA concentrations associated with externalizing scores among females (β = 6.0, 95% CI 0.1–12.0). BPA concentrations at 16 weeks associated with externalizing behavior among all children (β = 2.9, 95% CI 0.2–5.7).</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Maternal age, race, education, marital status, SES, maternal depression.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Female appear to be more affected.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Behavior</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Yolton et al., 2011</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Bisphenol-A</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2011</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Prospective Cohort Study</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">350 mothers and their children up to 5 weeks.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Urinary BPA concentrations (ng/mL).</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Neurobehavioral outcomes. Multivariable linear regression (<italic>p</italic>-value).</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">No significant associations between gestational exposure to BPA and infant neurobehavior. Higher BPA exposure associated with greater hypotonia at 26 weeks (<italic>p</italic>-value = 0.09).</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Maternal race, household income, marital status, maternal depression, maternal BMI, maternal cotinine levels, infant weight, NICU stay after birth.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Phthalates also measured.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Behavior</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Roen et al., 2015</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Bisphenol-A</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2015</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Prospective Cohort Study</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">250 mothers and their children followed prenatally up to 7–9 years of age.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Urinary BPA concentrations (µg/L).</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Neurobehavioral outcomes. Poisson Regression (β, <italic>p</italic>-value).</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Among boys, high prenatal BPA concentrations was associated with increase internalizing (β = 0.41, <italic>p</italic> &lt; 0.0001) and externalizing scores (β = 0.40, <italic>p</italic> &lt; 0.0001). High postnatal BPA concentrations was associated with increased internalizing (β = 0.30, <italic>p</italic> = 0.0002) and externalizing scores (β = 0.33, <italic>p</italic> &lt; 0.0001).</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Prenatal and postnatal BPA concentration, child age, ethnicity, gestational age, maternal intelligence, maternal education, demoralization, tobacco smoke exposure, and phthalate exposure.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Possible sex specific and timing of exposure mechanism.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Behavior</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Braun et al., 2011</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Bisphenol-A</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2011</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Prospective Cohort Study</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">244 mothers and their children followed from gestation up to 3 years of age.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Urinary BPA concentrations (µg/L).</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Neurobehavioral outcomes. Multivariate linear regression (β, 95% CI).</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">BPA detected in &gt;97% of gestational and childhood samples. Each 10-fold increase in gestational BPA concentrations was associated with more anxious and depressed behavior. The effects were more pronounced in boys.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Mother’s race, education, marital status, household income, maternal depressive behavior, phthalate exposure, tobacco smoke.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Childhood exposure was not significantly associated with behavioral modifications.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Behavior</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Miodovnik et al., 2011</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Bisphenol-A</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2011</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Prospective Cohort Study</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">404 mothers and their children followed from gestation up to 9 years of age.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Urinary BPA concentrations (µg/L).</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Neurobehavioral outcomes. General linear models (β, 95% CI).</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">No associations found with BPA and outcomes.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Maternal age, maternal IQ, marital status, maternal education, child race, sex, child IQ, age at exam, urinary creatinine.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Significant associations found with phthalate exposure.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Behavior</td>
</tr>
<tr>
<td align="center" colspan="11" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>Phthalates, Behavioral Disorders, and IQ</bold>
</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Yolton et al., 2011</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Phthalates</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2011</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Prospective Cohort Study</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">350 mothers and their children up to 5 weeks.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Urinary phthalate concentrations (ng/mL).</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Neurobehavioral outcomes. Multivariable linear regression (<italic>p</italic>-value).</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Prenatal exposure to dibutyl phthalate was associated with improved behavioral organization in 5 week old infants characterized by decreased arousal (<italic>p</italic> = 0.04), increased self-regulation (<italic>p</italic> = 0.052), and decreased handling (<italic>p</italic> = 0.02). Prenatal exposure to diethylhexyl phthalate at 26 weeks was associated with nonoptimal reflexes (<italic>p</italic> = 0.02) in male infants.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Maternal race, household income, marital status, maternal depression, maternal BMI, maternal cotinine levels, infant weight, NICU stay after birth.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Results are inconsistent between phthalate types.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Behavior</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Miodovnik et al., 2011</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Phthalates</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2011</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Prospective Cohort Study</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">404 mothers and their children followed from gestation up to 9 years of age.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Urinary phthalate concentrations (µg/L).</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Neurobehavioral outcomes. General linear models (β, 95% CI).</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Increased phthalate exposure associated with greater social deficits (β = 1.52, 95% CI: 0.25–2.8).</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Maternal age, maternal IQ, marital status, maternal education, child race, sex, child IQ, age at exam, urinary creatinine.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Significant associations found with phthalate exposure.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Behavior</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Factor-Litvak et al., 2014</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Phthalates</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2014</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Prospective Cohort Study</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">328 inner-city mothers and their children followed up to 7 years of age.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Urinary phthalate concentrations (ng/mL).</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">IQ test results. Linear regression models (β, 95% CI).</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Prenatal metabolite concentrations of DnBP and DiBP inversely associated with IQ (β = −2.69, 95% CI −4.33, −1.05). Inverse associations seen between IQ, cognitive function, and maternal prenatal metabolite concentrations.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Race, maternal education, marital status, income, parity, gestational age, birth weight, child sex, breastfeeding history, tobacco smoke exposure, prenatal alcohol, hardships during pregnancy, maternal depression.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Phthalate-specific effects were observed.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Child IQ and cognitive function.</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="ijms-17-02086-t003" position="float">
<object-id pub-id-type="pii">ijms-17-02086-t003_Table 3</object-id>
<label>Table 3</label>
<caption>
<p>Experimental animal studies showing association between Bisphenol-A, phthalates, polychlorinated biphenyls and neurotoxicity.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Reference</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">EDC</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Study Type</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Effects on Brain Health</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">Bowman et al., 2015</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">Bisphenol-A</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">Adolescent male and female adolescent rats</td>
<td align="left" colspan="1" rowspan="1" valign="middle">In male rats: Decrease in non-spatial memory and object recognition.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">In both sexes: Decreased spine density on apical and basal dendrites on pyramidal cells in CA1 of the hippocampus.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="3" style="border-bottom:solid thin" valign="middle">Eilam-Stock et al., 2012</td>
<td align="center" colspan="1" rowspan="3" style="border-bottom:solid thin" valign="middle">Bisphenol-A</td>
<td align="center" colspan="1" rowspan="3" style="border-bottom:solid thin" valign="middle">Adult male rats</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Significantly impaired visual and spatial memory.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Decreased spine density on pyramidal cells in the CA1 and mPFC.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Decrease expression of PSD-95, increased expression of pCREB.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">Elsworth et al., 2015</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">Bisphenol-A</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">Adult male vervet monkeys</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Decreased working memory and accuracy.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Decreased excitatory synaptic outputs on dendritic spines of pyramidal neurons in pfc and hippocampus.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">Inagaki et al., 2012</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">Bisphenol-A</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">Ovariectomized female rats</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Exposure to BPA alters E-induced enhancements of spatial and nonspatial memory.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">In the hippocampus, BPA blocked E2 induced increases in basal spine density.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="4" style="border-bottom:solid thin" valign="middle">Wang et al., 2014</td>
<td align="center" colspan="1" rowspan="4" style="border-bottom:solid thin" valign="middle">Bisphenol-A</td>
<td align="center" colspan="1" rowspan="4" style="border-bottom:solid thin" valign="middle">Postnatal male rats born from BPA exposed female rats</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Maternal exposure affected locomotor activity, exploratory habits, emotional behavior.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Increase reference and working memory errors.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Decreased mRNA and protein expression of synaptophysin, PSD-95, spinophilin, GluR1, and NMDAR1 in hippocampus.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Adverse effects on synaptic structure.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="3" style="border-bottom:solid thin" valign="middle">Xu et al., 2013</td>
<td align="center" colspan="1" rowspan="3" style="border-bottom:solid thin" valign="middle">Bisphenol-A</td>
<td align="center" colspan="1" rowspan="3" style="border-bottom:solid thin" valign="middle">Male and female adult mice</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Sex-specific effects of BPA exposure on spatial and passive avoidance memory.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Reduced synaptic density and adversely affected structure of synaptic interface.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">In hippocampus, down-regulation of snynapsin I, PSD-95, NDMA receptor subunit NR1 and AMPA receptor subunit GluR1 in male mice.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="4" style="border-bottom:solid thin" valign="middle">Jang et al., 2012</td>
<td align="center" colspan="1" rowspan="4" style="border-bottom:solid thin" valign="middle">Bisphenol-A</td>
<td align="center" colspan="1" rowspan="4" style="border-bottom:solid thin" valign="middle">Postnatal female rats born from BPA expose female rats</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Decrease in newly generated cells in the hippocampus.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Negatively affected memory attention.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Lower levels of phospho-ERK, BDNF, phosphor-CREB in hippocampus.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Increased DNA methylation of Crtc1.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">Kim et al., 2011</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">Bisphenol-A</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">Young adult mice</td>
<td align="left" colspan="1" rowspan="1" valign="middle">High dose BPA exposure decreased the number of newly generated cells in the hippocampus, while low dose exposure had the opposite effect.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">High dose BPA exposure was shown to impair learning and memory performance significantly.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="3" style="border-bottom:solid thin" valign="middle">Diaz Weinstein et al., 2013</td>
<td align="center" colspan="1" rowspan="3" style="border-bottom:solid thin" valign="middle">Bisphenol-A</td>
<td align="center" colspan="1" rowspan="3" style="border-bottom:solid thin" valign="middle">Adolescent male and female rats</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Decreased spatial memory.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Adverse locomotor activity.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Increased anxiety.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">Elsworth et al., 2015</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">Bisphenol-A</td>
<td align="center" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="middle">Pregnant female rhesus monkeys</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Abnormal fetal brain development.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Fetuses of female monkeys showed a decrease in midbrain dopamine neurons and a reduction in spine synapses in the CA1 region of the hippocampus.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Johnson et al., 2015</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Bisphenol-A</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Pregnant female rats and offspring</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">In the offspring: Developmental exposure disrupted navigational learning and navigational memory.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="3" style="border-bottom:solid thin" valign="middle">Kumar and Kumar Thakur 2014</td>
<td align="center" colspan="1" rowspan="3" style="border-bottom:solid thin" valign="middle">Bisphenol-A</td>
<td align="center" colspan="1" rowspan="3" style="border-bottom:solid thin" valign="middle">Pregnant female mice and male offspring</td>
<td align="left" colspan="1" rowspan="1" valign="middle">In the offspring: Impaired spatial memory.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Increased dendritic spine density in the cerebral cortex and hippocampus.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Upregulation of synaptic proteins Nrxn1 and Nlgn3.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="3" style="border-bottom:solid thin" valign="middle">Matsuda et al., 2013</td>
<td align="center" colspan="1" rowspan="3" style="border-bottom:solid thin" valign="middle">Bisphenol-A</td>
<td align="center" colspan="1" rowspan="3" style="border-bottom:solid thin" valign="middle">Pregnant female mice and offspring</td>
<td align="left" colspan="1" rowspan="1" valign="middle">In the offspring: Enhanced fear memory.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Increased serotonin metabolites.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Increased expression of Tph2, Slc6a4, and Maoa.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Xu et al., 2014</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Bisphenol-A</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Pregnant female rats and offspring</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">In the offspring: Interference with estrogen receptor signaling in the developing hippocampus.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Zhang et al., 2014</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Bisphenol-A</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Adult male mice</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Enhanced the acquisition and retention of fear memory by the increased levels of histone acetylation, NMDA receptor, and phosphorylation of the ERK1/2 in the hippocampus of male mice.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Stump et al., 2010</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Bisphenol-A</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Pregnant female rats and offspring</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">No adverse effects reported.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Ishido et al., 2011</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Bisphenol-A</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Postnatal male mice</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Apparent hyperactivity observed.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Viberg et al., 2011</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Bisphenol-A</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Postnatal mice</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Alterations in spontaneous behavior and cognitive function observed.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Kimura et al., 2015</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Bisphenol-A</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Prenatal mice</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">In utero exposure to BPA reduced spine densities in the hippocampal CA1 region of the brain in prenatal mice.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Kim et al., 2009</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Bisphenol-A</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Neonatal and postnatal mice</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Stimulation of neuronal differentiation and possible disruption of neonatal brain development observed.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Dai et al., 2015</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Phthalates</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Young mice</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Negatively affected locomotion activity and memory.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Betz et al., 2013</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Phthalates</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Young mice</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Negatively affects learning and social behavior.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Li et al., 2013</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Phthalates</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Young mice</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Induced apoptotic cell death, synaptic loss, and synaptic dysfunction.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Elnar et al., 2015</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Phthalates</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Young mice</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Early exposure to PCBs induced neuronal susceptibility to amyloid stress. Lower expression of synaptic proteins.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Reilly et al., 2015</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">PCBs</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Young mice</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Negatively affects social behavior.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Zahara et al., 2015</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">PCBs</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Juvenile Avians</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Reduction in learning ability.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Hilgier et al., 2012</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">PCBs</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Adult Rats</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Exposure resulted in neuronal injury and loss.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Lee et al., 2012</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">PCBs</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Adult mice</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Exposure resulted in hyperactivity and dopaminergic neuron degeneration.</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="ijms-17-02086-t004" position="float">
<object-id pub-id-type="pii">ijms-17-02086-t004_Table 4</object-id>
<label>Table 4</label>
<caption>
<p>Top 10 enriched pathways for E2 and NRF1-Target genes associated with estrogenic endocrine disruptors—BPA, PCB, phthalates, As, Cd, and Mn.</p>
</caption>
<table frame="hsides" rules="groups">
<tbody>
<tr>
<td align="center" colspan="3" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">
<bold>17 β-Estradiol (E2) Interacting NRF1 Target Genes</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>KEGG Pathway</bold>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>Number of Genes</bold>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>Annotated Genes</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Disease</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">86</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ADCY9|AKT2|ALDOA|AP1S1|CCNT2|CDC42|CDK1|CDKN2B|CHMP2A|CHMP2B|CHMP5|CREB1|CSK|CSNK1A1|CTBP1|CYB5A|ENO1|EPS15L1|ERCC2|EXT2|FASN|FZD4|GLB1|GTF2E2|HDAC2|HDAC3|HDAC4|HMMR|HRAS|HSP90AA1|IRS1|MAP2K7|MKNK1|MMADHC|MTHFD1|NAMPT|NPM1|NUP107|NUP50|OS9|P4HB|PAPSS1|PFKFB4|PIP5K1B|PLCG1|POLR2A|POM121|PPIA|PRKAR2A|PSENEN|PYGL|RAC1|RAE1|RAF1|RAN|RBX1|RHOA|RPL10|RPL13A|RPL14|RPL36|RPS13|RPS16|RPS21|RPS29|RPS9|SHC1|SLC25A10|SLC37A4|SMARCA4|SNW1|SOS1|SRC|STUB1|STX1A|TAF12|TAF5|TCEB2|TGIF1|TNKS2|TPR|UBA52|WNT5A|XRCC5|XRCC6|YWHAZ</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Metabolism</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">86</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ACADM|ADCY9|ADI1|AGPAT5|AKR7A2|ALAS1|ALDOA|AMACR|ATP5O|AUH|BCAT1|BCAT2|BSG|CBR1|COX5B|COX6C|CTPS1|CYB5A|CYCS|DTYMK|ELOVL4|ENO1|ERCC2|ETFB|ETFDH|EXT2|FASN|FDPS|GCLC|GLB1|GNG5|GPD1L|GSR|GSS|GSTM3|HDAC3|HMMR|HSD17B4|HSP90AA1|INPP5A|INPP5K|IP6K2|LDHA|LPCAT3|LSS|MGST3|MMADHC|MPC2|MTHFD1|NAMPT|NDUFA3|NDUFB4|NUBP1|NUP107|NUP50|OAZ2|ODC1|P4HB|PAICS|PAPSS1|PDHB|PFKFB4|PIP5K1B|PLA2G12A|PLCG1|PLD1|POM121|PPAT|PRKAR2A|PSAP|PYGL|RAE1|RAN|SDHA|SGMS1|SIN3B|SLC16A1|SLC25A10|SLC37A4|SLC44A2|STX1A|SUCLA2|TPMT|TPR|UBA52|VAPB</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Gene Expression</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">77</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>CCNT2|CDKN2B|CNOT1|DHX9|DNMT1|EEF1A1|EEF1D|EEF1G|EIF2S1|EIF2S2|EIF3K|EIF4E|EIF4G1|ERCC2|ESRRA|EXOSC2|EZH2|FARSB|GEMIN4|GTF2E2|HARS|HDAC2|HNRNPA1|HNRNPH1|HNRNPU|HSPA8|LSM2|MARS2|MED20|MED4|NR1D1|PCBP2|POLR1A|POLR2A|POLRMT|PPA1|PTBP1|RAN|RBBP4|RBBP7|RNPS1|RPL10|RPL13A|RPL14|RPL36|RPS13|RPS16|RPS21|RPS29|RPS9|RUNX2|SAP18|SARS|SEC61G|SET|SIN3B|SNW1|SRRM1|SRSF1|TAF12|TAF5|TARS|TCEB2|TGIF1|THRA|TRAM1|U2AF1|UBA52|UPF1|UPF2|VARS2|XPO5|YWHAZ|ZNF610|ZNF658|ZNF711|ZNF750</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Signal Transduction</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">72</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ABI1|ADCY9|AKT2|ARHGDIA|BRK1|CASP2|CCNT2|CDC42|CDK1|CDKN2B|CREB1|CRK|CRKL|CSK|CSNK1A1|CTBP1|DAAM1|DGKH|E2F1|EIF4E|EIF4G1|EPS15L1|FSTL3|FZD4|GNG5|GPR37|HDAC2|HDAC3|HDAC4|HRAS|HSP90AA1|IRS1|JAK2|LFNG|MAPK7|MEF2A|MKNK1|OS9|P4HB|PFN1|PIP5K1B|PLCG1|PRDM4|PRKAR2A|PSAP|PSENEN|PTCH1|PTK2|RAC1|RAF1|RBX1|RELA|RHOA|RIPK2|ROCK1|RPS6KA5|RPS6KB1|SHC1|SMARCA4|SNW1|SOCS1|SOS1|SRC|STARD13|STUB1|TGIF1|THBS2|TNKS2|TRIO|UBA52|WNT5A|YWHAZ</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Immune System</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">67</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ABI1|ADCY9|AKT2|ANAPC1|ANAPC11|AP1S1|ARPC2|ARPC5|BRK1|CASP2|CDC34|CDC42|CDK1|CREB1|CRK|CRKL|CSK|CTSD|DHX9|DYNLL1|EIF4E|EIF4G1|FADD|FZR1|HRAS|HSP90AA1|IP6K2|IRS1|JAK2|KIF18A|KIF4A|MAP2K7|MAPK7|MEF2A|NUP107|NUP50|PCBP2|PELI1|PLCG1|PLD1|POM121|PRKAR2A|PRKDC|PTK2|PVR|RAC1|RAE1|RAF1|RBX1|RELA|RIPK2|RNF19B|RPS6KA5|SEC61G|SHC1|SOCS1|SOS1|SRC|STUB1|TCEB2|TPR|TUBB4B|UBA52|UBE2D4|XRCC5|XRCC6|YWHAZ</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cell Cycle</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">62</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ANAPC1|ANAPC11|APITD1|ATM|AURKA|AURKB|BUB1|CCNB1|CCNE1|CDC7|CDK1|CDKN2B|CDKN2D|CDT1|CENPN|CKS1B|CLASP2|DKC1|DSN1|DYNLL1|E2F1|ERCC6L|FBXO5|FZR1|GOLGA2|HSP90AA1|KIF18A|LIN37|MAD2L1|MCM2|MCM4|MCM6|MLH3|NEK2|NPM1|NUP107|NUP50|OIP5|ORC6|PCNA|PLK4|POLA1|POM121|PPP1R12A|RAB1B|RAD50|RAE1|RBBP4|RBBP7|RBBP8|RBL2|RSF1|SDCCAG8|SET|SMC4|SPC24|SPDL1|TPR|TUBB|TUBB4B|UBA52|ZWINT</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Metabolic pathways</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">62</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ACADM|ADI1|ALAS1|ALDOA|AMACR|ATP5O|AUH|BCAT1|BCAT2|CBR1|COX5B|COX6A2|COX6C|CTPS1|DAD1|DGKH|DNMT1|DTYMK|ENO1|EXT2|FASN|FBL|FDPS|FUT8|GAA|GCLC|GFPT1|GLB1|GSS|HSD17B4|INPP5A|INPP5K|LAP3|LDHA|LSS|MECR|MTHFD1|NDUFA3|NDUFB4|ODC1|PAICS|PAPSS1|PDHB|PGAM5|PGAP1|PIGA|PIP5K1B|PLA2G12A|PLCG1|PLD1|POLA1|POLE4|POLG2|POLR1A|POLR2A|PPAT|SDHA|SGMS1|SHMT2|SUCLA2|SUFU|TGDS</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Metabolism of proteins</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">48</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>B3GNTL1|CCT3|CCT6A|CCT8|CTSD|DAD1|DDIT3|DNAJB9|DNAJC3|DOHH|EEF1A1|EEF1D|EEF1G|EIF2S1|EIF2S2|EIF3K|EIF4E|EIF4G1|EIF5A|FBXW5|FUT8|GFPT1|GLB1|GRPEL2|HSPA9|HSPD1|IGFBP3|MANEA|PFDN1|PGAP1|PIGA|RPL10|RPL13A|RPL14|RPL36|RPS13|RPS16|RPS21|RPS29|RPS9|SEC61G|SHC1|STX1A|THBS2|TRAM1|TSPYL2|TUBB4B|UBA52</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Developmental Biology</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">42</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ABLIM2|AKT2|ARPC2|ARPC5|CDC42|CDK1|CLASP2|CREB1|CRMP1|CTNNA2|DPYSL2|HDAC3|HRAS|HSP90AA1|HSPA8|ITGA1|KIF4A|MED11|MED18|MED20|MED4|MEF2A|MYH10|MYH14|NRTN|PFN1|PLCG1|PSENEN|PTK2|RAC1|RAF1|RHOA|ROCK1|RPS6KA5|RPS6KA6|SCN3B|SDCBP|SIAH2|SOS1|SPTAN1|SRC|TRIO|TUBB4B</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Mitotic M-M/G1 phases</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">35</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ANAPC1|ANAPC11|APITD1|AURKB|BUB1|CCNB1|CDC7|CDK1|CDT1|CENPN|CLASP2|DSN1|ERCC6L|FBXO5|GOLGA2|KIF18A|MAD2L1|MCM2|MCM4|MCM6|NUP107|NUP50|ORC6|POLA1|POM121|RAB1B|RAE1|SET|SMC4|SPC24|SPDL1|TPR|TUBB4B|UBA52|ZWINT</italic>
</td>
</tr>
<tr>
<td align="center" colspan="3" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>Ethinyl Estradiol Interacting Common E2- and NRF1-Target Genes</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>KEGG Pathway</bold>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>Number of Genes</bold>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>Annotated Genes</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Metabolism</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">49</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ACADM|ADCY9|AGPAT5|ALAS1|ALDOA|ATP5O|BCAT1|BSG|CBR1|COX5B|COX6C|CTPS1|CYB5A|CYCS|ENO1|ERCC2|ETFDH|EXT2|FASN|FDPS|GCLC|GLB1|GSR|GSS|GSTM3|HDAC3|HSD17B4|HSP90AA1|INPP5A|LDHA|LSS|MGST3|MTHFD1|NAMPT|NUP50|ODC1|P4HB|PAPSS1|PDHB|PPAT|PSAP|PYGL|RAE1|RAN|SGMS1|SIN3B|SLC16A1|SLC25A10|SLC37A4</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Disease</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">48</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ADCY9|AKT2|ALDOA|AP1S1|CDC42|CDK1|CHMP2A|CREB1|CSK|CSNK1A1|CYB5A|ENO1|ERCC2|EXT2|FASN|GLB1|GTF2E2|HDAC2|HDAC3|HRAS|HSP90AA1|MAP2K7|MTHFD1|NAMPT|NPM1|NUP50|OS9|P4HB|PAPSS1|PSENEN|PYGL|RAE1|RAN|RBX1|RHOA|RPL36|RPS16|RPS9|SLC25A10|SLC37A4|SMARCA4|STUB1|TAF12|TAF5|TCEB2|WNT5A|XRCC5|YWHAZ</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Gene Expression</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">43</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>DNMT1|EEF1A1|EEF1G|EIF2S1|EIF2S2|EIF3K|EIF4E|ERCC2|EZH2|FARSB|GTF2E2|HARS|HDAC2|HNRNPA1|HNRNPH1|HNRNPU|HSPA8|MED4|NR1D1|PCBP2|POLR1A|POLRMT|RAN|RBBP4|RBBP7|RNPS1|RPL36|RPS16|RPS9|SAP18|SARS|SEC61G|SET|SIN3B|SRSF1|TAF12|TAF5|TARS|TCEB2|THRA|UPF1|VARS2|YWHAZ</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Immune System</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">36</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ABI1|ADCY9|AKT2|ANAPC1|ANAPC11|AP1S1|ARPC2|ARPC5|CASP2|CDC42|CDK1|CREB1|CRK|CSK|CTSD|DYNLL1|EIF4E|FADD|FZR1|HRAS|HSP90AA1|MAP2K7|MAPK7|NUP50|PCBP2|PTK2|PVR|RAE1|RBX1|SEC61G|SOCS1|STUB1|TCEB2|TUBB4B|XRCC5|YWHAZ</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cell Cycle</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">35</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ANAPC1|ANAPC11|AURKB|BUB1|CCNB1|CCNE1|CDC7|CDK1|CDT1|CKS1B|DYNLL1|E2F1|FZR1|GOLGA2|HSP90AA1|LIN37|MAD2L1|MCM2|MCM4|MCM6|NPM1|NUP50|ORC6|PCNA|PLK4|PPP1R12A|RAE1|RBBP4|RBBP7|RBBP8|RSF1|SET|SPC24|SPDL1|TUBB4B</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Metabolic pathways</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">33</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ACADM|ALAS1|ALDOA|ATP5O|BCAT1|CBR1|COX5B|COX6C|CTPS1|DNMT1|ENO1|EXT2|FASN|FDPS|GCLC|GLB1|GSS|HSD17B4|INPP5A|LDHA|LSS|MECR|MTHFD1|ODC1|PAPSS1|PDHB|PGAM5|PIGA|POLE4|POLG2|POLR1A|PPAT|SGMS1</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Signal Transduction</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">33</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ABI1|ADCY9|AKT2|CASP2|CDC42|CDK1|CREB1|CRK|CSK|CSNK1A1|E2F1|EIF4E|HDAC2|HDAC3|HRAS|HSP90AA1|MAPK7|OS9|P4HB|PFN1|PRDM4|PSAP|PSENEN|PTCH1|PTK2|RBX1|RHOA|SMARCA4|SOCS1|STUB1|TRIO|WNT5A|YWHAZ</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Metabolism of proteins</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">28</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>B3GNTL1|CCT3|CCT6A|CCT8|CTSD|DDIT3|DNAJC3|EEF1A1|EEF1G|EIF2S1|EIF2S2|EIF3K|EIF4E|EIF5A|FBXW5|GLB1|GRPEL2|HSPA9|HSPD1|IGFBP3|PFDN1|PIGA|RPL36|RPS16|RPS9|SEC61G|TSPYL2|TUBB4B</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Developmental Biology</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">25</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>AKT2|ARPC2|ARPC5|CDC42|CDK1|CREB1|CTNNA2|HDAC3|HRAS|HSP90AA1|HSPA8|ITGA1|MED11|MED4|MYH10|NRTN|PFN1|PSENEN|PTK2|RHOA|RPS6KA6|SDCBP|SIAH2|TRIO|TUBB4B</italic>
</td>
</tr>
<tr>
<td align="center" colspan="3" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>Bisphenol A Interacting Common E2- and NRF1-Target Genes</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>KEGG Pathway</bold>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>Number of Genes</bold>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>Annotated Genes</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Metabolism</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">85</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ACADM|ADCY9|ADI1|AGPAT5|AKR7A2|ALAS1|ALDOA|AMACR|ATP5O|BCAT1|BCAT2|BSG|CBR1|COX5B|COX6C|CTPS1|CYB5A|CYCS|DTYMK|ELOVL4|ENO1|ERCC2|ETFB|ETFDH|EXT2|FASN|FDPS|GCLC|GLB1|GNG5|GPD1L|GSR|GSS|GSTM3|HDAC3|HMMR|HSD17B4|HSP90AA1|INPP5A|INPP5K|IP6K2|LDHA|LPCAT3|LSS|MGST3|MMADHC|MPC2|MTHFD1|NAMPT|NDUFA3|NDUFB4|NUBP1|NUP107|NUP50|OAZ2|ODC1|P4HB|PAICS|PAPSS1|PDHB|PFKFB4|PIP5K1B|PLA2G12A|PLCG1|PLD1|POM121|PPAT|PRKAR2A|PSAP|PYGL|RAE1|RAN|SDHA|SGMS1|SIN3B|SLC16A1|SLC25A10|SLC37A4|SLC44A2|STX1A|SUCLA2|TPMT|TPR|UBA52|VAPB</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Disease</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">84</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ADCY9|AKT2|ALDOA|AP1S1|CCNT2|CDC42|CDK1|CDKN2B|CHMP2A|CHMP2B|CHMP5|CREB1|CSK|CSNK1A1|CTBP1|CYB5A|ENO1|ERCC2|EXT2|FASN|FZD4|GLB1|GTF2E2|HDAC2|HDAC3|HDAC4|HMMR|HRAS|HSP90AA1|IRS1|MAP2K7|MKNK1|MMADHC|MTHFD1|NAMPT|NPM1|NUP107|NUP50|OS9|P4HB|PAPSS1|PFKFB4|PIP5K1B|PLCG1|POLR2A|POM121|PPIA|PRKAR2A|PSENEN|PYGL|RAC1|RAE1|RAF1|RAN|RBX1|RHOA|RPL13A|RPL14|RPL36|RPS13|RPS16|RPS21|RPS29|RPS9|SHC1|SLC25A10|SLC37A4|SMARCA4|SNW1|SOS1|SRC|STUB1|STX1A|TAF12|TAF5|TCEB2|TGIF1|TNKS2|TPR|UBA52|WNT5A|XRCC5|XRCC6|YWHAZ</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Gene Expression</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">71</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>CCNT2|CDKN2B|CNOT1|DHX9|DNMT1|EEF1A1|EEF1D|EEF1G|EIF2S1|EIF2S2|EIF3K|EIF4E|EIF4G1|ERCC2|ESRRA|EXOSC2|EZH2|FARSB|GEMIN4|GTF2E2|HARS|HDAC2|HNRNPA1|HNRNPH1|HNRNPU|HSPA8|LSM2|MARS2|MED20|MED4|NR1D1|PCBP2|POLR1A|POLR2A|PPA1|PTBP1|RAN|RBBP4|RBBP7|RNPS1|RPL13A|RPL14|RPL36|RPS13|RPS16|RPS21|RPS29|RPS9|RUNX2|SAP18|SARS|SEC61G|SET|SIN3B|SNW1|SRRM1|SRSF1|TAF12|TAF5|TARS|TCEB2|TGIF1|THRA|TRAM1|U2AF1|UBA52|UPF1|UPF2|XPO5|YWHAZ|ZNF711</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Signal Transduction</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">68</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ABI1|ADCY9|AKT2|ARHGDIA|BRK1|CASP2|CCNT2|CDC42|CDK1|CDKN2B|CREB1|CRK|CRKL|CSK|CSNK1A1|CTBP1|DAAM1|DGKH|E2F1|EIF4E|EIF4G1|FSTL3|FZD4|GNG5|GPR37|HDAC2|HDAC3|HDAC4|HRAS|HSP90AA1|IRS1|JAK2|LFNG|MAPK7|MKNK1|OS9|P4HB|PFN1|PIP5K1B|PLCG1|PRKAR2A|PSAP|PSENEN|PTCH1|PTK2|RAC1|RAF1|RBX1|RELA|RHOA|RIPK2|ROCK1|RPS6KA5|RPS6KB1|SHC1|SMARCA4|SNW1|SOCS1|SOS1|SRC|STARD13|STUB1|TGIF1|THBS2|TNKS2|UBA52|WNT5A|YWHAZ</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Immune System</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">66</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ABI1|ADCY9|AKT2|ANAPC1|ANAPC11|AP1S1|ARPC2|ARPC5|BRK1|CASP2|CDC34|CDC42|CDK1|CREB1|CRK|CRKL|CSK|CTSD|DHX9|DYNLL1|EIF4E|EIF4G1|FADD|FZR1|HRAS|HSP90AA1|IP6K2|IRS1|JAK2|KIF18A|KIF4A|MAP2K7|MAPK7|NUP107|NUP50|PCBP2|PELI1|PLCG1|PLD1|POM121|PRKAR2A|PRKDC|PTK2|PVR|RAC1|RAE1|RAF1|RBX1|RELA|RIPK2|RNF19B|RPS6KA5|SEC61G|SHC1|SOCS1|SOS1|SRC|STUB1|TCEB2|TPR|TUBB4B|UBA52|UBE2D4|XRCC5|XRCC6|YWHAZ</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cell Cycle</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">61</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ANAPC1|ANAPC11|ATM|AURKA|AURKB|BUB1|CCNB1|CCNE1|CDC7|CDK1|CDKN2B|CDKN2D|CDT1|CENPN|CKS1B|CLASP2|DKC1|DSN1|DYNLL1|E2F1|ERCC6L|FBXO5|FZR1|GOLGA2|HSP90AA1|KIF18A|LIN37|MAD2L1|MCM2|MCM4|MCM6|MLH3|NEK2|NPM1|NUP107|NUP50|OIP5|ORC6|PCNA|PLK4|POLA1|POM121|PPP1R12A|RAB1B|RAD50|RAE1|RBBP4|RBBP7|RBBP8|RBL2|RSF1|SDCCAG8|SET|SMC4|SPC24|SPDL1|TPR|TUBB|TUBB4B|UBA52|ZWINT</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Metabolic pathways</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">58</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ACADM|ADI1|ALAS1|ALDOA|AMACR|ATP5O|BCAT1|BCAT2|CBR1|COX5B|COX6C|CTPS1|DAD1|DGKH|DNMT1|DTYMK|ENO1|EXT2|FASN|FBL|FDPS|FUT8|GAA|GCLC|GFPT1|GLB1|GSS|HSD17B4|INPP5A|INPP5K|LDHA|LSS|MECR|MTHFD1|NDUFA3|NDUFB4|ODC1|PAICS|PAPSS1|PDHB|PGAM5|PGAP1|PIGA|PIP5K1B|PLA2G12A|PLCG1|PLD1|POLA1|POLG2|POLR1A|POLR2A|PPAT|SDHA|SGMS1|SHMT2|SUCLA2|SUFU|TGDS</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Metabolism of proteins</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">47</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>B3GNTL1|CCT3|CCT6A|CCT8|CTSD|DAD1|DDIT3|DNAJB9|DNAJC3|DOHH|EEF1A1|EEF1D|EEF1G|EIF2S1|EIF2S2|EIF3K|EIF4E|EIF4G1|EIF5A|FBXW5|FUT8|GFPT1|GLB1|GRPEL2|HSPA9|HSPD1|IGFBP3|MANEA|PFDN1|PGAP1|PIGA|RPL13A|RPL14|RPL36|RPS13|RPS16|RPS21|RPS29|RPS9|SEC61G|SHC1|STX1A|THBS2|TRAM1|TSPYL2|TUBB4B|UBA52</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Developmental Biology</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">41</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ABLIM2|AKT2|ARPC2|ARPC5|CDC42|CDK1|CLASP2|CREB1|CRMP1|CTNNA2|DPYSL2|HDAC3|HRAS|HSP90AA1|HSPA8|ITGA1|KIF4A|MED11|MED18|MED20|MED4|MYH10|MYH14|NRTN|PFN1|PLCG1|PSENEN|PTK2|RAC1|RAF1|RHOA|ROCK1|RPS6KA5|RPS6KA6|SCN3B|SDCBP|SIAH2|SOS1|SPTAN1|SRC|TUBB4B</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Pathways in cancer</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">34</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>AKT2|ARAF|CCNE1|CDC42|CDKN2B|CKS1B|CKS2|CRK|CRKL|CTBP1|CTNNA2|CYCS|E2F1|FADD|FZD4|HDAC2|HRAS|HSP90AA1|MSH2|PLCG1|PLD1|PTCH1|PTK2|RAC1|RAF1|RASSF1|RBX1|RELA|RHOA|SOS1|SUFU|TCEB2|TPR|WNT5A</italic>
</td>
</tr>
<tr>
<td align="center" colspan="3" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>Dibutyl Phthalate Interacting Common E2- and NRF1-Target Genes</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>KEGG Pathway</bold>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>Number of Genes</bold>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>Annotated Genes</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Metabolism</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">56</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ACADM|ADCY9|ADI1|AKR7A2|ALAS1|ALDOA|AMACR|ATP5O|BCAT1|BCAT2|BSG|CBR1|CYB5A|CYCS|DTYMK|ENO1|ETFB|ETFDH|EXT2|FASN|FDPS|GCLC|GLB1|GNG5|GSR|GSS|HDAC3|HMMR|HSD17B4|HSP90AA1|INPP5A|IP6K2|LDHA|LPCAT3|LSS|MGST3|MTHFD1|NAMPT|NDUFA3|NDUFB4|NUBP1|NUP50|OAZ2|ODC1|PAPSS1|PLA2G12A|PLD1|POM121|PRKAR2A|PYGL|RAE1|RAN|SDHA|SGMS1|SLC25A10|UBA52</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Disease</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">45</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ADCY9|ALDOA|CCNT2|CDK1|CREB1|CSNK1A1|CTBP1|CYB5A|ENO1|EXT2|FASN|GLB1|HDAC3|HMMR|HSP90AA1|MTHFD1|NAMPT|NPM1|NUP50|PAPSS1|POLR2A|POM121|PRKAR2A|PYGL|RAE1|RAF1|RAN|RHOA|RPL13A|RPL14|RPL36|RPS13|RPS21|RPS29|SLC25A10|SMARCA4|SNW1|SRC|STUB1|TCEB2|TGIF1|TNKS2|UBA52|WNT5A|XRCC5</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Gene Expression</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">39</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>CCNT2|DNMT1|EEF1A1|EEF1D|EIF2S1|EIF2S2|EIF4E|EIF4G1|ESRRA|EXOSC2|EZH2|GEMIN4|HNRNPA1|HNRNPU|HSPA8|LSM2|MED20|POLR1A|POLR2A|PTBP1|RAN|RBBP4|RNPS1|RPL13A|RPL14|RPL36|RPS13|RPS21|RPS29|SET|SNW1|SRSF1|TARS|TCEB2|TGIF1|THRA|U2AF1|UBA52|XPO5</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Metabolic pathways</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">38</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ACADM|ADI1|ALAS1|ALDOA|AMACR|ATP5O|BCAT1|BCAT2|CBR1|COX6A2|DNMT1|DTYMK|ENO1|EXT2|FASN|FBL|FDPS|GCLC|GFPT1|GLB1|GSS|HSD17B4|INPP5A|LDHA|LSS|MTHFD1|NDUFA3|NDUFB4|ODC1|PAPSS1|PGAM5|PLA2G12A|PLD1|POLE4|POLR1A|POLR2A|SDHA|SGMS1</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cell Cycle</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">34</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ANAPC1|ANAPC11|APITD1|ATM|AURKB|CCNB1|CCNE1|CDC7|CDK1|CDKN2D|CDT1|CENPN|CKS1B|CLASP2|FBXO5|FZR1|HSP90AA1|MCM2|MCM4|MCM6|NPM1|NUP50|OIP5|ORC6|PCNA|POM121|PPP1R12A|RAE1|RBBP4|SET|SPC24|SPDL1|UBA52|ZWINT</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Signal Transduction</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">32</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ADCY9|ARHGDIA|CCNT2|CDK1|CREB1|CSNK1A1|CTBP1|DAAM1|EIF4E|EIF4G1|GNG5|HDAC3|HSP90AA1|JAK2|LFNG|MEF2A|PRDM4|PRKAR2A|PTCH1|RAF1|RHOA|SMARCA4|SNW1|SOCS1|SRC|STUB1|TGIF1|THBS2|TNKS2|TRIO|UBA52|WNT5A</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Immune System</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">31</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ADCY9|ANAPC1|ANAPC11|ARPC2|ARPC5|CDK1|CREB1|CTSD|EIF4E|EIF4G1|FADD|FZR1|HSP90AA1|IP6K2|JAK2|MEF2A|NUP50|PLD1|POM121|PRKAR2A|PRKDC|PVR|RAE1|RAF1|RNF19B|SOCS1|SRC|STUB1|TCEB2|UBA52|XRCC5</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Metabolism of proteins</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">25</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>CCT3|CTSD|DDIT3|DNAJB9|DNAJC3|EEF1A1|EEF1D|EIF2S1|EIF2S2|EIF4E|EIF4G1|FBXW5|GFPT1|GLB1|HSPA9|HSPD1|PFDN1|RPL13A|RPL14|RPL36|RPS13|RPS21|RPS29|THBS2|UBA52</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Mitotic M-M/G1 phases</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">23</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ANAPC1|ANAPC11|APITD1|AURKB|CCNB1|CDC7|CDK1|CDT1|CENPN|CLASP2|FBXO5|MCM2|MCM4|MCM6|NUP50|ORC6|POM121|RAE1|SET|SPC24|SPDL1|UBA52|ZWINT</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Developmental Biology</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">21</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ARPC2|ARPC5|CDK1|CLASP2|CREB1|CTNNA2|DPYSL2|HDAC3|HSP90AA1|HSPA8|ITGA1|MED20|MEF2A|MYH10|NRTN|RAF1|RHOA|SCN3B|SDCBP|SRC|TRIO</italic>
</td>
</tr>
<tr>
<td align="center" colspan="3" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>Diethylhexyl Phthalate Interacting Common E2- and NRF1-Target Genes</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>KEGG Pathway</bold>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>Number of Genes</bold>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>Annotated Genes</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Metabolism</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">21</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ACADM|ALAS1|ALDOA|BCAT2|BSG|CYCS|FASN|FDPS|GSR|GSTM3|HSD17B4|HSP90AA1|LDHA|LSS|MMADHC|NDUFA3|ODC1|PAPSS1|PLD1|PYGL|SLC37A4</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Metabolic pathways</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">15</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ACADM|ALAS1|ALDOA|BCAT2|DNMT1|FASN|FDPS|HSD17B4|LDHA|LSS|NDUFA3|ODC1|PAPSS1|PLD1|POLE4</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Disease</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">15</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>AKT2|ALDOA|FASN|HDAC2|HDAC4|HSP90AA1|IRS1|MMADHC|NPM1|PAPSS1|PYGL|RBX1|RPL36|RPS13|SLC37A4</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Immune System</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">12</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>AKT2|ANAPC11|CDC34|DYNLL1|EIF4G1|HSP90AA1|IRS1|KIF18A|PLD1|RBX1|SEC61G|TUBB4B</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Metabolism of proteins</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">11</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>CCT3|CCT6A|DNAJB9|EIF4G1|GRPEL2|HSPA9|HSPD1|RPL36|RPS13|SEC61G|TUBB4B</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cell Cycle</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">9</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ANAPC11|CCNB1|CCNE1|DYNLL1|HSP90AA1|KIF18A|NPM1|TUBB4B|ZWINT</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cellular responses to stress</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">8</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ANAPC11|CBX2|CCNE1|CYCS|GSR|HSP90AA1|HSPA8|RBX1</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Pathways in cancer</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">8</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>AKT2|CCNE1|CYCS|HDAC2|HSP90AA1|MSH2|PLD1|RBX1</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Developmental Biology</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">8</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>AKT2|DPYSL2|HSP90AA1|HSPA8|ITGA1|SCN3B|SIAH2|TUBB4B</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cell cycle</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">5</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ANAPC11|CCNB1|CCNE1|HDAC2|RBX1</italic>
</td>
</tr>
<tr>
<td align="center" colspan="3" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>Polychlorinated Biphenyls Interacting Common E2- and NRF1-Target Gene</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>KEGG Pathway</bold>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>Number of Genes</bold>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>Annotated Genes</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cell Cycle</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">13</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>AURKA|AURKB|CDK1|CDT1|CENPN|CKS1B|FBXO5|MCM2|MCM6|PCNA|PLK4|SMC4|ZWINT</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Mitotic M-M/G1 phases</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">9</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>AURKB|CDK1|CDT1|CENPN|FBXO5|MCM2|MCM6|SMC4|ZWINT</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">DNA Replication</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">4</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>CDT1|MCM2|MCM6|PCNA</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cell cycle</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">4</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>CDK1|MCM2|MCM6|PCNA</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">DNA replication</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">3</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>MCM2|MCM6|PCNA</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">DNA replication and repair</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">3</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>CDK1|PCNA|UNG</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Pancreatic cancer</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">3</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ARAF|CDC42|RAF1</italic>
</td>
</tr>
<tr>
<td align="center" colspan="3" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>Cadmium Interacting Common E2- and NRF1-Target Genes</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>KEGG Pathway</bold>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>Number of Genes</bold>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>Annotated Genes</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Metabolism</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">26</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ACADM|ALDOA|AUH|BCAT1|COX5B|COX6C|CYCS|DTYMK|ENO1|FASN|GCLC|GSR|GSS|GSTM3|HSD17B4|HSP90AA1|INPP5K|LDHA|MGST3|OAZ2|PAICS|RAN|SDHA|SGMS1|SLC16A1|SLC37A4</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Gene Expression</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">25</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>CCNT2|CDKN2B|DNMT1|EEF1A1|EEF1D|EEF1G|EXOSC2|HARS|HNRNPA1|HNRNPH1|HSPA8|LSM2|MARS2|MED20|RAN|RPL10|RPL13A|RPL14|RUNX2|SRRM1|TAF12|TCEB2|THRA|XPO5|YWHAZ</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Disease</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">24</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ALDOA|CCNT2|CDC42|CDK1|CDKN2B|CREB1|CTBP1|ENO1|FASN|HSP90AA1|IRS1|OS9|PPIA|RAC1|RAF1|RAN|RPL10|RPL13A|RPL14|SHC1|SLC37A4|TAF12|TCEB2|YWHAZ</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Signal Transduction</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">21</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ARHGDIA|CCNT2|CDC42|CDK1|CDKN2B|CREB1|CTBP1|E2F1|FSTL3|GPR37|HSP90AA1|IRS1|OS9|PTK2|RAC1|RAF1|RELA|ROCK1|RPS6KB1|SHC1|YWHAZ</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Metabolic pathways</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">20</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ACADM|ALDOA|AUH|BCAT1|COX5B|COX6C|DNMT1|DTYMK|ENO1|FASN|GAA|GCLC|GSS|HSD17B4|INPP5K|LDHA|PAICS|SDHA|SGMS1|SHMT2</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Immune System</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">18</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>CDC42|CDK1|CREB1|CTSD|HSP90AA1|IRS1|KIF4A|PELI1|PTK2|PVR|RAC1|RAF1|RELA|RNF19B|SHC1|TCEB2|UBE2D4|YWHAZ</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cell Cycle</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">17</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>AURKA|BUB1|CCNB1|CCNE1|CDK1|CDKN2B|CKS1B|E2F1|FBXO5|HSP90AA1|MAD2L1|MCM2|MCM4|MCM6|NEK2|OIP5|SMC4</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Pathways in cancer</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">15</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>CCNE1|CDC42|CDKN2B|CKS1B|CTBP1|CYCS|E2F1|HSP90AA1|MSH2|PTK2|RAC1|RAF1|RASSF1|RELA|TCEB2</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Developmental Biology</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">15</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>CDC42|CDK1|CREB1|HSP90AA1|HSPA8|KIF4A|MED20|MYH10|MYH14|NRTN|PTK2|RAC1|RAF1|ROCK1|SPTAN1</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Metabolism of proteins</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">12</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>CTSD|DDIT3|DNAJB9|EEF1A1|EEF1D|EEF1G|EIF5A|HSPD1|RPL10|RPL13A|RPL14|SHC1</italic>
</td>
</tr>
<tr>
<td align="center" colspan="3" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>Arsenic Interacting Common E2- and NRF1-Target Genes</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>KEGG Pathway</bold>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>Number of Genes</bold>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>Annotated Genes</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Metabolism</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">33</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ADCY9|ALDOA|CYCS|ENO1|ERCC2|ETFB|ETFDH|FASN|GCLC|GSR|GSS|GSTM3|HSD17B4|HSP90AA1|INPP5A|IP6K2|LDHA|MMADHC|NUBP1|P4HB|PAICS|PLCG1|PLD1|POM121|PPAT|PRKAR2A|SDHA|SGMS1|SLC44A2|STX1A|SUCLA2|TPMT|UBA52</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Immune System</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">30</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ADCY9|ARPC2|CASP2|CDC42|CDK1|CREB1|CTSD|FZR1|HRAS|HSP90AA1|IP6K2|JAK2|KIF4A|MAPK7|PCBP2|PELI1|PLCG1|PLD1|POM121|PRKAR2A|PRKDC|PTK2|PVR|RAF1|SOS1|SRC|TUBB4B|UBA52|UBE2D4|XRCC5</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Disease</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">27</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ADCY9|ALDOA|CDC42|CDK1|CDKN2B|CREB1|CTBP1|ENO1|ERCC2|FASN|HDAC4|HRAS|HSP90AA1|MMADHC|NPM1|P4HB|PLCG1|POM121|PRKAR2A|RAF1|RPL36|SMARCA4|SOS1|SRC|STX1A|UBA52|XRCC5</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Signal Transduction</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">24</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ADCY9|CASP2|CDC42|CDK1|CDKN2B|CREB1|CTBP1|E2F1|HDAC4|HRAS|HSP90AA1|JAK2|MAPK7|P4HB|PLCG1|PRKAR2A|PTCH1|PTK2|RAF1|ROCK1|SMARCA4|SOS1|SRC|UBA52</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Developmental Biology</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">22</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ABLIM2|ARPC2|CDC42|CDK1|CREB1|HRAS|HSP90AA1|HSPA8|KIF4A|MED18|MYH10|MYH14|NRTN|PLCG1|PTK2|RAF1|ROCK1|SCN3B|SIAH2|SOS1|SRC|TUBB4B</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Metabolic pathways</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">20</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ALDOA|COX6A2|DNMT1|ENO1|FASN|FUT8|GCLC|GSS|HSD17B4|INPP5A|LAP3|LDHA|PAICS|PLCG1|PLD1|PPAT|SDHA|SGMS1|SUCLA2|SUFU</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cell Cycle</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">19</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ATM|AURKA|CCNB1|CCNE1|CDK1|CDKN2B|CDKN2D|E2F1|FZR1|HSP90AA1|MAD2L1|NPM1|PCNA|POM121|SET|SPDL1|TUBB|TUBB4B|UBA52</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Gene Expression</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">19</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>CDKN2B|CNOT1|DNMT1|EEF1G|ERCC2|EZH2|HNRNPA1|HSPA8|LSM2|PCBP2|PTBP1|RNPS1|RPL36|RUNX2|SET|UBA52|UPF1|VARS2|ZNF610</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Pathways in cancer</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">17</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>CCNE1|CDC42|CDKN2B|CTBP1|CYCS|E2F1|HRAS|HSP90AA1|MSH2|PLCG1|PLD1|PTCH1|PTK2|RAF1|RASSF1|SOS1|SUFU</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cellular responses to stress</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">16</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ATM|CCNE1|CDKN2B|CDKN2D|CYCS|E2F1|EHMT1|EZH2|FZR1|GSR|HSP90AA1|HSPA8|MAPK7|P4HB|PRDX5|UBA52</italic>
</td>
</tr>
<tr>
<td align="center" colspan="3" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>Manganese Interacting Common E2- and NRF1-Target Genes</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>KEGG Pathway</bold>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>Number of Genes</bold>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>Annotated Genes</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cellular responses to stress</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">6</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ATM|CYCS|GSR|HSPA8|P4HB|RELA</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Developmental Biology</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">5</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>CREB1|HSPA8|SCN3B|SPTAN1|SRC</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Tuberculosis</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">4</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>CREB1|CYCS|RELA|SRC</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">p53 signaling pathway</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">3</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ATM|CYCS|PPM1D</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Small cell lung cancer</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">3</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>CKS2|CYCS|RELA</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Apoptosis</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">3</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ATM|CYCS|RELA</italic>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cell cycle</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">3</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>ATM|BUB1|MCM4</italic>
</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="ijms-17-02086-t005" position="float">
<object-id pub-id-type="pii">ijms-17-02086-t005_Table 5</object-id>
<label>Table 5</label>
<caption>
<p>Interaction of estrogenic endocrine disrupting chemicals modified genes with estrogen signaling and NRF1 network genes in the individual neurodegenerative disease.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Endocrine Disrupting Chemical (EDC)</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Individual EDC Responsive Modified Genes Common to Both NRF1 and E2 Target. * Indicates E2 Responsive</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="2" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>Alzheimer’s Disease (AD)</bold>
</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">17 β-estradiol</td>
<td align="center" colspan="1" rowspan="1" valign="middle">6 genes: <italic>APBB2|DPYSL2|EIF2S1|ENO1|MAPT|PAXIP1</italic></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Ethinyl Estradiol</td>
<td align="center" colspan="1" rowspan="1" valign="middle">6 genes: <italic>APBB2 *|EIF2S1 *|ENO1 *|IDE|MAPT *|PAXIP1 *</italic></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Bisphenol A</td>
<td align="center" colspan="1" rowspan="1" valign="middle">8 genes: <italic>APBB2 *|DPYSL2 *|EIF2S1 *|ENO1 *|IDE|MAPT *|PAXIP1 *|SLC30A4</italic></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Dibutyl Phthalate</td>
<td align="center" colspan="1" rowspan="1" valign="middle">4 genes: <italic>DPYSL2 *|EIF2S1 *|ENO1 *|IDE</italic></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Diethylhexyl Phthalate</td>
<td align="center" colspan="1" rowspan="1" valign="middle">2 genes: <italic>DPYSL2 *|MAPT *</italic></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Cadmium</td>
<td align="center" colspan="1" rowspan="1" valign="middle">2 genes: <italic>ENO1 *|SLC30A4</italic></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Arsenic</td>
<td align="center" colspan="1" rowspan="1" valign="middle">2 genes: <italic>ENO1 *|MAPT</italic></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Manganese</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">1 gene: <italic>ENO1 *</italic></td>
</tr>
<tr>
<td align="center" colspan="2" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>Parkinson’s Disease (PD)</bold>
</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">17 β-estradiol</td>
<td align="center" colspan="1" rowspan="1" valign="middle">8 genes: <italic>HSPA9|MAPT|RPL14</italic></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Ethinyl Estradiol</td>
<td align="center" colspan="1" rowspan="1" valign="middle">3 genes: <italic>HSPA9 *|MAPT *|PINK1</italic></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Bisphenol A</td>
<td align="center" colspan="1" rowspan="1" valign="middle">8 genes: <italic>GAK|HSPA9 *|MAPT *|PARK2|PARK7|PINK1|RPL14 *|VPS35</italic></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Dibutyl Phthalate</td>
<td align="center" colspan="1" rowspan="1" valign="middle">4 genes: <italic>HSPA9 *|PARK2|PARK7|RPL14 *</italic></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Diethylhexyl Phthalate</td>
<td align="center" colspan="1" rowspan="1" valign="middle">3 genes: <italic>HSPA9 *|MAPT *|PARK2</italic></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Cadmium</td>
<td align="center" colspan="1" rowspan="1" valign="middle">3 genes: <italic>PARK2|PINK1|RPL14 *</italic></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Arsenic</td>
<td align="center" colspan="1" rowspan="1" valign="middle">4 genes: <italic>GAK|HSPA9 *|MAPT *|PARK2</italic></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Manganese</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2 genes: <italic>PARK2|PARK7</italic></td>
</tr>
<tr>
<td align="center" colspan="2" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>Huntington’s Disease (HD)</bold>
</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">17 β-estradiol</td>
<td align="center" colspan="1" rowspan="1" valign="middle">2 genes: <italic>AIFM1|P6K2</italic></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Ethinyl Estradiol</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1 gene: <italic>AIFM1 *</italic></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Bisphenol A</td>
<td align="center" colspan="1" rowspan="1" valign="middle">2 genes: <italic>AIFM1 *|IP6K2 *</italic></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Dibutyl Phthalate</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1 gene: <italic>IP6K2 *</italic></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Cadmium</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1 gene: <italic>AIFM1 *</italic></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Arsenic</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">1 gene: <italic>IP6K2 *</italic></td>
</tr>
<tr>
<td align="center" colspan="2" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>Amyotrophic Lateral Sclerosis (ALS)</bold>
</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">17 β-estradiol</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1 gene: <italic>GSR|CHMP2B</italic></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Ethinyl Estradiol</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1 gene: <italic>GSR *</italic></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Bisphenol A</td>
<td align="center" colspan="1" rowspan="1" valign="middle">2 genes: <italic>GSR *|CHMP2B *|UNC13A</italic></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Dibutyl Phthalate</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1 gene: <italic>GSR *</italic></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Diethylhexyl Phthalate</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1 gene: <italic>GSR *</italic></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Cadmium</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1 gene: <italic>GSR *</italic></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Arsenic</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1 gene: <italic>GSR *</italic></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Manganese</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">1 gene: <italic>GSR</italic></td>
</tr>
<tr>
<td align="center" colspan="2" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>Autism Spectrum Disorder (ASD)</bold>
</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">17 β-estradiol</td>
<td align="center" colspan="1" rowspan="1" valign="middle">3 genes: <italic>CIRBP|PCDH9|GTF2I</italic></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Ethinyl Estradiol</td>
<td align="center" colspan="1" rowspan="1" valign="middle">2 genes: <italic>CIRBP *|GTF2I *</italic></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Bisphenol A</td>
<td align="center" colspan="1" rowspan="1" valign="middle">3 genes: <italic>CIRBP *|GTF2I *|PCDH9 *</italic></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Polychlorinated Biphenyls</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1 gene: <italic>CIRBP *</italic></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Cadmium</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1 gene: <italic>CIRBP *</italic></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Arsenic</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">1 gene: <italic>PCDH9 *</italic></td>
</tr>
<tr>
<td align="center" colspan="2" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>Brain Neoplasms</bold>
</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">17 β-estradiol</td>
<td align="center" colspan="1" rowspan="1" valign="middle">3 genes: <italic>PCNA|PTCH1|RELA</italic></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Ethinyl Estradiol</td>
<td align="center" colspan="1" rowspan="1" valign="middle">2 genes: <italic>PCNA *|PTCH1 *</italic></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Bisphenol A</td>
<td align="center" colspan="1" rowspan="1" valign="middle">4 genes: <italic>EML4|PCNA *|PTCH1 *|RELA *</italic></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Dibutyl Phthalate</td>
<td align="center" colspan="1" rowspan="1" valign="middle">2 genes: <italic>PCNA *|PTCH1 *</italic></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Polychlorinated Biphenyls</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1 gene: <italic>PCNA</italic></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Cadmium</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1 gene: <italic>RELA *</italic></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Arsenic</td>
<td align="center" colspan="1" rowspan="1" valign="middle">2 genes: <italic>PCNA *|PTCH1 *</italic></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Manganese</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">1 gene: <italic>RELA *</italic></td>
</tr>
</tbody>
</table>
</table-wrap>
</floats-group>
</article>
</pmc-articleset>